id
stringlengths 7
10
| query
stringlengths 559
87.6k
| answer
stringlengths 16
1.58k
| text
stringlengths 288
87.3k
|
|---|---|---|---|
edtsum5478
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (Scott+Scott), an international shareholder and consumer rights litigation firm, announces the filing of a class action lawsuit against Loop Industries, Inc. (Loop or the Company) (NASDAQ: LOOP) and certain of its officers and directors, alleging violations of federal securities laws. If you purchased Loop securities between September 24, 2018 and October 12, 2020, inclusive, and have suffered losses, you are encouraged to contact attorney Rhiana Swartz at (844) 818-6980 or [email protected] for additional information about your rights. The lawsuit alleges that Loop and the other named defendants issued materially false and/or misleading information, and failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, according to the complaint: (1) Loop scientists were encouraged to misrepresent the results of Loops purportedly proprietary process for recycling plastics; (2) Loop did not have the technology to break PET plastics down to its base chemicals at a recovery rate of 100%; and (3) as a result, the Company was unlikely to realize the purported benefits of Loops announced partnerships with Indorama and Thyssenkrupp. On October 13, 2020, Hindenburg Research (Hindenburg) published a report describing Loops technology for recycling plastics as being smoke and mirrors. Having purportedly spoken with multiple former employees, company partners, experts, and competitors during its 6-month investigation, Hindenburg stated that Loops scientists had been tacitly encouraged to lie about the results of the [C]ompanys process, that Loops previous claims of breaking PET down to its base chemicals at a recovery rate of 100% were technically and industrially impossible, and that Loops partnership with Thyssenkrupp was on an indefinite hold. On this news, Loops stock price fell sharply from $11.61 per share on October 12, 2020 to close at $7.83 per share on October 13, 2020 a drop of more than 32%. What You Can Do If you purchased or otherwise own Loop stock, or if you have questions about this notice or your legal rights, you are encouraged to contact attorney Rhiana Swartz at (844) 818-6980, or at [email protected], or visit the Loop page on our website at https://scott-scott.com/case/loop-industries-inc/. The lead plaintiff deadline is December 14, 2020. About Scott+Scott Attorneys at Law LLP Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio. Attorney Advertising
Answer:
|
Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against Loop Industries, Inc. (LOOP)
|
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (Scott+Scott), an international shareholder and consumer rights litigation firm, announces the filing of a class action lawsuit against Loop Industries, Inc. (Loop or the Company) (NASDAQ: LOOP) and certain of its officers and directors, alleging violations of federal securities laws. If you purchased Loop securities between September 24, 2018 and October 12, 2020, inclusive, and have suffered losses, you are encouraged to contact attorney Rhiana Swartz at (844) 818-6980 or [email protected] for additional information about your rights. The lawsuit alleges that Loop and the other named defendants issued materially false and/or misleading information, and failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, according to the complaint: (1) Loop scientists were encouraged to misrepresent the results of Loops purportedly proprietary process for recycling plastics; (2) Loop did not have the technology to break PET plastics down to its base chemicals at a recovery rate of 100%; and (3) as a result, the Company was unlikely to realize the purported benefits of Loops announced partnerships with Indorama and Thyssenkrupp. On October 13, 2020, Hindenburg Research (Hindenburg) published a report describing Loops technology for recycling plastics as being smoke and mirrors. Having purportedly spoken with multiple former employees, company partners, experts, and competitors during its 6-month investigation, Hindenburg stated that Loops scientists had been tacitly encouraged to lie about the results of the [C]ompanys process, that Loops previous claims of breaking PET down to its base chemicals at a recovery rate of 100% were technically and industrially impossible, and that Loops partnership with Thyssenkrupp was on an indefinite hold. On this news, Loops stock price fell sharply from $11.61 per share on October 12, 2020 to close at $7.83 per share on October 13, 2020 a drop of more than 32%. What You Can Do If you purchased or otherwise own Loop stock, or if you have questions about this notice or your legal rights, you are encouraged to contact attorney Rhiana Swartz at (844) 818-6980, or at [email protected], or visit the Loop page on our website at https://scott-scott.com/case/loop-industries-inc/. The lead plaintiff deadline is December 14, 2020. About Scott+Scott Attorneys at Law LLP Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio. Attorney Advertising
|
edtsum5485
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOS ANGELES, Nov. 24, 2020 /PRNewswire/ --Maslo ai, the leader in AI-driven empathetic computing, and Lactation Lab, the first at-home milk collection and full-spectrum breast milk analysis solution, today released 'Emily,' the world's first digital companion for new moms. A mobile app built using Maslo's revolutionary technology, Emily is designed to support breastfeeding mothers as they track their own wellness (mental and physical) via daily journaling/tracking and the nutritional makeup of their breast milk including vitamin content, proteins, and environmental toxins. "After the birth of my second child, I noticed she wasn't gaining weight despite getting enough milk.Being a doctor and a mother, I sought answers everywhere but realized there was a void in the market that would not allow mothers to test the health of breast milk themselves," said Dr. Stephanie Canale, MD and Founder, Lactation Lab. "Ultimately, due to an iron-deficiency, anemia, and low B-12 levels, my daughter developed spina bifida. I knew in an instant I needed to utilize technology to ensure mothers felt empowered and confident in breastfeeding their children. Additionally, there are numerous personal and social stressors today that impact mothers, so I wanted to take it one step further and create a confidante that gave mothers confidence and comfort during what can be a difficult time." Emily aims to assist new mothers by tracking baby's feedings, diaper outputs, and growth charts, in addition to mom's diet, vitamin and supplement intake. The app also serves as a hub for educational content targeting a woman's journey through preconception counseling, pregnancy, lactation and returning to work. Using Maslo's open-source AI-based empathetic computing, Emily learns to synthesize human emotions through signal processing across various data collection points such as verbal tone, facial expressions, typed language and more. This approach opens up entirely new possibilities for users to deepen relationships with technology moving away from a traditional transactional digital assistant model and into a more companion-based approach. "Our goal at Maslo is to make technology that cares about humans, and ultimately make this world a better place. Emily is more than just an app, it is a companion that offers empathetic, AI-enhanced emotional support in the form of everyday check-ins, tracking mood, energy, sleep patterns and anxiety, helping mother, child and family thrive," said Ross Ingram, Co-Founder and CEO, Maslo ai. "Though some may argue machines can't have human emotions we disagree. We're using human thought and emotion to create companions that can help all of us in our daily lives no matter the challenge. The use cases involving empathetic computing are limitless. Empathetic digital companions are the positive side of what's possible with AI, and with Emily we've created a companion for mothers to give them knowledge and confidence that they are doing what's right for their child." In addition to providing empathetic support, the information Emily tracks can be easily exported and shared with medical professionals to provide a more complete picture of how mother and child are doing. Future capabilities are already in the works for Emily, including additional customized diagnostic testing that can be performed within the comfort of your home. Emily can be downloaded for both Apple and Android devices. About Lactation Lab: Lactation Lab empowers mothers and optimizes their children's nutrition using a research-based approach to maternal diet.Lactation Lab was founded with a mission to bring scientific advancement to the field of breast milk research and for the first time ever offer a comprehensive, personalized analysis of a mother's breast milk. Using the latest academic research and most advanced lab technologies, our team of dedicated physicians, research scientists and clinicians has truly innovated in a field that has long been neglected by science. About Maslo ai: Based in Los Angeles, CA, Maslo is a leader in developing open-sourced empathetic computing solutions to create AI experiences that help humanity. At Maslo, we're teaching our machines to synthesize human thought and emotional data using signal processing techniques across various data collection points. We work to apply empathetic computing solutions in various industries including gaming, transportation, education, HR, social services and healthcare, and more - fostering connections between people and between humans and their technology for the betterment of both business and humanity. For additional information visit us at www.maslo.ai or on Twitter, Instagram or our blog. ContactsErin Anne Sarsfield, +1 708-646-9708[emailprotected] SOURCE Maslo ai Related Links http://www.maslo.ai
Answer:
|
Maslo ai and Lactation Lab Launch First Empathetic Companion App for Breastfeeding Mothers 'Emily' Uses Ai-Driven Empathetic Computing to Support Health of Moms and Babies
|
LOS ANGELES, Nov. 24, 2020 /PRNewswire/ --Maslo ai, the leader in AI-driven empathetic computing, and Lactation Lab, the first at-home milk collection and full-spectrum breast milk analysis solution, today released 'Emily,' the world's first digital companion for new moms. A mobile app built using Maslo's revolutionary technology, Emily is designed to support breastfeeding mothers as they track their own wellness (mental and physical) via daily journaling/tracking and the nutritional makeup of their breast milk including vitamin content, proteins, and environmental toxins. "After the birth of my second child, I noticed she wasn't gaining weight despite getting enough milk.Being a doctor and a mother, I sought answers everywhere but realized there was a void in the market that would not allow mothers to test the health of breast milk themselves," said Dr. Stephanie Canale, MD and Founder, Lactation Lab. "Ultimately, due to an iron-deficiency, anemia, and low B-12 levels, my daughter developed spina bifida. I knew in an instant I needed to utilize technology to ensure mothers felt empowered and confident in breastfeeding their children. Additionally, there are numerous personal and social stressors today that impact mothers, so I wanted to take it one step further and create a confidante that gave mothers confidence and comfort during what can be a difficult time." Emily aims to assist new mothers by tracking baby's feedings, diaper outputs, and growth charts, in addition to mom's diet, vitamin and supplement intake. The app also serves as a hub for educational content targeting a woman's journey through preconception counseling, pregnancy, lactation and returning to work. Using Maslo's open-source AI-based empathetic computing, Emily learns to synthesize human emotions through signal processing across various data collection points such as verbal tone, facial expressions, typed language and more. This approach opens up entirely new possibilities for users to deepen relationships with technology moving away from a traditional transactional digital assistant model and into a more companion-based approach. "Our goal at Maslo is to make technology that cares about humans, and ultimately make this world a better place. Emily is more than just an app, it is a companion that offers empathetic, AI-enhanced emotional support in the form of everyday check-ins, tracking mood, energy, sleep patterns and anxiety, helping mother, child and family thrive," said Ross Ingram, Co-Founder and CEO, Maslo ai. "Though some may argue machines can't have human emotions we disagree. We're using human thought and emotion to create companions that can help all of us in our daily lives no matter the challenge. The use cases involving empathetic computing are limitless. Empathetic digital companions are the positive side of what's possible with AI, and with Emily we've created a companion for mothers to give them knowledge and confidence that they are doing what's right for their child." In addition to providing empathetic support, the information Emily tracks can be easily exported and shared with medical professionals to provide a more complete picture of how mother and child are doing. Future capabilities are already in the works for Emily, including additional customized diagnostic testing that can be performed within the comfort of your home. Emily can be downloaded for both Apple and Android devices. About Lactation Lab: Lactation Lab empowers mothers and optimizes their children's nutrition using a research-based approach to maternal diet.Lactation Lab was founded with a mission to bring scientific advancement to the field of breast milk research and for the first time ever offer a comprehensive, personalized analysis of a mother's breast milk. Using the latest academic research and most advanced lab technologies, our team of dedicated physicians, research scientists and clinicians has truly innovated in a field that has long been neglected by science. About Maslo ai: Based in Los Angeles, CA, Maslo is a leader in developing open-sourced empathetic computing solutions to create AI experiences that help humanity. At Maslo, we're teaching our machines to synthesize human thought and emotional data using signal processing techniques across various data collection points. We work to apply empathetic computing solutions in various industries including gaming, transportation, education, HR, social services and healthcare, and more - fostering connections between people and between humans and their technology for the betterment of both business and humanity. For additional information visit us at www.maslo.ai or on Twitter, Instagram or our blog. ContactsErin Anne Sarsfield, +1 708-646-9708[emailprotected] SOURCE Maslo ai Related Links http://www.maslo.ai
|
edtsum5491
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN FRANCISCO, May 4, 2020 /PRNewswire/ -- Salesforce (NYSE: CRM), the global leader in CRM, today announced Work.com new technology solutions and resources to help business and community leaders around the world reopen safely, re-skill employees and respond efficiently on the heels of the COVID-19 pandemic. Work.com includes new solutions to accelerate private and public sector response to the COVID-19 pandemic, including employee wellness assessment; shift management; contact tracing; emergency response management; and grants and volunteer management. The Work.com Command Center brings all data streams together so that businesses and communities can make more informed decisions. In addition, Work.com brings together the full power of health experts, business leaders and the Salesforce ecosystem in a resource center informed by the Business Roundtable and the University of California San Francisco (UCSF) with insights from business, health and government leaders as well as analysis, best practices and recovery stories from our trusted partner ecosystem. "Every company and community in the world is focusing on how to safely reopen and get to a new normal," said Bret Taylor, President and COO, Salesforce. "With Work.com, we're bringing together powerful new technology, our partners and network of experts to help organizations reopen and recover from this crisis while putting employee and visitor health and safety first." "Business Roundtable is focused on an economic recovery that puts public health first and allows businesses of all sizes to reopen swiftly and safely," said Joshua Bolten, President & CEO of Business Roundtable. "Safety first and consistent guidelines are critical to reopening. Salesforce is providing an important public service by giving businesses and organizations of all sizes this suite of free resources to help them navigate current guidance and get back to business safely when they can do so." Reopening in a New World To support the initial response to COVID-19, Salesforce launched Salesforce Care, a suite of solutions free for 90-days designed to help businesses stabilize during the initial phase of the crisis. Now, as COVID-19 containment improves and the economy begins to restart, a more complicated recovery phase lies ahead. Businesses and other organizations will need to stay apprised of, and adhere to, ever-changing local and federal guidelines. They'll need new ways of planning, managing and monitoring employee and workforce readiness; facilities preparedness; and emergency management response. They'll need strong collaboration across departments, and tools to make data-driven decisions quickly and communicate to employees, partners and customers at scale. New Salesforce Work.com Solutions Our Work.com solutions enable organizations to reopen safely and manage the logistics of returning to work while putting employee and visitor health and safety first. Work.com Command Centeris a single hub for leaders to get a 360-degree view of return-to-work readiness across locations, employees and visitors, make data-driven decisions, take action and communicate effectively. The command center allows organizations to bring together trusted data from internal applications and employee wellness surveys, create and disseminate important employee communications at scale, and surface public data through the Tableau COVID-19 data hub. Users can also add on MuleSoft to integrate additional data sources and Tableau for more custom data visualizations. Contact Tracing allows public and private sector leaders to manually trace health and relationship contacts in a safe and private manner, by collecting data from individuals who are infected or potentially exposed to an infectious disease and creating visual maps of contacts and locations to monitor potential interactions and outbreak. Emergency Response Management is a suite of products built in collaboration with Accenture that allows public health organizations, government agencies and the private sector to manage all types of emergencies, deliver care to those affected and allocate resources and services quickly. Public health institutions can protect communities from widespread impacts by enabling contact tracers to effectively record and understand data; quickly triage and evaluate patients; and provide ongoing engagement and monitoring. Government agencies can streamline emergency response operations and approvals, deploy resources and schedule emergency services. Employee Wellnessallows leaders to gather the data needed to monitor and analyze employee and visitor health and wellness. Companies can create employee health surveys, monitor wellness trends and use data to make informed decisions on the return to work, all while keeping employee health information secure. Shift Managementenables organizations to orchestrate the eventual return of employees to the office through shift management capabilities that can help reduce office density. In addition, organizations can avoid large groups in the office or elevators through spatial distance and scheduling breaks, including the management of third-party suppliers or vendor services. myTrailhead for Employees delivers content to help employees skill up on new ways of working with out-of-the-box training, learning and wellness programs. In addition, employers can ensure returning employees comply with new safety policies and have the information they need to succeed. Volunteer & Grants Management will help organizations fulfill their relief goals with flexible, scalable tools that streamline volunteer coordination and grant-making processes. Now any organization will be able to achieve mission success by matching the right volunteers to events and automating the grants lifecycle for greater impact. New Resources Feature Insights and Commentary From Top Experts Every business and community around the world is navigating this crisis together, learning and drawing inspiration from new places every day. To help provide guidance and insights for businesses navigating the COVID-19 crisis and what comes next, Salesforce's new Work.com resource center includes expert commentary and advice from respected voices, such as Dr. David Agus, Dr. Larry Brilliant, Dr. Scott Gottlieb, Harvard Business School economist Linda A. Hill, political scientist Ian Bremmer and more. The resource center gives everyone access to ideas and industry trends that are top of mind for business leaders looking to stabilize their businesses, adapt to a new normal, and plan for an eventual return to growth. Extending Innovation and Impact with our Trusted Partner Ecosystem Salesforce's trusted partner ecosystem is providing guidance and solutions for organizations of all sizes and across industries to return to the workplace safely. Global Strategic Consulting Partners, including Accenture, Deloitte and PwC, are Work.com's inaugural industry and business transformation specialists. Equipped with a deep understanding of the Salesforce platform and industry-specific knowledge, these advisors provide critical services to help organizations transform for the future. Partners including Fusion Risk Management, Traction Guest and ComplianceQuest are building the inaugural ISV solutions on the Salesforce platform to extend Work.com. These solutions will empower customers to build business continuity and risk management plans, adapt supply chains, manage employees and visitors on site and more. Salesforce Care Allows Organizations to Rapidly Respond to Customers, Employees and Partners More than 8,000 companies have already signed up for Salesforce Care, a suite of free solutions designed to help businesses stabilize during the initial phase of the crisis. This includes employee and customer support, social media monitoring and engagement, remote collaboration and data analysis solutions with Tableau, specific offerings for the healthcare and manufacturing industries, and free access to Salesforce Essentials to help small businesses. Salesforce also launched the AppExchange COVID-19 Resource Center, a central resource of COVID-related solutions, and partnered with Amazon to offer free access to Amazon Connect so service teams working remotely can stay connected. Comments on the news "I am confident that without the digital quote-to-cash transformation we completed with Salesforce and the AppExchange we would not have been able to adapt and respond as quickly," said Steve Stessman, VP of Sales, Tuff Shed. "We're looking forward to the continued partnership with Salesforce to help us navigate to our new normal." "We really needed to stay connected to our customers, because they mean so much to us, and we want them to continue to feel connected to our small business and our mission," said Amy Wright, Founder and CEO of Bitty & Beau's Coffee. "We know that Salesforce will help us build even stronger relationships as we reopen our shops in this new world." Pricing and Availability Work.com Command Center and Shift Management are expected to be generally available in June 2020. Each is an add-on to Platform Starter with introductory pricing of $5 per user per month. Employee Wellness will be included with Work.com Command Center. Emergency Response Management, which includes Contact Tracing, will be generally available in the second half of May 2020. It is a suite of existing products, Health Cloud, Service Cloud, Lightning Scheduler, and Salesforce Maps, as well as a new product, Emergency Program Management. Emergency Program Management is an add-on to any Health Cloud or Service Cloud license in Enterprise Edition or above priced at $50 per user per month. New Employee Learning and Well-being content on myTrailhead will be generally available in June 2020 and will be included with myTrailhead for Employees, which is priced at $25 per user per month. New and existing customers should visit Work.com for additional details on how to get started today. ABOUT SALESFORCE Salesforce is the global leader in Customer Relationship Management (CRM), bringing companies closer to their customers in the digital age. Founded in 1999, Salesforce enables companies of every size and industry to take advantage of powerful technologiescloud, mobile, social, internet of things, artificial intelligence, voice and blockchainto create a 360-degree view of their customers. For more information about Salesforce (NYSE: CRM), visit: www.salesforce.com. Any unreleased services or features referenced in this or other press releases or public statements are not currently available and may not be delivered on time or at all. Customers who purchase Salesforce applications should make their purchase decisions based upon features that are currently available. Salesforce has headquarters in San Francisco, with offices in Europe and Asia, and trades on the New York Stock Exchange under the ticker symbol "CRM." For more information please visit https://www.salesforce.com, or call 1-800-NO-SOFTWARE. SOURCE Salesforce Related Links http://www.salesforce.com
Answer:
|
Salesforce Announces Work.com to Help Businesses and Communities Safely Reopen
|
SAN FRANCISCO, May 4, 2020 /PRNewswire/ -- Salesforce (NYSE: CRM), the global leader in CRM, today announced Work.com new technology solutions and resources to help business and community leaders around the world reopen safely, re-skill employees and respond efficiently on the heels of the COVID-19 pandemic. Work.com includes new solutions to accelerate private and public sector response to the COVID-19 pandemic, including employee wellness assessment; shift management; contact tracing; emergency response management; and grants and volunteer management. The Work.com Command Center brings all data streams together so that businesses and communities can make more informed decisions. In addition, Work.com brings together the full power of health experts, business leaders and the Salesforce ecosystem in a resource center informed by the Business Roundtable and the University of California San Francisco (UCSF) with insights from business, health and government leaders as well as analysis, best practices and recovery stories from our trusted partner ecosystem. "Every company and community in the world is focusing on how to safely reopen and get to a new normal," said Bret Taylor, President and COO, Salesforce. "With Work.com, we're bringing together powerful new technology, our partners and network of experts to help organizations reopen and recover from this crisis while putting employee and visitor health and safety first." "Business Roundtable is focused on an economic recovery that puts public health first and allows businesses of all sizes to reopen swiftly and safely," said Joshua Bolten, President & CEO of Business Roundtable. "Safety first and consistent guidelines are critical to reopening. Salesforce is providing an important public service by giving businesses and organizations of all sizes this suite of free resources to help them navigate current guidance and get back to business safely when they can do so." Reopening in a New World To support the initial response to COVID-19, Salesforce launched Salesforce Care, a suite of solutions free for 90-days designed to help businesses stabilize during the initial phase of the crisis. Now, as COVID-19 containment improves and the economy begins to restart, a more complicated recovery phase lies ahead. Businesses and other organizations will need to stay apprised of, and adhere to, ever-changing local and federal guidelines. They'll need new ways of planning, managing and monitoring employee and workforce readiness; facilities preparedness; and emergency management response. They'll need strong collaboration across departments, and tools to make data-driven decisions quickly and communicate to employees, partners and customers at scale. New Salesforce Work.com Solutions Our Work.com solutions enable organizations to reopen safely and manage the logistics of returning to work while putting employee and visitor health and safety first. Work.com Command Centeris a single hub for leaders to get a 360-degree view of return-to-work readiness across locations, employees and visitors, make data-driven decisions, take action and communicate effectively. The command center allows organizations to bring together trusted data from internal applications and employee wellness surveys, create and disseminate important employee communications at scale, and surface public data through the Tableau COVID-19 data hub. Users can also add on MuleSoft to integrate additional data sources and Tableau for more custom data visualizations. Contact Tracing allows public and private sector leaders to manually trace health and relationship contacts in a safe and private manner, by collecting data from individuals who are infected or potentially exposed to an infectious disease and creating visual maps of contacts and locations to monitor potential interactions and outbreak. Emergency Response Management is a suite of products built in collaboration with Accenture that allows public health organizations, government agencies and the private sector to manage all types of emergencies, deliver care to those affected and allocate resources and services quickly. Public health institutions can protect communities from widespread impacts by enabling contact tracers to effectively record and understand data; quickly triage and evaluate patients; and provide ongoing engagement and monitoring. Government agencies can streamline emergency response operations and approvals, deploy resources and schedule emergency services. Employee Wellnessallows leaders to gather the data needed to monitor and analyze employee and visitor health and wellness. Companies can create employee health surveys, monitor wellness trends and use data to make informed decisions on the return to work, all while keeping employee health information secure. Shift Managementenables organizations to orchestrate the eventual return of employees to the office through shift management capabilities that can help reduce office density. In addition, organizations can avoid large groups in the office or elevators through spatial distance and scheduling breaks, including the management of third-party suppliers or vendor services. myTrailhead for Employees delivers content to help employees skill up on new ways of working with out-of-the-box training, learning and wellness programs. In addition, employers can ensure returning employees comply with new safety policies and have the information they need to succeed. Volunteer & Grants Management will help organizations fulfill their relief goals with flexible, scalable tools that streamline volunteer coordination and grant-making processes. Now any organization will be able to achieve mission success by matching the right volunteers to events and automating the grants lifecycle for greater impact. New Resources Feature Insights and Commentary From Top Experts Every business and community around the world is navigating this crisis together, learning and drawing inspiration from new places every day. To help provide guidance and insights for businesses navigating the COVID-19 crisis and what comes next, Salesforce's new Work.com resource center includes expert commentary and advice from respected voices, such as Dr. David Agus, Dr. Larry Brilliant, Dr. Scott Gottlieb, Harvard Business School economist Linda A. Hill, political scientist Ian Bremmer and more. The resource center gives everyone access to ideas and industry trends that are top of mind for business leaders looking to stabilize their businesses, adapt to a new normal, and plan for an eventual return to growth. Extending Innovation and Impact with our Trusted Partner Ecosystem Salesforce's trusted partner ecosystem is providing guidance and solutions for organizations of all sizes and across industries to return to the workplace safely. Global Strategic Consulting Partners, including Accenture, Deloitte and PwC, are Work.com's inaugural industry and business transformation specialists. Equipped with a deep understanding of the Salesforce platform and industry-specific knowledge, these advisors provide critical services to help organizations transform for the future. Partners including Fusion Risk Management, Traction Guest and ComplianceQuest are building the inaugural ISV solutions on the Salesforce platform to extend Work.com. These solutions will empower customers to build business continuity and risk management plans, adapt supply chains, manage employees and visitors on site and more. Salesforce Care Allows Organizations to Rapidly Respond to Customers, Employees and Partners More than 8,000 companies have already signed up for Salesforce Care, a suite of free solutions designed to help businesses stabilize during the initial phase of the crisis. This includes employee and customer support, social media monitoring and engagement, remote collaboration and data analysis solutions with Tableau, specific offerings for the healthcare and manufacturing industries, and free access to Salesforce Essentials to help small businesses. Salesforce also launched the AppExchange COVID-19 Resource Center, a central resource of COVID-related solutions, and partnered with Amazon to offer free access to Amazon Connect so service teams working remotely can stay connected. Comments on the news "I am confident that without the digital quote-to-cash transformation we completed with Salesforce and the AppExchange we would not have been able to adapt and respond as quickly," said Steve Stessman, VP of Sales, Tuff Shed. "We're looking forward to the continued partnership with Salesforce to help us navigate to our new normal." "We really needed to stay connected to our customers, because they mean so much to us, and we want them to continue to feel connected to our small business and our mission," said Amy Wright, Founder and CEO of Bitty & Beau's Coffee. "We know that Salesforce will help us build even stronger relationships as we reopen our shops in this new world." Pricing and Availability Work.com Command Center and Shift Management are expected to be generally available in June 2020. Each is an add-on to Platform Starter with introductory pricing of $5 per user per month. Employee Wellness will be included with Work.com Command Center. Emergency Response Management, which includes Contact Tracing, will be generally available in the second half of May 2020. It is a suite of existing products, Health Cloud, Service Cloud, Lightning Scheduler, and Salesforce Maps, as well as a new product, Emergency Program Management. Emergency Program Management is an add-on to any Health Cloud or Service Cloud license in Enterprise Edition or above priced at $50 per user per month. New Employee Learning and Well-being content on myTrailhead will be generally available in June 2020 and will be included with myTrailhead for Employees, which is priced at $25 per user per month. New and existing customers should visit Work.com for additional details on how to get started today. ABOUT SALESFORCE Salesforce is the global leader in Customer Relationship Management (CRM), bringing companies closer to their customers in the digital age. Founded in 1999, Salesforce enables companies of every size and industry to take advantage of powerful technologiescloud, mobile, social, internet of things, artificial intelligence, voice and blockchainto create a 360-degree view of their customers. For more information about Salesforce (NYSE: CRM), visit: www.salesforce.com. Any unreleased services or features referenced in this or other press releases or public statements are not currently available and may not be delivered on time or at all. Customers who purchase Salesforce applications should make their purchase decisions based upon features that are currently available. Salesforce has headquarters in San Francisco, with offices in Europe and Asia, and trades on the New York Stock Exchange under the ticker symbol "CRM." For more information please visit https://www.salesforce.com, or call 1-800-NO-SOFTWARE. SOURCE Salesforce Related Links http://www.salesforce.com
|
edtsum5496
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market" report has been added to ResearchAndMarkets.com's offering. The Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries' biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and contrasts between various Asian countries in specialty generics R&D, manufacturing, adoption, and access. Specialty generics do not have a commonly accepted definition, often used interchangeably as complex generics. Specialty pharmaceuticals are often large, injectable, protein-based molecules produced through a biotechnology process. But they may also be small molecules produced through traditional pharmaceutical manufacturing methods. Specialty generics offer lucrative market opportunities to Asian drug manufacturers to increase profit margins by developing innovative, value-added alternatives of existing drugs to offset traditional generics' shrinking margins in developed countries. The focus on improving the R&D landscape, especially for biologics, will attract global biopharmaceuticals to Asia due to the inherent advantage of a large patient pool and low-cost development and manufacturing. This report reviews drivers propelling specialty generics adoption in these countries. For example, the rising prevalence of chronic diseases such as diabetes and cancer, where specialty drugs primarily drive treatment, will drive the demand for economic and easy-to-administer generic formulations to improve access. Self-administered medications using new drug delivery systems such as nasal sprays, autoinjectors, pen injectors, prefilled syringes, and needle-free injectors offer convenience that will drive the specialty generics demand. Specialty generics development provides competitive differentiation to companies compared to traditional generics. Compared to the 505(b)(1) pathway for new drug approval (NDA), the 505(b)(2) pathway in the US offers faster approval, lower risk, and market exclusivity from 3 to 7 years in some instances when coupled with the correct development and regulatory strategies. The report highlights biopharmaceutical industry dynamics in selected countries. China is the most attractive site due to its strong focus on developing R&D infrastructure and capabilities specifically for biologics. India is the most lucrative location for low-cost manufacturing. Generics participants in India are increasingly focusing on developing innovative products, although the country lags in macroeconomic indicators due to low healthcare spending. Singapore and Hong Kong have a conducive macroeconomic and biopharma environment, followed by Thailand. While the market is nascent, there are signs that strong growth and new regulatory and infrastructure reforms are ahead, and this report will outline and provide commentary regarding those signs. Key Topics Covered: Strategic Imperatives Executive Summary - Specialty Generics Market Growth Opportunity Analysis - Specialty Generics Market New Drug Application Regulatory Pathways in the US - Specialty Generics Market Growth Opportunity Universe - Specialty Generics Market For more information about this report visit https://www.researchandmarkets.com/r/7u5bvw About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Answer:
|
Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market - ResearchAndMarkets.com
|
DUBLIN--(BUSINESS WIRE)--The "Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market" report has been added to ResearchAndMarkets.com's offering. The Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries' biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and contrasts between various Asian countries in specialty generics R&D, manufacturing, adoption, and access. Specialty generics do not have a commonly accepted definition, often used interchangeably as complex generics. Specialty pharmaceuticals are often large, injectable, protein-based molecules produced through a biotechnology process. But they may also be small molecules produced through traditional pharmaceutical manufacturing methods. Specialty generics offer lucrative market opportunities to Asian drug manufacturers to increase profit margins by developing innovative, value-added alternatives of existing drugs to offset traditional generics' shrinking margins in developed countries. The focus on improving the R&D landscape, especially for biologics, will attract global biopharmaceuticals to Asia due to the inherent advantage of a large patient pool and low-cost development and manufacturing. This report reviews drivers propelling specialty generics adoption in these countries. For example, the rising prevalence of chronic diseases such as diabetes and cancer, where specialty drugs primarily drive treatment, will drive the demand for economic and easy-to-administer generic formulations to improve access. Self-administered medications using new drug delivery systems such as nasal sprays, autoinjectors, pen injectors, prefilled syringes, and needle-free injectors offer convenience that will drive the specialty generics demand. Specialty generics development provides competitive differentiation to companies compared to traditional generics. Compared to the 505(b)(1) pathway for new drug approval (NDA), the 505(b)(2) pathway in the US offers faster approval, lower risk, and market exclusivity from 3 to 7 years in some instances when coupled with the correct development and regulatory strategies. The report highlights biopharmaceutical industry dynamics in selected countries. China is the most attractive site due to its strong focus on developing R&D infrastructure and capabilities specifically for biologics. India is the most lucrative location for low-cost manufacturing. Generics participants in India are increasingly focusing on developing innovative products, although the country lags in macroeconomic indicators due to low healthcare spending. Singapore and Hong Kong have a conducive macroeconomic and biopharma environment, followed by Thailand. While the market is nascent, there are signs that strong growth and new regulatory and infrastructure reforms are ahead, and this report will outline and provide commentary regarding those signs. Key Topics Covered: Strategic Imperatives Executive Summary - Specialty Generics Market Growth Opportunity Analysis - Specialty Generics Market New Drug Application Regulatory Pathways in the US - Specialty Generics Market Growth Opportunity Universe - Specialty Generics Market For more information about this report visit https://www.researchandmarkets.com/r/7u5bvw About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
|
edtsum5503
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Polyethylene Terephthalate (PET) Fabric Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global polyethylene terephthalate (PET) fabric market grew at a CAGR of around 5% during 2013-2019. Looking forward, the publisher expects the global polyethylene terephthalate (PET) fabric market to grow moderately during the next five years. Polyethylene terephthalate (PET) fabric stands for a form of polyester that is synthetically produced from polymerized ethylene glycol and terephthalic acid. It exhibits several benefits over natural fabric, including high durability, lightweight, resistance to wind and water, cost effectiveness, better tensile strength, drag resistance, etc. Owing to this, the fabric is used in apparels, homewares, industrial clothing, carpet and rugs, interior fabrics, and other furnishing applications. The increasing demand for polyethylene terephthalate fabrics can be attributed to its rising utilization in the textile industry coupled with the escalating need for reducing dependency on natural fabrics such as cotton, wool, etc. Furthermore, growing consumer awareness towards several benefits of PET fabrics, such as resistance to wrinkles, heat, stretching, abrasion, etc. has also catalyzed the product demand. Moreover, the increasing adoption of PET fiber in manufacturing disposable medical garments, owing to its anti-bacterial and anti-fungal properties, along with its high usage in fiber filling for insulated clothing is also driving the product demand. Furthermore, the rising environmental concerns towards reducing carbon emissions due to increasing plastic waste have propelled the need for recycling PET materials. The fabric made from recycled PET bottles helps in reducing pollution levels by minimizing waste disposal, without any quality degradation. Competitive Landscape: The competitive landscape of the industry has also been examined with some of the key players being Alpek S.A.B., Toray Industries, Inc., Eastman Chemical Company, William Barnet & Son, LLC., Reliance Industries Limited, Indorama Ventures Public Company Limited, Markische Faser GmbH, Sun Fiber LLC., Zhejiang Hengyi Group Co., Ltd. etc. Key Questions Answered in This Report: Key Topics Covered: 1 Preface 2 Scope and Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Polyethylene Terephthalate Fabric Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of Covid-19 5.4 Market Forecast 6 Market Breakup by Source 6.1 Virgin PET 6.1.1 Market Trend 6.1.2 Market Forecast 6.2 Recycled PET 6.2.1 Market Trend 6.2.2 Market Forecast 6.3 Blended PET 6.3.1 Market Trend 6.3.2 Market Forecast 7 Market Breakup by Fabric Type 7.1 Woven 7.1.1 Market Trend 7.1.2 Market Forecast 7.2 Non-Woven 7.2.1 Market Trend 7.2.2 Market Forecast 7.3 Knitted 7.3.1 Market Trend 7.3.2 Market Forecast 8 Market Breakup by Form 8.1 Staple 8.1.1 Market Trend 8.1.2 Market Forecast 8.2 Filament 8.2.1 Market Trend 8.2.2 Market Forecast 8.3 Fiberfill 8.3.1 Market Trend 8.3.2 Market Forecast 8.4 Tow 8.4.1 Market Trend 8.4.2 Market Forecast 9 Market Breakup by Application 9.1 Apparel 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Household 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Industrial 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Carpets and Rugs 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Others 9.5.1 Market Trends 9.5.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.2 Europe 10.3 Asia Pacific 10.4 Middle East and Africa 10.5 Latin America 11 SWOT Analysis 12 Value Chain Analysis 13 Porters Five Forces Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players For more information about this report visit https://www.researchandmarkets.com/r/wf9o2u
Answer:
|
Global Polyethylene Terephthalate Fabric Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast - ResearchAndMarkets.com
|
DUBLIN--(BUSINESS WIRE)--The "Polyethylene Terephthalate (PET) Fabric Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global polyethylene terephthalate (PET) fabric market grew at a CAGR of around 5% during 2013-2019. Looking forward, the publisher expects the global polyethylene terephthalate (PET) fabric market to grow moderately during the next five years. Polyethylene terephthalate (PET) fabric stands for a form of polyester that is synthetically produced from polymerized ethylene glycol and terephthalic acid. It exhibits several benefits over natural fabric, including high durability, lightweight, resistance to wind and water, cost effectiveness, better tensile strength, drag resistance, etc. Owing to this, the fabric is used in apparels, homewares, industrial clothing, carpet and rugs, interior fabrics, and other furnishing applications. The increasing demand for polyethylene terephthalate fabrics can be attributed to its rising utilization in the textile industry coupled with the escalating need for reducing dependency on natural fabrics such as cotton, wool, etc. Furthermore, growing consumer awareness towards several benefits of PET fabrics, such as resistance to wrinkles, heat, stretching, abrasion, etc. has also catalyzed the product demand. Moreover, the increasing adoption of PET fiber in manufacturing disposable medical garments, owing to its anti-bacterial and anti-fungal properties, along with its high usage in fiber filling for insulated clothing is also driving the product demand. Furthermore, the rising environmental concerns towards reducing carbon emissions due to increasing plastic waste have propelled the need for recycling PET materials. The fabric made from recycled PET bottles helps in reducing pollution levels by minimizing waste disposal, without any quality degradation. Competitive Landscape: The competitive landscape of the industry has also been examined with some of the key players being Alpek S.A.B., Toray Industries, Inc., Eastman Chemical Company, William Barnet & Son, LLC., Reliance Industries Limited, Indorama Ventures Public Company Limited, Markische Faser GmbH, Sun Fiber LLC., Zhejiang Hengyi Group Co., Ltd. etc. Key Questions Answered in This Report: Key Topics Covered: 1 Preface 2 Scope and Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Polyethylene Terephthalate Fabric Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of Covid-19 5.4 Market Forecast 6 Market Breakup by Source 6.1 Virgin PET 6.1.1 Market Trend 6.1.2 Market Forecast 6.2 Recycled PET 6.2.1 Market Trend 6.2.2 Market Forecast 6.3 Blended PET 6.3.1 Market Trend 6.3.2 Market Forecast 7 Market Breakup by Fabric Type 7.1 Woven 7.1.1 Market Trend 7.1.2 Market Forecast 7.2 Non-Woven 7.2.1 Market Trend 7.2.2 Market Forecast 7.3 Knitted 7.3.1 Market Trend 7.3.2 Market Forecast 8 Market Breakup by Form 8.1 Staple 8.1.1 Market Trend 8.1.2 Market Forecast 8.2 Filament 8.2.1 Market Trend 8.2.2 Market Forecast 8.3 Fiberfill 8.3.1 Market Trend 8.3.2 Market Forecast 8.4 Tow 8.4.1 Market Trend 8.4.2 Market Forecast 9 Market Breakup by Application 9.1 Apparel 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Household 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Industrial 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Carpets and Rugs 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Others 9.5.1 Market Trends 9.5.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.2 Europe 10.3 Asia Pacific 10.4 Middle East and Africa 10.5 Latin America 11 SWOT Analysis 12 Value Chain Analysis 13 Porters Five Forces Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players For more information about this report visit https://www.researchandmarkets.com/r/wf9o2u
|
edtsum5506
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BELLEVUE, Wash., Aug. 18, 2020 /PRNewswire/ --Icertis, the contract intelligence company that pushes the boundaries of what's possible with contract lifecycle management (CLM), announced today that identity management leader Auth0 will deploy the Icertis Contract Intelligence (ICI) platform to optimize the performance and compliance of all its sales and sourcing contracts and contracting processes. Auth0 supports 9,000+ customers in 70+ countries that use its identity platform to secure more than 4.5 billion login transactions per month. As a result of the company's continued growth, the identity management company needed intelligent contract management software to help optimize its commercial and legal entitlements and commitments in an ever-changing business environment. "At Auth0, we help solve complex and large-scale identity use cases for customers ranging from small developer shops to medium-sized businesses to large global enterprises, and are committed to helping our customers succeed," said Jeremy Freeland, General Counsel, Auth0. "To support our rapid growth, we needed a contracting system that could structure and connect critical contract information, and provide us with analytical tools we can use to help optimize our processes and operations and respond to customer trends. The ICI platform will give us the insights and capabilities we need to run our business better now and into the future." Auth0 chose Icertis because of its focus on delivering business excellence through contracting and track record of rapid, organization-wide implementations with leading technology companies Like Adobe, Apple, Microsoft, and others. Additionally, the ICI platform's integration with Salesforce will enable the company's sales and legal teams to stay ahead of Auth0's growing volume of contracts by reducing cycle times, increasing negotiation effectiveness and enhancing agility with a seamless lead-to-contract process. "As a fellow CEO of a Seattle-based SaaS company, I've long admired what Eugenio Pace and his team at Auth0 have done as true pioneers in their field," said Samir Bodas, CEO and Co-founder of Icertis. "It's an honor to have them as a customer, and I look forward to a strong partnership with another company that's growing rapidly and anchored in delivering excellence for their customers." For more information about Icertis, visit www.icertis.com. About IcertisWith unmatched technology and category-defining innovation, Icertis pushes the boundaries of what's possible with contract lifecycle management (CLM). The AI-powered, analyst-validated Icertis Contract Intelligence (ICI) platform turns contracts from static documents into strategic advantages by structuring and connecting the critical contract information that defines how an organization runs. Today, the world's most iconic brands and disruptive innovators alike trust Icertis to govern the rights and commitments in 7.5 million+ contracts worth more than $1 trillion, in 40+ languages and 90+ countries. Icertis Media Contact:Haley FlanaganManager of Corporate Communications, Icertis[emailprotected] SOURCE Icertis Related Links http://www.icertis.com
Answer:
|
Auth0 Selects Icertis to Increase Contract Intelligence for Next Wave of Growth Identity Management Leader to Optimize Contracting Organization-wide, Drive Excellence Across Customer Acquisition
|
BELLEVUE, Wash., Aug. 18, 2020 /PRNewswire/ --Icertis, the contract intelligence company that pushes the boundaries of what's possible with contract lifecycle management (CLM), announced today that identity management leader Auth0 will deploy the Icertis Contract Intelligence (ICI) platform to optimize the performance and compliance of all its sales and sourcing contracts and contracting processes. Auth0 supports 9,000+ customers in 70+ countries that use its identity platform to secure more than 4.5 billion login transactions per month. As a result of the company's continued growth, the identity management company needed intelligent contract management software to help optimize its commercial and legal entitlements and commitments in an ever-changing business environment. "At Auth0, we help solve complex and large-scale identity use cases for customers ranging from small developer shops to medium-sized businesses to large global enterprises, and are committed to helping our customers succeed," said Jeremy Freeland, General Counsel, Auth0. "To support our rapid growth, we needed a contracting system that could structure and connect critical contract information, and provide us with analytical tools we can use to help optimize our processes and operations and respond to customer trends. The ICI platform will give us the insights and capabilities we need to run our business better now and into the future." Auth0 chose Icertis because of its focus on delivering business excellence through contracting and track record of rapid, organization-wide implementations with leading technology companies Like Adobe, Apple, Microsoft, and others. Additionally, the ICI platform's integration with Salesforce will enable the company's sales and legal teams to stay ahead of Auth0's growing volume of contracts by reducing cycle times, increasing negotiation effectiveness and enhancing agility with a seamless lead-to-contract process. "As a fellow CEO of a Seattle-based SaaS company, I've long admired what Eugenio Pace and his team at Auth0 have done as true pioneers in their field," said Samir Bodas, CEO and Co-founder of Icertis. "It's an honor to have them as a customer, and I look forward to a strong partnership with another company that's growing rapidly and anchored in delivering excellence for their customers." For more information about Icertis, visit www.icertis.com. About IcertisWith unmatched technology and category-defining innovation, Icertis pushes the boundaries of what's possible with contract lifecycle management (CLM). The AI-powered, analyst-validated Icertis Contract Intelligence (ICI) platform turns contracts from static documents into strategic advantages by structuring and connecting the critical contract information that defines how an organization runs. Today, the world's most iconic brands and disruptive innovators alike trust Icertis to govern the rights and commitments in 7.5 million+ contracts worth more than $1 trillion, in 40+ languages and 90+ countries. Icertis Media Contact:Haley FlanaganManager of Corporate Communications, Icertis[emailprotected] SOURCE Icertis Related Links http://www.icertis.com
|
edtsum5510
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Semiconductor Gas Filters Market by Construction (In-line Filters, Gasket Filters) and Filter Element (Metallic Filter Element, Non-Metallic Filter Element) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Semiconductor Gas Filters (SGF) Market is expected to reach $21.7 billion by 2027, growing at a CAGR of 5% during the forecast period of 2020 to 2027. The growth of the semiconductor gas filters market is primarily driven by the factors such as rapid adoption of digital transformation technologies, significant growth in the demand for crystalline silicon wafer solar cells, and emergence of 5G. Furthermore, the growing demand for hardware used in AI applications is expected to offer growth opportunities for the players operating in this market. Based on construction, the in-line filters segment is estimated to account for the largest share of the overall semiconductor gas filters market in 2020. The large share of this segment is primarily accounted to the factors such as increasing adoption of LED coupled with favorable government initiatives, increasing demand for memory cards & storage devices, and increasing demand for in-line filters to protect critical semiconductor components from contamination. In addition, the growing developments among players for rising efficiency and improving performance of filters is encouraging the fastest growth of the semiconductor in-line gas filters market over the forecast period. These filters are mainly employed for high or ultra-high purity (UHP) systems and high-flow processes, such as diffusion, annealing, epitaxy tools, and connections, among others. These filters are primarily designed for use in high-pressure and high-temperature applications, particularly in the semiconductor sector, including flat panel displays, data storage, and LED manufacturing, among others. Based on filter element, the metallic filter element segment is estimated to account for the largest share of the overall semiconductor gas filters market in 2020. The large share of this segment is mainly attributed to the growing consumption of metallic filters coupled with the growing need for high-performance filters and technological advancements. In addition, the growing need for higher purity process gases used in IC manufacture and high adoption rate owing to compact size and flexible choice of fittings is also expected to contribute to the fastest growth of this market over the forecast period. Geographically, the SGF market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is estimated to account for the largest share of the global semiconductor gas filters market in 2020. The large share of this region is primarily attributed to the saturation of the semiconductor manufacturing industry coupled with the high consumption of semiconductor devices and the large electronics manufacturing sector in the region. Taiwan is estimated to account for the largest share of the Asia-Pacific semiconductor gas filters market in 2020. The large share of this market is mainly attributed to the factors such as favorable government policies, robust infrastructure, and skilled workforce; increasing investment for R&D to boost technological innovations and expand global presence; advancements in the development of gas filters; proliferation of semiconductor devices; and transfer of orders from the U.S.-China trade war. Key Topics Covered: 1. Introduction 2. Research Methodology 3. Executive Summary 4. Market Insights 4.1. Introduction 4.1.1. Drivers 4.1.1.1. Rapid Adoption of Digital Transformation Technologies 4.1.1.2. Growing Demand for Crystalline Silicon Wafer Solar Cells 4.1.1.3. Emergence of 5G Connectivity 4.1.2. Restraints 4.1.2.1. Dynamic Nature of the Semiconductors Market 4.1.3. Opportunities 4.1.3.1. Development of AI Hardware 4.1.3.2. Increasing Investment in R&D Activities 4.1.4. Challenges 4.1.4.1. Development of Advanced Filters at Relatively Low Cost 4.1.5. Trends 4.1.5.1. Use of New Materials and Alloys as Filter Elements 4.2. Impact of Covid-19 on the Semiconductor Gas Filters Market 4.3. Supply Chain Analysis 4.4. Value Chain Analysis 4.4.1. Pre-Competitive Stage 4.4.1.1. Research & Development 4.4.1.2. Design 4.4.2. Competitive Stage 4.4.2.1. Manufacturing 4.4.2.2. Assembly 4.4.2.3. Testing & Packaging 4.4.2.4. Distribution & Logistics 4.5. Pricing Analysis 4.5.1. Pricing Analysis, by Filter Element 4.5.2. Pricing Analysis, by Construction/Type 4.5.3. Pricing Analysis, by Region 5. Semiconductor Gas Filters Market, by Construction Type 5.1. Introduction 5.2. In-Line Filters 5.3. Gasket Filters 6. Semiconductor Gas Filters Market, by Filter Element 6.1. Introduction 6.2. Metallic Filter Elements 6.2.1. Stainless Steel (SS) 6.2.2. Nickel 6.2.3. Hastelloy 6.2.4. Other Metallic Filters 6.3. Non-Metallic Filter Elements 6.3.1. Polytetrafluoroethylene (PTFE) 6.3.2. Ceramic 6.3.3. Nylon 6.3.4. Other Non-Metallic Filters 7. Semiconductor Gas Filters Market, by Geography 8. Competitive Landscape 8.1. Introduction 8.2. Key Growth Strategies 8.3. Market Share Analysis (2019) 8.3.1. Entegris, Inc. (U.S.) 8.3.2. Pall Corporation (U.S.) 8.3.3. Parker Hannifin Corporation (U.S.) 8.3.3. Other Players 9. Company Profiles (Business Overview, Product Portfolio, Financial Overview, Strategic Developments) 9.1. Entegris, Inc. 9.2. Porvair Filtration Group (A Part Porvair Plc) 9.3. Donaldson Company, Inc. 9.4. Pall Corporation (a Part of Danaher Corporation) 9.5. Ewald Associates, Inc. 9.6. Mott Corporation 9.7. Valin Corporation 9.8. Nippon Seisen Co., Ltd. 9.9. Parker Hannifin Corporation 9.10. Witt-Gasetechnik GmbH & Co KG 9.11. Mycropore Corporation 9.12. Teesing B.V. 9.13. Bronkhorst High-Tech B.V. 10. Appendix For more information about this report visit https://www.researchandmarkets.com/r/nurnui
Answer:
|
Semiconductor Gas Filters Market by Construction (In-line Filters, Gasket Filters) and Filter Element (Metallic Filter Element, Non-Metallic Filter Element) - Global Forecast to 2027 - ResearchAndMarkets.com
|
DUBLIN--(BUSINESS WIRE)--The "Semiconductor Gas Filters Market by Construction (In-line Filters, Gasket Filters) and Filter Element (Metallic Filter Element, Non-Metallic Filter Element) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Semiconductor Gas Filters (SGF) Market is expected to reach $21.7 billion by 2027, growing at a CAGR of 5% during the forecast period of 2020 to 2027. The growth of the semiconductor gas filters market is primarily driven by the factors such as rapid adoption of digital transformation technologies, significant growth in the demand for crystalline silicon wafer solar cells, and emergence of 5G. Furthermore, the growing demand for hardware used in AI applications is expected to offer growth opportunities for the players operating in this market. Based on construction, the in-line filters segment is estimated to account for the largest share of the overall semiconductor gas filters market in 2020. The large share of this segment is primarily accounted to the factors such as increasing adoption of LED coupled with favorable government initiatives, increasing demand for memory cards & storage devices, and increasing demand for in-line filters to protect critical semiconductor components from contamination. In addition, the growing developments among players for rising efficiency and improving performance of filters is encouraging the fastest growth of the semiconductor in-line gas filters market over the forecast period. These filters are mainly employed for high or ultra-high purity (UHP) systems and high-flow processes, such as diffusion, annealing, epitaxy tools, and connections, among others. These filters are primarily designed for use in high-pressure and high-temperature applications, particularly in the semiconductor sector, including flat panel displays, data storage, and LED manufacturing, among others. Based on filter element, the metallic filter element segment is estimated to account for the largest share of the overall semiconductor gas filters market in 2020. The large share of this segment is mainly attributed to the growing consumption of metallic filters coupled with the growing need for high-performance filters and technological advancements. In addition, the growing need for higher purity process gases used in IC manufacture and high adoption rate owing to compact size and flexible choice of fittings is also expected to contribute to the fastest growth of this market over the forecast period. Geographically, the SGF market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is estimated to account for the largest share of the global semiconductor gas filters market in 2020. The large share of this region is primarily attributed to the saturation of the semiconductor manufacturing industry coupled with the high consumption of semiconductor devices and the large electronics manufacturing sector in the region. Taiwan is estimated to account for the largest share of the Asia-Pacific semiconductor gas filters market in 2020. The large share of this market is mainly attributed to the factors such as favorable government policies, robust infrastructure, and skilled workforce; increasing investment for R&D to boost technological innovations and expand global presence; advancements in the development of gas filters; proliferation of semiconductor devices; and transfer of orders from the U.S.-China trade war. Key Topics Covered: 1. Introduction 2. Research Methodology 3. Executive Summary 4. Market Insights 4.1. Introduction 4.1.1. Drivers 4.1.1.1. Rapid Adoption of Digital Transformation Technologies 4.1.1.2. Growing Demand for Crystalline Silicon Wafer Solar Cells 4.1.1.3. Emergence of 5G Connectivity 4.1.2. Restraints 4.1.2.1. Dynamic Nature of the Semiconductors Market 4.1.3. Opportunities 4.1.3.1. Development of AI Hardware 4.1.3.2. Increasing Investment in R&D Activities 4.1.4. Challenges 4.1.4.1. Development of Advanced Filters at Relatively Low Cost 4.1.5. Trends 4.1.5.1. Use of New Materials and Alloys as Filter Elements 4.2. Impact of Covid-19 on the Semiconductor Gas Filters Market 4.3. Supply Chain Analysis 4.4. Value Chain Analysis 4.4.1. Pre-Competitive Stage 4.4.1.1. Research & Development 4.4.1.2. Design 4.4.2. Competitive Stage 4.4.2.1. Manufacturing 4.4.2.2. Assembly 4.4.2.3. Testing & Packaging 4.4.2.4. Distribution & Logistics 4.5. Pricing Analysis 4.5.1. Pricing Analysis, by Filter Element 4.5.2. Pricing Analysis, by Construction/Type 4.5.3. Pricing Analysis, by Region 5. Semiconductor Gas Filters Market, by Construction Type 5.1. Introduction 5.2. In-Line Filters 5.3. Gasket Filters 6. Semiconductor Gas Filters Market, by Filter Element 6.1. Introduction 6.2. Metallic Filter Elements 6.2.1. Stainless Steel (SS) 6.2.2. Nickel 6.2.3. Hastelloy 6.2.4. Other Metallic Filters 6.3. Non-Metallic Filter Elements 6.3.1. Polytetrafluoroethylene (PTFE) 6.3.2. Ceramic 6.3.3. Nylon 6.3.4. Other Non-Metallic Filters 7. Semiconductor Gas Filters Market, by Geography 8. Competitive Landscape 8.1. Introduction 8.2. Key Growth Strategies 8.3. Market Share Analysis (2019) 8.3.1. Entegris, Inc. (U.S.) 8.3.2. Pall Corporation (U.S.) 8.3.3. Parker Hannifin Corporation (U.S.) 8.3.3. Other Players 9. Company Profiles (Business Overview, Product Portfolio, Financial Overview, Strategic Developments) 9.1. Entegris, Inc. 9.2. Porvair Filtration Group (A Part Porvair Plc) 9.3. Donaldson Company, Inc. 9.4. Pall Corporation (a Part of Danaher Corporation) 9.5. Ewald Associates, Inc. 9.6. Mott Corporation 9.7. Valin Corporation 9.8. Nippon Seisen Co., Ltd. 9.9. Parker Hannifin Corporation 9.10. Witt-Gasetechnik GmbH & Co KG 9.11. Mycropore Corporation 9.12. Teesing B.V. 9.13. Bronkhorst High-Tech B.V. 10. Appendix For more information about this report visit https://www.researchandmarkets.com/r/nurnui
|
edtsum5512
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN DIEGO--(BUSINESS WIRE)--Suffolk, one of the most innovative and successful builders and real estate enterprises in the country, has announced the hiring of Karri Novak as Vice President of Project Development in the West Region to help strengthen the firms positioning in the rapidly growing higher-education sector. In her new role, Ms. Novak will be responsible for leading growth strategies, business acquisition, project design development, project oversight and client relationship management. Ms. Novak will contribute to the growing portfolio of Suffolk projects in the West Region, which includes developments like 1500 Granville, a mixed-use residential complex in West Los Angeles; Flight at Tustin Legacy, a creative mixed-use office campus in Orange County; and the Palisade Residential Tower, a 23-story luxury residential building in the University Towne Center of San Diego. Were thrilled Karri has joined the Suffolk team as we continue to expand our brand and diversify our portfolio across California, said Tony Rango, President of the West Region for Suffolk. The higher-education sector in the West Region is showing significant signs of growth. Karris breadth of experience and strong relationships in higher-ed will allow us to expand our market share and grow our brand presence in this vitally important market. Prior to joining Suffolk, Ms. Novak served as Vice President for Clark Construction, where she led teams delivering projects at higher-education campuses throughout the Western United States. With over 25 years of industry experience, Ms. Novak is knowledgeable about current trends related to academic and student life services and has frequently led design-build teams through the planning, design, development and delivery of new campus projects. She also has demonstrated a passion for improving the productivity and safety of projects through modern methods of construction, such as modular, prefabrication and design for industrialized methods. Her extensive academic project portfolio includes the University of California, San Francisco (UCSF) Genentech Hall; the UC Hastings Law School building; Engineering VI Phase Two building at the University of California, Los Angeles (UCLA); University of California San Diego (USCD) North Torrey Pines Living and Learning Neighborhood; San Diego State University (SDSU) Engineering & Interdisciplinary Sciences Complex and the Los Angeles Community College District (LACCD) Los Angeles Valley College Athletic Training Facility. Ms. Novaks student housing experience includes Bowles Hall Restoration and Modernization at University of California, Berkeley, The Village at Torrey Pines East at University of California, San Diego, Glenmore II at University of California, Riverside (UCR), University Gateway Housing at University of Southern California (USC) and the recently completed new residence hall, Huaxyacac at San Diego State. The hiring of Ms. Novak continues a recent spate of Suffolk leadership hires from competing contractors on the West Coast, including Suffolk West Region president Tony Rango from Webcor, Suffolk Los Angeles General Manager Ken Summers from Webcor and Suffolk director of client development for San Diego Jennifer McCarthy from Swinerton, among others. About Suffolk Suffolk is a national enterprise that invests, innovates, and builds. Suffolk is an end-to-end business that provides value throughout the entire project lifecycle by leveraging its core construction management services with vertical service lines that include real estate capital investment, design, self-perform construction services, technology start-up investment and innovation research/development. Suffolk is a national company with $4.0 billion in annual revenue, 2,500 employees and main offices in Boston (headquarters), New York, Miami, West Palm Beach, Tampa, Estero, Dallas, Los Angeles, San Francisco, and San Diego. Suffolk serves clients in every major industry sector, including healthcare, science and technology, education, gaming, transportation/aviation, and commercial. Suffolk is privately held and is led by founder, chairman and CEO John Fish. Suffolk is ranked #23 on the Engineering News Record list of Top 400 Contractors. For more information, visit www.suffolk.com and follow Suffolk on Facebook, Twitter, LinkedIn, YouTube, and Instagram.
Answer:
|
Suffolk Hires Karri Novak as VP of Project Development to Strengthen Positioning in Higher-Ed Sector Innovative real estate enterprise and builder hires seasoned executive with experience managing sophisticated higher-education projects on the West Coast
|
SAN DIEGO--(BUSINESS WIRE)--Suffolk, one of the most innovative and successful builders and real estate enterprises in the country, has announced the hiring of Karri Novak as Vice President of Project Development in the West Region to help strengthen the firms positioning in the rapidly growing higher-education sector. In her new role, Ms. Novak will be responsible for leading growth strategies, business acquisition, project design development, project oversight and client relationship management. Ms. Novak will contribute to the growing portfolio of Suffolk projects in the West Region, which includes developments like 1500 Granville, a mixed-use residential complex in West Los Angeles; Flight at Tustin Legacy, a creative mixed-use office campus in Orange County; and the Palisade Residential Tower, a 23-story luxury residential building in the University Towne Center of San Diego. Were thrilled Karri has joined the Suffolk team as we continue to expand our brand and diversify our portfolio across California, said Tony Rango, President of the West Region for Suffolk. The higher-education sector in the West Region is showing significant signs of growth. Karris breadth of experience and strong relationships in higher-ed will allow us to expand our market share and grow our brand presence in this vitally important market. Prior to joining Suffolk, Ms. Novak served as Vice President for Clark Construction, where she led teams delivering projects at higher-education campuses throughout the Western United States. With over 25 years of industry experience, Ms. Novak is knowledgeable about current trends related to academic and student life services and has frequently led design-build teams through the planning, design, development and delivery of new campus projects. She also has demonstrated a passion for improving the productivity and safety of projects through modern methods of construction, such as modular, prefabrication and design for industrialized methods. Her extensive academic project portfolio includes the University of California, San Francisco (UCSF) Genentech Hall; the UC Hastings Law School building; Engineering VI Phase Two building at the University of California, Los Angeles (UCLA); University of California San Diego (USCD) North Torrey Pines Living and Learning Neighborhood; San Diego State University (SDSU) Engineering & Interdisciplinary Sciences Complex and the Los Angeles Community College District (LACCD) Los Angeles Valley College Athletic Training Facility. Ms. Novaks student housing experience includes Bowles Hall Restoration and Modernization at University of California, Berkeley, The Village at Torrey Pines East at University of California, San Diego, Glenmore II at University of California, Riverside (UCR), University Gateway Housing at University of Southern California (USC) and the recently completed new residence hall, Huaxyacac at San Diego State. The hiring of Ms. Novak continues a recent spate of Suffolk leadership hires from competing contractors on the West Coast, including Suffolk West Region president Tony Rango from Webcor, Suffolk Los Angeles General Manager Ken Summers from Webcor and Suffolk director of client development for San Diego Jennifer McCarthy from Swinerton, among others. About Suffolk Suffolk is a national enterprise that invests, innovates, and builds. Suffolk is an end-to-end business that provides value throughout the entire project lifecycle by leveraging its core construction management services with vertical service lines that include real estate capital investment, design, self-perform construction services, technology start-up investment and innovation research/development. Suffolk is a national company with $4.0 billion in annual revenue, 2,500 employees and main offices in Boston (headquarters), New York, Miami, West Palm Beach, Tampa, Estero, Dallas, Los Angeles, San Francisco, and San Diego. Suffolk serves clients in every major industry sector, including healthcare, science and technology, education, gaming, transportation/aviation, and commercial. Suffolk is privately held and is led by founder, chairman and CEO John Fish. Suffolk is ranked #23 on the Engineering News Record list of Top 400 Contractors. For more information, visit www.suffolk.com and follow Suffolk on Facebook, Twitter, LinkedIn, YouTube, and Instagram.
|
edtsum5514
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: - GAC MOTOR "Together, Go Better" (), 24 2021 . /PRNewswire/ -- 28 GAC MOTOR (2021 International Distributor Conference). , 26 , "Together, Go Better" ( ), GAC MOTOR . 2020 , , GAC MOTOR . 18% , . , GAC MOTOR Al Jomaih Automotive Company Outstanding Distributor Diamond Award. 2020 Al Jomaih GAC MOTOR . GAC MOTOR 2021 . , GAC MOTOR . , . , GAC MOTOR , , . GAC MOTOR - (Yu Jun) , GAC MOTOR . GAC MOTOR , . GAC MOTOR - (Zeng He Bin) : GAC MOTOR - . GAC MOTOR . 25 - . 2021 GAC MOTOR International Distributor Conference GAC MOTOR , . GAC MOTOR , . , . SOURCE GAC MOTOR
Answer:
|
- GAC MOTOR "Together, Go Better" - P Espaa - espaol USA - English USA - English USA - English USA - English Polska - Polski Latin America - espaol Brazil - Portugus Deutschland - Deutsch
|
- GAC MOTOR "Together, Go Better" (), 24 2021 . /PRNewswire/ -- 28 GAC MOTOR (2021 International Distributor Conference). , 26 , "Together, Go Better" ( ), GAC MOTOR . 2020 , , GAC MOTOR . 18% , . , GAC MOTOR Al Jomaih Automotive Company Outstanding Distributor Diamond Award. 2020 Al Jomaih GAC MOTOR . GAC MOTOR 2021 . , GAC MOTOR . , . , GAC MOTOR , , . GAC MOTOR - (Yu Jun) , GAC MOTOR . GAC MOTOR , . GAC MOTOR - (Zeng He Bin) : GAC MOTOR - . GAC MOTOR . 25 - . 2021 GAC MOTOR International Distributor Conference GAC MOTOR , . GAC MOTOR , . , . SOURCE GAC MOTOR
|
edtsum5527
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MENLO PARK, Calif., April 9, 2020 /PRNewswire/ -- Facebook, Inc. (NASDAQ: FB) announced today that the company's first quarter 2020 financial results will be released after market close on Wednesday, April 29, 2020. Facebook will host a conference call to discuss its results at 2 p.m. PT / 5 p.m. ET the same day. The live webcast of the call can be accessed at the Facebook Investor Relations website at investor.fb.com, along with the company's earnings press release, financial tables, and slide presentation. Following the call, a replay will be available at the same website. A telephonic replay will be available for one week following the conference call at 404.537.3406 or 855.859.2056, Conference ID: 2865867. Transcripts of conference calls with publishing equity research analysts held on April 29, 2020 will also be posted to the investor.fb.com website. Disclosure Information Facebook uses theinvestor.fb.com and newsroom.fb.com websites as well as Mark Zuckerberg's Facebook Page (facebook.com/zuck) as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. About Facebook Founded in 2004, Facebook's mission is to give people the power to build community and bring the world closer together. People use Facebook's apps and technologies to connect with friends and family, find communities and grow businesses. Facebook is a trademark of Facebook, Inc. ContactsInvestors:Deborah Crawford[emailprotected] / investor.fb.com Press:Ryan Moore[emailprotected] / newsroom.fb.com SOURCE Facebook
Answer:
|
Facebook to Announce First Quarter 2020 Results
|
MENLO PARK, Calif., April 9, 2020 /PRNewswire/ -- Facebook, Inc. (NASDAQ: FB) announced today that the company's first quarter 2020 financial results will be released after market close on Wednesday, April 29, 2020. Facebook will host a conference call to discuss its results at 2 p.m. PT / 5 p.m. ET the same day. The live webcast of the call can be accessed at the Facebook Investor Relations website at investor.fb.com, along with the company's earnings press release, financial tables, and slide presentation. Following the call, a replay will be available at the same website. A telephonic replay will be available for one week following the conference call at 404.537.3406 or 855.859.2056, Conference ID: 2865867. Transcripts of conference calls with publishing equity research analysts held on April 29, 2020 will also be posted to the investor.fb.com website. Disclosure Information Facebook uses theinvestor.fb.com and newsroom.fb.com websites as well as Mark Zuckerberg's Facebook Page (facebook.com/zuck) as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. About Facebook Founded in 2004, Facebook's mission is to give people the power to build community and bring the world closer together. People use Facebook's apps and technologies to connect with friends and family, find communities and grow businesses. Facebook is a trademark of Facebook, Inc. ContactsInvestors:Deborah Crawford[emailprotected] / investor.fb.com Press:Ryan Moore[emailprotected] / newsroom.fb.com SOURCE Facebook
|
edtsum5535
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOS ANGELES, March 24, 2020 /PRNewswire/ -- Attorney Gerald L. Marcus has been named by Attorney and Practice Magazine as one of California's Top 10 Plaintiff's Personal Injury Attorneys. The exclusive honor considers all attorneys in a specific practice area and state and recognizes fewer than 1% nationwide. The attorneys selected to their list have been featured by major media including: The Washington Post CBS News MSNBC The New York Times Newsweek The Law Offices of Gerald L. Marcus Attorney Marcus has been a plaintiff's personal injury attorney since 1987 and is also the founder of the Professional Accident Injury Network (P.A.I.N.). His firm, The Law Offices of Gerald L. Marcus, brings together passionate litigators, private investigators, case managers, and other support staff so personal injury victims have access to a depth of resources. This approach has helped him recover over $200 million for accident victims over the course of his career and also earned him recognitions including: The National Association of Distinguished Counsel's "Nation's Top One Percent" America's Top 100 Personal Injury Attorneys Personal Injury Super Lawyers of Southern California This latest acknowledgment by Attorney and Practice Magazine is a great honor to Attorney Marcus. Having his work recognized by national institutions endorses his values-driven approach: Providing fierce advocacy for accident victims of all types from all walks of life creates an impact that goes far beyond one man. He is thankful for the chance to continue to support Californians in personal injury cases. The Law Offices of Gerald L. Marcus has been representing injury victims in the Los Angeles area for over 30 years. In that time, the firm has recovered hundreds of millions for clients. Along with a robust team of personal injury litigators, The Law Offices of Gerald L. Marcus employs in-house investigators to help clarify the details of accidents and present them to judges and juries. The compassionate support injury victims receive is matched by fierce advocacy on their behalf. The Law Offices of Gerald L. Marcus offers big-firm resources that allow clients to take on big insurers and corporations and takes every case on a contingency basis. The firm can be found online at www.geraldmarcuslaw.com. SOURCE The Law Offices of Gerald L. Marcus Related Links https://www.geraldmarcuslaw.com
Answer:
|
Attorney & Practice Magazine Recognizes Gerald L. Marcus Among California's Top 10 Plaintiff's Personal Injury Lawyers The honor, awarded each year, recognizes attorneys who help not only their clients but also the larger legal community.
|
LOS ANGELES, March 24, 2020 /PRNewswire/ -- Attorney Gerald L. Marcus has been named by Attorney and Practice Magazine as one of California's Top 10 Plaintiff's Personal Injury Attorneys. The exclusive honor considers all attorneys in a specific practice area and state and recognizes fewer than 1% nationwide. The attorneys selected to their list have been featured by major media including: The Washington Post CBS News MSNBC The New York Times Newsweek The Law Offices of Gerald L. Marcus Attorney Marcus has been a plaintiff's personal injury attorney since 1987 and is also the founder of the Professional Accident Injury Network (P.A.I.N.). His firm, The Law Offices of Gerald L. Marcus, brings together passionate litigators, private investigators, case managers, and other support staff so personal injury victims have access to a depth of resources. This approach has helped him recover over $200 million for accident victims over the course of his career and also earned him recognitions including: The National Association of Distinguished Counsel's "Nation's Top One Percent" America's Top 100 Personal Injury Attorneys Personal Injury Super Lawyers of Southern California This latest acknowledgment by Attorney and Practice Magazine is a great honor to Attorney Marcus. Having his work recognized by national institutions endorses his values-driven approach: Providing fierce advocacy for accident victims of all types from all walks of life creates an impact that goes far beyond one man. He is thankful for the chance to continue to support Californians in personal injury cases. The Law Offices of Gerald L. Marcus has been representing injury victims in the Los Angeles area for over 30 years. In that time, the firm has recovered hundreds of millions for clients. Along with a robust team of personal injury litigators, The Law Offices of Gerald L. Marcus employs in-house investigators to help clarify the details of accidents and present them to judges and juries. The compassionate support injury victims receive is matched by fierce advocacy on their behalf. The Law Offices of Gerald L. Marcus offers big-firm resources that allow clients to take on big insurers and corporations and takes every case on a contingency basis. The firm can be found online at www.geraldmarcuslaw.com. SOURCE The Law Offices of Gerald L. Marcus Related Links https://www.geraldmarcuslaw.com
|
edtsum5539
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: RENO, Nev., Feb. 17, 2021 /PRNewswire/ -- Itronics Inc. (OTC: ITRO) an emerging "Cleantech Materials" growth Company that manufactures GOLD'n GRO Multi-Nutrient Fertilizers and produces silver, gold, zinc, critical minerals, and battery minerals recovered from industrial and mining waste, today reported its full year 2020 sales, and updated its operations and growth projects. Itronics Reports 2020 Silver Sales Up 224 Percent, Total Sales Down 3 Percent (PRNewsfoto/Itronics Inc.) Total Revenues for the 12 months ended December 31, 2020 were $1,876,022 compared to $1,943,609 in the same period in 2019, for a 3 percent decrease. Full year GOLD'n GRO fertilizer sales were $1,681,857 compared to $1,838,619 in the prior year for a 9 percent decrease due to a sharp Covid-19 driven decline in the fourth quarter. Full year silver sales were $141,493 compared to $43,700 in the prior year for a 224 percent increase. The 2021 outlook for GOLD'n GRO fertilizer sales is for a significant increase over 2020 due to a greatly reduced impact from Covid-19 and driven by sharp improvements in demand for crops grown in our primary California markets. The 2021 outlook for silver sales is for continued improvement due to a combination of on-going recovery optimization and to sharply higher silver and gold prices compared to 2020. During the year, the Company optimized a GOLD'n GRO magnesium fertilizer and prepared it for field testing and registration in California. The Company also created and successfully field tested a GOLD'n GRO copper fertilizer for sale in California to strawberry growers. Sales development of these fertilizers was delayed to 2021 due to restrictions imposed by the state of California due to Covid-19. During the year, the Company updated its Corporate Profile, which is available on the Itronics website. The Company also completed and announced its growth forecast which centers upon its 10year business plan designed to integrate its Zero Waste Energy Saving Technologies and to grow annual sales from $2 million in 2019, to $140 million in 2025. During the third quarter the Company continued its fast-track development of its revolutionary Rock Kleen Technology. A second series of tests designed to determine maximum metal recovery of metals contained in silver/gold mine tailings was completed with very positive results. A third set of tests were completed to determine if residual silver and gold recovery using cyanide would be improved if the rocks were first leached using the Rock Kleen, then re-leached using cyanide. Unoptimized test results indicate that recoveries could be improved to the point that up to 90 percent of the residual silver and gold could be recovered. The cumulative results of all the Rock Kleen testing performed to date indicate that the Rock Kleen technology has a high probability to be technically and economically successful for processing silver/gold mine tailings. In early October the Company announced that it is developing two technologies that recover manganese, one of the four most important battery metals, and that as these developments continue, the Company could become one of the first domestic producers of manganese since the 1970's. In addition, the Rock Kleen technology has demonstrated the ability to recover the "Critical Minerals", magnesium, manganese, and potassium from mine tailings, and the battery metals manganese, nickel, silver, and zinc. Late in the fourth quarter the Company began to prepare the records needed to re-establish its annual audits beginning in 2021. Completing this work is a high priority project for 2021 and will be started as soon as operating funds permit. 2020. Full Year Sales Results Unaudited Revenues for the fourth quarter, and 12 months ended December 31, 2020 together with comparative figures for 2019 are presented below: Operations and Expansion Updates GOLD'n GRO Multi-Nutrient Fertilizers: During the second quarter the Company began testing a GOLD'n GRO copper micronutrient formulation for use on strawberries. This testing is complete and produced very positive results. In August, the Company received approval to sell the fertilizer commercially in California under a provisional label. The Company is assembling the information needed to formally register the fertilizer in Nevada and California. Due to Covid-19 restrictions, sales of this new fertilizer were delayed until the first quarter 2021. The GOLD'n GRO sales team was planning to start field testing a GOLD'n GRO magnesium fertilizer in the fourth quarter, but that was delayed until the first quarter 2021. In recent years, widespread magnesium deficiencies have emerged in the California vegetable and berry growing areas so, at our distributor's request, we have upgraded the fertilizer to a fully chelated magnesium fertilizer and have generated all the information needed for re-registration. This magnesium fertilizer is already registered in Nevada. Earlier in 2020, the Company was informed by its Distributor that in certain areas in California, crop calcium deficiencies are emerging. Several years ago, Itronics developed a chelated calciummagnesium fertilizer. In early 2020 we upgraded this fertilizer to a fully chelated calcium-magnesium fertilizer. We believe that this fertilizer will improve calcium and magnesium uptake by the crops. Current plans are to start field testing this fertilizer in the first quarter 2021. This fertilizer is not yet registered in California, but it is registered for sale in Nevada. Calcium fertilizers are already widely used in California, but the use is primarily for soil conditioning and pH adjustment. Itronics believes that its GOLD'n GRO "Advanced Nutrient Transfer Technology" will improve calcium uptake by the crops. Several field tests performed with other GOLD'n GRO fertilizers have already demonstrated that calcium and magnesium uptake is improved when these fertilizers are used. Magnesium and Calcium are "middle nutrients" as is sulfur. Middle nutrients are used in much larger quantities than the micronutrient fertilizers. Because of this, sales of the GOLD'n GRO magnesium and calcium fertilizers could materially increase total GOLD'n GRO sales in coming years as the calcium and magnesium fertilizers are introduced into the markets to help reduce the deficiencies that are emerging. Silver Bullion and Other Metal Production: The pilot scale computer circuit board refining operation is operating reliably. Metal recovery optimization is underway and is improving bullion silver and gold content while at the same time improving furnace efficiency and reducing the unit cost of metals being recovered. The Company plans to have this division include its hydrometallurgy and its electro-chemistry operations. The hydrometallurgy section is operating at a pilot scale and is presently recovering iron (FeLix Process) and sulfur (SuLix Process) from its internally produced silver concentrates. The iron and sulfur are being used as ingredients in the GOLD'n GRO fertilizers which reduces the cost of raw materials purchased from outside suppliers. The Company is evaluating the feasibility of expanding these operations in the coming year to include pilot scale recovery of zinc from certain types of flue dusts (ZnLix Process). This will continue zinc metal recovery R & D that was started several years ago and has two objectives. One objective is to produce zinc raw material for use in manufacturing GOLD'n GRO fertilizers which would reduce the amount of zinc purchased from outside suppliers and reduce the cost of goods for the GOLD'n GRO fertilizers. A second important objective of this work would be to initiate pilot scale use of electro-chemistry to recover zinc metal. If commercial scale zinc metal production can be achieved, then it would be possible to begin continuous processing of certain zinc flue dusts to produce pure zinc metal. This is expected to expand and diversify the Company's metal sales by adding another stable revenue stream to reduce the seasonality of the Company's total sales. The experimental work to produce zinc metal using electro-winning technology was started in early January 2021 using a laboratory scale electrowinning cell developed by the Company. Currently small amounts of zinc metal are being produced while the operating parameters are being developed. The Company plans to expand zinc output in stages starting at laboratory scale and expanding to pilot scale at the Company's 35,000 square foot Reno, Nevada manufacturing and R & D facility. The Company already owns most of the equipment needed to do this. The equipment is on site and can be put into operation with only minor modifications. The zinc bearing liquid (Pregnant Leach Solution, also called PLS) fed to the electrowinning cell is produced by recovering zinc from flue dust produced by a brass/bronze manufacturer. The residuals from the leaching process contain measurable amounts of silver and gold which will be used as feed materials for the Company's circuit board assembly (E-Scrap) refining process. This will expand the supply of silver concentrate for refining printed circuit boards. The contained metals will be incorporated into the silver bullion for sale making this another "Zero Waste Energy Saving" operation for the Company. Processing zinc bearing flue dust is one of the technologies in the Company's portfolio of "Zero Waste Energy Saving" technologies that are being prepared for expansion to commercial scale. Activating this technology development starts the process of establishing the ability to produce pure metals using electrochemistry and opens the door to processing alkaline battery paste which contains zinc, manganese, and potassium. Some of the new EV battery technologies use manganese, one of the four most important battery metals, so this technology development may enable the company to process Electric Vehicle (EV) battery pastes in the future. In addition, the Company's Rock Kleen technology has shown the ability to recover the battery metals nickel, manganese, and zinc from silver/gold mine leach tailings, all of which will need to be separated and recovered using electrochemistry. Beginning zinc recovery R & D opens the door to following this work with a continuation of R & D started several years ago to recover zinc, manganese, and potassium from paste extracted from discarded alkaline batteries. Our laboratory scale research has already shown that we can extract zinc, manganese, and potassium for use in GOLD'n GRO fertilizers. We believe that electro-chemistry may be useable to recover manganese chemicals that could be sold into outside markets, such as for battery materials. The ability to produce manganese chemicals is critical because the Company believes that the amount of manganese contained in battery pastes greatly exceeds the amount of manganese required for the fertilizer markets. In 2020 the company announced that it plans to resume experimental recovery of pure copper and possibly tin from the silver bullion which will further increase the silver and gold content of the bullion being shipped for sale to its finish refiner. The zinc metal recovery research is further along and so that work was started first. Manganese recovery research is expected to follow. The copper-tin recovery research would start after that. The plan is to start the research at the Reno manufacturing facility and then to expand the electrochemistry recovery operations to the Itronics Cleantech Materials Campus that is being planned for development at its 48-acre Wabuska site north of Yerington, Nevada. Rock Kleen Technology and Business Plan Development: During the first quarter the Company announced completion of a detailed 3-year growth plan for Reno manufacturing operations. A 10 year growth plan for consolidated operations that include expansion to the new "Itronics Cleantech Materials Campus" was completed in the second quarter. This plan was updated in the third quarter to factor in the 2020 impacts of Covid-19 on the growth plan. The expected impacts of expanded materials recoveries using the Rock Kleen technology were also incorporated into the plan. Itronics is anticipating rapid growth over the next several years, to be driven by GOLD'n GRO fertilizer sales and to be supported by development of the new Rock Kleen technology which was selected from the Company's portfolio of "Zero Waste Technologies" for commercial development as a major new line of business. In early August, Whitney & Whitney, Inc., the Company's technical services subsidiary signed a second research contract to further evaluate the potential for silver tailings processing for a silver mining company. The project used the Company's newly developed Rock Kleen Technology to accomplish the processing. The test work was completed in November and produced positive silver, manganese, and other metal recovery results. Manganese has been designated by the Federal Government as a "Critical Mineral". Manganese is one of the four most important industrial metals and is widely used by the steel industry worldwide. It is a major component of non-rechargeable alkaline batteries, one of the largest battery categories sold in the world. The use of manganese in EV batteries is increasing as EV battery technology is shifting to use of more nickel and manganese in battery formulations. According to a recent United Nations report, manganese is one of the four most important battery materials. According to the U.S. Department of Interior, there is no mine production of manganese in the United States. Itronics is using its revolutionary Rock Kleen Technology to test metal recoverability from mine tailings obtained from a former silver mine in western Nevada that has a high manganese content. The Rock Kleen process is recovering silver, manganese, lead, zinc, and nickel. The Company has calculated, based on laboratory test results, that if a Rock Kleen tailings process is put into commercial production, the tailings processing operation would become the largest primary manganese producer in the United States. A long-term objective for Itronics is to become a leading producer of high purity metals, including the U.S. critical metals manganese and tin, using the Company's breakthrough hydrometallurgy, pyrometallurgy, and electrochemical technologies. Additionally, Itronics is also strategically positioned with its portfolio of "Zero Waste Energy Saving Technologies" to help solve the recently declared emergency need for domestic production of Critical Minerals from materials located at mine sites. In August, Itronics announced that the Rock Kleen silver/gold mine tailings processing research is showing that the revolutionary Rock Kleen technology not only neutralizes cyanide and recovers nitrogen, and a broad group of base and ferrous metals, but it also recovers sulfur and potassium that is naturally contained in many Nevada silver/gold deposits. Because of this, as development of Rock Kleen processing operations progresses, the Rock Kleen operations have the potential to provide a whole new source of virgin raw materials, not only to supply the metal industries, but also certain nutrient raw materials for the fertilizer industry and industrial mineral materials for many industries including the Construction and Ceramics industries and industries that use mineral fillers. Existing mines and tailings from previously operating mines will be the source of these new virgin raw materials, so it will not be necessary to build as many new mines to gain access to these materials. Rock Kleen commercialization is expected to permanently supply a portion of the recovered nutrient metals, zinc, iron, manganese, and copper, and the nitrogen, potassium, and sulfur for use as raw materials for the manufacture of the GOLD'n GRO Multi-nutrient fertilizers. Rock Kleen commercialization will also supply silver concentrates for use in printed circuit board refining on a permanent basis. This will enable expanded printed circuit board refining as new Rock Kleen operations are added. Auric Fulstone Polymetallic Gold Project: Early in the first half the Company was successful in getting two mining companies to review the project for possible joint venture development, but those activities were shelved due to COVID-19 risks. Subsequently, gold and silver prices have risen dramatically creating expanded revenues for all gold and silver production companies. Because of this, and after the COVID-19 risks are deemed to be acceptable, the Company is expecting that there will be considerable interest in the Auric Fulstone Polymetallic Gold project as a potential joint venture development. If you would like to be added to our e-mail list for all updates on our emerging clean technologies, please call us at 775-689-7696, e-mail "[emailprotected], or leave a message in our message box on our website at www.itronics.com so that we can get a profile report to you. The Company thanks all its supporters as it expands its technologies to make the world cleaner and greener. About Itronics Headquartered in Reno, Nevada, Itronics Inc. is a "Zero Waste Energy Saving Technology" Company which produces GOLD'n GRO specialty liquid fertilizers, silver bullion, and silver-bearing glass. The Company is an emerging "critical mineral", and "battery materials" producer. The Company's goal is to achieve profitable cleantech materials technology driven organic growth in specialty GOLD'n GRO fertilizers, silver, gold, zinc, critical minerals, and battery minerals. The Company's technologies maximize the recovery and uses of metals and minerals and by doing this maximize sustainability. The Company's growth forecast centers upon its 10-year business plan designed to integrate its Zero Waste Energy Saving Technologies and to grow annual sales from $2 million in 2019, to $100 million in 2025. The Company's environmentally friendly award winning GOLD'n GRO liquid fertilizers, which are extensively used in agriculture, can be used for lawns and houseplants, and are available at the Company's "estore" on Amazon.Com at http://www.amazon.com/s/ref=bl_sr_lawn-garden?ie+UTF8&fieldbrandtextbin=GOLD%27n+GRO&node+2972638011.Due to expanded retail customer interest, GOLD'n GRO fertilizer may now be purchased in Reno, Nevada at "Buy Nevada First Gift Shop", 4001 S. Virginia St. Follow Itronics on Facebook: https://www.facebook.com/itronicsinc Follow Itronics on Twitter: https://twitter.com/itronicsinc * * * * * * * * * * VISIT OUR WEB SITE: http://www.itronics.com ("Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.) Contact: Paul Knopick 888-795-6336[emailprotected]Photo - https://mma.prnewswire.com/media/1440063/Itronics_Sales.jpg SOURCE Itronics Inc.
Answer:
|
Itronics Reports 2020 Silver Sales Up 224 Percent, Total Sales Down 3 Percent
|
RENO, Nev., Feb. 17, 2021 /PRNewswire/ -- Itronics Inc. (OTC: ITRO) an emerging "Cleantech Materials" growth Company that manufactures GOLD'n GRO Multi-Nutrient Fertilizers and produces silver, gold, zinc, critical minerals, and battery minerals recovered from industrial and mining waste, today reported its full year 2020 sales, and updated its operations and growth projects. Itronics Reports 2020 Silver Sales Up 224 Percent, Total Sales Down 3 Percent (PRNewsfoto/Itronics Inc.) Total Revenues for the 12 months ended December 31, 2020 were $1,876,022 compared to $1,943,609 in the same period in 2019, for a 3 percent decrease. Full year GOLD'n GRO fertilizer sales were $1,681,857 compared to $1,838,619 in the prior year for a 9 percent decrease due to a sharp Covid-19 driven decline in the fourth quarter. Full year silver sales were $141,493 compared to $43,700 in the prior year for a 224 percent increase. The 2021 outlook for GOLD'n GRO fertilizer sales is for a significant increase over 2020 due to a greatly reduced impact from Covid-19 and driven by sharp improvements in demand for crops grown in our primary California markets. The 2021 outlook for silver sales is for continued improvement due to a combination of on-going recovery optimization and to sharply higher silver and gold prices compared to 2020. During the year, the Company optimized a GOLD'n GRO magnesium fertilizer and prepared it for field testing and registration in California. The Company also created and successfully field tested a GOLD'n GRO copper fertilizer for sale in California to strawberry growers. Sales development of these fertilizers was delayed to 2021 due to restrictions imposed by the state of California due to Covid-19. During the year, the Company updated its Corporate Profile, which is available on the Itronics website. The Company also completed and announced its growth forecast which centers upon its 10year business plan designed to integrate its Zero Waste Energy Saving Technologies and to grow annual sales from $2 million in 2019, to $140 million in 2025. During the third quarter the Company continued its fast-track development of its revolutionary Rock Kleen Technology. A second series of tests designed to determine maximum metal recovery of metals contained in silver/gold mine tailings was completed with very positive results. A third set of tests were completed to determine if residual silver and gold recovery using cyanide would be improved if the rocks were first leached using the Rock Kleen, then re-leached using cyanide. Unoptimized test results indicate that recoveries could be improved to the point that up to 90 percent of the residual silver and gold could be recovered. The cumulative results of all the Rock Kleen testing performed to date indicate that the Rock Kleen technology has a high probability to be technically and economically successful for processing silver/gold mine tailings. In early October the Company announced that it is developing two technologies that recover manganese, one of the four most important battery metals, and that as these developments continue, the Company could become one of the first domestic producers of manganese since the 1970's. In addition, the Rock Kleen technology has demonstrated the ability to recover the "Critical Minerals", magnesium, manganese, and potassium from mine tailings, and the battery metals manganese, nickel, silver, and zinc. Late in the fourth quarter the Company began to prepare the records needed to re-establish its annual audits beginning in 2021. Completing this work is a high priority project for 2021 and will be started as soon as operating funds permit. 2020. Full Year Sales Results Unaudited Revenues for the fourth quarter, and 12 months ended December 31, 2020 together with comparative figures for 2019 are presented below: Operations and Expansion Updates GOLD'n GRO Multi-Nutrient Fertilizers: During the second quarter the Company began testing a GOLD'n GRO copper micronutrient formulation for use on strawberries. This testing is complete and produced very positive results. In August, the Company received approval to sell the fertilizer commercially in California under a provisional label. The Company is assembling the information needed to formally register the fertilizer in Nevada and California. Due to Covid-19 restrictions, sales of this new fertilizer were delayed until the first quarter 2021. The GOLD'n GRO sales team was planning to start field testing a GOLD'n GRO magnesium fertilizer in the fourth quarter, but that was delayed until the first quarter 2021. In recent years, widespread magnesium deficiencies have emerged in the California vegetable and berry growing areas so, at our distributor's request, we have upgraded the fertilizer to a fully chelated magnesium fertilizer and have generated all the information needed for re-registration. This magnesium fertilizer is already registered in Nevada. Earlier in 2020, the Company was informed by its Distributor that in certain areas in California, crop calcium deficiencies are emerging. Several years ago, Itronics developed a chelated calciummagnesium fertilizer. In early 2020 we upgraded this fertilizer to a fully chelated calcium-magnesium fertilizer. We believe that this fertilizer will improve calcium and magnesium uptake by the crops. Current plans are to start field testing this fertilizer in the first quarter 2021. This fertilizer is not yet registered in California, but it is registered for sale in Nevada. Calcium fertilizers are already widely used in California, but the use is primarily for soil conditioning and pH adjustment. Itronics believes that its GOLD'n GRO "Advanced Nutrient Transfer Technology" will improve calcium uptake by the crops. Several field tests performed with other GOLD'n GRO fertilizers have already demonstrated that calcium and magnesium uptake is improved when these fertilizers are used. Magnesium and Calcium are "middle nutrients" as is sulfur. Middle nutrients are used in much larger quantities than the micronutrient fertilizers. Because of this, sales of the GOLD'n GRO magnesium and calcium fertilizers could materially increase total GOLD'n GRO sales in coming years as the calcium and magnesium fertilizers are introduced into the markets to help reduce the deficiencies that are emerging. Silver Bullion and Other Metal Production: The pilot scale computer circuit board refining operation is operating reliably. Metal recovery optimization is underway and is improving bullion silver and gold content while at the same time improving furnace efficiency and reducing the unit cost of metals being recovered. The Company plans to have this division include its hydrometallurgy and its electro-chemistry operations. The hydrometallurgy section is operating at a pilot scale and is presently recovering iron (FeLix Process) and sulfur (SuLix Process) from its internally produced silver concentrates. The iron and sulfur are being used as ingredients in the GOLD'n GRO fertilizers which reduces the cost of raw materials purchased from outside suppliers. The Company is evaluating the feasibility of expanding these operations in the coming year to include pilot scale recovery of zinc from certain types of flue dusts (ZnLix Process). This will continue zinc metal recovery R & D that was started several years ago and has two objectives. One objective is to produce zinc raw material for use in manufacturing GOLD'n GRO fertilizers which would reduce the amount of zinc purchased from outside suppliers and reduce the cost of goods for the GOLD'n GRO fertilizers. A second important objective of this work would be to initiate pilot scale use of electro-chemistry to recover zinc metal. If commercial scale zinc metal production can be achieved, then it would be possible to begin continuous processing of certain zinc flue dusts to produce pure zinc metal. This is expected to expand and diversify the Company's metal sales by adding another stable revenue stream to reduce the seasonality of the Company's total sales. The experimental work to produce zinc metal using electro-winning technology was started in early January 2021 using a laboratory scale electrowinning cell developed by the Company. Currently small amounts of zinc metal are being produced while the operating parameters are being developed. The Company plans to expand zinc output in stages starting at laboratory scale and expanding to pilot scale at the Company's 35,000 square foot Reno, Nevada manufacturing and R & D facility. The Company already owns most of the equipment needed to do this. The equipment is on site and can be put into operation with only minor modifications. The zinc bearing liquid (Pregnant Leach Solution, also called PLS) fed to the electrowinning cell is produced by recovering zinc from flue dust produced by a brass/bronze manufacturer. The residuals from the leaching process contain measurable amounts of silver and gold which will be used as feed materials for the Company's circuit board assembly (E-Scrap) refining process. This will expand the supply of silver concentrate for refining printed circuit boards. The contained metals will be incorporated into the silver bullion for sale making this another "Zero Waste Energy Saving" operation for the Company. Processing zinc bearing flue dust is one of the technologies in the Company's portfolio of "Zero Waste Energy Saving" technologies that are being prepared for expansion to commercial scale. Activating this technology development starts the process of establishing the ability to produce pure metals using electrochemistry and opens the door to processing alkaline battery paste which contains zinc, manganese, and potassium. Some of the new EV battery technologies use manganese, one of the four most important battery metals, so this technology development may enable the company to process Electric Vehicle (EV) battery pastes in the future. In addition, the Company's Rock Kleen technology has shown the ability to recover the battery metals nickel, manganese, and zinc from silver/gold mine leach tailings, all of which will need to be separated and recovered using electrochemistry. Beginning zinc recovery R & D opens the door to following this work with a continuation of R & D started several years ago to recover zinc, manganese, and potassium from paste extracted from discarded alkaline batteries. Our laboratory scale research has already shown that we can extract zinc, manganese, and potassium for use in GOLD'n GRO fertilizers. We believe that electro-chemistry may be useable to recover manganese chemicals that could be sold into outside markets, such as for battery materials. The ability to produce manganese chemicals is critical because the Company believes that the amount of manganese contained in battery pastes greatly exceeds the amount of manganese required for the fertilizer markets. In 2020 the company announced that it plans to resume experimental recovery of pure copper and possibly tin from the silver bullion which will further increase the silver and gold content of the bullion being shipped for sale to its finish refiner. The zinc metal recovery research is further along and so that work was started first. Manganese recovery research is expected to follow. The copper-tin recovery research would start after that. The plan is to start the research at the Reno manufacturing facility and then to expand the electrochemistry recovery operations to the Itronics Cleantech Materials Campus that is being planned for development at its 48-acre Wabuska site north of Yerington, Nevada. Rock Kleen Technology and Business Plan Development: During the first quarter the Company announced completion of a detailed 3-year growth plan for Reno manufacturing operations. A 10 year growth plan for consolidated operations that include expansion to the new "Itronics Cleantech Materials Campus" was completed in the second quarter. This plan was updated in the third quarter to factor in the 2020 impacts of Covid-19 on the growth plan. The expected impacts of expanded materials recoveries using the Rock Kleen technology were also incorporated into the plan. Itronics is anticipating rapid growth over the next several years, to be driven by GOLD'n GRO fertilizer sales and to be supported by development of the new Rock Kleen technology which was selected from the Company's portfolio of "Zero Waste Technologies" for commercial development as a major new line of business. In early August, Whitney & Whitney, Inc., the Company's technical services subsidiary signed a second research contract to further evaluate the potential for silver tailings processing for a silver mining company. The project used the Company's newly developed Rock Kleen Technology to accomplish the processing. The test work was completed in November and produced positive silver, manganese, and other metal recovery results. Manganese has been designated by the Federal Government as a "Critical Mineral". Manganese is one of the four most important industrial metals and is widely used by the steel industry worldwide. It is a major component of non-rechargeable alkaline batteries, one of the largest battery categories sold in the world. The use of manganese in EV batteries is increasing as EV battery technology is shifting to use of more nickel and manganese in battery formulations. According to a recent United Nations report, manganese is one of the four most important battery materials. According to the U.S. Department of Interior, there is no mine production of manganese in the United States. Itronics is using its revolutionary Rock Kleen Technology to test metal recoverability from mine tailings obtained from a former silver mine in western Nevada that has a high manganese content. The Rock Kleen process is recovering silver, manganese, lead, zinc, and nickel. The Company has calculated, based on laboratory test results, that if a Rock Kleen tailings process is put into commercial production, the tailings processing operation would become the largest primary manganese producer in the United States. A long-term objective for Itronics is to become a leading producer of high purity metals, including the U.S. critical metals manganese and tin, using the Company's breakthrough hydrometallurgy, pyrometallurgy, and electrochemical technologies. Additionally, Itronics is also strategically positioned with its portfolio of "Zero Waste Energy Saving Technologies" to help solve the recently declared emergency need for domestic production of Critical Minerals from materials located at mine sites. In August, Itronics announced that the Rock Kleen silver/gold mine tailings processing research is showing that the revolutionary Rock Kleen technology not only neutralizes cyanide and recovers nitrogen, and a broad group of base and ferrous metals, but it also recovers sulfur and potassium that is naturally contained in many Nevada silver/gold deposits. Because of this, as development of Rock Kleen processing operations progresses, the Rock Kleen operations have the potential to provide a whole new source of virgin raw materials, not only to supply the metal industries, but also certain nutrient raw materials for the fertilizer industry and industrial mineral materials for many industries including the Construction and Ceramics industries and industries that use mineral fillers. Existing mines and tailings from previously operating mines will be the source of these new virgin raw materials, so it will not be necessary to build as many new mines to gain access to these materials. Rock Kleen commercialization is expected to permanently supply a portion of the recovered nutrient metals, zinc, iron, manganese, and copper, and the nitrogen, potassium, and sulfur for use as raw materials for the manufacture of the GOLD'n GRO Multi-nutrient fertilizers. Rock Kleen commercialization will also supply silver concentrates for use in printed circuit board refining on a permanent basis. This will enable expanded printed circuit board refining as new Rock Kleen operations are added. Auric Fulstone Polymetallic Gold Project: Early in the first half the Company was successful in getting two mining companies to review the project for possible joint venture development, but those activities were shelved due to COVID-19 risks. Subsequently, gold and silver prices have risen dramatically creating expanded revenues for all gold and silver production companies. Because of this, and after the COVID-19 risks are deemed to be acceptable, the Company is expecting that there will be considerable interest in the Auric Fulstone Polymetallic Gold project as a potential joint venture development. If you would like to be added to our e-mail list for all updates on our emerging clean technologies, please call us at 775-689-7696, e-mail "[emailprotected], or leave a message in our message box on our website at www.itronics.com so that we can get a profile report to you. The Company thanks all its supporters as it expands its technologies to make the world cleaner and greener. About Itronics Headquartered in Reno, Nevada, Itronics Inc. is a "Zero Waste Energy Saving Technology" Company which produces GOLD'n GRO specialty liquid fertilizers, silver bullion, and silver-bearing glass. The Company is an emerging "critical mineral", and "battery materials" producer. The Company's goal is to achieve profitable cleantech materials technology driven organic growth in specialty GOLD'n GRO fertilizers, silver, gold, zinc, critical minerals, and battery minerals. The Company's technologies maximize the recovery and uses of metals and minerals and by doing this maximize sustainability. The Company's growth forecast centers upon its 10-year business plan designed to integrate its Zero Waste Energy Saving Technologies and to grow annual sales from $2 million in 2019, to $100 million in 2025. The Company's environmentally friendly award winning GOLD'n GRO liquid fertilizers, which are extensively used in agriculture, can be used for lawns and houseplants, and are available at the Company's "estore" on Amazon.Com at http://www.amazon.com/s/ref=bl_sr_lawn-garden?ie+UTF8&fieldbrandtextbin=GOLD%27n+GRO&node+2972638011.Due to expanded retail customer interest, GOLD'n GRO fertilizer may now be purchased in Reno, Nevada at "Buy Nevada First Gift Shop", 4001 S. Virginia St. Follow Itronics on Facebook: https://www.facebook.com/itronicsinc Follow Itronics on Twitter: https://twitter.com/itronicsinc * * * * * * * * * * VISIT OUR WEB SITE: http://www.itronics.com ("Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.) Contact: Paul Knopick 888-795-6336[emailprotected]Photo - https://mma.prnewswire.com/media/1440063/Itronics_Sales.jpg SOURCE Itronics Inc.
|
edtsum5545
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SANTA CLARA, Calif., March 5, 2021 /PRNewswire/ --Marvell Technology Group Ltd. (NASDAQ: MRVL), today announced a quarterly dividend of $0.06 per share of common stock payable on April 28, 2021 to shareholders of record as of April 9, 2021. About Marvell To deliver the data infrastructure technology that connects the world, we're building solutions on the most powerful foundation: our partnerships with our customers. Trusted by the world's leading technology companies for 25 years, we move, store, process and secure the world's data with semiconductor solutions designed for our customers' current needs and future ambitions. Through a process of deep collaboration and transparency, we're ultimately changing the way tomorrow's enterprise, cloud, automotive, and carrier architectures transformfor the better. Marvell and the Marvell logo are registered trademarks of Marvell and/or its affiliates. For further information, contact: Ashish Saran Vice President, Investor Relations 408-222-0777 [emailprotected] SOURCE Marvell Related Links http://www.marvell.com
Answer:
|
Marvell Technology Group Ltd. Declares Quarterly Dividend Payment
|
SANTA CLARA, Calif., March 5, 2021 /PRNewswire/ --Marvell Technology Group Ltd. (NASDAQ: MRVL), today announced a quarterly dividend of $0.06 per share of common stock payable on April 28, 2021 to shareholders of record as of April 9, 2021. About Marvell To deliver the data infrastructure technology that connects the world, we're building solutions on the most powerful foundation: our partnerships with our customers. Trusted by the world's leading technology companies for 25 years, we move, store, process and secure the world's data with semiconductor solutions designed for our customers' current needs and future ambitions. Through a process of deep collaboration and transparency, we're ultimately changing the way tomorrow's enterprise, cloud, automotive, and carrier architectures transformfor the better. Marvell and the Marvell logo are registered trademarks of Marvell and/or its affiliates. For further information, contact: Ashish Saran Vice President, Investor Relations 408-222-0777 [emailprotected] SOURCE Marvell Related Links http://www.marvell.com
|
edtsum5546
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ALBUQUERQUE, N.M., July 21, 2020 /PRNewswire/ --Trove.Video (https://trovevideo.com/) aims to ease the pain caused by a looming U.S. ban of TikTok by providing creators and their fans with software, allowing them to easily and quickly backup all of their TikTok videos with a click of a button. Trove.Video recently launched a video downloaderapp for Windows 10, allowing for automatic backups of TikTok posts. The software is used by creators to easily backup the many short-form video posts that they had created over years of hard work. In most cases, these video posts were not backed up by the creators. "With a popular creator having hundreds to thousands of TikTok posts, it would be a challenging and time-consuming process to back these videos up manually," says Scarlett Olsen, Head of Marketing for Trove.Video. Continue Reading Trove Media, LLC "Without knowing for certain whether a U.S. ban will cause some TikTok posts to disappear overnight, preserving the history and legacy of these young creators is of utmost importance and may be an unforeseen loss to many," says Scarlett Olsen. "The software was built to provide ease of downloading hundreds to tens of thousands of videos within a short period. And time is of the essence with the looming TikTok ban. We do not know how TikTok will react to a government ban and whether the content will remain active on their web presence." It's widely speculated that the web property will still be operational to avoid closing off the long-standing policy of operating an "open Internet" in the West. Web access will be welcomed news for fans of creators, as they will continue to enjoy access to the popular videos created on TikTok. By making local copies of their favorite TikTok posts, it is something they can enjoy in the years to come whether there is a ban or not. You can download the Trove.Video softwarefor free and give it a try today. For media inquiries, please contact Scarlett Olsen.Media Contact:Scarlett OlsenPhone: (323) 380-0993Email: [emailprotected]Related FilesTrove-Video-Screenshot.jpgTrove-Video-Horizontal-Logo-Drk.pngRelated Imagesimage1.jpg Related LinksTrove.Video Download Trove.Video VPN SOURCE Trove Media, LLC Related Links https://trovevideo.com
Answer:
|
Trove.Video Launches TikTok Downloader as US Looks to Ban the Popular Social Network TikTok, owned by the Chinese company Bytedance, has a large app following in the U.S. that may disappear overnight. This has caused much anguish within the TikTok community, and Trove.Video aims to ease this pain with the launch of their video downloader and backup software for TikTok videos.
|
ALBUQUERQUE, N.M., July 21, 2020 /PRNewswire/ --Trove.Video (https://trovevideo.com/) aims to ease the pain caused by a looming U.S. ban of TikTok by providing creators and their fans with software, allowing them to easily and quickly backup all of their TikTok videos with a click of a button. Trove.Video recently launched a video downloaderapp for Windows 10, allowing for automatic backups of TikTok posts. The software is used by creators to easily backup the many short-form video posts that they had created over years of hard work. In most cases, these video posts were not backed up by the creators. "With a popular creator having hundreds to thousands of TikTok posts, it would be a challenging and time-consuming process to back these videos up manually," says Scarlett Olsen, Head of Marketing for Trove.Video. Continue Reading Trove Media, LLC "Without knowing for certain whether a U.S. ban will cause some TikTok posts to disappear overnight, preserving the history and legacy of these young creators is of utmost importance and may be an unforeseen loss to many," says Scarlett Olsen. "The software was built to provide ease of downloading hundreds to tens of thousands of videos within a short period. And time is of the essence with the looming TikTok ban. We do not know how TikTok will react to a government ban and whether the content will remain active on their web presence." It's widely speculated that the web property will still be operational to avoid closing off the long-standing policy of operating an "open Internet" in the West. Web access will be welcomed news for fans of creators, as they will continue to enjoy access to the popular videos created on TikTok. By making local copies of their favorite TikTok posts, it is something they can enjoy in the years to come whether there is a ban or not. You can download the Trove.Video softwarefor free and give it a try today. For media inquiries, please contact Scarlett Olsen.Media Contact:Scarlett OlsenPhone: (323) 380-0993Email: [emailprotected]Related FilesTrove-Video-Screenshot.jpgTrove-Video-Horizontal-Logo-Drk.pngRelated Imagesimage1.jpg Related LinksTrove.Video Download Trove.Video VPN SOURCE Trove Media, LLC Related Links https://trovevideo.com
|
edtsum5551
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code) 1. KEY INFORMATION (a) Full name of discloser: Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree AA plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 3rd February 2021 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state N/A No 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 0.1p ordinary (GB00BMSKPJ95) Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: - - - - (2) Cash-settled derivatives: 7,363,872 1.180% - - (3) Stock-settled derivatives (including options) and agreements to purchase/sell: - - - - TOTAL: 7,363,872 1.180% - - All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (GBP) GB00BMSKPJ95 Equity Swap Reducing a long position 44,182 0.35 (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 4th February 2021 Contact name: Milos Naumovic Telephone number: +44 203 650 8203 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
Answer:
|
Form 8.3 - AA plc
|
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code) 1. KEY INFORMATION (a) Full name of discloser: Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree AA plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 3rd February 2021 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state N/A No 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 0.1p ordinary (GB00BMSKPJ95) Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: - - - - (2) Cash-settled derivatives: 7,363,872 1.180% - - (3) Stock-settled derivatives (including options) and agreements to purchase/sell: - - - - TOTAL: 7,363,872 1.180% - - All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (GBP) GB00BMSKPJ95 Equity Swap Reducing a long position 44,182 0.35 (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 4th February 2021 Contact name: Milos Naumovic Telephone number: +44 203 650 8203 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
|
edtsum5554
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DALLAS, July 29, 2020 /PRNewswire/ --Luther J. Battiste, III, received the National Bar Association's (NBA) Civil Trial Advocacy Trial Master Award at the association's annual convention. Mr. Battiste, a founding shareholder of Johnson, Toal & Battiste, P.A., in Columbia, South Carolina, has been a member of the NBA for more than 40 years and is the National President of the American Board of Trial Advocates. (PRNewsfoto/American Board of Trial Advocat) NBA President Alfreda Bennett Robinson thanked Mr. Battiste for his longtime commitment with the NBA, including serving as chair of the NBA Civil Trial Advocacy Section. "For more than four decades Mr. Battiste has embodied the objectives of the National Bar Associationbyupholding the honor and integrity of the legal profession and passing along professionalism and expertise to the next generation of lawyers." She added that Mr. Battiste has worked to protect the civil and political rights of the citizens and residents of the United States. Mr. Battiste received the award virtually when he appeared by videoconference on July 25 during the Civil Trial Advocacy Master Class program. "The Civil Trial Advocacy Trial Master Award is presented to exceptional NBA trial lawyers who have distinguished themselves as champions of justice and the American jury system," said Vanita M. Banks, Chair of the NBA's Civil Trial Advocacy section and NBA Past President. "In addition to Luther Battiste's extraordinary achievements, through a lifetime of dedication and service to his clients and the legal profession, he has demonstrated a relentless commitment to teaching and mentoring the next generation of trial lawyers."Mr. Battiste is the first African-American to serve as ABOTA National President. He also made history in 1983 by becoming one of the first two African-Americans elected to the Columbia City Council since Reconstruction. He served 15 years as a member of the Columbia City Council, including two terms as Mayor Pro Tempore. In 1998, the City of Columbia dedicated a monument and plaza in honor of his dedicated service as a public servant.Accepting the award from his law office in Columbia, South Carolina, Mr. Battiste spoke about earning his law degree from Emory University School of Law in Atlanta and choosing to return to his home state of South Carolina to contribute to the community that helped shape him. Mr. Battiste commented that he was influenced by iconic Howard University School of Law DeanCharles Hamilton Houston to be a "social engineer for change" in his home state.Mr. Battiste referred to his mentor, the late U.S. District Judge Matthew J. Perry, who spurred social and educational integration and was appointed as the first African-American U.S. District Judge in South Carolina."I'm proud that Judge Perry was a distinguished member of the NBA," Mr. Battiste said. "Judge Perry worked his entire life to try to produce change. And as a lawyer, he was a fierce advocate for his clients."During the virtual NBA Convention, John E. Sweeney, a Los Angeles lawyer and an ABOTA National Board member, appeared by video to honor Mr. Battiste. Mr. Sweeney was the inaugural recipient of the award in 2017.Mr. Battiste was admitted to ABOTA on January 29, 2000, and has served as a National Board Member since 2005. He served two terms as National Treasurer and has served as a chair or member on a number of committees and task forces. In 2011, he served as the President of the Southeastern Chapters of ABOTA, a regional organization representing 11 ABOTA chapters. The NBA was founded in 1925 and is the nation's oldest and largest national network of predominantly African-American attorneys and judges. It represents the interests of more than 65,000 lawyers, judges, law professors and law students. The NBA is organized around 23 substantive law sections, 9 divisions, 12 regions and 80 affiliate chapters throughout the United States and the world.ABOTA is an invitation-only national association of experienced trial lawyers and judges dedicated to the preservation and promotion of the Seventh Amendment to the U.S. Constitution, which guarantees the right to civil jury trials. ABOTA's primary goal is to educate the American public about the history and value of the right to trial by jury, and it is dedicated to elevating the standards of skill, integrity, honor and courtesy in the legal profession. For more information contact:Brian Tyson at (800) 932-2682 [emailprotected]SOURCE American Board of Trial Advocates
Answer:
|
Luther J. Battiste, III, receives National Bar Association's Trial Master Award
|
DALLAS, July 29, 2020 /PRNewswire/ --Luther J. Battiste, III, received the National Bar Association's (NBA) Civil Trial Advocacy Trial Master Award at the association's annual convention. Mr. Battiste, a founding shareholder of Johnson, Toal & Battiste, P.A., in Columbia, South Carolina, has been a member of the NBA for more than 40 years and is the National President of the American Board of Trial Advocates. (PRNewsfoto/American Board of Trial Advocat) NBA President Alfreda Bennett Robinson thanked Mr. Battiste for his longtime commitment with the NBA, including serving as chair of the NBA Civil Trial Advocacy Section. "For more than four decades Mr. Battiste has embodied the objectives of the National Bar Associationbyupholding the honor and integrity of the legal profession and passing along professionalism and expertise to the next generation of lawyers." She added that Mr. Battiste has worked to protect the civil and political rights of the citizens and residents of the United States. Mr. Battiste received the award virtually when he appeared by videoconference on July 25 during the Civil Trial Advocacy Master Class program. "The Civil Trial Advocacy Trial Master Award is presented to exceptional NBA trial lawyers who have distinguished themselves as champions of justice and the American jury system," said Vanita M. Banks, Chair of the NBA's Civil Trial Advocacy section and NBA Past President. "In addition to Luther Battiste's extraordinary achievements, through a lifetime of dedication and service to his clients and the legal profession, he has demonstrated a relentless commitment to teaching and mentoring the next generation of trial lawyers."Mr. Battiste is the first African-American to serve as ABOTA National President. He also made history in 1983 by becoming one of the first two African-Americans elected to the Columbia City Council since Reconstruction. He served 15 years as a member of the Columbia City Council, including two terms as Mayor Pro Tempore. In 1998, the City of Columbia dedicated a monument and plaza in honor of his dedicated service as a public servant.Accepting the award from his law office in Columbia, South Carolina, Mr. Battiste spoke about earning his law degree from Emory University School of Law in Atlanta and choosing to return to his home state of South Carolina to contribute to the community that helped shape him. Mr. Battiste commented that he was influenced by iconic Howard University School of Law DeanCharles Hamilton Houston to be a "social engineer for change" in his home state.Mr. Battiste referred to his mentor, the late U.S. District Judge Matthew J. Perry, who spurred social and educational integration and was appointed as the first African-American U.S. District Judge in South Carolina."I'm proud that Judge Perry was a distinguished member of the NBA," Mr. Battiste said. "Judge Perry worked his entire life to try to produce change. And as a lawyer, he was a fierce advocate for his clients."During the virtual NBA Convention, John E. Sweeney, a Los Angeles lawyer and an ABOTA National Board member, appeared by video to honor Mr. Battiste. Mr. Sweeney was the inaugural recipient of the award in 2017.Mr. Battiste was admitted to ABOTA on January 29, 2000, and has served as a National Board Member since 2005. He served two terms as National Treasurer and has served as a chair or member on a number of committees and task forces. In 2011, he served as the President of the Southeastern Chapters of ABOTA, a regional organization representing 11 ABOTA chapters. The NBA was founded in 1925 and is the nation's oldest and largest national network of predominantly African-American attorneys and judges. It represents the interests of more than 65,000 lawyers, judges, law professors and law students. The NBA is organized around 23 substantive law sections, 9 divisions, 12 regions and 80 affiliate chapters throughout the United States and the world.ABOTA is an invitation-only national association of experienced trial lawyers and judges dedicated to the preservation and promotion of the Seventh Amendment to the U.S. Constitution, which guarantees the right to civil jury trials. ABOTA's primary goal is to educate the American public about the history and value of the right to trial by jury, and it is dedicated to elevating the standards of skill, integrity, honor and courtesy in the legal profession. For more information contact:Brian Tyson at (800) 932-2682 [emailprotected]SOURCE American Board of Trial Advocates
|
edtsum5559
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code) 1. KEY INFORMATION (a) Full name of discloser: Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree AA plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 4th March 2021 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state N/A No 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 0.1p ordinary (GB00BMSKPJ95) Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: - - - - (2) Cash-settled derivatives: 7,009,195 1.122% - - (3) Stock-settled derivatives (including options) and agreements to purchase/sell: - - - - TOTAL: 7,009,195 1.122% - - All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (GBP) GB00BMSKPJ95 Equity Swap Increasing a long position 10,307 0.35 GB00BMSKPJ95 Equity Swap Reducing a long position 46,441 0.35 (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 5th March 2021 Contact name: Milos Naumovic Telephone number: +44 203 650 8203 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
Answer:
|
Form 8.3 - AA plc
|
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code) 1. KEY INFORMATION (a) Full name of discloser: Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree AA plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 4th March 2021 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state N/A No 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 0.1p ordinary (GB00BMSKPJ95) Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: - - - - (2) Cash-settled derivatives: 7,009,195 1.122% - - (3) Stock-settled derivatives (including options) and agreements to purchase/sell: - - - - TOTAL: 7,009,195 1.122% - - All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (GBP) GB00BMSKPJ95 Equity Swap Increasing a long position 10,307 0.35 GB00BMSKPJ95 Equity Swap Reducing a long position 46,441 0.35 (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 5th March 2021 Contact name: Milos Naumovic Telephone number: +44 203 650 8203 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
|
edtsum5571
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Apache Corporation ("Apache" or "the Company") (NASDAQ: APA) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Apache securities between September 7, 2016, through March 13, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/apa. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose to investors that: (1) Apache intentionally used unrealistic assumptions regarding the amount and composition of available oil and gas in Alpine High; (2) Apache did not have the proper infrastructure in place to safely and/or economically drill and/or transport those resources even if they existed in the amounts purported; (3) these misleading statements and omissions artificially inflated the value of the Company's operations in the Permian Basin. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firms site: www.bgandg.com/apa or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Apache you have until April 26, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firms expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Answer:
|
APA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Apache Corporation Investors of Class Action and Encourages Shareholders to Contact the Firm
|
NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Apache Corporation ("Apache" or "the Company") (NASDAQ: APA) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Apache securities between September 7, 2016, through March 13, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/apa. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose to investors that: (1) Apache intentionally used unrealistic assumptions regarding the amount and composition of available oil and gas in Alpine High; (2) Apache did not have the proper infrastructure in place to safely and/or economically drill and/or transport those resources even if they existed in the amounts purported; (3) these misleading statements and omissions artificially inflated the value of the Company's operations in the Permian Basin. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firms site: www.bgandg.com/apa or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Apache you have until April 26, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firms expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
|
edtsum5586
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SO PAULO, Dec. 11, 2020 /PRNewswire/ -- Following the nomination of Milton Maluhy Filho as its Chief Executive Officer as of February 2021, Ita Unibanco Holding S.A. ("Ita Unibanco or Company") announced today several changes in its Executive Committee. The new composition aims to bring the Executive Committee even closer to the business, simplify Ita's operation and management model and allow for greater autonomy and speed in decision making. The new Committee will be composed by the following executives: Alexandre Zancani will be responsible for Auto Loans, Mortgage and Consrcio, as well as Ita Correspondente, Digital Customer Acquisition and Retail Credit and Recovery. Andr Rodrigues will be responsible for the Retail Bank (Ita Agencias, Ita Uniclass, Personnalit, Companies, Branches Network, Individual and SME Products, CRM, Digital Channels and User Experience), Insurance and SME Loans. Andr Sapoznik will be responsible for the new Payments structure, covering Credit Cards, Rede, iti and Cash Management. Andr will remain responsible for Operations and Customer Services and will also be in charge of Marketing. Carlos Constantini will be responsible for WMS (Wealth Management and Services), which comprises the areas of Asset Management, Funds of Funds, Private Global and vertical of Investments, Investment Products and Investment Services and Operations. Flavio Souza will be the Chief Executive Officer of Ita BBA, responsible for the Commercial Banking and Corporate and Investment Bank (CIB) areas, including fixed income and equity distribution, and Research, as well as for the Corporate credit department. Additionally, a new structure will be created to encompass Treasury, Corporate Products and Trading Desk, Macroeconomics, as well as the bank's operations in South America ex-Brazil (Argentina, Paraguay, Uruguay, Chile and Colombia). We will soon announce the person responsible for this structure. Alexsandro Broedel will be the bank's CFO, responsible for Finance and Investor Relations, Real Estate and Procurement. Leila Melo will be responsible for Legal, Ombudsman, Institutional Communication, Institutional Relations, Sustainability and Government Relations. Matias Granata will be the CRO, responsible for Market, Credit and Operational Risks, Capital Management, as well as for the Corporate Security, Compliance and Anti- Money Laundering. Ricardo Guerra will be responsible for Technology. Sergio Fajerman will be responsible for People. Candido Bracher will remain in the presidency until February 2, 2021 and until then he will conduct the transition with Milton Maluhy in a structured way. ALEXSANDRO BROEDEL Group Executive Finance Director and Head of Investor Relations CNPJ 60.872.504/0001-23Companhia AbertaNIRE 35300010230 SOURCE Ita Unibanco Holding S.A. Related Links www.itau.com.br
Answer:
|
Ita Unibanco Holding S.A. Announcement to the Market Brazil - Portugus USA - English Ita Unibanco announces new Executive Committee
|
SO PAULO, Dec. 11, 2020 /PRNewswire/ -- Following the nomination of Milton Maluhy Filho as its Chief Executive Officer as of February 2021, Ita Unibanco Holding S.A. ("Ita Unibanco or Company") announced today several changes in its Executive Committee. The new composition aims to bring the Executive Committee even closer to the business, simplify Ita's operation and management model and allow for greater autonomy and speed in decision making. The new Committee will be composed by the following executives: Alexandre Zancani will be responsible for Auto Loans, Mortgage and Consrcio, as well as Ita Correspondente, Digital Customer Acquisition and Retail Credit and Recovery. Andr Rodrigues will be responsible for the Retail Bank (Ita Agencias, Ita Uniclass, Personnalit, Companies, Branches Network, Individual and SME Products, CRM, Digital Channels and User Experience), Insurance and SME Loans. Andr Sapoznik will be responsible for the new Payments structure, covering Credit Cards, Rede, iti and Cash Management. Andr will remain responsible for Operations and Customer Services and will also be in charge of Marketing. Carlos Constantini will be responsible for WMS (Wealth Management and Services), which comprises the areas of Asset Management, Funds of Funds, Private Global and vertical of Investments, Investment Products and Investment Services and Operations. Flavio Souza will be the Chief Executive Officer of Ita BBA, responsible for the Commercial Banking and Corporate and Investment Bank (CIB) areas, including fixed income and equity distribution, and Research, as well as for the Corporate credit department. Additionally, a new structure will be created to encompass Treasury, Corporate Products and Trading Desk, Macroeconomics, as well as the bank's operations in South America ex-Brazil (Argentina, Paraguay, Uruguay, Chile and Colombia). We will soon announce the person responsible for this structure. Alexsandro Broedel will be the bank's CFO, responsible for Finance and Investor Relations, Real Estate and Procurement. Leila Melo will be responsible for Legal, Ombudsman, Institutional Communication, Institutional Relations, Sustainability and Government Relations. Matias Granata will be the CRO, responsible for Market, Credit and Operational Risks, Capital Management, as well as for the Corporate Security, Compliance and Anti- Money Laundering. Ricardo Guerra will be responsible for Technology. Sergio Fajerman will be responsible for People. Candido Bracher will remain in the presidency until February 2, 2021 and until then he will conduct the transition with Milton Maluhy in a structured way. ALEXSANDRO BROEDEL Group Executive Finance Director and Head of Investor Relations CNPJ 60.872.504/0001-23Companhia AbertaNIRE 35300010230 SOURCE Ita Unibanco Holding S.A. Related Links www.itau.com.br
|
edtsum5588
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CHICAGO--(BUSINESS WIRE)--R.R. Donnelley & Sons Company (NYSE:RRD) (RRD or the Company) announced today that it will report fourth quarter results after the close of business on Tuesday, February 23, 2021 and host a conference call and webcast on Wednesday, February 24, 2021 at 11:00 am Eastern time. The full earnings release and a slide presentation will be available on the Investors section of the RRD website or by clicking this link. Participants must register in advance in order to either join the webcast or request the dial-in information to join by telephone. Registration links for both the webcast and the telephone options are available on the Events & Presentations page of the Investor Relations website. For those unable to join live, a replay of the webcast will be available until April 30, 2021 under the Past Events section of the Investor Relations website. About RRD RRD is a leading global provider of multichannel business communications services and marketing solutions. With more than 35,000 employees across 29 countries, RRD offers the industrys most comprehensive offering of solutions designed to help companiesfrom Main Street to Wall Streetoptimize customer engagement and streamline business operations across the complete customer journey. RRD offers a comprehensive portfolio of capabilities, experience and scale that enables organizations around the world to create, manage, deliver, and optimize their marketing and business communications strategies. For more information, visit the Company's web site at www.rrd.com. Use of Forward-Looking Statements This news release may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements and any such forward-looking statements are qualified in their entirety by reference to the following cautionary statements. All forward-looking statements speak only as of the date of this news release and are based on current expectations and involve a number of assumptions, risks, and uncertainties that could cause the actual results to differ materially from such forward-looking statements. Readers are strongly encouraged to read the full cautionary statements contained in RRD's filings with the SEC. RRD disclaims any obligation to update or revise any forward-looking statements.
Answer:
|
RRD to Announce Fourth Quarter Results on February 23rd and Host a Conference Call on February 24th
|
CHICAGO--(BUSINESS WIRE)--R.R. Donnelley & Sons Company (NYSE:RRD) (RRD or the Company) announced today that it will report fourth quarter results after the close of business on Tuesday, February 23, 2021 and host a conference call and webcast on Wednesday, February 24, 2021 at 11:00 am Eastern time. The full earnings release and a slide presentation will be available on the Investors section of the RRD website or by clicking this link. Participants must register in advance in order to either join the webcast or request the dial-in information to join by telephone. Registration links for both the webcast and the telephone options are available on the Events & Presentations page of the Investor Relations website. For those unable to join live, a replay of the webcast will be available until April 30, 2021 under the Past Events section of the Investor Relations website. About RRD RRD is a leading global provider of multichannel business communications services and marketing solutions. With more than 35,000 employees across 29 countries, RRD offers the industrys most comprehensive offering of solutions designed to help companiesfrom Main Street to Wall Streetoptimize customer engagement and streamline business operations across the complete customer journey. RRD offers a comprehensive portfolio of capabilities, experience and scale that enables organizations around the world to create, manage, deliver, and optimize their marketing and business communications strategies. For more information, visit the Company's web site at www.rrd.com. Use of Forward-Looking Statements This news release may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements and any such forward-looking statements are qualified in their entirety by reference to the following cautionary statements. All forward-looking statements speak only as of the date of this news release and are based on current expectations and involve a number of assumptions, risks, and uncertainties that could cause the actual results to differ materially from such forward-looking statements. Readers are strongly encouraged to read the full cautionary statements contained in RRD's filings with the SEC. RRD disclaims any obligation to update or revise any forward-looking statements.
|
edtsum5597
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)-- FORM 8.5 (EPT/NON-RI) PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (RI) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE) Rule 8.5 of the Takeover Code (the Code) 1. KEY INFORMATION 2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Interests Short Positions Number (%) Number (%) (1) 19,655,521 1.27% 4,273,778 0.28% (2) 2,896,714 0.19% 17,996,628 1.16% (3) 0 0.00% 0 0.00% 22,552,235 1.45% 22,270,406 1.44% All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Purchase/sale Total number of Highest price per unit Lowest price per unit securities paid/received paid/received Purchase 2,598,080 20.9809 DKK 20.9644 DKK Purchase 1,179,844 2.5516 GBP 2.538 GBP Sale 61,114 20.8500 DKK 20.85 DKK Sale 3,026,573 2.5517 GBP 2.538 GBP (b) Cash-settled derivative transactions Product Nature of dealing Number of Price per description reference unit securities SWAP Long 42 20.9900 DKK SWAP Long 1,648 2.5453 GBP CFD Long 3,622 20.9281 DKK SWAP Long 4,876 2.5403 GBP CFD Long 28,952 2.5400 GBP SWAP Long 51,468 2.5391 GBP CFD Long 52,185 2.5423 GBP CFD Long 52,662 20.9981 DKK CFD Long 400,000 20.9400 DKK CFD Long 500,000 20.9850 DKK CFD Long 2,234,994 2.5416 GBP CFD Short 39 2.5428 GBP SWAP Short 266 20.8200 DKK CFD Short 1,479 2.5388 GBP SWAP Short 7,356 2.5426 GBP SWAP Short 8,108 2.5469 GBP CFD Short 9,010 20.9183 DKK SWAP Short 11,559 2.5420 GBP CFD Short 12,654 2.5429 GBP CFD Short 49,002 2.5468 GBP SWAP Short 96,501 20.9951 DKK SWAP Short 117,614 2.5418 GBP SWAP Short 148,621 2.5466 GBP SWAP Short 248,991 20.9958 DKK SWAP Short 347,270 2.5408 GBP CFD Short 400,000 2.5447 GBP CFD Short 500,000 2.5502 GBP CFD Short 2,238,524 20.9377 DKK (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none None (c) Attachments 17 Dec 2020 Large Holdings Regulatory Operations 020 3134 7213 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
Answer:
|
FORM 8.5 (EPT/NON-RI) - G4S plc
|
LONDON--(BUSINESS WIRE)-- FORM 8.5 (EPT/NON-RI) PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (RI) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE) Rule 8.5 of the Takeover Code (the Code) 1. KEY INFORMATION 2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Interests Short Positions Number (%) Number (%) (1) 19,655,521 1.27% 4,273,778 0.28% (2) 2,896,714 0.19% 17,996,628 1.16% (3) 0 0.00% 0 0.00% 22,552,235 1.45% 22,270,406 1.44% All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Purchase/sale Total number of Highest price per unit Lowest price per unit securities paid/received paid/received Purchase 2,598,080 20.9809 DKK 20.9644 DKK Purchase 1,179,844 2.5516 GBP 2.538 GBP Sale 61,114 20.8500 DKK 20.85 DKK Sale 3,026,573 2.5517 GBP 2.538 GBP (b) Cash-settled derivative transactions Product Nature of dealing Number of Price per description reference unit securities SWAP Long 42 20.9900 DKK SWAP Long 1,648 2.5453 GBP CFD Long 3,622 20.9281 DKK SWAP Long 4,876 2.5403 GBP CFD Long 28,952 2.5400 GBP SWAP Long 51,468 2.5391 GBP CFD Long 52,185 2.5423 GBP CFD Long 52,662 20.9981 DKK CFD Long 400,000 20.9400 DKK CFD Long 500,000 20.9850 DKK CFD Long 2,234,994 2.5416 GBP CFD Short 39 2.5428 GBP SWAP Short 266 20.8200 DKK CFD Short 1,479 2.5388 GBP SWAP Short 7,356 2.5426 GBP SWAP Short 8,108 2.5469 GBP CFD Short 9,010 20.9183 DKK SWAP Short 11,559 2.5420 GBP CFD Short 12,654 2.5429 GBP CFD Short 49,002 2.5468 GBP SWAP Short 96,501 20.9951 DKK SWAP Short 117,614 2.5418 GBP SWAP Short 148,621 2.5466 GBP SWAP Short 248,991 20.9958 DKK SWAP Short 347,270 2.5408 GBP CFD Short 400,000 2.5447 GBP CFD Short 500,000 2.5502 GBP CFD Short 2,238,524 20.9377 DKK (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none None (c) Attachments 17 Dec 2020 Large Holdings Regulatory Operations 020 3134 7213 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
|
edtsum5603
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PHILADELPHIA--(BUSINESS WIRE)--Today, Delaware Enhanced Global Dividend and Income Fund (NYSE: DEX) (the Fund), a New York Stock Exchangelisted closed-end fund trading under the symbol DEX, announced that, effective September 30, 2020, Michael G. Wildstein will be appointed as co-manager for the Fund. Mr. Wildstein will join sa Annerstedt, Adam H. Brown, Liu-Er Chen, Chris Gowlland, Jens Hansen, Allan Saustrup Jensen, Claus Juul, Nikhil G. Lalvani, John P. McCarthy, and Klaus Petersen in making day-to-day investment decisions for the Fund. Michael G. Wildstein, CFA, Senior Managing Director, is head of US credit and insurance for Macquarie Investment Management Fixed Income (MFI). He manages corporate credit-related portfolios. Before joining the team, he was a senior corporate bond analyst for MFI, focused on the telecommunications sector for high-grade and high yield portfolios. Prior to joining Macquarie Investment Management (MIM) in March 2007 as a senior research analyst, Wildstein spent five years at Merrill Lynch Investment Managers in various roles that included portfolio manager for the core bond team, corporate bond research analyst, and corporate bond trader. Prior to this, Wildstein worked in finance, corporate strategy, and business development with several firms including RCN Corporation and AT&T Local Services. He earned an MBA from Drexel University and a bachelors degree from the University of Tampa. The Funds primary investment objective is to seek current income, with a secondary objective of capital appreciation. The Fund invests globally in dividend-paying or income-generating securities across multiple asset classes, including but not limited to: equity securities of large, well-established companies; securities issued by real estate companies (including real estate investment trusts and real estate industry operating companies); debt securities (such as government bonds; investment grade and high risk, high yield corporate bonds; and convertible bonds); and emerging market securities. The Fund also uses enhanced income strategies by engaging in dividend capture trading; option overwriting; and realization of gains on the sale of securities, dividend growth, and currency forwards. There is no assurance that the Fund will achieve its investment objectives. Under normal market conditions, the Fund will invest: (1) at most 60% of its net assets in securities of U.S. issuers; and (2) at least 40% of its net assets in securities of non-U.S. issuers, unless market conditions are not deemed favorable by the Manager, in which case, the Fund would invest at least 30% of its net assets in securities of non-U.S. issuers; and 3) the Fund may invest up to 25% of its net assets in securities issued by real estate companies (including real estate investment trusts and real estate industry operating companies). In addition, the Fund utilizes leveraging techniques in an attempt to obtain higher return for the Fund. About Macquarie Investment Management Macquarie Investment Management, a member of Macquarie Group, is a global asset manager with offices throughout the United States, Europe, Asia, and Australia. As active managers, we prioritize autonomy and accountability at the team level in pursuit of opportunities that matter for clients. In the US, retail investors recognize our Delaware Funds by Macquarie as one of the longest standing mutual fund families, with more than 90 years in existence. Macquarie Investment Management is supported by the resources of Macquarie Group (ASX: MQG; ADR: MQBKY), a global provider of asset management, investment, banking, financial and advisory services. Advisory services are provided by Macquarie Investment Management Business Trust, a registered investment advisor. Macquarie Group refers to Macquarie Group Limited and its subsidiaries and affiliates worldwide. For more information about Delaware Funds by Macquarie, visit delawarefunds.com or call 800 523-1918. Other than Macquarie Bank Limited (MBL), none of the entities referred to in this document are authorized deposit-taking institutions for the purposes of the Banking Act 1959 (Commonwealth of Australia). The obligations of these entities do not represent deposits or other liabilities of MBL, a subsidiary of Macquarie Group Limited and an affiliate of Macquarie Investment Management. MBL does not guarantee or otherwise provide assurance in respect of the obligations of these entities, unless noted otherwise. 2020 Macquarie Management Holdings, Inc.
Answer:
|
Delaware Enhanced Global Dividend and Income Fund appoints Michael G. Wildstein as co-manager
|
PHILADELPHIA--(BUSINESS WIRE)--Today, Delaware Enhanced Global Dividend and Income Fund (NYSE: DEX) (the Fund), a New York Stock Exchangelisted closed-end fund trading under the symbol DEX, announced that, effective September 30, 2020, Michael G. Wildstein will be appointed as co-manager for the Fund. Mr. Wildstein will join sa Annerstedt, Adam H. Brown, Liu-Er Chen, Chris Gowlland, Jens Hansen, Allan Saustrup Jensen, Claus Juul, Nikhil G. Lalvani, John P. McCarthy, and Klaus Petersen in making day-to-day investment decisions for the Fund. Michael G. Wildstein, CFA, Senior Managing Director, is head of US credit and insurance for Macquarie Investment Management Fixed Income (MFI). He manages corporate credit-related portfolios. Before joining the team, he was a senior corporate bond analyst for MFI, focused on the telecommunications sector for high-grade and high yield portfolios. Prior to joining Macquarie Investment Management (MIM) in March 2007 as a senior research analyst, Wildstein spent five years at Merrill Lynch Investment Managers in various roles that included portfolio manager for the core bond team, corporate bond research analyst, and corporate bond trader. Prior to this, Wildstein worked in finance, corporate strategy, and business development with several firms including RCN Corporation and AT&T Local Services. He earned an MBA from Drexel University and a bachelors degree from the University of Tampa. The Funds primary investment objective is to seek current income, with a secondary objective of capital appreciation. The Fund invests globally in dividend-paying or income-generating securities across multiple asset classes, including but not limited to: equity securities of large, well-established companies; securities issued by real estate companies (including real estate investment trusts and real estate industry operating companies); debt securities (such as government bonds; investment grade and high risk, high yield corporate bonds; and convertible bonds); and emerging market securities. The Fund also uses enhanced income strategies by engaging in dividend capture trading; option overwriting; and realization of gains on the sale of securities, dividend growth, and currency forwards. There is no assurance that the Fund will achieve its investment objectives. Under normal market conditions, the Fund will invest: (1) at most 60% of its net assets in securities of U.S. issuers; and (2) at least 40% of its net assets in securities of non-U.S. issuers, unless market conditions are not deemed favorable by the Manager, in which case, the Fund would invest at least 30% of its net assets in securities of non-U.S. issuers; and 3) the Fund may invest up to 25% of its net assets in securities issued by real estate companies (including real estate investment trusts and real estate industry operating companies). In addition, the Fund utilizes leveraging techniques in an attempt to obtain higher return for the Fund. About Macquarie Investment Management Macquarie Investment Management, a member of Macquarie Group, is a global asset manager with offices throughout the United States, Europe, Asia, and Australia. As active managers, we prioritize autonomy and accountability at the team level in pursuit of opportunities that matter for clients. In the US, retail investors recognize our Delaware Funds by Macquarie as one of the longest standing mutual fund families, with more than 90 years in existence. Macquarie Investment Management is supported by the resources of Macquarie Group (ASX: MQG; ADR: MQBKY), a global provider of asset management, investment, banking, financial and advisory services. Advisory services are provided by Macquarie Investment Management Business Trust, a registered investment advisor. Macquarie Group refers to Macquarie Group Limited and its subsidiaries and affiliates worldwide. For more information about Delaware Funds by Macquarie, visit delawarefunds.com or call 800 523-1918. Other than Macquarie Bank Limited (MBL), none of the entities referred to in this document are authorized deposit-taking institutions for the purposes of the Banking Act 1959 (Commonwealth of Australia). The obligations of these entities do not represent deposits or other liabilities of MBL, a subsidiary of Macquarie Group Limited and an affiliate of Macquarie Investment Management. MBL does not guarantee or otherwise provide assurance in respect of the obligations of these entities, unless noted otherwise. 2020 Macquarie Management Holdings, Inc.
|
edtsum5611
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: OLYMPIA, Wash., Oct. 8, 2020 /PRNewswire/ --Fungi Perfecti, LLC (maker of Host Defense Mushrooms) launched 3 new MycoBotanicals Powders Microbiome, Greens, and Complete Calm, and Elderberry Plus, a mushroom mycelium-based elderberry syrup. Each of the new products contains a hand-crafted, synergistic blend of superfood mushroom mycelium and herbs.All 4 products are available at fungi.comand hostdefense.com, and can also be found at health food stores nationwide.The MycoBotanicalsPowder line now includes 3 new hand-crafted blends of mushrooms and herbs: Microbiome This Pre & Probiotic formula is specially formulated for digestive health.*Made with Lion's Mane, Turkey Tail, and Reishi mushroom mycelium, Marshmallow Root, Burdock, and an extraordinary 10 billion CFUs of shelf-stable probiotics, this synbiotic blend is sure to become a staple for anyone looking to support intestinal and liver health!*Greens Nutritionally charged antioxidant blend.*This blend of Lion's Mane mushroom mycelium, Moringa, and Stinging Nettle is a powerhouse of food-based antioxidants and micronutrients to promote energy, support intestinal health, and balance the immune system when exposed to environmental triggers.*Complete Calm- 2020 NEXTY award WINNER for Best New Condition-Specific Product!This powder is designed to support a calm and relaxed body and mind. Complete Calmhelps both the body and the mind by supporting balanced cortisol levels, quiet overactive thinking, and relaxation for a restful night's sleep.*It has mushroom mycelium from Lion's Mane and Reishi, and a soothing blend of herbs, including: Skullcap, Holy Basil, Passion Flower, and California Poppy.* The Host DefenseMycoBotanicalsPowders line started out with Brain & Bodyand Brain Energy. The addition of Microbiome, Greens, and Complete Calmmeans that regardless of your health goals, Host DefenseMycoBotanicalspowders has a solution for you. With a great-tasting flavor profile, each of the MycoBotanicalsPowders offers convenient wellness support and can be mixed into your favorite beverage, smoothies, or added to food recipes.*Host DefenseMushroomsis excited to introduce a brand-new delivery method: Elderberry Plus Syrup!Elderberry Plus Syrup This delicious-tasting blend of superfood mushroom mycelium and Elderberry is ideal for people seeking daily immune support, respiratory health, and antioxidant activity.*With both Elderberry fruit juice concentrate and fruit extract, plus 333 mgs each of Reishi, Chaga, and Turkey Tail, there is nothing on the market that compares to Host DefenseElderberry Plus syrup.*Whether you're looking for seasonal wellness support, proactive immune-support, or just daily overall health support, Host DefenseElderberry Plus Syrupis a great option right from the bottle or drizzled onto foods or into beverages.*About Host DefenseMushrooms:Host DefenseMushroomsbegan as a direct-to-store manufacturer of mushroom supplements more than 10 yearsago. Today, Host Defense Mushrooms isthe industry leader andthe #1 best-selling mushroom supplement brand in the U.S.But, long before that, Paul Stamets and Fungi Perfecti, LLC were well-known for their ground-breaking research in the field of mycology and mycological solutions to help bees, trees, people & planet. Host Defensesupplements are produced under the supervision of Paul Stamets, D.Sc.* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.Source: SPINS scan Natural / Natural Products Supermarkets > $2MM /Total US Natural Channel / Mushrooms Ingredient Report / 52 Wks 6/14/2020SOURCE Fungi Perfecti Related Links http://www.fungi.com
Answer:
|
Fungi Perfecti - Makers of Host Defense Mushrooms Supplements - Introduces 4 New Mushroom Mycelium Superfood Products Industry leader Host Defense Mushrooms is pleased to announce 4 new specially formulated blends of beneficial mushroom mycelium and herbs!
|
OLYMPIA, Wash., Oct. 8, 2020 /PRNewswire/ --Fungi Perfecti, LLC (maker of Host Defense Mushrooms) launched 3 new MycoBotanicals Powders Microbiome, Greens, and Complete Calm, and Elderberry Plus, a mushroom mycelium-based elderberry syrup. Each of the new products contains a hand-crafted, synergistic blend of superfood mushroom mycelium and herbs.All 4 products are available at fungi.comand hostdefense.com, and can also be found at health food stores nationwide.The MycoBotanicalsPowder line now includes 3 new hand-crafted blends of mushrooms and herbs: Microbiome This Pre & Probiotic formula is specially formulated for digestive health.*Made with Lion's Mane, Turkey Tail, and Reishi mushroom mycelium, Marshmallow Root, Burdock, and an extraordinary 10 billion CFUs of shelf-stable probiotics, this synbiotic blend is sure to become a staple for anyone looking to support intestinal and liver health!*Greens Nutritionally charged antioxidant blend.*This blend of Lion's Mane mushroom mycelium, Moringa, and Stinging Nettle is a powerhouse of food-based antioxidants and micronutrients to promote energy, support intestinal health, and balance the immune system when exposed to environmental triggers.*Complete Calm- 2020 NEXTY award WINNER for Best New Condition-Specific Product!This powder is designed to support a calm and relaxed body and mind. Complete Calmhelps both the body and the mind by supporting balanced cortisol levels, quiet overactive thinking, and relaxation for a restful night's sleep.*It has mushroom mycelium from Lion's Mane and Reishi, and a soothing blend of herbs, including: Skullcap, Holy Basil, Passion Flower, and California Poppy.* The Host DefenseMycoBotanicalsPowders line started out with Brain & Bodyand Brain Energy. The addition of Microbiome, Greens, and Complete Calmmeans that regardless of your health goals, Host DefenseMycoBotanicalspowders has a solution for you. With a great-tasting flavor profile, each of the MycoBotanicalsPowders offers convenient wellness support and can be mixed into your favorite beverage, smoothies, or added to food recipes.*Host DefenseMushroomsis excited to introduce a brand-new delivery method: Elderberry Plus Syrup!Elderberry Plus Syrup This delicious-tasting blend of superfood mushroom mycelium and Elderberry is ideal for people seeking daily immune support, respiratory health, and antioxidant activity.*With both Elderberry fruit juice concentrate and fruit extract, plus 333 mgs each of Reishi, Chaga, and Turkey Tail, there is nothing on the market that compares to Host DefenseElderberry Plus syrup.*Whether you're looking for seasonal wellness support, proactive immune-support, or just daily overall health support, Host DefenseElderberry Plus Syrupis a great option right from the bottle or drizzled onto foods or into beverages.*About Host DefenseMushrooms:Host DefenseMushroomsbegan as a direct-to-store manufacturer of mushroom supplements more than 10 yearsago. Today, Host Defense Mushrooms isthe industry leader andthe #1 best-selling mushroom supplement brand in the U.S.But, long before that, Paul Stamets and Fungi Perfecti, LLC were well-known for their ground-breaking research in the field of mycology and mycological solutions to help bees, trees, people & planet. Host Defensesupplements are produced under the supervision of Paul Stamets, D.Sc.* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.Source: SPINS scan Natural / Natural Products Supermarkets > $2MM /Total US Natural Channel / Mushrooms Ingredient Report / 52 Wks 6/14/2020SOURCE Fungi Perfecti Related Links http://www.fungi.com
|
edtsum5615
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BOSTON--(BUSINESS WIRE)--Find the top OnePlus deals for Black Friday & Cyber Monday 2020, including all the latest OnePlus 8, 8 Pro, 8T, 7, 7 Pro and 7T discounts. Access the full range of deals in the list below. Best OnePlus Deals: Want some more deals? Click here to check out the entire selection of active deals at Walmarts Black Friday & Cyber Monday sale and click here to shop Amazons live Black Friday & Cyber Monday deals. Retail Fuse earns commissions from purchases made using the links provided. About Retail Fuse: Retail Fuse reports the latest retail news. As an Amazon Associate and affiliate Retail Fuse earns from qualifying purchases.
Answer:
|
OnePlus Black Friday & Cyber Monday Deals (2020): OnePlus 8, 8T, 8 Pro, 7, 7T & 7 Pro Savings Reported by Retail Fuse Heres a summary of the latest OnePlus deals for Black Friday & Cyber Monday, including discounts on OnePlus 7 & 8 smartphones
|
BOSTON--(BUSINESS WIRE)--Find the top OnePlus deals for Black Friday & Cyber Monday 2020, including all the latest OnePlus 8, 8 Pro, 8T, 7, 7 Pro and 7T discounts. Access the full range of deals in the list below. Best OnePlus Deals: Want some more deals? Click here to check out the entire selection of active deals at Walmarts Black Friday & Cyber Monday sale and click here to shop Amazons live Black Friday & Cyber Monday deals. Retail Fuse earns commissions from purchases made using the links provided. About Retail Fuse: Retail Fuse reports the latest retail news. As an Amazon Associate and affiliate Retail Fuse earns from qualifying purchases.
|
edtsum5621
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LAS VEGAS, April 7, 2020 /PRNewswire/ --GVB Medical, a division of the hemp-extraction, manufacturing, and cannabinoid research company GVB Biopharma, announced today that it has secured a supply of 200,000 high-quality personal protective equipment (PPE) items for delivery to the American workforce on the front lines of the COVID-19 pandemic. Working with several state governments, GVB has ordered two million more PPE items, with requests to order an additional 30 million from a rich network of FDA-registered suppliers. Continue Reading 3-Ply masks being manufactured at GVB vetted facility These items will be donated or sold below market value, and will include the most critical equipment to help protect American workers: 3-Ply Masks KN95 Respirators Isolation Gowns Goggles Gloves Face Shields Sources for the products were requisitioned by the Chinese government to manufacture PPE at the onset of the COVID-19 outbreak in Wuhan, where the crisis is now subsiding. With highly reputable partners who have formidable respirator production capacity up to one million masks per day and considerable inventories but no domestic market, GVB has utilized its sizeable global supply chain to import KN95 respirators, and other PPE at a time when the United States is in critical need of them.Quality control and process integrity have been the lifeblood of GVB, and this is reflected in the company's PPE procurement. Led by industry veterans and guided by a high-powered quality management system, GVB has deployed its own quality control group to China, ensuring the robustness of supply chains and the finest caliber of products. All products are inspected by GVB employees in China to ensure conformity before being shipped to their final destination. To ensure timely delivery of PPE to the United States, GVB has arranged for dedicated, twice-weekly cargo flights from Hong Kong on an as-needed basis.As companies all over the country do their part to reduce the harm from the current COVID-19 pandemic, GVB is proud to offer affordable PPE that directly addresses the dire current shortage of supplies. With innovative solutions, trusted global relationships, efficient importing capacity and a firm commitment to process integrity, GVB is marshaling its resources to help protect American workers.Media Contact: Sebastian Ravitz (541) 248-2703 [emailprotected]SOURCE GVB Medical
Answer:
|
GVB Medical Secures High-Quality Personal Protective Equipment for American Workers
|
LAS VEGAS, April 7, 2020 /PRNewswire/ --GVB Medical, a division of the hemp-extraction, manufacturing, and cannabinoid research company GVB Biopharma, announced today that it has secured a supply of 200,000 high-quality personal protective equipment (PPE) items for delivery to the American workforce on the front lines of the COVID-19 pandemic. Working with several state governments, GVB has ordered two million more PPE items, with requests to order an additional 30 million from a rich network of FDA-registered suppliers. Continue Reading 3-Ply masks being manufactured at GVB vetted facility These items will be donated or sold below market value, and will include the most critical equipment to help protect American workers: 3-Ply Masks KN95 Respirators Isolation Gowns Goggles Gloves Face Shields Sources for the products were requisitioned by the Chinese government to manufacture PPE at the onset of the COVID-19 outbreak in Wuhan, where the crisis is now subsiding. With highly reputable partners who have formidable respirator production capacity up to one million masks per day and considerable inventories but no domestic market, GVB has utilized its sizeable global supply chain to import KN95 respirators, and other PPE at a time when the United States is in critical need of them.Quality control and process integrity have been the lifeblood of GVB, and this is reflected in the company's PPE procurement. Led by industry veterans and guided by a high-powered quality management system, GVB has deployed its own quality control group to China, ensuring the robustness of supply chains and the finest caliber of products. All products are inspected by GVB employees in China to ensure conformity before being shipped to their final destination. To ensure timely delivery of PPE to the United States, GVB has arranged for dedicated, twice-weekly cargo flights from Hong Kong on an as-needed basis.As companies all over the country do their part to reduce the harm from the current COVID-19 pandemic, GVB is proud to offer affordable PPE that directly addresses the dire current shortage of supplies. With innovative solutions, trusted global relationships, efficient importing capacity and a firm commitment to process integrity, GVB is marshaling its resources to help protect American workers.Media Contact: Sebastian Ravitz (541) 248-2703 [emailprotected]SOURCE GVB Medical
|
edtsum5629
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, March 19, 2021 /PRNewswire/ -- The "Blockchain IoT Market by Component (Hardware (IoT Sensors & Crypto-Wallets), Software and Platform, and Services), Application (Smart Contract, Security, and Asset Tracking and Management), Organization Size, Vertical, and Region - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The global blockchain IoT market size is projected to grow from USD 258 million in 2020 to USD 2,409 million by 2026, at a Compound Annual Growth Rate (CAGR) of 45.1% during the forecast period. The growing need for IoT security, simplified processes supported with transparency and immutability, and high adoption of blockchain-based IoT solutions using smart contracts and AI is expected to surge demand for blockchain IoT market globally. By component, the software and platform segment to grow at a higher CAGR during the forecast period The software for blockchain IoT connects network-based requests placed by users for accessing backend data to the network. The blockchain software components consist of node application, consensus mechanism, virtual machines, and shared ledger. Blockchain helps cumulate technical and business information, fraud detection results, and user behavior data with the rest of the enterprise architecture via real-time demand tools. Software tools help visualize insights for quick and simple data gathering and enhanced predictive capabilities. A blockchain software integrated with IoT ensures secure device communication. The blockchain IoT platform is expected to witness wide adoption during the forecast period as an increasing number of enterprises of all sizes are realizing the benefits offered by this platform. The blockchain IoT software helps enterprises carry out complex tasks in a decentralized digital economy to avert risks, enable secure transactions, and optimize their daily operations, leading to reduced operational costs. This need for increased efficiency and security is expected to drive the adoption of the blockchain IoT market in the future. By application, the asset tracking and management segment to register the highest growth rate during the forecast period Merging IoT with blockchain can not only increase operational efficiency but also ensures a more secure environment. The symphony of IoT and blockchain technology is tremendously contributing to the growth of industries, such as healthcare, transportation, energy and utilities, and supply chain management in asset tracking and management. Asset management is primarily used for planning assets, improving real-time communication, monitoring asset condition, and proactively managing enterprise assets. The blockchain-backed IoT asset tracking and management application drives transparency along clients' supply chains. The combined power of IoT and blockchain helps detect patterns, malfunctions, and anomalies to optimize processes, faster transaction processing, enhanced supply chain traceability, and cost-efficiency. Asia Pacific to register the highest growth rate during the forecast period Asia Pacific (APAC) has witnessed an advanced and dynamic adoption of new technologies and is expected to record the highest CAGR in the global Blockchain IoT market during the forecast period. The Blockchain IoT market in Asia Pacific (APAC) is projected to grow at the highest CAGR during the forecast period. APAC countries are increasingly investing in blockchain IoT projects. The region comprises emerging economies, such as ANZ, China, Japan, Singapore, and rest of APAC countries. With the proliferation of IoT in the APAC region, security and fraud concerns have risen; the integration of blockchain with IoT would enhance enterprise databases' trust and security. Enterprises in the APAC region are embracing blockchain technologies. Companies operating in APAC would benefit from the flexible economic conditions, industrialization-motivated policies, political transformation, and the growing digitalization, which is expected to have a significant impact on the business community and drive the blockchain IoT market growth. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Attractive Opportunities in the Blockchain IoT Market4.2 Blockchain IoT Market, by Component4.3 Blockchain IoT Market, by Hardware4.4 Blockchain IoT Market, by Service4.5 Blockchain IoT Market, by Organization Size4.6 Blockchain IoT Market, by Application4.7 Blockchain IoT Market, by Vertical4.8 Market Investment Scenario 5 Market Overview5.1 Market Dynamics5.1.1 Drivers5.1.1.1 Growing Need for IoT Security5.1.1.2 Simplification of Processes Along with Transparency and Immutability5.1.1.3 Low Operational Costs5.1.2 Restraints5.1.2.1 Limited Number of Blockchain IoT Experts5.1.2.2 Uncertain Regulatory and Compliance Environment5.1.2.3 Scalability, Processing Power, and Storage Issues5.1.3 Opportunities5.1.3.1 Higher Adoption of Blockchain-Based IoT Solutions Using Smart Contracts and Ai5.1.3.2 Combating Deepfake Content Using Blockchain5.1.4 Challenges5.1.4.1 Lack of Awareness Related to Blockchain-Iot Technology5.1.4.2 Security, Privacy, and Control of Blockchain Transactions5.2 COVID-19-Driven Market Dynamics5.2.1 Drivers and Opportunities5.2.2 Restraints and Challenges5.2.3 Cumulative Growth Analysis5.3 Value Chain Analysis5.4 Blockchain Ecosystem5.5 Average Selling Price/Pricing Model, 2019-20205.5.1 IoT Sensors and Crypto-Wallets Average Selling Price5.6 Technology Analysis5.6.1 Big Data Analytics5.6.2 Cloud5.6.3 Other Technologies5.7 Revenue Shift - Yc/Ycc Shift5.8 Patent Analysis5.8.1 Blockchain IoT Patents5.9 Porter's Five Forces Model Analysis5.9.1 Threat of New Entrants5.9.2 Threat of Substitutes5.9.3 Bargaining Power of Suppliers5.9.4 Bargaining Power of Buyers5.9.5 Intensity of Competitive Rivalry5.10 Blockchain Associations and Consortiums5.11 Use Cases 6 Blockchain IoT Market, by Component6.1 Introduction6.2 Hardware6.2.1 Hardware: Blockchain IoT Market Drivers6.2.2 Hardware: COVID-19 Impact6.2.3 IoT Sensors6.2.3.1 Motion Sensors6.2.3.2 Gps6.2.3.3 Temperature Sensors6.2.3.4 Vehicle Information6.2.3.5 Connected Devices6.2.4 Crypto Wallets6.3 Software and Platform6.3.1 Software and Platform: Blockchain IoT Market Drivers6.3.2 Software and Platform: COVID-19 Impact6.4 Services6.4.1 Services: Blockchain IoT Market Drivers6.4.2 Services: COVID-19 Impact6.4.3 Technology Advisory and Consulting Services6.4.4 Development and Integration Services6.4.5 Support and Maintenance 7 Blockchain IoT Market, by Organization Size7.1 Introduction7.2 Large Enterprises7.2.1 Large Enterprises: Blockchain IoT Market Drivers7.2.2 Large Enterprises: COVID-19 Impact7.3 Small and Medium-Sized Enterprises7.3.1 Small and Medium-Sized Enterprises: Blockchain IoT Market Drivers7.3.2 Small and Medium-Sized Enterprises: COVID-19 Impact 8 Blockchain IoT Market, by Application8.1 Introduction8.2 Smart Contracts8.2.1 Smart Contracts: Blockchain IoT Market Drivers8.2.2 Smart Contracts: COVID-19 Impact8.3 Security8.3.1 Security: Blockchain IoT Market Drivers8.3.2 Security: COVID-19 Impact8.4 Data Sharing/Communication8.4.1 Data Sharing/Communication: Blockchain IoT Market Drivers8.4.2 Data Sharing/Communication: COVID-19 Impact8.5 Asset Tracking and Management8.5.1 Asset Tracking and Management: Blockchain IoT Market Drivers8.5.2 Asset Tracking and Management: COVID-19 Impact8.6 Other Applications 9 Blockchain IoT Market, by Vertical9.1 Introduction9.2 Energy and Utilities9.2.1 Energy and Utilities: Blockchain IoT Market Drivers9.2.2 Energy and Utilities: COVID-19 Impact9.3 Transportation and Logistics9.3.1 Transportation and Logistics: Blockchain IoT Market Drivers9.3.2 Transportation and Logistics: COVID-19 Impact9.4 Manufacturing9.4.1 Manufacturing: Blockchain IoT Market Drivers9.4.2 Manufacturing: COVID-19 Impact9.5 Building Management9.5.1 Building Management: Blockchain IoT Market Drivers9.6 Healthcare9.6.1 Healthcare: Blockchain IoT Market Drivers9.6.2 Healthcare: COVID-19 Impact9.7 Retail9.7.1 Retail: Blockchain IoT Market Drivers9.7.2 Retail: COVID-19 Impact9.8 Wearable and Mobile Devices9.8.1 Wearable and Mobile Devices: Blockchain IoT Market Drivers9.8.2 Wearable and Mobile Devices: COVID-19 Impact9.9 Smart City9.9.1 Smart City: Blockchain IoT Market Drivers9.9.2 Smart City: COVID-19 Impact9.10 Other Verticals 10 Blockchain IoT Market, by Region10.1 Introduction10.2 North America10.3 Europe10.4 Asia-Pacific10.5 Middle East and Africa10.6 Latin America 11 Competitive Landscape11.1 Introduction11.2 Market Evaluation Framework11.3 Key Player Strategies/Right to Win11.3.1 Overview of Strategies Adopted by Key Blockchain IoT Vendors11.4 Revenue Share Analysis of Top Market Players11.5 Historic Revenue Analysis11.6 Competitive Evaluation Matrix, 202011.6.1 Star11.6.2 Emerging Leaders11.6.3 Pervasive11.6.4 Participants11.7 Strength of Product Portfolio Analysis of Blockchain IoT Players11.8 Business Strategy Excellence Analysis of Blockchain IoT Players11.9 Startup/SME Evaluation Matrix, 202011.9.1 Progressive Companies11.9.2 Responsive Companies11.9.3 Dynamic Companies11.9.4 Starting Blocks11.10 Ranking of Key Players in the Blockchain IoT Market, 2020 12 Company Profiles12.1 Introduction12.2 Key Players12.2.1 IBM12.2.2 Microsoft12.2.3 Intel12.2.4 Amazon Web Services12.2.5 Huawei12.2.6 Cisco12.2.7 SAP12.2.8 Ethereum Foundation12.2.9 The Linux Foundation12.2.10 R312.2.11 Arctouch12.2.12 Waltonchain12.2.13 Helium12.3 Startup/SME Profiles12.3.1 Factom12.3.2 Hypr12.3.3 Chronicled12.3.4 Krypc12.3.5 IoTex12.3.6 Discovery12.3.7 IoTa12.3.8 Atonomi12.3.9 Xage12.3.10 AmbrosUS12.3.11 Netobjex12.3.12 Grid+ 13 Adjacent Market13.1 Introduction13.2 Limitations13.3 Blockchain Market13.3.1 Introduction13.3.2 by Component13.3.3 by Application Area13.4 AI in IoT Market13.4.1 Introduction13.4.2 by Component13.4.3 by Technology13.5 Blockchain AI Market13.5.1 Introduction13.5.2 by Component 14 Appendix14.1 Discussion Guide14.2 Knowledge Store: The Subscription Portal14.3 Available Customizations14.4 Related Reports14.5 Author Details For more information about this report visit https://www.researchandmarkets.com/r/z6kk0v Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer:
|
The Worldwide Blockchain IoT Industry is Expected to Reach $2.4 Billion by 2026
|
DUBLIN, March 19, 2021 /PRNewswire/ -- The "Blockchain IoT Market by Component (Hardware (IoT Sensors & Crypto-Wallets), Software and Platform, and Services), Application (Smart Contract, Security, and Asset Tracking and Management), Organization Size, Vertical, and Region - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The global blockchain IoT market size is projected to grow from USD 258 million in 2020 to USD 2,409 million by 2026, at a Compound Annual Growth Rate (CAGR) of 45.1% during the forecast period. The growing need for IoT security, simplified processes supported with transparency and immutability, and high adoption of blockchain-based IoT solutions using smart contracts and AI is expected to surge demand for blockchain IoT market globally. By component, the software and platform segment to grow at a higher CAGR during the forecast period The software for blockchain IoT connects network-based requests placed by users for accessing backend data to the network. The blockchain software components consist of node application, consensus mechanism, virtual machines, and shared ledger. Blockchain helps cumulate technical and business information, fraud detection results, and user behavior data with the rest of the enterprise architecture via real-time demand tools. Software tools help visualize insights for quick and simple data gathering and enhanced predictive capabilities. A blockchain software integrated with IoT ensures secure device communication. The blockchain IoT platform is expected to witness wide adoption during the forecast period as an increasing number of enterprises of all sizes are realizing the benefits offered by this platform. The blockchain IoT software helps enterprises carry out complex tasks in a decentralized digital economy to avert risks, enable secure transactions, and optimize their daily operations, leading to reduced operational costs. This need for increased efficiency and security is expected to drive the adoption of the blockchain IoT market in the future. By application, the asset tracking and management segment to register the highest growth rate during the forecast period Merging IoT with blockchain can not only increase operational efficiency but also ensures a more secure environment. The symphony of IoT and blockchain technology is tremendously contributing to the growth of industries, such as healthcare, transportation, energy and utilities, and supply chain management in asset tracking and management. Asset management is primarily used for planning assets, improving real-time communication, monitoring asset condition, and proactively managing enterprise assets. The blockchain-backed IoT asset tracking and management application drives transparency along clients' supply chains. The combined power of IoT and blockchain helps detect patterns, malfunctions, and anomalies to optimize processes, faster transaction processing, enhanced supply chain traceability, and cost-efficiency. Asia Pacific to register the highest growth rate during the forecast period Asia Pacific (APAC) has witnessed an advanced and dynamic adoption of new technologies and is expected to record the highest CAGR in the global Blockchain IoT market during the forecast period. The Blockchain IoT market in Asia Pacific (APAC) is projected to grow at the highest CAGR during the forecast period. APAC countries are increasingly investing in blockchain IoT projects. The region comprises emerging economies, such as ANZ, China, Japan, Singapore, and rest of APAC countries. With the proliferation of IoT in the APAC region, security and fraud concerns have risen; the integration of blockchain with IoT would enhance enterprise databases' trust and security. Enterprises in the APAC region are embracing blockchain technologies. Companies operating in APAC would benefit from the flexible economic conditions, industrialization-motivated policies, political transformation, and the growing digitalization, which is expected to have a significant impact on the business community and drive the blockchain IoT market growth. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Attractive Opportunities in the Blockchain IoT Market4.2 Blockchain IoT Market, by Component4.3 Blockchain IoT Market, by Hardware4.4 Blockchain IoT Market, by Service4.5 Blockchain IoT Market, by Organization Size4.6 Blockchain IoT Market, by Application4.7 Blockchain IoT Market, by Vertical4.8 Market Investment Scenario 5 Market Overview5.1 Market Dynamics5.1.1 Drivers5.1.1.1 Growing Need for IoT Security5.1.1.2 Simplification of Processes Along with Transparency and Immutability5.1.1.3 Low Operational Costs5.1.2 Restraints5.1.2.1 Limited Number of Blockchain IoT Experts5.1.2.2 Uncertain Regulatory and Compliance Environment5.1.2.3 Scalability, Processing Power, and Storage Issues5.1.3 Opportunities5.1.3.1 Higher Adoption of Blockchain-Based IoT Solutions Using Smart Contracts and Ai5.1.3.2 Combating Deepfake Content Using Blockchain5.1.4 Challenges5.1.4.1 Lack of Awareness Related to Blockchain-Iot Technology5.1.4.2 Security, Privacy, and Control of Blockchain Transactions5.2 COVID-19-Driven Market Dynamics5.2.1 Drivers and Opportunities5.2.2 Restraints and Challenges5.2.3 Cumulative Growth Analysis5.3 Value Chain Analysis5.4 Blockchain Ecosystem5.5 Average Selling Price/Pricing Model, 2019-20205.5.1 IoT Sensors and Crypto-Wallets Average Selling Price5.6 Technology Analysis5.6.1 Big Data Analytics5.6.2 Cloud5.6.3 Other Technologies5.7 Revenue Shift - Yc/Ycc Shift5.8 Patent Analysis5.8.1 Blockchain IoT Patents5.9 Porter's Five Forces Model Analysis5.9.1 Threat of New Entrants5.9.2 Threat of Substitutes5.9.3 Bargaining Power of Suppliers5.9.4 Bargaining Power of Buyers5.9.5 Intensity of Competitive Rivalry5.10 Blockchain Associations and Consortiums5.11 Use Cases 6 Blockchain IoT Market, by Component6.1 Introduction6.2 Hardware6.2.1 Hardware: Blockchain IoT Market Drivers6.2.2 Hardware: COVID-19 Impact6.2.3 IoT Sensors6.2.3.1 Motion Sensors6.2.3.2 Gps6.2.3.3 Temperature Sensors6.2.3.4 Vehicle Information6.2.3.5 Connected Devices6.2.4 Crypto Wallets6.3 Software and Platform6.3.1 Software and Platform: Blockchain IoT Market Drivers6.3.2 Software and Platform: COVID-19 Impact6.4 Services6.4.1 Services: Blockchain IoT Market Drivers6.4.2 Services: COVID-19 Impact6.4.3 Technology Advisory and Consulting Services6.4.4 Development and Integration Services6.4.5 Support and Maintenance 7 Blockchain IoT Market, by Organization Size7.1 Introduction7.2 Large Enterprises7.2.1 Large Enterprises: Blockchain IoT Market Drivers7.2.2 Large Enterprises: COVID-19 Impact7.3 Small and Medium-Sized Enterprises7.3.1 Small and Medium-Sized Enterprises: Blockchain IoT Market Drivers7.3.2 Small and Medium-Sized Enterprises: COVID-19 Impact 8 Blockchain IoT Market, by Application8.1 Introduction8.2 Smart Contracts8.2.1 Smart Contracts: Blockchain IoT Market Drivers8.2.2 Smart Contracts: COVID-19 Impact8.3 Security8.3.1 Security: Blockchain IoT Market Drivers8.3.2 Security: COVID-19 Impact8.4 Data Sharing/Communication8.4.1 Data Sharing/Communication: Blockchain IoT Market Drivers8.4.2 Data Sharing/Communication: COVID-19 Impact8.5 Asset Tracking and Management8.5.1 Asset Tracking and Management: Blockchain IoT Market Drivers8.5.2 Asset Tracking and Management: COVID-19 Impact8.6 Other Applications 9 Blockchain IoT Market, by Vertical9.1 Introduction9.2 Energy and Utilities9.2.1 Energy and Utilities: Blockchain IoT Market Drivers9.2.2 Energy and Utilities: COVID-19 Impact9.3 Transportation and Logistics9.3.1 Transportation and Logistics: Blockchain IoT Market Drivers9.3.2 Transportation and Logistics: COVID-19 Impact9.4 Manufacturing9.4.1 Manufacturing: Blockchain IoT Market Drivers9.4.2 Manufacturing: COVID-19 Impact9.5 Building Management9.5.1 Building Management: Blockchain IoT Market Drivers9.6 Healthcare9.6.1 Healthcare: Blockchain IoT Market Drivers9.6.2 Healthcare: COVID-19 Impact9.7 Retail9.7.1 Retail: Blockchain IoT Market Drivers9.7.2 Retail: COVID-19 Impact9.8 Wearable and Mobile Devices9.8.1 Wearable and Mobile Devices: Blockchain IoT Market Drivers9.8.2 Wearable and Mobile Devices: COVID-19 Impact9.9 Smart City9.9.1 Smart City: Blockchain IoT Market Drivers9.9.2 Smart City: COVID-19 Impact9.10 Other Verticals 10 Blockchain IoT Market, by Region10.1 Introduction10.2 North America10.3 Europe10.4 Asia-Pacific10.5 Middle East and Africa10.6 Latin America 11 Competitive Landscape11.1 Introduction11.2 Market Evaluation Framework11.3 Key Player Strategies/Right to Win11.3.1 Overview of Strategies Adopted by Key Blockchain IoT Vendors11.4 Revenue Share Analysis of Top Market Players11.5 Historic Revenue Analysis11.6 Competitive Evaluation Matrix, 202011.6.1 Star11.6.2 Emerging Leaders11.6.3 Pervasive11.6.4 Participants11.7 Strength of Product Portfolio Analysis of Blockchain IoT Players11.8 Business Strategy Excellence Analysis of Blockchain IoT Players11.9 Startup/SME Evaluation Matrix, 202011.9.1 Progressive Companies11.9.2 Responsive Companies11.9.3 Dynamic Companies11.9.4 Starting Blocks11.10 Ranking of Key Players in the Blockchain IoT Market, 2020 12 Company Profiles12.1 Introduction12.2 Key Players12.2.1 IBM12.2.2 Microsoft12.2.3 Intel12.2.4 Amazon Web Services12.2.5 Huawei12.2.6 Cisco12.2.7 SAP12.2.8 Ethereum Foundation12.2.9 The Linux Foundation12.2.10 R312.2.11 Arctouch12.2.12 Waltonchain12.2.13 Helium12.3 Startup/SME Profiles12.3.1 Factom12.3.2 Hypr12.3.3 Chronicled12.3.4 Krypc12.3.5 IoTex12.3.6 Discovery12.3.7 IoTa12.3.8 Atonomi12.3.9 Xage12.3.10 AmbrosUS12.3.11 Netobjex12.3.12 Grid+ 13 Adjacent Market13.1 Introduction13.2 Limitations13.3 Blockchain Market13.3.1 Introduction13.3.2 by Component13.3.3 by Application Area13.4 AI in IoT Market13.4.1 Introduction13.4.2 by Component13.4.3 by Technology13.5 Blockchain AI Market13.5.1 Introduction13.5.2 by Component 14 Appendix14.1 Discussion Guide14.2 Knowledge Store: The Subscription Portal14.3 Available Customizations14.4 Related Reports14.5 Author Details For more information about this report visit https://www.researchandmarkets.com/r/z6kk0v Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
|
edtsum5630
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LINZ & LONDON--(BUSINESS WIRE)--Mindbreeze is pleased to announce a new partnership with Akeydor Ltd, a specialized IT consulting services company focusing on both out-of-the-box and custom software automation solutions. Akeydor Ltd implements software for remote access, remote support, and classroom management that serves distance and remote contexts for both teaching and learning. Mindbreezes customer base is growing globally with over 2.000 customers worldwide. Helping their customers align with the future of digitization and online learning, the Mindbreeze InSpire insight engine provides quick indexing of data and enables information crawling. Uniting knowledge and information from company-internal data sources into one semantic search index, Mindbreeze InSpire makes analyzing, understanding, and finding of largest volumes of information efficient and easy. Akeydor Ltd has partnered with Mindbreeze to offer customers a best-in-class cognitive search experience. Through this new partnership, Akeydor Ltd will have the ability to provide customers with the leading service in enterprise search and digital transformation. We are excited to launch a new partnership with Mindbreeze. As our customers continue to accelerate their digital transformation in both corporate and classroom settings, they will now receive the highest quality product available on the market for enterprise search, said Michael Chatzilias, founder and CEO of Akeydor Ltd. We warmly welcome Akeydor Ltd into our select group of strategic partnerships. Since our main focus is on enterprise search and artificial intelligence, it helps make this an excellent alliance. Partnering with Akeydor Ltd will allow us to expand into new corporate and educational verticals, explains Daniel Fallmann, founder and CEO of Mindbreeze. About Akeydor Akeydor Limited today is the Leader in Remote Control and Classroom Management Technology. Their philosophy is that leadership is a state of mind, not something that can be taught, and the personalities of leaders make companies thrive. Based in London, United Kingdom and Athens, Greece, Akeydor Ltd has been in business since 2007, bringing customers relevant software solutions for classroom management, endpoint security, and more. About Mindbreeze Mindbreeze is a leading international provider of appliances and cloud services for enterprise search, applied artificial intelligence, and knowledge management. Mindbreezes global network of partners enables the company to serve customers anywhere in the world across all time zones. You can find more information at https://www.mindbreeze.com or follow us on LinkedIn and Twitter @Mindbreeze.
Answer:
|
Mindbreeze partners with Akeydor Limited to bring customers best-in-class enterprise search solutions
|
LINZ & LONDON--(BUSINESS WIRE)--Mindbreeze is pleased to announce a new partnership with Akeydor Ltd, a specialized IT consulting services company focusing on both out-of-the-box and custom software automation solutions. Akeydor Ltd implements software for remote access, remote support, and classroom management that serves distance and remote contexts for both teaching and learning. Mindbreezes customer base is growing globally with over 2.000 customers worldwide. Helping their customers align with the future of digitization and online learning, the Mindbreeze InSpire insight engine provides quick indexing of data and enables information crawling. Uniting knowledge and information from company-internal data sources into one semantic search index, Mindbreeze InSpire makes analyzing, understanding, and finding of largest volumes of information efficient and easy. Akeydor Ltd has partnered with Mindbreeze to offer customers a best-in-class cognitive search experience. Through this new partnership, Akeydor Ltd will have the ability to provide customers with the leading service in enterprise search and digital transformation. We are excited to launch a new partnership with Mindbreeze. As our customers continue to accelerate their digital transformation in both corporate and classroom settings, they will now receive the highest quality product available on the market for enterprise search, said Michael Chatzilias, founder and CEO of Akeydor Ltd. We warmly welcome Akeydor Ltd into our select group of strategic partnerships. Since our main focus is on enterprise search and artificial intelligence, it helps make this an excellent alliance. Partnering with Akeydor Ltd will allow us to expand into new corporate and educational verticals, explains Daniel Fallmann, founder and CEO of Mindbreeze. About Akeydor Akeydor Limited today is the Leader in Remote Control and Classroom Management Technology. Their philosophy is that leadership is a state of mind, not something that can be taught, and the personalities of leaders make companies thrive. Based in London, United Kingdom and Athens, Greece, Akeydor Ltd has been in business since 2007, bringing customers relevant software solutions for classroom management, endpoint security, and more. About Mindbreeze Mindbreeze is a leading international provider of appliances and cloud services for enterprise search, applied artificial intelligence, and knowledge management. Mindbreezes global network of partners enables the company to serve customers anywhere in the world across all time zones. You can find more information at https://www.mindbreeze.com or follow us on LinkedIn and Twitter @Mindbreeze.
|
edtsum5642
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: WASHINGTON, Oct. 28, 2020 /PRNewswire/ -- With millions of Americans losing their employer coverage, record numbers could be choosing a plan on the Marketplace for the first time. Unfortunately, without the right advice they will probably pick the wrong plan, costing them thousands of dollars and unknown health repercussions. Luckily, the experts at National Patient Advocate Foundation are here to help. Rebecca Kirch, executive vice president of programs and policy, knows how often people get overwhelmed and rush the process. "Regardless of whether you are new to the Marketplace or have enrolled before, taking your time during open enrollment to evaluate your needs and choose the correct plan could save you thousands of dollars." With open enrollment starting on November 1, Kirch advises that patients take the time to "do a health care audit" and critically evaluate their plans, their doctors and their treatment plans to make sure they are working for them. "Open enrollment is a good time to ask everything from whether you're comfortable with your doctor to if you could switch to generics and save money on prescription drugs," she noted. Other expert tips include: Know the deadlines and don't miss them. For instance, while open enrollment for the federally-run Marketplace begins on November 1st and closes on December 15th, states that run their own Marketplaces may have extended deadlines. Buyer beware, though: if you buy a plan after the new year, your coverage will not begin for several weeks, if not months. Consider all types of out-of-pocket spending. Most people tend to pick a plan based on the monthly premium, but that's not enough to really understand what your costs will be. Equally important costs to consider are the deductible and your copays or coinsurance. Unsure of a term? Find out before committing to a plan. People encounter plenty of unfamiliar words that are unique to health insurance but not knowing what a term means could hurt your budget. If you don't know what a term means, look it up using Patient Advocate Foundation's Patient Healthcare Glossary. Bronze may not be for you. Marketplace plans are tiered as Bronze, Silver, Gold and Platinum with increasing levels of coverage. While the Bronze plan will have the smallest monthly premium, the Silver plan may ultimately cover more of your costs. Consider your subsidy first. Enter your annual household income on healthcare.gov before comparing plans to see premium rates personalized for you. You may also be eligible for assistance paying your out-of-pocket costs. Most people do receive financial assistance. Remember, too, that plans on the Marketplace may look more expensive at first, but they're the only place you can use that federal subsidy. Buy a comprehensive plan to avoid surprises. Short-term plans or health care sharing ministries may look like a good bargain, but they often won't cover you when you really need it, or require you to pay even more money upfront while you wait for reimbursement. Stay in-network. Before committing to a plan for the year, make sure that your preferred providers will be in-network on that plan. Review, review, review: Almost all insurance plans can change their benefit structure annually. Even if your plan stays the same, your own medical needs may change. Review your coverage every year to make sure that you are enrolled in the best plan for your needs. NPAF provides a free guide to choosing a Marketplace health plan on its website, where users can also access the entire library of educational materials available from the Patient Advocate Foundation. "We know that choosing a plan can be daunting, but with the right tools and enough time, we're confident people can make good choices," said Kirch. National Patient Advocate Foundation is a national non-profit organization advocating for access to affordable, equitable care for people nationwide. As it advocates for patients, it also teaches patients to advocate for themselves. Learn more at www.npaf.org. Caitlin DonovanSenior Director, National Patient Advocate Foundation202-465-5113[emailprotected] SOURCE National Patient Advocate Foundation Related Links http://www.npaf.org
Answer:
|
8 Tips For Picking the Best Marketplace Health Plan
|
WASHINGTON, Oct. 28, 2020 /PRNewswire/ -- With millions of Americans losing their employer coverage, record numbers could be choosing a plan on the Marketplace for the first time. Unfortunately, without the right advice they will probably pick the wrong plan, costing them thousands of dollars and unknown health repercussions. Luckily, the experts at National Patient Advocate Foundation are here to help. Rebecca Kirch, executive vice president of programs and policy, knows how often people get overwhelmed and rush the process. "Regardless of whether you are new to the Marketplace or have enrolled before, taking your time during open enrollment to evaluate your needs and choose the correct plan could save you thousands of dollars." With open enrollment starting on November 1, Kirch advises that patients take the time to "do a health care audit" and critically evaluate their plans, their doctors and their treatment plans to make sure they are working for them. "Open enrollment is a good time to ask everything from whether you're comfortable with your doctor to if you could switch to generics and save money on prescription drugs," she noted. Other expert tips include: Know the deadlines and don't miss them. For instance, while open enrollment for the federally-run Marketplace begins on November 1st and closes on December 15th, states that run their own Marketplaces may have extended deadlines. Buyer beware, though: if you buy a plan after the new year, your coverage will not begin for several weeks, if not months. Consider all types of out-of-pocket spending. Most people tend to pick a plan based on the monthly premium, but that's not enough to really understand what your costs will be. Equally important costs to consider are the deductible and your copays or coinsurance. Unsure of a term? Find out before committing to a plan. People encounter plenty of unfamiliar words that are unique to health insurance but not knowing what a term means could hurt your budget. If you don't know what a term means, look it up using Patient Advocate Foundation's Patient Healthcare Glossary. Bronze may not be for you. Marketplace plans are tiered as Bronze, Silver, Gold and Platinum with increasing levels of coverage. While the Bronze plan will have the smallest monthly premium, the Silver plan may ultimately cover more of your costs. Consider your subsidy first. Enter your annual household income on healthcare.gov before comparing plans to see premium rates personalized for you. You may also be eligible for assistance paying your out-of-pocket costs. Most people do receive financial assistance. Remember, too, that plans on the Marketplace may look more expensive at first, but they're the only place you can use that federal subsidy. Buy a comprehensive plan to avoid surprises. Short-term plans or health care sharing ministries may look like a good bargain, but they often won't cover you when you really need it, or require you to pay even more money upfront while you wait for reimbursement. Stay in-network. Before committing to a plan for the year, make sure that your preferred providers will be in-network on that plan. Review, review, review: Almost all insurance plans can change their benefit structure annually. Even if your plan stays the same, your own medical needs may change. Review your coverage every year to make sure that you are enrolled in the best plan for your needs. NPAF provides a free guide to choosing a Marketplace health plan on its website, where users can also access the entire library of educational materials available from the Patient Advocate Foundation. "We know that choosing a plan can be daunting, but with the right tools and enough time, we're confident people can make good choices," said Kirch. National Patient Advocate Foundation is a national non-profit organization advocating for access to affordable, equitable care for people nationwide. As it advocates for patients, it also teaches patients to advocate for themselves. Learn more at www.npaf.org. Caitlin DonovanSenior Director, National Patient Advocate Foundation202-465-5113[emailprotected] SOURCE National Patient Advocate Foundation Related Links http://www.npaf.org
|
edtsum5646
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BAUDETTE, Minn., April 30, 2020 /PRNewswire/ --ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its first quarter 2020 financial results on Thursday, May 7, 2020, before the opening of the U.S. financial markets. The earnings press release will be accessible through the Investor Relations section of the Company's website, www.anipharmaceuticals.com. Arthur S. Przybyl, President and Chief Executive Officer, and Stephen P. Carey, Vice President, Finance, and Chief Financial Officer, also plan to host a conference call to review those results starting at 10:30am Eastern Time on Thursday, May 7, 2020. The call will be open to the public and can be accessed through a conference line by dialing (866) 776-8875. The conference ID is 5243607. A recording of the conference call will be available within two hours of the completion of the call and will remain accessible for a period of seven days following the call. To access the replay, dial (800) 585-8367. The access code for the replay is 5243607. About ANI ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. The Company's targeted areas of product development currently include controlled substances, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products. For more information, please visit our website www.anipharmaceuticals.com. For more information about ANI, please contact:Investor Relations[emailprotected] SOURCE ANI Pharmaceuticals, Inc. Related Links www.anipharmaceuticals.com
Answer:
|
ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2020 Financial Results
|
BAUDETTE, Minn., April 30, 2020 /PRNewswire/ --ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its first quarter 2020 financial results on Thursday, May 7, 2020, before the opening of the U.S. financial markets. The earnings press release will be accessible through the Investor Relations section of the Company's website, www.anipharmaceuticals.com. Arthur S. Przybyl, President and Chief Executive Officer, and Stephen P. Carey, Vice President, Finance, and Chief Financial Officer, also plan to host a conference call to review those results starting at 10:30am Eastern Time on Thursday, May 7, 2020. The call will be open to the public and can be accessed through a conference line by dialing (866) 776-8875. The conference ID is 5243607. A recording of the conference call will be available within two hours of the completion of the call and will remain accessible for a period of seven days following the call. To access the replay, dial (800) 585-8367. The access code for the replay is 5243607. About ANI ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. The Company's targeted areas of product development currently include controlled substances, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products. For more information, please visit our website www.anipharmaceuticals.com. For more information about ANI, please contact:Investor Relations[emailprotected] SOURCE ANI Pharmaceuticals, Inc. Related Links www.anipharmaceuticals.com
|
edtsum5648
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SHOREHAM-BY-SEA, England--(BUSINESS WIRE)--As part of its mission to support the decarbonisation of the global transport and energy sectors, Ricardo, a world-class environmental, engineering and strategic consulting company, has today announced an initial investment of 2.5million to build a hydrogen development and test facility at its Shoreham Technical Centre in the UK. Designed to support the companys existing work in hydrogen, fuel cells and green alternative fuels, the new facility will deliver state-of-the-art test and development to advance capability in both alternative fuels and electric vehicles. It will significantly increase the range of hydrogen and fuel cell services and solutions which can be delivered to Ricardos global customers. Steve Dyke, Managing Director of Ricardo Automotive and Industrial said: We are already working with a range of clients on hydrogen and fuel cell technology, providing clean efficient solutions which reduce carbon and noxious emissions across a wide range of sectors. By building our hydrogen fuel cell and propulsion capability, we shall further advance our facilities and technology for clean vehicles across all transport sectors, and increase the range of hydrogen and fuel cell services and solutions that we can offer to our clients. A particular focus for the new facility will be a systems-led approach to vehicle development, integrating our enhanced test capability with our leading-edge digital and simulation tools to deliver fully optimised hardware and software system solutions for our customers. This will further enhance our established digital engineering expertise, allowing the company to provide solutions which: are greener because they are less energy and resource-intensive; remove risk from development through more efficient, faster digital techniques; and reduce cost and time to market to provide competitive advantage. This investment is a further boost to Ricardos hydrogen capability, following the companys announcement on 14 January 2021 of a collaboration with AFC Energy plc aimed at identifying new and innovative alternative fuel solutions, including hydrogen power applications. Fuel cell test facilities with this level of capability to develop and test hydrogen technologies are rare across the globe, so this investment will accelerate Ricardos position as a leader in hydrogen transport technology. Ends About Ricardo Ricardo plc is a world-class environmental, engineering and strategic consulting company listed on the London Stock Exchange. With over 100 years of engineering excellence, we provide exceptional levels of expertise in delivering leading edge and innovative cross sector sustainable products and solutions, helping our global customers increase efficiencies, achieve growth and create a clear and safer future. Our mission is clear -- to create a world fit for the future. For more information visit www.ricardo.com About Ricardo Automotive and Industrial Division Ricardo Automotive & Industrial Ricardo Automotive and Industrial, a division of Ricardo plc, provides global engineering services for OEMs across all transport sectors. The vision is to be the consulting partner of choice for clean efficient, integrated propulsion and energy solutions, underpinned by digitisation. Ricardo is a supporter of the UK Hydrogen Strategy Now campaign. This group of leading UK businesses which has together committed to invest 3bn into hydrogen projects is calling on the Chancellor of the Exchequer for a UK-wide hydrogen strategy.
Answer:
|
Ricardo Invests in a Hydrogen Development and Testing Facility Leading the Way in the Future of Sustainable Transport Designed to leverage and extend Ricardos expertise in building solutions to support zero emission mobility, this new facility will form part of a global centre of excellence for hydrogen, defossilised fuels and electrified transport engineering.
|
SHOREHAM-BY-SEA, England--(BUSINESS WIRE)--As part of its mission to support the decarbonisation of the global transport and energy sectors, Ricardo, a world-class environmental, engineering and strategic consulting company, has today announced an initial investment of 2.5million to build a hydrogen development and test facility at its Shoreham Technical Centre in the UK. Designed to support the companys existing work in hydrogen, fuel cells and green alternative fuels, the new facility will deliver state-of-the-art test and development to advance capability in both alternative fuels and electric vehicles. It will significantly increase the range of hydrogen and fuel cell services and solutions which can be delivered to Ricardos global customers. Steve Dyke, Managing Director of Ricardo Automotive and Industrial said: We are already working with a range of clients on hydrogen and fuel cell technology, providing clean efficient solutions which reduce carbon and noxious emissions across a wide range of sectors. By building our hydrogen fuel cell and propulsion capability, we shall further advance our facilities and technology for clean vehicles across all transport sectors, and increase the range of hydrogen and fuel cell services and solutions that we can offer to our clients. A particular focus for the new facility will be a systems-led approach to vehicle development, integrating our enhanced test capability with our leading-edge digital and simulation tools to deliver fully optimised hardware and software system solutions for our customers. This will further enhance our established digital engineering expertise, allowing the company to provide solutions which: are greener because they are less energy and resource-intensive; remove risk from development through more efficient, faster digital techniques; and reduce cost and time to market to provide competitive advantage. This investment is a further boost to Ricardos hydrogen capability, following the companys announcement on 14 January 2021 of a collaboration with AFC Energy plc aimed at identifying new and innovative alternative fuel solutions, including hydrogen power applications. Fuel cell test facilities with this level of capability to develop and test hydrogen technologies are rare across the globe, so this investment will accelerate Ricardos position as a leader in hydrogen transport technology. Ends About Ricardo Ricardo plc is a world-class environmental, engineering and strategic consulting company listed on the London Stock Exchange. With over 100 years of engineering excellence, we provide exceptional levels of expertise in delivering leading edge and innovative cross sector sustainable products and solutions, helping our global customers increase efficiencies, achieve growth and create a clear and safer future. Our mission is clear -- to create a world fit for the future. For more information visit www.ricardo.com About Ricardo Automotive and Industrial Division Ricardo Automotive & Industrial Ricardo Automotive and Industrial, a division of Ricardo plc, provides global engineering services for OEMs across all transport sectors. The vision is to be the consulting partner of choice for clean efficient, integrated propulsion and energy solutions, underpinned by digitisation. Ricardo is a supporter of the UK Hydrogen Strategy Now campaign. This group of leading UK businesses which has together committed to invest 3bn into hydrogen projects is calling on the Chancellor of the Exchequer for a UK-wide hydrogen strategy.
|
edtsum5650
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, Aug. 25, 2020 /PRNewswire/ -- The "Data Annotation Tools Market to 2027 - Global Analysis and Forecasts by Type; Annotation Type; End-user" report has been added to ResearchAndMarkets.com's offering. The global data annotation tools market was valued at US$ 695.5 million in 2019 and is projected to reach US$ 6,450.0 million by 2027; it is expected to grow at a CAGR of 32.54% from 2020 to 2027.The process of data annotation includes labeling of data which makes it usable for machine learning. Data annotation tools are important for data scientists as they make use of the labeled data with machine learning algorithms. Data can be in any form, such as images (from cars, phones, or medical instruments), text (in English, Spanish, Chinese, and among others), audio, and video. There are different types of annotation techniques like polygon annotation, semantic segmentation, bounding box annotation, landmark annotation, polylines annotation, and 3D point cloud annotation. In house teams can label the data if it is a small set, but this can be time consuming. When large amount of data is to be annotated, it is outsourced to companies like Precise BPO Solution, who can handle millions of annotations in a week and it significantly saves time. Further, the increasing investments by various market players in data annotation techniques in order to offer high quality labeled data are expected to play a significant role in the growth of the market.The applications of data annotation are growing strongly across the globe. Face detection and recognition is one of the major applications of data annotation. Countries across the globe are implementing various facial technologies to create social status and award penalties for public menace to its citizens. For instance, China has installed 200 million surveillance cameras, one camera for every seven of its citizens. It plans to install about 400 million new cameras by 2021 in the country, for security and traffic control purposes.The market for data annotation tools has been segmented into type, annotation type, end user, and geography. Based on type, the data annotation tools market has been segmented into text, image, and others. Based on annotation type, the data annotation tools market has been segmented into manual, semi-supervised, and automatic. Based on end user, the data annotation tools market has been segmented into automotive, government, healthcare, financial services, retail, IT & telecom, and others. Geographically, the data annotation tools market is segmented into five regions: North America, Europe, APAC, MEA, and South America.Appen Limited, CloudFactory Limited, Cogito, Deep Systems, Google LLC, Labelbox, Inc, LIGHTTAG, Tagtog Sp. z o.o., PLAYMENT INC., and SCALE AI, INC. are some of the well-established market players present in the global data annotation tools market.Reasons to Buy: Highlights key business priorities in order to assist companies to realign their business strategies. The key findings and recommendations highlight crucial progressive industry trends in the data annotation tools market, thereby allowing players to develop effective long-term strategies. Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it. Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to components, aircraft type, and end-users. Key Topics Covered: 1. Introduction1.1 Study Scope1.2 Report Guidance1.3 Market Segmentation2. Key Takeaways3. Research Methodology3.1 Coverage3.2 Secondary Research3.3 Primary Research4. Data Annotation Tools Market Landscape4.1 Market Overview4.2 PEST Analysis4.2.1 North America PEST Analysis4.2.2 Europe PEST Analysis4.2.3 APAC PEST Analysis4.2.4 MEA PEST Analysis4.2.5 SAM PEST Analysis4.3 Ecosystem Analysis4.4 Expert Opinions5. Data Annotation Tools Market - Key Industry Dynamics5.1 Drivers5.1.1 Growing Applications of Data Annotation5.1.2 Increasing Investments by Market Players5.2 Market Restraints5.2.1 Lack of Skilled Labor and Disadvantages Associated with Annotation Techniques5.3 Market Opportunities5.3.1 Trend of e-Education Across the world5.4 Future Trends5.4.1 Increasing Organic Development by Market Players5.5 Impact Analysis of Drivers and Restraints6. Data Annotation Tools Market - Global Market Analysis6.1 Data Annotation Tools Market Overview6.2 Data Annotation Tools Market -Revenue, and Forecast to 2027 (US$ Million)6.3 Market Positioning - Global Key Players7. Data Annotation Tools Market Analysis - By Type7.1 Overview7.2 Global Data Annotation Tools Market Breakdown, By Type, 2017 & 20277.3 Text7.3.1 Overview7.3.2 Text Market Revenue and Forecast to 2027 (US$ Mn)7.4 Image7.4.1 Overview7.4.2 Image Market Revenue and Forecast to 2027 (US$ Mn)7.5 Others7.5.1 Overview7.5.2 Others Market Revenue and Forecast to 2027 (US$ Mn)8. Data Annotation Tools Market Analysis - By Annotation Type8.1 Overview8.2 Global Data Annotation Tools Market Breakdown, By Annotation Type, 2017 & 20278.3 Manual8.3.1 Overview8.3.2 Manual Market Revenue and Forecast to 2027 (US$ Mn)8.4 Semi-Supervised8.4.1 Overview8.4.2 Semi-Supervised Market Revenue and Forecast to 2027 (US$ Mn)8.5 Automatic8.5.1 Overview8.5.2 Automatic Market Revenue and Forecast to 2027 (US$ Mn)9. Data Annotation Tools Market Analysis - By End User9.1 Overview9.2 Global Data Annotation Tools Market Breakdown, By End User, 2017 & 20279.3 Automotive9.3.1 Overview9.3.2 Automotive Market Revenue and Forecast to 2027 (US$ Mn)9.4 Healthcare9.4.1 Overview9.4.2 Healthcare Market Revenue and Forecast to 2027 (US$ Mn)9.5 Government9.5.1 Overview9.5.2 Government Market Revenue and Forecast to 2027 (US$ Mn)9.6 Financial Services9.6.1 Overview9.6.2 Financial Services Market Revenue and Forecast to 2027 (US$ Mn)9.7 Retail9.7.1 Overview9.7.2 Semi-Supervised Market Revenue and Forecast to 2027 (US$ Mn)9.8 IT and Telecom9.8.1 Overview9.8.2 IT and Telecom Market Revenue and Forecast to 2027 (US$ Mn)9.9 Others9.9.1 Overview9.9.2 Others Market Revenue and Forecast to 2027 (US$ Mn)10. Data Annotation Tools Market - Geographic Analysis10.1 Overview10.2 North America: Data Annotation Tools Market10.3 Europe: Data Annotation Tools Market10.4 APAC: Data Annotation Tools Market10.5 MEA: Data Annotation Tools Market10.6 SAM: Data Annotation Tools Market11. Industry Landscape11.1 Overview11.2 Growth Strategies Done By the Companies in the Market, (%)11.3 Organic Developments Done By The Companies In The Market11.4 Inorganic Developments Done By The Companies In The Market12. COMPANY PROFILES12.1 Cogito12.1.1 Key Facts12.1.2 Business Description12.1.3 Products and Services12.1.4 Financial Overview12.1.5 SWOT Analysis12.1.6 Key Developments12.2 Google LLC12.2.1 Key Facts12.2.2 Business Description12.2.3 Products and Services12.2.4 Financial Overview12.2.5 SWOT Analysis12.2.6 Key Developments12.3 Deep Systems12.3.1 Key Facts12.3.2 Business Description12.3.3 Products and Services12.3.4 Financial Overview12.3.5 SWOT Analysis12.3.6 Key Developments12.4 Appen Limited12.4.1 Key Facts12.4.2 Business Description12.4.3 Products and Services12.4.4 Financial Overview12.4.5 SWOT Analysis12.4.6 Key Developments12.5 Labelbox, Inc12.5.1 Key Facts12.5.2 Business Description12.5.3 Products and Services12.5.4 Financial Overview12.5.5 SWOT Analysis12.5.6 Key Developments12.6 LightTag12.6.1 Key Facts12.6.2 Business Description12.6.3 Products and Services12.6.4 Financial Overview12.6.5 SWOT Analysis12.6.6 Key Developments12.7 PLAYMENT INC.12.7.1 Key Facts12.7.2 Business Description12.7.3 Products and Services12.7.4 Financial Overview12.7.5 SWOT Analysis12.7.6 Key Developments12.8 Scale AI, Inc.12.8.1 Key Facts12.8.2 Business Description12.8.3 Products and Services12.8.4 Financial Overview12.8.5 SWOT Analysis12.8.6 Key Developments12.9 Tagtog Sp. z o.o.12.9.1 Key Facts12.9.2 Business Description12.9.3 Products and Services12.9.4 Financial Overview12.9.5 SWOT Analysis12.9.6 Key Developments12.10 CloudFactory Limited12.10.1 Key Facts12.10.2 Business Description12.10.3 Products and Services12.10.4 Financial Overview12.10.5 SWOT Analysis12.10.6 Key Developments13. Appendix13.1 About the Publisher13.2 Glossary of TermsFor more information about this report visit https://www.researchandmarkets.com/r/y7zg4z Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer:
|
Worldwide Data Annotation Tools Industry to 2027 - Trends of e-Education Across the World Present Opportunities
|
DUBLIN, Aug. 25, 2020 /PRNewswire/ -- The "Data Annotation Tools Market to 2027 - Global Analysis and Forecasts by Type; Annotation Type; End-user" report has been added to ResearchAndMarkets.com's offering. The global data annotation tools market was valued at US$ 695.5 million in 2019 and is projected to reach US$ 6,450.0 million by 2027; it is expected to grow at a CAGR of 32.54% from 2020 to 2027.The process of data annotation includes labeling of data which makes it usable for machine learning. Data annotation tools are important for data scientists as they make use of the labeled data with machine learning algorithms. Data can be in any form, such as images (from cars, phones, or medical instruments), text (in English, Spanish, Chinese, and among others), audio, and video. There are different types of annotation techniques like polygon annotation, semantic segmentation, bounding box annotation, landmark annotation, polylines annotation, and 3D point cloud annotation. In house teams can label the data if it is a small set, but this can be time consuming. When large amount of data is to be annotated, it is outsourced to companies like Precise BPO Solution, who can handle millions of annotations in a week and it significantly saves time. Further, the increasing investments by various market players in data annotation techniques in order to offer high quality labeled data are expected to play a significant role in the growth of the market.The applications of data annotation are growing strongly across the globe. Face detection and recognition is one of the major applications of data annotation. Countries across the globe are implementing various facial technologies to create social status and award penalties for public menace to its citizens. For instance, China has installed 200 million surveillance cameras, one camera for every seven of its citizens. It plans to install about 400 million new cameras by 2021 in the country, for security and traffic control purposes.The market for data annotation tools has been segmented into type, annotation type, end user, and geography. Based on type, the data annotation tools market has been segmented into text, image, and others. Based on annotation type, the data annotation tools market has been segmented into manual, semi-supervised, and automatic. Based on end user, the data annotation tools market has been segmented into automotive, government, healthcare, financial services, retail, IT & telecom, and others. Geographically, the data annotation tools market is segmented into five regions: North America, Europe, APAC, MEA, and South America.Appen Limited, CloudFactory Limited, Cogito, Deep Systems, Google LLC, Labelbox, Inc, LIGHTTAG, Tagtog Sp. z o.o., PLAYMENT INC., and SCALE AI, INC. are some of the well-established market players present in the global data annotation tools market.Reasons to Buy: Highlights key business priorities in order to assist companies to realign their business strategies. The key findings and recommendations highlight crucial progressive industry trends in the data annotation tools market, thereby allowing players to develop effective long-term strategies. Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it. Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to components, aircraft type, and end-users. Key Topics Covered: 1. Introduction1.1 Study Scope1.2 Report Guidance1.3 Market Segmentation2. Key Takeaways3. Research Methodology3.1 Coverage3.2 Secondary Research3.3 Primary Research4. Data Annotation Tools Market Landscape4.1 Market Overview4.2 PEST Analysis4.2.1 North America PEST Analysis4.2.2 Europe PEST Analysis4.2.3 APAC PEST Analysis4.2.4 MEA PEST Analysis4.2.5 SAM PEST Analysis4.3 Ecosystem Analysis4.4 Expert Opinions5. Data Annotation Tools Market - Key Industry Dynamics5.1 Drivers5.1.1 Growing Applications of Data Annotation5.1.2 Increasing Investments by Market Players5.2 Market Restraints5.2.1 Lack of Skilled Labor and Disadvantages Associated with Annotation Techniques5.3 Market Opportunities5.3.1 Trend of e-Education Across the world5.4 Future Trends5.4.1 Increasing Organic Development by Market Players5.5 Impact Analysis of Drivers and Restraints6. Data Annotation Tools Market - Global Market Analysis6.1 Data Annotation Tools Market Overview6.2 Data Annotation Tools Market -Revenue, and Forecast to 2027 (US$ Million)6.3 Market Positioning - Global Key Players7. Data Annotation Tools Market Analysis - By Type7.1 Overview7.2 Global Data Annotation Tools Market Breakdown, By Type, 2017 & 20277.3 Text7.3.1 Overview7.3.2 Text Market Revenue and Forecast to 2027 (US$ Mn)7.4 Image7.4.1 Overview7.4.2 Image Market Revenue and Forecast to 2027 (US$ Mn)7.5 Others7.5.1 Overview7.5.2 Others Market Revenue and Forecast to 2027 (US$ Mn)8. Data Annotation Tools Market Analysis - By Annotation Type8.1 Overview8.2 Global Data Annotation Tools Market Breakdown, By Annotation Type, 2017 & 20278.3 Manual8.3.1 Overview8.3.2 Manual Market Revenue and Forecast to 2027 (US$ Mn)8.4 Semi-Supervised8.4.1 Overview8.4.2 Semi-Supervised Market Revenue and Forecast to 2027 (US$ Mn)8.5 Automatic8.5.1 Overview8.5.2 Automatic Market Revenue and Forecast to 2027 (US$ Mn)9. Data Annotation Tools Market Analysis - By End User9.1 Overview9.2 Global Data Annotation Tools Market Breakdown, By End User, 2017 & 20279.3 Automotive9.3.1 Overview9.3.2 Automotive Market Revenue and Forecast to 2027 (US$ Mn)9.4 Healthcare9.4.1 Overview9.4.2 Healthcare Market Revenue and Forecast to 2027 (US$ Mn)9.5 Government9.5.1 Overview9.5.2 Government Market Revenue and Forecast to 2027 (US$ Mn)9.6 Financial Services9.6.1 Overview9.6.2 Financial Services Market Revenue and Forecast to 2027 (US$ Mn)9.7 Retail9.7.1 Overview9.7.2 Semi-Supervised Market Revenue and Forecast to 2027 (US$ Mn)9.8 IT and Telecom9.8.1 Overview9.8.2 IT and Telecom Market Revenue and Forecast to 2027 (US$ Mn)9.9 Others9.9.1 Overview9.9.2 Others Market Revenue and Forecast to 2027 (US$ Mn)10. Data Annotation Tools Market - Geographic Analysis10.1 Overview10.2 North America: Data Annotation Tools Market10.3 Europe: Data Annotation Tools Market10.4 APAC: Data Annotation Tools Market10.5 MEA: Data Annotation Tools Market10.6 SAM: Data Annotation Tools Market11. Industry Landscape11.1 Overview11.2 Growth Strategies Done By the Companies in the Market, (%)11.3 Organic Developments Done By The Companies In The Market11.4 Inorganic Developments Done By The Companies In The Market12. COMPANY PROFILES12.1 Cogito12.1.1 Key Facts12.1.2 Business Description12.1.3 Products and Services12.1.4 Financial Overview12.1.5 SWOT Analysis12.1.6 Key Developments12.2 Google LLC12.2.1 Key Facts12.2.2 Business Description12.2.3 Products and Services12.2.4 Financial Overview12.2.5 SWOT Analysis12.2.6 Key Developments12.3 Deep Systems12.3.1 Key Facts12.3.2 Business Description12.3.3 Products and Services12.3.4 Financial Overview12.3.5 SWOT Analysis12.3.6 Key Developments12.4 Appen Limited12.4.1 Key Facts12.4.2 Business Description12.4.3 Products and Services12.4.4 Financial Overview12.4.5 SWOT Analysis12.4.6 Key Developments12.5 Labelbox, Inc12.5.1 Key Facts12.5.2 Business Description12.5.3 Products and Services12.5.4 Financial Overview12.5.5 SWOT Analysis12.5.6 Key Developments12.6 LightTag12.6.1 Key Facts12.6.2 Business Description12.6.3 Products and Services12.6.4 Financial Overview12.6.5 SWOT Analysis12.6.6 Key Developments12.7 PLAYMENT INC.12.7.1 Key Facts12.7.2 Business Description12.7.3 Products and Services12.7.4 Financial Overview12.7.5 SWOT Analysis12.7.6 Key Developments12.8 Scale AI, Inc.12.8.1 Key Facts12.8.2 Business Description12.8.3 Products and Services12.8.4 Financial Overview12.8.5 SWOT Analysis12.8.6 Key Developments12.9 Tagtog Sp. z o.o.12.9.1 Key Facts12.9.2 Business Description12.9.3 Products and Services12.9.4 Financial Overview12.9.5 SWOT Analysis12.9.6 Key Developments12.10 CloudFactory Limited12.10.1 Key Facts12.10.2 Business Description12.10.3 Products and Services12.10.4 Financial Overview12.10.5 SWOT Analysis12.10.6 Key Developments13. Appendix13.1 About the Publisher13.2 Glossary of TermsFor more information about this report visit https://www.researchandmarkets.com/r/y7zg4z Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
|
edtsum5652
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TORONTO--(BUSINESS WIRE)--Warrior Gold Inc. (TSX-V - WAR) (Warrior Gold or the Company) is pleased to announce a non-brokered private placement to raise up to $1 million through the issuance of a combination of common share units (the HD Units) and flow-through share units (the FT Units) of the Company at a price of $0.09 per HD Unit and $0.12 per FT Unit (the Private Placement). Each Unit will comprise one common share, and in the case of the FT Units, one flow-through share, and one-half of one common share purchase warrant (each whole common share purchase warrant, a Warrant) with each Warrant entitling the holder to purchase one additional common share in the capital of the Company for a period of 18 months from the date of closing of the Private Placement, at a purchase price of $0.15 per common share, provided, however, that, if, at any time following the statutory four month hold period, the closing price of the common shares on the TSX Venture Exchange is greater than $0.20 for 20 or more consecutive trading days, the Warrants will be accelerated and will expire on the 30th business day following the date of such notice. The Company may pay finders fees on a portion of the Private Placement in accordance with applicable securities laws and the policies of the TSX Venture Exchange. All securities issued under the Private Placement will be subject to a four month and one day hold period under applicable Canadian securities legislation. The Private Placement is subject to approval of the TSX Venture Exchange. The proceeds from the sale of the HD Units will be utilized by the Company for working capital and general corporate purposes and the proceeds from the sale of the FT Units will be used by the Company to incur eligible "Canadian exploration expenses" that will qualify as "flow-through mining expenditures" as such terms are defined in the Income Tax Act (Canada) (the "Qualifying Expenditures") related to the Company's Goodfish-Kirana Property located in Kirkland Lake, Ontario. About Warrior Gold Inc. Warrior Gold is a TSX Venture Exchange listed Company that owns the Goodfish-Kirana Property located five km from the town of Kirkland Lake, Ontario. The Property is located in the historic Kirkland Lake Gold Camp which is situated in the prolific Abitibi Greenstone Belt, recognized as one of the worlds highest grade greenstone belts with over 200 million ounces of gold produced to date. The Goodfish-Kirana Property is 11.5 km long by roughly three km wide (34 km2) and contains three major structural trends: the east-west trending Kirana Deformation Zone; the northeast trending Goodfish Deformation Zone; and the Victoria Creek Deformation Zone on the recently acquired Sutton claims on the northeast side of the property. The Property contains numerous historical gold showings, as well as 18 historical pits and shafts. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements: This press release contains forward-looking statements. Forward-looking statements are frequently characterized by words such as "plan", "expect", "project", "intend", "believe", anticipate", "estimate", "may", "will", "would", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. The forward-looking statements are based on certain key expectations and assumptions made by the Company. Although Warrior Gold believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because Warrior Gold can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. In addition to other risks that may affect the forward-looking statements in this press release are those set out in the Companys management discussion and analysis of the financial condition and results of operations for the year ended March 31, 2020 and the second quarter ended September 30, 2020, which are available on the Companys profile at www.sedar.com. The forward-looking statements contained in this press release are made as of the date hereof and Warrior Gold undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.
Answer:
|
Warrior Gold Announces $1 Million Private Placement Not for Distribution to United States Newswire Services or for Dissemination in the United States
|
TORONTO--(BUSINESS WIRE)--Warrior Gold Inc. (TSX-V - WAR) (Warrior Gold or the Company) is pleased to announce a non-brokered private placement to raise up to $1 million through the issuance of a combination of common share units (the HD Units) and flow-through share units (the FT Units) of the Company at a price of $0.09 per HD Unit and $0.12 per FT Unit (the Private Placement). Each Unit will comprise one common share, and in the case of the FT Units, one flow-through share, and one-half of one common share purchase warrant (each whole common share purchase warrant, a Warrant) with each Warrant entitling the holder to purchase one additional common share in the capital of the Company for a period of 18 months from the date of closing of the Private Placement, at a purchase price of $0.15 per common share, provided, however, that, if, at any time following the statutory four month hold period, the closing price of the common shares on the TSX Venture Exchange is greater than $0.20 for 20 or more consecutive trading days, the Warrants will be accelerated and will expire on the 30th business day following the date of such notice. The Company may pay finders fees on a portion of the Private Placement in accordance with applicable securities laws and the policies of the TSX Venture Exchange. All securities issued under the Private Placement will be subject to a four month and one day hold period under applicable Canadian securities legislation. The Private Placement is subject to approval of the TSX Venture Exchange. The proceeds from the sale of the HD Units will be utilized by the Company for working capital and general corporate purposes and the proceeds from the sale of the FT Units will be used by the Company to incur eligible "Canadian exploration expenses" that will qualify as "flow-through mining expenditures" as such terms are defined in the Income Tax Act (Canada) (the "Qualifying Expenditures") related to the Company's Goodfish-Kirana Property located in Kirkland Lake, Ontario. About Warrior Gold Inc. Warrior Gold is a TSX Venture Exchange listed Company that owns the Goodfish-Kirana Property located five km from the town of Kirkland Lake, Ontario. The Property is located in the historic Kirkland Lake Gold Camp which is situated in the prolific Abitibi Greenstone Belt, recognized as one of the worlds highest grade greenstone belts with over 200 million ounces of gold produced to date. The Goodfish-Kirana Property is 11.5 km long by roughly three km wide (34 km2) and contains three major structural trends: the east-west trending Kirana Deformation Zone; the northeast trending Goodfish Deformation Zone; and the Victoria Creek Deformation Zone on the recently acquired Sutton claims on the northeast side of the property. The Property contains numerous historical gold showings, as well as 18 historical pits and shafts. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements: This press release contains forward-looking statements. Forward-looking statements are frequently characterized by words such as "plan", "expect", "project", "intend", "believe", anticipate", "estimate", "may", "will", "would", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. The forward-looking statements are based on certain key expectations and assumptions made by the Company. Although Warrior Gold believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because Warrior Gold can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. In addition to other risks that may affect the forward-looking statements in this press release are those set out in the Companys management discussion and analysis of the financial condition and results of operations for the year ended March 31, 2020 and the second quarter ended September 30, 2020, which are available on the Companys profile at www.sedar.com. The forward-looking statements contained in this press release are made as of the date hereof and Warrior Gold undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.
|
edtsum5656
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TRIESTE, Italy, Jan. 26, 2021 /PRNewswire/ -- illycaff, a leading company in high quality coffee, today announced the launch of Arabica Selection Costa Rica, the sixth single origin coffee in the illy Arabica Selection product line-up. illy first introduced the illy Arabica Selection rangein 2018, made from the best coffee productions around the world, each dedicated to the origins of the individual aromas that make up the illy blend.The new illy Arabica Selection Costa Rica coffee offersa sweet Arabica with characteristic notes of honey and vanilla, along with citrus, hints of caramel and dried fruit. Continue Reading (PRNewsfoto/illy) The specialness of illy Arabica Selection Costa Rica, as for every Arabica Selection, lies in its geographical origin. The illy experts, together with the internal research laboratories AromaLab, SensoryLab and Food ScienceLab, have developed the best roasting profile for each coffee, refining the perfect expression of each individual territory. As a result, the best harvests from Ethiopia, Colombia, Brazil, Guatemala, India, and now Costa Rica offer the chance to experience the singular taste and aroma of each origin and celebrate their unique characteristics. Organized in a crescendo of intensity, from the most delicate to the most robust, the Arabica Selection line's packaging scales in earth tone colors to distinguish its flavor profile from that of the legendary, unmistakable illy blend. "With the illy Arabica Selection range, we differentiate the origins of the individual aromas of our blend to offer them in purity. We wanted to offer our customers the opportunity to dive into a sensory journey around the world," comments Massimiliano Pogliani, CEO of the company. "In these difficult times when everyone's borders have necessarily narrowed, our new Arabica Selection Costa Rica, with its aromas and notes that evoke the enchantment of unspoiled landscapes, is our way to look to the future with hope to rediscover the pleasure of exploring distant countries and cultures through a cup of coffee." illy Arabica Selection Costa Ricawhole bean is available exclusively on illy.com and in illy Caff locations and Shops for a retail price of $14.99. The single-origin illy Arabica Selection Ethiopia, Colombia, Brazil, Guatemala and India are available on illy.com and in illy Caff locations and Shops in ground, whole bean and Iperespresso capsule formats.illycaffis a family-owned Italian company founded in Trieste in 1933, whose goal from the onset has been to offer the world's best coffee. illycaff makes a unique 100% Arabica blend that combines 9 of the world's best coffees according to illycaff. Every day, over 8 million cups of illy coffee are enjoyed worldwide in over 140 countries, in the best coffee bars, restaurants, and hotels, in our illy brand stores, and of course at home. Thanks to its innovations, illy is contributing to technological advancement in the coffee sector. Thanks to its "Ernesto Illy Quality Award for Espresso Coffee", which was established in Brazil in 1991, illy has helped disseminate know-how, achieved higher prices for growers of high-quality illy coffee, and established partnerships on the basis of the principles of sustainable development. The company has also founded its own University of Coffee, with the goal of promoting coffee culture at all levels. The university provided comprehensive and practical training for growers, baristas, and coffee lovers covering all aspects of this product. Anything 'made in illy' is made more valuable through beauty and art, two of the brand's core values, starting with the logo designed by the artist James Rosenquist and encompassing the illy Art Collection cups, decorated by over 100 international artists. In 2019 the company employed 1405 people and had a consolidated turnover of 520.5. There are about 269 single-brand illy stores in over 40 countries worldwide.SOURCE illy Related Links https://www.illy.com
Answer:
|
Discover the sweetness of a tropical paradise with the new illy Arabica Selection Costa Rica
|
TRIESTE, Italy, Jan. 26, 2021 /PRNewswire/ -- illycaff, a leading company in high quality coffee, today announced the launch of Arabica Selection Costa Rica, the sixth single origin coffee in the illy Arabica Selection product line-up. illy first introduced the illy Arabica Selection rangein 2018, made from the best coffee productions around the world, each dedicated to the origins of the individual aromas that make up the illy blend.The new illy Arabica Selection Costa Rica coffee offersa sweet Arabica with characteristic notes of honey and vanilla, along with citrus, hints of caramel and dried fruit. Continue Reading (PRNewsfoto/illy) The specialness of illy Arabica Selection Costa Rica, as for every Arabica Selection, lies in its geographical origin. The illy experts, together with the internal research laboratories AromaLab, SensoryLab and Food ScienceLab, have developed the best roasting profile for each coffee, refining the perfect expression of each individual territory. As a result, the best harvests from Ethiopia, Colombia, Brazil, Guatemala, India, and now Costa Rica offer the chance to experience the singular taste and aroma of each origin and celebrate their unique characteristics. Organized in a crescendo of intensity, from the most delicate to the most robust, the Arabica Selection line's packaging scales in earth tone colors to distinguish its flavor profile from that of the legendary, unmistakable illy blend. "With the illy Arabica Selection range, we differentiate the origins of the individual aromas of our blend to offer them in purity. We wanted to offer our customers the opportunity to dive into a sensory journey around the world," comments Massimiliano Pogliani, CEO of the company. "In these difficult times when everyone's borders have necessarily narrowed, our new Arabica Selection Costa Rica, with its aromas and notes that evoke the enchantment of unspoiled landscapes, is our way to look to the future with hope to rediscover the pleasure of exploring distant countries and cultures through a cup of coffee." illy Arabica Selection Costa Ricawhole bean is available exclusively on illy.com and in illy Caff locations and Shops for a retail price of $14.99. The single-origin illy Arabica Selection Ethiopia, Colombia, Brazil, Guatemala and India are available on illy.com and in illy Caff locations and Shops in ground, whole bean and Iperespresso capsule formats.illycaffis a family-owned Italian company founded in Trieste in 1933, whose goal from the onset has been to offer the world's best coffee. illycaff makes a unique 100% Arabica blend that combines 9 of the world's best coffees according to illycaff. Every day, over 8 million cups of illy coffee are enjoyed worldwide in over 140 countries, in the best coffee bars, restaurants, and hotels, in our illy brand stores, and of course at home. Thanks to its innovations, illy is contributing to technological advancement in the coffee sector. Thanks to its "Ernesto Illy Quality Award for Espresso Coffee", which was established in Brazil in 1991, illy has helped disseminate know-how, achieved higher prices for growers of high-quality illy coffee, and established partnerships on the basis of the principles of sustainable development. The company has also founded its own University of Coffee, with the goal of promoting coffee culture at all levels. The university provided comprehensive and practical training for growers, baristas, and coffee lovers covering all aspects of this product. Anything 'made in illy' is made more valuable through beauty and art, two of the brand's core values, starting with the logo designed by the artist James Rosenquist and encompassing the illy Art Collection cups, decorated by over 100 international artists. In 2019 the company employed 1405 people and had a consolidated turnover of 520.5. There are about 269 single-brand illy stores in over 40 countries worldwide.SOURCE illy Related Links https://www.illy.com
|
edtsum5658
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SHANGHAI, April 14, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, announced today the appointment of Dr. Jennifer Yang as chief scientific officer. Dr. Yang has two decades of leadership experience in drug discovery and development at global pharmaceutical companies. "We are pleased to welcome Dr. Yang to Everest's leadership team. Jennifer's deep expertise in drug discovery and translational medicine combined with her extensive experience in global development will be invaluable to the Company. She will establish a strong discovery organization that contributes to the strategic expansion of our clinical development pipeline," said Kerry Blanchard, MD, PhD, chief executive officer of Everest Medicines. "I'm very excited to join Everest Medicines's top-tier team of global healthcare professionals to bring innovative medicines that address diseases with high unmet medical needs to patients in China and around the world," said Dr. Yang. "I look forward to building a robust discovery organization with deep scientific expertise with the mission to expand Everest Medicine's already impressive portfolio." Most recently, Dr. Yang served as vice president and head of China for Johnson & Johnson's Lung Cancer Initiative where she established and led a cross-sector research and development (R&D) organization for the creation of innovative solutions for lung cancer prevention, interception and cure. Jennifer transitioned into this role from Janssen (China) Research & Development Center, where she was the head of Discovery Center. Prior to joining Johnson and Johnson, Dr. Yang held global leadership positions at Eli Lilly and Company and Pfizer Inc Oncology Research Unit in the United States. Dr. Yang holds a Ph.D. in molecular biology and human genetics from the Eccles Institute of Human Genetics at the University of Utah, a Master's degree in immunology and microbiology from Southern Illinois University, and a Bachelor of Science degree in microbiology from Fudan University in China. About Everest Medicines Everest Medicines is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record of high-quality clinical development, regulatory affairs, CMC, business development and operations both in China and with leading global pharmaceutical companies. Everest Medicines has built a portfolio of eight potentially global first-in-class or best-in-class molecules, many of which are in late stage clinical development. The Company's therapeutic areas of interest include oncology, autoimmune disorders, cardio-renal diseases and infectious diseases. For more information, please visit its website atwww.everestmedicines.com. SOURCE Everest Medicines
Answer:
|
Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer
|
SHANGHAI, April 14, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, announced today the appointment of Dr. Jennifer Yang as chief scientific officer. Dr. Yang has two decades of leadership experience in drug discovery and development at global pharmaceutical companies. "We are pleased to welcome Dr. Yang to Everest's leadership team. Jennifer's deep expertise in drug discovery and translational medicine combined with her extensive experience in global development will be invaluable to the Company. She will establish a strong discovery organization that contributes to the strategic expansion of our clinical development pipeline," said Kerry Blanchard, MD, PhD, chief executive officer of Everest Medicines. "I'm very excited to join Everest Medicines's top-tier team of global healthcare professionals to bring innovative medicines that address diseases with high unmet medical needs to patients in China and around the world," said Dr. Yang. "I look forward to building a robust discovery organization with deep scientific expertise with the mission to expand Everest Medicine's already impressive portfolio." Most recently, Dr. Yang served as vice president and head of China for Johnson & Johnson's Lung Cancer Initiative where she established and led a cross-sector research and development (R&D) organization for the creation of innovative solutions for lung cancer prevention, interception and cure. Jennifer transitioned into this role from Janssen (China) Research & Development Center, where she was the head of Discovery Center. Prior to joining Johnson and Johnson, Dr. Yang held global leadership positions at Eli Lilly and Company and Pfizer Inc Oncology Research Unit in the United States. Dr. Yang holds a Ph.D. in molecular biology and human genetics from the Eccles Institute of Human Genetics at the University of Utah, a Master's degree in immunology and microbiology from Southern Illinois University, and a Bachelor of Science degree in microbiology from Fudan University in China. About Everest Medicines Everest Medicines is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record of high-quality clinical development, regulatory affairs, CMC, business development and operations both in China and with leading global pharmaceutical companies. Everest Medicines has built a portfolio of eight potentially global first-in-class or best-in-class molecules, many of which are in late stage clinical development. The Company's therapeutic areas of interest include oncology, autoimmune disorders, cardio-renal diseases and infectious diseases. For more information, please visit its website atwww.everestmedicines.com. SOURCE Everest Medicines
|
edtsum5659
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, Nov. 20, 2020 /PRNewswire/ -- The "Medical Adhesives and Sealants Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Application and Geography" report has been added to ResearchAndMarkets.com's offering. The global medical adhesive and sealants market is expected to reach US$ 17,468.1 million in 2027 from US$ 9,867.9 million in 2019. The market is estimated to grow with a CAGR of 7.5% from 2020-2027. Growing number of medical implantation/transplantation procedures being carried out in the world and rising adoption of minimally invasive procedures are the major factors driving the growth of the medical adhesive and sealants market. However, complication related medical adhesives and sealants are hindering the growth of the market growth. The minimally invasive procedures are among the preferred ones that are being adopted over the traditional open procedures such as endoscopic surgeries and diagnostic procedures, and robotic-assisted surgeries. The endoscopic surgical processes are widely used in the procedures related to heart, lungs, and stomach cancer; and kidney stone. The wounds are sealed post-procedure with surgical sutures, surgical staplers, sealants, or relevant adhesive tapes. However, due to technological advancements in wound closure methods, medical adhesives and sealants are among the preferred products. For instance, an inguinal hernia is among the most common disorders observed among men and women, with surgery being the only possible treatment. The primary type of repair procedures is open surgery and laparoscopy. According to OECD, there have been ~106,682 laparoscopic repairs of inguinal hernia in Germany in 2017. The medical adhesives and sealants are preferred for surgical sutures during laparoscopic repair as there is a minimal incision to the site of the procedure, thereby leading to the growth of the medical adhesives and sealants market. The global medical adhesive and sealants market is segmented on the basis of product type and application. Based on product, the market is segmented into synthetic and natural. The market for the synthetic segment is further segmented acrylic, silicone, cyanoacrylate, polyethylene glycol, and others. Moreover, the market for the natural segment is subsegmented into collagen, fibrin, albumin, and others. The synthetic segment held a larger share of the market in 2019, and it is also is estimated to register a higher CAGR during the forecast period. Based on application, the medical adhesive and sealants market has been segmented into dental, internal, and external. The dental segment held the largest share of the market in 2019, and the internal segment is estimated to register the highest CAGR in during the forecast period. Australian Research Council, World Health Organization (WHO), Centers For Disease Control and Prevention, European Medical Association, International Trade Administration, and Council for Scientific and Industrial Research are a few of the essential secondary sources referred to while preparing this report. Reasons to Buy: Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the medical adhesive and sealants market. Highlights key business priorities in order to assist companies to realign their business strategies. The key findings and recommendations highlight crucial progressive industry trends in the global medical adhesive and sealants market, thereby allowing players across the value chain to develop effective long-term strategies. Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it. Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution. Key Topics Covered: 1. Introduction1.1 Scope of the Study1.2 Report Guidance1.3 Market Segmentation1.3.1 Global Medical Adhesive and Sealants Market - By Product1.3.2 Global Medical Adhesive and Sealants Market - By Application1.3.3 Global Medical Adhesive and Sealants Market - By Geography2. Medical Adhesive and Sealants Market - Key Takeaways2.1 Synthetic Segment Held Largest Share Of Product Segment In Medical Adhesives and Sealants Market2.2 Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period2.3 Global Medical Adhesives and Sealants Market, By Geography (US$ Million)2.4 Global Medical Adhesives and Sealants Market- Leading Country Markets (US$ Million)2.5 Global Medical Adhesives and Sealants Market, Industry Landscape3. Research Methodology3.1 Coverage3.2 Secondary Research3.3 Primary Research4. Global Medical Adhesive and Sealants Market - Market Landscape4.1 Overview4.2 PEST Analysis4.2.1 North America- PEST Analysis4.2.2 Europe- PEST Analysis4.2.3 Asia Pacific- PEST Analysis4.2.4 Middle East & Africa4.2.5 South and Central America4.3 Expert Opinion5. Medical Adhesive and Sealants Market - Key Market Dynamics5.1 Market Drivers5.1.1 Increasing Number of MedicalImplant/Transplant Procedures5.1.2 Rising Adoption of Minimally Invasive Procedures5.2 Key Market Restraints5.2.1 Complication Related Medical Adhesives and Sealants5.3 Key Market OpportunitY5.3.1 Wide Applications in Medical Devices and Drug Delivery Systems5.4 Future Trend5.4.1 Increasing Development in the Medical Adhesive and Sealant Technologies5.5 Impact Analysis6. Medical Adhesive and Sealants Market - Global Analysis6.1 Global Medical Adhesive and Sealants Market Revenue Forecast And Analysis6.2 Global Medical Adhesive and Sealants Market, By Geography - Forecast And Analysis6.3 Market Positioning of Key Players7. Medical Adhesive and Sealants Market Analysis - By Product7.1 Overview7.2 Medical Adhesives and Sealants Market Share, by Product, 2019 and 2027 (%)7.3 Synthetic7.3.1 Overview7.3.2 Synthetic: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.3.3 Acrylic7.3.3.1 Overview7.3.4 Acrylic: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.3.5 Silicone7.3.5.1 Overview7.3.5.2 Silicone: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.3.6 Cyanoacrylate7.3.6.1 Overview7.3.6.2 Cyanoacrylate: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.3.7 Polyethylene Glycol7.3.7.1 Overview7.3.7.2 Polyethylene Glycol: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.3.8 Others7.3.8.1 Overview7.3.8.2 Others : Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.4 Natural7.4.1 Overview7.4.2 Natural: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.4.3 Collagen7.4.3.1 Overview7.4.3.2 Collagen: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.4.4 Fibrin7.4.4.1 Overview7.4.4.2 Fibrin: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.4.5 Albumin7.4.5.1 Overview7.4.5.2 Albumin: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.4.6 Others7.4.6.1 Overview7.4.6.2 Others: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8. Medical Adhesives And Sealants Market Analysis - By Application8.1 Overview8.2 Medical Adhesives And Sealants Market Share, by Application, 2019 and 2027 (%)8.3 Dental8.3.1 Overview8.3.2 Dental: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.3 Denture Bonding8.3.3.1 Overview8.3.4 Denture Bonding: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.5 Pit and Fissure Sealants8.3.5.1 Overview8.3.5.2 Pit and Fissure Sealants: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.6 Restorative Adhesives8.3.6.1 Overview8.3.6.2 Restorative Adhesives: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.7 Luting Cements8.3.7.1 Overview8.3.7.2 Luting Cements: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.8 Orthodontic Bonding8.3.8.1 Overview8.3.8.2 Orthodontic Bonding: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.9 Tray Adhesives8.3.9.1 Overview8.3.9.2 Tray Adhesives: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.10 Dental Surgical Tissue Bonding8.3.10.1 Overview8.3.10.2 Dental Surgical Tissue Bonding: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4 Internal8.4.1 Overview8.4.2 Internal: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4.3 Bone8.4.3.1 Overview8.4.4 Bone: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4.5 Cardiovascular8.4.5.1 Overview8.4.5.2 Cardiovascular: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4.6 Cranial8.4.6.1 Overview8.4.6.2 Cranial: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4.7 Pulmonary8.4.7.1 Overview8.4.7.2 Pulmonary: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4.8 Abdominal8.4.8.1 Overview8.4.8.2 Abdominal: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4.9 Others8.4.9.1 Overview8.4.9.2 Others: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.5 External8.5.1 Overview8.5.2 External: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.5.3 Wound Dressing8.5.3.1 Overview8.5.3.2 Wound Dressing: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.5.4 Skin Tissue Adhesives8.5.4.1 Overview8.5.4.2 Skin Tissue Adhesives: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.5.5 Others8.5.5.1 Overview8.5.5.2 Others: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)9. Medical Adhesive and Sealants Market - Geographic Analysis9.1 North America: Medical Adhesive and Sealants Market9.2 Europe: Medical Adhesive and Sealants Market9.3 Asia Pacific: Medical Adhesive and Sealants Market9.4 Middle East & Africa: Medical Adhesive and Sealants Market9.5 South and Central America: Medical Adhesives and Sealants Market10. Impact of COVID-19 Pandemic on Global Medical Adhesive and Sealants Market10.1 North America: Impact Assessment of COVID-19 Pandemic10.2 Europe: Impact Assessment of COVID-19 Pandemic10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic11. Medical Adhesives and Sealants Market -Industry Landscape11.1 Overview11.1 Growth Strategies Done by the Companies in the Market, (%)11.2 Organic Developments11.2.1 Overview11.3 Inorganic Developments11.3.1 Overview12. Company Profiles12.1 3M12.2 GlaxoSmithKline plc.12.3 Henkel AG & COMPANY, KGAA12.4 Dentsply Sirona12.5 Grunenthal12.6 Johnson & Johnson Services, Inc.12.7 Puritan Medical Products12.8 Mactac12.9 Dymax Corporation12.10 B. Braun Melsungen AG13. Appendix13.1 About the Publisher13.2 Glossary of TermsFor more information about this report visit https://www.researchandmarkets.com/r/2ys7an Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer:
|
The Worldwide Medical Adhesives and Sealants Industry is Expected to Grow at a CAGR of 7.5% Between 2020 and 2027
|
DUBLIN, Nov. 20, 2020 /PRNewswire/ -- The "Medical Adhesives and Sealants Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Application and Geography" report has been added to ResearchAndMarkets.com's offering. The global medical adhesive and sealants market is expected to reach US$ 17,468.1 million in 2027 from US$ 9,867.9 million in 2019. The market is estimated to grow with a CAGR of 7.5% from 2020-2027. Growing number of medical implantation/transplantation procedures being carried out in the world and rising adoption of minimally invasive procedures are the major factors driving the growth of the medical adhesive and sealants market. However, complication related medical adhesives and sealants are hindering the growth of the market growth. The minimally invasive procedures are among the preferred ones that are being adopted over the traditional open procedures such as endoscopic surgeries and diagnostic procedures, and robotic-assisted surgeries. The endoscopic surgical processes are widely used in the procedures related to heart, lungs, and stomach cancer; and kidney stone. The wounds are sealed post-procedure with surgical sutures, surgical staplers, sealants, or relevant adhesive tapes. However, due to technological advancements in wound closure methods, medical adhesives and sealants are among the preferred products. For instance, an inguinal hernia is among the most common disorders observed among men and women, with surgery being the only possible treatment. The primary type of repair procedures is open surgery and laparoscopy. According to OECD, there have been ~106,682 laparoscopic repairs of inguinal hernia in Germany in 2017. The medical adhesives and sealants are preferred for surgical sutures during laparoscopic repair as there is a minimal incision to the site of the procedure, thereby leading to the growth of the medical adhesives and sealants market. The global medical adhesive and sealants market is segmented on the basis of product type and application. Based on product, the market is segmented into synthetic and natural. The market for the synthetic segment is further segmented acrylic, silicone, cyanoacrylate, polyethylene glycol, and others. Moreover, the market for the natural segment is subsegmented into collagen, fibrin, albumin, and others. The synthetic segment held a larger share of the market in 2019, and it is also is estimated to register a higher CAGR during the forecast period. Based on application, the medical adhesive and sealants market has been segmented into dental, internal, and external. The dental segment held the largest share of the market in 2019, and the internal segment is estimated to register the highest CAGR in during the forecast period. Australian Research Council, World Health Organization (WHO), Centers For Disease Control and Prevention, European Medical Association, International Trade Administration, and Council for Scientific and Industrial Research are a few of the essential secondary sources referred to while preparing this report. Reasons to Buy: Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the medical adhesive and sealants market. Highlights key business priorities in order to assist companies to realign their business strategies. The key findings and recommendations highlight crucial progressive industry trends in the global medical adhesive and sealants market, thereby allowing players across the value chain to develop effective long-term strategies. Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it. Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution. Key Topics Covered: 1. Introduction1.1 Scope of the Study1.2 Report Guidance1.3 Market Segmentation1.3.1 Global Medical Adhesive and Sealants Market - By Product1.3.2 Global Medical Adhesive and Sealants Market - By Application1.3.3 Global Medical Adhesive and Sealants Market - By Geography2. Medical Adhesive and Sealants Market - Key Takeaways2.1 Synthetic Segment Held Largest Share Of Product Segment In Medical Adhesives and Sealants Market2.2 Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period2.3 Global Medical Adhesives and Sealants Market, By Geography (US$ Million)2.4 Global Medical Adhesives and Sealants Market- Leading Country Markets (US$ Million)2.5 Global Medical Adhesives and Sealants Market, Industry Landscape3. Research Methodology3.1 Coverage3.2 Secondary Research3.3 Primary Research4. Global Medical Adhesive and Sealants Market - Market Landscape4.1 Overview4.2 PEST Analysis4.2.1 North America- PEST Analysis4.2.2 Europe- PEST Analysis4.2.3 Asia Pacific- PEST Analysis4.2.4 Middle East & Africa4.2.5 South and Central America4.3 Expert Opinion5. Medical Adhesive and Sealants Market - Key Market Dynamics5.1 Market Drivers5.1.1 Increasing Number of MedicalImplant/Transplant Procedures5.1.2 Rising Adoption of Minimally Invasive Procedures5.2 Key Market Restraints5.2.1 Complication Related Medical Adhesives and Sealants5.3 Key Market OpportunitY5.3.1 Wide Applications in Medical Devices and Drug Delivery Systems5.4 Future Trend5.4.1 Increasing Development in the Medical Adhesive and Sealant Technologies5.5 Impact Analysis6. Medical Adhesive and Sealants Market - Global Analysis6.1 Global Medical Adhesive and Sealants Market Revenue Forecast And Analysis6.2 Global Medical Adhesive and Sealants Market, By Geography - Forecast And Analysis6.3 Market Positioning of Key Players7. Medical Adhesive and Sealants Market Analysis - By Product7.1 Overview7.2 Medical Adhesives and Sealants Market Share, by Product, 2019 and 2027 (%)7.3 Synthetic7.3.1 Overview7.3.2 Synthetic: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.3.3 Acrylic7.3.3.1 Overview7.3.4 Acrylic: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.3.5 Silicone7.3.5.1 Overview7.3.5.2 Silicone: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.3.6 Cyanoacrylate7.3.6.1 Overview7.3.6.2 Cyanoacrylate: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.3.7 Polyethylene Glycol7.3.7.1 Overview7.3.7.2 Polyethylene Glycol: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.3.8 Others7.3.8.1 Overview7.3.8.2 Others : Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.4 Natural7.4.1 Overview7.4.2 Natural: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.4.3 Collagen7.4.3.1 Overview7.4.3.2 Collagen: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.4.4 Fibrin7.4.4.1 Overview7.4.4.2 Fibrin: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.4.5 Albumin7.4.5.1 Overview7.4.5.2 Albumin: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)7.4.6 Others7.4.6.1 Overview7.4.6.2 Others: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8. Medical Adhesives And Sealants Market Analysis - By Application8.1 Overview8.2 Medical Adhesives And Sealants Market Share, by Application, 2019 and 2027 (%)8.3 Dental8.3.1 Overview8.3.2 Dental: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.3 Denture Bonding8.3.3.1 Overview8.3.4 Denture Bonding: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.5 Pit and Fissure Sealants8.3.5.1 Overview8.3.5.2 Pit and Fissure Sealants: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.6 Restorative Adhesives8.3.6.1 Overview8.3.6.2 Restorative Adhesives: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.7 Luting Cements8.3.7.1 Overview8.3.7.2 Luting Cements: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.8 Orthodontic Bonding8.3.8.1 Overview8.3.8.2 Orthodontic Bonding: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.9 Tray Adhesives8.3.9.1 Overview8.3.9.2 Tray Adhesives: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.3.10 Dental Surgical Tissue Bonding8.3.10.1 Overview8.3.10.2 Dental Surgical Tissue Bonding: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4 Internal8.4.1 Overview8.4.2 Internal: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4.3 Bone8.4.3.1 Overview8.4.4 Bone: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4.5 Cardiovascular8.4.5.1 Overview8.4.5.2 Cardiovascular: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4.6 Cranial8.4.6.1 Overview8.4.6.2 Cranial: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4.7 Pulmonary8.4.7.1 Overview8.4.7.2 Pulmonary: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4.8 Abdominal8.4.8.1 Overview8.4.8.2 Abdominal: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.4.9 Others8.4.9.1 Overview8.4.9.2 Others: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.5 External8.5.1 Overview8.5.2 External: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.5.3 Wound Dressing8.5.3.1 Overview8.5.3.2 Wound Dressing: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.5.4 Skin Tissue Adhesives8.5.4.1 Overview8.5.4.2 Skin Tissue Adhesives: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)8.5.5 Others8.5.5.1 Overview8.5.5.2 Others: Medical Adhesives And Sealants Market- Revenue and Forecast to 2027 (US$ Million)9. Medical Adhesive and Sealants Market - Geographic Analysis9.1 North America: Medical Adhesive and Sealants Market9.2 Europe: Medical Adhesive and Sealants Market9.3 Asia Pacific: Medical Adhesive and Sealants Market9.4 Middle East & Africa: Medical Adhesive and Sealants Market9.5 South and Central America: Medical Adhesives and Sealants Market10. Impact of COVID-19 Pandemic on Global Medical Adhesive and Sealants Market10.1 North America: Impact Assessment of COVID-19 Pandemic10.2 Europe: Impact Assessment of COVID-19 Pandemic10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic11. Medical Adhesives and Sealants Market -Industry Landscape11.1 Overview11.1 Growth Strategies Done by the Companies in the Market, (%)11.2 Organic Developments11.2.1 Overview11.3 Inorganic Developments11.3.1 Overview12. Company Profiles12.1 3M12.2 GlaxoSmithKline plc.12.3 Henkel AG & COMPANY, KGAA12.4 Dentsply Sirona12.5 Grunenthal12.6 Johnson & Johnson Services, Inc.12.7 Puritan Medical Products12.8 Mactac12.9 Dymax Corporation12.10 B. Braun Melsungen AG13. Appendix13.1 About the Publisher13.2 Glossary of TermsFor more information about this report visit https://www.researchandmarkets.com/r/2ys7an Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
|
edtsum5662
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, Dec. 29, 2020 /PRNewswire/ --Q BioMed Inc. (OTCQB:QBIO), a commercial stage biotech company, today issued a letter to shareholders. Dear Fellow Shareholders, As 2020 draws to a close, we join the rest of the world in looking forward to a new year with new beginnings and hope for a quick return to whatever the new normal will be. Leaving behind the constant threat of lockdowns and the interruptionthe COVID-19 pandemic has had on our liveswill be a welcome change. With that in mind we acknowledge that 2020 was not the year we promised and feel even more committed to achieving our stated goals. We learned a great deal about Q BioMed's place in the fragile world in which we live and operate. With the 20/20 view of hindsight, we are excited about the coming year. Strontium Chloride Sr89 Injection, USP (Strontium89), a Palliative Treatment for Metastatic Bone Cancer In January we expect treatment with Strontium89 in the hospital out-patient setting will be fully reimbursed by Medicare. When this occurs, we will launch a hospital-focused marketing initiative andexpect to see hospitals more actively treat appropriate patients with Strontium89. We also anticipate being approved as a federal supplier in January 2021which will allow us to sell into federal hospital systems, notably the U.S. Department of Veteran Affairs (VA) and the U.S. Department of Defense. The VA is potentially our largest target customer, with asignificantpercentage of itspatients suffering from prostate, breast and lung cancer, and at rates higher than the national average. We have free-standing clinics in at least eight states that are undergoing the required operational steps to become a 'Strontium89 practice', including having it on their radioactive materials license, with some clinics already up and running. We also expect to have group purchasing contracts in place in early January and have begun to negotiate with national and regional oncology organizations. We have been deploying a multi-channel marketing campaign, driving awareness among our target audiences, both on the physician and the patient side. We have exhibited Strontium89 at several conferences including ASTRO (American Society of Therapeutic Radiation Oncology) and ONS (Oncology Nursing Society) and plan to begin speaker programs in the first quarter of 2021. Virtual and live sales calls have been ongoing since June 2020 within the confines of COVID-19 access, and we intend to expand our field force efforts in early 2021 with the addition of a contract sales organization. We are expecting to have additional international markets available to potential patients as we continue to work through the registration of Strontium89 in multiple jurisdictions around the world. We anticipate revenues from Strontium89 to continue rampingup in our 2021 fiscal year as we build capacity and demand worldwide. We are assessing several potential clinical trial programs that may expand the indication beyond palliation into a therapeutic use that may increase utilization in years to come. COVID-19, Glaucoma and Other Mannin Platform Drugs Even as vaccines for COVID-19 are being rolled out, the infection numbers are soaring around the world. Together with Mannin Research Inc., our technology partner, we are pursuing a treatment for Acute Respiratory Distress Syndrome, the condition that causes the most severe symptoms in COVID-19 patients usually resulting in hospitalizations and worse. Given the urgent need for therapeutics to treat COVID-19, we are rapidly accelerating the time to the first clinical milestone for MAN-19. An Investigational New Drug (IND) application (or similar clinical trial proposal) to regulators is planned for the first quarter of our 2021 fiscal year with trials commencing in the first half of 2021. It is important to note that we believe the MAN-19 therapeutic is virus-agnostic, which makes it relevant to other viral diseases today like influenza and future viral pandemic outbreaks. Therefore, a successful infectious disease application in COVID-19 could position MAN-19 as a potential government stockpile drug for possible future pandemics. Furthermore, a successful proof-of-concept clinical trial with MAN-19 in COVID-19 patients would provide the clinical dataset to quickly support the development of therapeutics for other vascular diseases such as sepsis, acute kidney injury, and of course glaucoma. All of these are large markets with significant potential. We continue to support the development of Mannin's MAN-01 and MAN-11 therapeutics, a novel small-molecule, and novel biologic therapeutic for glaucoma, respectively. There are over 60 million patients worldwide with primary open-angle glaucoma. The MAN-01 program is developing topical drops designed to reduce pressure build-up in the eye by assisting with, and correcting, drainage problems in tiny vessels in the eye. We have advanced this asset from 'concept to compound', and the preliminary data that we have reviewed has convinced us to continue pursuing these products in earnest. GDF-15 Diagnostic for Glaucoma - In Clinical Trial and Product Development with FDA Approval anticipated late in 2021 In early 2019, we licensed a diagnostic biomarker known as GDF-15for determining the severity of glaucoma from Washington University in St. Louis. GDF-15 is a perfect companion diagnostic for the MAN-01 and MAN-11 drugs, as well as a novel tool for practicing ophthalmologists and drug developers, because it is designed to assess the efficacy of the treatment or disease progression in their practice. This product represents a unique opportunity, and we believe that the current clinical trial is yielding promising results that will inform the 510(K) filing. In partnership, Mannin and McMaster University are nearing the completion of development of an in vitro diagnostic (IVD) with both point-of-care (detection in a doctor's office) as well as an external laboratory-based detection (i.e. for use in existing CLIA laboratories using existing diagnostic equipment). We anticipate completion of the IVD device by the end of June 2021 with submission to the FDA (510K) for in vitro diagnostic approval in late 2021. Uttroside-B - Liver Cancer Chemotherapeutic Along with our drug developmental partners, Chemveda Life Sciences, the Ragiv Ghandi Center and Oklahoma Medical Research Foundation, we are developing an innovative treatment for liver cancer, a disease indication that currently has a high unmet need. Currently, there are only two approved first-line therapies. We are now preparing to advance this into a pre-clinical program and IND application with the FDA in 2021 followed by a proof-of-concept clinical trial. Initiation of scale-up and GMP material has begun and is progressing well. QBM-001 - Early Stage Treatment for Young Minimally Verbal Children on the Autism Spectrum While our immediate focus is on the above-mentioned assets, we are also developing a new drug candidate to treat young children with minimally verbal autism. The advancement of this program will depend on the availability of funds and resources as we prioritize our clinical development milestones. There is no effective treatment available to help an estimated 250,000 children born with the condition worldwide each year, 20,000 of them in the United States. We are working on a discovery and development program to address this highly unmet need. Corporate Strategic Goals Our mission is to solve problems by accelerating the development of important therapies and availability of those therapies to patients. Since Q BioMed's inception 5 years ago, we have been busy building significant value ranging from blockbuster potential drugs to revenue producing opportunities. To that end, we believe that our planned uplist to a senior exchange will result in an enhanced valuation as a larger group of investors and institutions can participate in our equity. We have begun the process to uplist to NASDAQ and look forward to updating our shareholders on this in the very near term.As we move through these milestones, we believe we are creating value for our shareholders as we approach some significant milestones and catalysts in 2021. Please visit http://www.QBioMed.com and sign up for regular updates. About Q BioMed Inc. Q BioMed Inc is a biotech acceleration and commercial stage company. Q BioMed is focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. Q BioMed is dedicated to providing these target assets the strategic resources, developmental support, and expansion capital needed to ensure they meet their developmental potential, enabling them to provide products to patients in need. Forward-Looking Statements: This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. Q BioMed Media Contact: Denis Corin CEO Investor Relations: Keith Pinder+1(404) 995-6671 mailto:[emailprotected] SOURCE Q BioMed Inc.
Answer:
|
Q BioMed Updates Shareholders at Year End Company Expects Several Milestones as Momentum Builds for 2021
|
NEW YORK, Dec. 29, 2020 /PRNewswire/ --Q BioMed Inc. (OTCQB:QBIO), a commercial stage biotech company, today issued a letter to shareholders. Dear Fellow Shareholders, As 2020 draws to a close, we join the rest of the world in looking forward to a new year with new beginnings and hope for a quick return to whatever the new normal will be. Leaving behind the constant threat of lockdowns and the interruptionthe COVID-19 pandemic has had on our liveswill be a welcome change. With that in mind we acknowledge that 2020 was not the year we promised and feel even more committed to achieving our stated goals. We learned a great deal about Q BioMed's place in the fragile world in which we live and operate. With the 20/20 view of hindsight, we are excited about the coming year. Strontium Chloride Sr89 Injection, USP (Strontium89), a Palliative Treatment for Metastatic Bone Cancer In January we expect treatment with Strontium89 in the hospital out-patient setting will be fully reimbursed by Medicare. When this occurs, we will launch a hospital-focused marketing initiative andexpect to see hospitals more actively treat appropriate patients with Strontium89. We also anticipate being approved as a federal supplier in January 2021which will allow us to sell into federal hospital systems, notably the U.S. Department of Veteran Affairs (VA) and the U.S. Department of Defense. The VA is potentially our largest target customer, with asignificantpercentage of itspatients suffering from prostate, breast and lung cancer, and at rates higher than the national average. We have free-standing clinics in at least eight states that are undergoing the required operational steps to become a 'Strontium89 practice', including having it on their radioactive materials license, with some clinics already up and running. We also expect to have group purchasing contracts in place in early January and have begun to negotiate with national and regional oncology organizations. We have been deploying a multi-channel marketing campaign, driving awareness among our target audiences, both on the physician and the patient side. We have exhibited Strontium89 at several conferences including ASTRO (American Society of Therapeutic Radiation Oncology) and ONS (Oncology Nursing Society) and plan to begin speaker programs in the first quarter of 2021. Virtual and live sales calls have been ongoing since June 2020 within the confines of COVID-19 access, and we intend to expand our field force efforts in early 2021 with the addition of a contract sales organization. We are expecting to have additional international markets available to potential patients as we continue to work through the registration of Strontium89 in multiple jurisdictions around the world. We anticipate revenues from Strontium89 to continue rampingup in our 2021 fiscal year as we build capacity and demand worldwide. We are assessing several potential clinical trial programs that may expand the indication beyond palliation into a therapeutic use that may increase utilization in years to come. COVID-19, Glaucoma and Other Mannin Platform Drugs Even as vaccines for COVID-19 are being rolled out, the infection numbers are soaring around the world. Together with Mannin Research Inc., our technology partner, we are pursuing a treatment for Acute Respiratory Distress Syndrome, the condition that causes the most severe symptoms in COVID-19 patients usually resulting in hospitalizations and worse. Given the urgent need for therapeutics to treat COVID-19, we are rapidly accelerating the time to the first clinical milestone for MAN-19. An Investigational New Drug (IND) application (or similar clinical trial proposal) to regulators is planned for the first quarter of our 2021 fiscal year with trials commencing in the first half of 2021. It is important to note that we believe the MAN-19 therapeutic is virus-agnostic, which makes it relevant to other viral diseases today like influenza and future viral pandemic outbreaks. Therefore, a successful infectious disease application in COVID-19 could position MAN-19 as a potential government stockpile drug for possible future pandemics. Furthermore, a successful proof-of-concept clinical trial with MAN-19 in COVID-19 patients would provide the clinical dataset to quickly support the development of therapeutics for other vascular diseases such as sepsis, acute kidney injury, and of course glaucoma. All of these are large markets with significant potential. We continue to support the development of Mannin's MAN-01 and MAN-11 therapeutics, a novel small-molecule, and novel biologic therapeutic for glaucoma, respectively. There are over 60 million patients worldwide with primary open-angle glaucoma. The MAN-01 program is developing topical drops designed to reduce pressure build-up in the eye by assisting with, and correcting, drainage problems in tiny vessels in the eye. We have advanced this asset from 'concept to compound', and the preliminary data that we have reviewed has convinced us to continue pursuing these products in earnest. GDF-15 Diagnostic for Glaucoma - In Clinical Trial and Product Development with FDA Approval anticipated late in 2021 In early 2019, we licensed a diagnostic biomarker known as GDF-15for determining the severity of glaucoma from Washington University in St. Louis. GDF-15 is a perfect companion diagnostic for the MAN-01 and MAN-11 drugs, as well as a novel tool for practicing ophthalmologists and drug developers, because it is designed to assess the efficacy of the treatment or disease progression in their practice. This product represents a unique opportunity, and we believe that the current clinical trial is yielding promising results that will inform the 510(K) filing. In partnership, Mannin and McMaster University are nearing the completion of development of an in vitro diagnostic (IVD) with both point-of-care (detection in a doctor's office) as well as an external laboratory-based detection (i.e. for use in existing CLIA laboratories using existing diagnostic equipment). We anticipate completion of the IVD device by the end of June 2021 with submission to the FDA (510K) for in vitro diagnostic approval in late 2021. Uttroside-B - Liver Cancer Chemotherapeutic Along with our drug developmental partners, Chemveda Life Sciences, the Ragiv Ghandi Center and Oklahoma Medical Research Foundation, we are developing an innovative treatment for liver cancer, a disease indication that currently has a high unmet need. Currently, there are only two approved first-line therapies. We are now preparing to advance this into a pre-clinical program and IND application with the FDA in 2021 followed by a proof-of-concept clinical trial. Initiation of scale-up and GMP material has begun and is progressing well. QBM-001 - Early Stage Treatment for Young Minimally Verbal Children on the Autism Spectrum While our immediate focus is on the above-mentioned assets, we are also developing a new drug candidate to treat young children with minimally verbal autism. The advancement of this program will depend on the availability of funds and resources as we prioritize our clinical development milestones. There is no effective treatment available to help an estimated 250,000 children born with the condition worldwide each year, 20,000 of them in the United States. We are working on a discovery and development program to address this highly unmet need. Corporate Strategic Goals Our mission is to solve problems by accelerating the development of important therapies and availability of those therapies to patients. Since Q BioMed's inception 5 years ago, we have been busy building significant value ranging from blockbuster potential drugs to revenue producing opportunities. To that end, we believe that our planned uplist to a senior exchange will result in an enhanced valuation as a larger group of investors and institutions can participate in our equity. We have begun the process to uplist to NASDAQ and look forward to updating our shareholders on this in the very near term.As we move through these milestones, we believe we are creating value for our shareholders as we approach some significant milestones and catalysts in 2021. Please visit http://www.QBioMed.com and sign up for regular updates. About Q BioMed Inc. Q BioMed Inc is a biotech acceleration and commercial stage company. Q BioMed is focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. Q BioMed is dedicated to providing these target assets the strategic resources, developmental support, and expansion capital needed to ensure they meet their developmental potential, enabling them to provide products to patients in need. Forward-Looking Statements: This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. Q BioMed Media Contact: Denis Corin CEO Investor Relations: Keith Pinder+1(404) 995-6671 mailto:[emailprotected] SOURCE Q BioMed Inc.
|
edtsum5670
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN FRANCISCO, May12, 2020 /PRNewswire/ -- MindTickle, the leader in Sales Readiness technology, today released usage analysis and insightsfrom the MindTickle Sales Readiness platform, indicating a strong demand for online enablement, skills development, microlearning and coaching to support remote readiness. With over 66% daily active user growth from March through Aprilamong various industries and 75% new readiness and enablement modules published,organizations are equipping customer-facing sales teams with the knowledge and skills required to be successful in the "new normal". As the world went into lockdown, MindTickle tracked the following applications usage trends from February to March: 1218% increase in virtual role play / virtual practice across the platform 983% increase in virtual instructor led training (vILT) Nearly 2x increase in one-on-one remote coaching initiatives MindTickle also tracked the following industry-specific usage in the same timeframe: 793% average increase in usage across Health and Life Sciences companies (Pharma, MedTech, BioTech, etc.) 497% average increase in usage across Technology companies 221% average increase for partner enablementacross companies whose go-to-market relies on channel distribution "Every organization regardless of their industry is taking advantage of MindTickle to drive customer-centricity in their customer-facing reps," said Deepak Diwakar, chief technology officer at MindTickle. "MindTickle is a trusted and relevant solution allowing companies to quickly pivot their strategy to enhance the readiness of their customer-facing teams -- all virtually and remotely. Across the board, we've seen dramatic increases in skills development activities, from video coaching and role-play to task evaluation and voice over PowerPoint. Many are providing more bite-sized content for just-in-time, just-in-context microlearning. They're leveraging more coaching activities to help reps adapt their own skills and approaches to engaging with prospects and customers. We're here to support our customers and look forward to continuing to serve them as we all navigate the new normal." As shelter in place mandates continued from March through April, some longer-term trends began to appear: Financial Services and Insurance companies accelerated their usage of MindTickle's Sales Readiness platform. With a 265% spike in usage from March to April, these organizations did more Assessments (4220% increase) to understand the knowledge and skills of their sellers and baseline their competencies for additional training. Additionally, they're shifting their classroom-based training online with a 2624% increase in vILT. Tech companies are shifting to remote training, online field communications and virtual skills development as evidenced by a 243% increase in vILT usage since February, more Quick Updates for microlearning and field alignment, and nearly a 50% increase in Missions virtual role play and skills development. Companies in the Healthcare and Life Sciences space, consisting of Pharmaceutical, BioTech and MedTech organizations, rolled out more coaching (5532% increase) after greater than 200% increases in longer format Courses, Quick Updates for microlearning and field communications, and Assessments to understand rep competencies. Companies are establishing new sales enablement and readiness strategies, and relying on proven platforms to develop and improve knowledge, hard and soft skills, and behaviors that foster positive customer experiences, drive revenue and build brand value. Previously, virtual training and coaching was viewed by many organizations as supplemental or optional. However, this is no longer possible with recent travel restrictions, work from home mandates and the updated restrictions that will be in place for the foreseeable future. Customers are leveraging MindTickle to prepare customer-facing employees for in-person or, as currently mandated, virtual person-to-person interactions through: Remote Onboarding and Re-boarding Field organization initiatives like Virtual Quarterly Business Reviews and Sales Kick-Offs Remote field communications for alignment and messaging consistency Remote skills development and coaching Measuring remote seller readiness with reporting and analytics insights "It is more important than ever for organizations to consistently deliver the 'right' message to effectively engage customers and prospects, while executing on task, whether in a web conference, email or phone call," said Gopkiran Rao, chief strategy and marketing officer at MindTickle."As companies adapt to the new normal, a platform for virtual enablement and training that incorporates a systematic approach to ongoing readiness is no longer optional -- it's mandatory. Some companies have needed to retrain their customer-facing teams that have traditionally engaged with customers in-person and face-to-face, to be more effective in using teleconferencing and engaging customers in digital real estate -- screens measured in square inches. Others are accelerating plans they had already had in place and reacting to a renewed sense of urgency in assessing and addressing the competencies and capabilities of their teams." MindTickle has developed numerousresources to assist organizations in effectively keeping their remote employees trained, connected and updated to handle any customer interaction. Additional information: Learn more about MindTickle's applications See MindTickle'scustomer stories Connect withMindTickleon LinkedIn About MindTickle MindTickle provides a comprehensive, data-driven solution for sales readiness and enablement that fuels revenue growth and brand value for dozens of Fortune 500 and Global 2000 companies, and hundreds of the world's most recognized companies across technology, life sciences, financial services, manufacturing and service sectors. With purpose-built applications, proven methodologies, and best practices designed to drive effective sales onboarding and ongoing readiness, MindTickle enables company leaders and sellers to continually assess, diagnose and develop the knowledge, skills, and behaviors required to effectively engage customers and drive growth. MindTickle has been recognized by leading industry analyst and research firms and has been ranked on G2's Best Software 2020 lists as the #1 Enterprise Software Product and the 5th ranked software product for sales. For more information visit www.MindTickle.com or find us on LinkedIn, Facebook and Twitter. CONTACT: Public Relations at MindTickle, [emailprotected] SOURCE MindTickle Related Links https://www.mindtickle.com/
Answer:
|
New MindTickle Data Illustrates Exponential Increase in Demand for Online Sales Enablement and Readiness Platform usage from sales readiness leader indicates that customer-facing teams are racing to be remote and ready
|
SAN FRANCISCO, May12, 2020 /PRNewswire/ -- MindTickle, the leader in Sales Readiness technology, today released usage analysis and insightsfrom the MindTickle Sales Readiness platform, indicating a strong demand for online enablement, skills development, microlearning and coaching to support remote readiness. With over 66% daily active user growth from March through Aprilamong various industries and 75% new readiness and enablement modules published,organizations are equipping customer-facing sales teams with the knowledge and skills required to be successful in the "new normal". As the world went into lockdown, MindTickle tracked the following applications usage trends from February to March: 1218% increase in virtual role play / virtual practice across the platform 983% increase in virtual instructor led training (vILT) Nearly 2x increase in one-on-one remote coaching initiatives MindTickle also tracked the following industry-specific usage in the same timeframe: 793% average increase in usage across Health and Life Sciences companies (Pharma, MedTech, BioTech, etc.) 497% average increase in usage across Technology companies 221% average increase for partner enablementacross companies whose go-to-market relies on channel distribution "Every organization regardless of their industry is taking advantage of MindTickle to drive customer-centricity in their customer-facing reps," said Deepak Diwakar, chief technology officer at MindTickle. "MindTickle is a trusted and relevant solution allowing companies to quickly pivot their strategy to enhance the readiness of their customer-facing teams -- all virtually and remotely. Across the board, we've seen dramatic increases in skills development activities, from video coaching and role-play to task evaluation and voice over PowerPoint. Many are providing more bite-sized content for just-in-time, just-in-context microlearning. They're leveraging more coaching activities to help reps adapt their own skills and approaches to engaging with prospects and customers. We're here to support our customers and look forward to continuing to serve them as we all navigate the new normal." As shelter in place mandates continued from March through April, some longer-term trends began to appear: Financial Services and Insurance companies accelerated their usage of MindTickle's Sales Readiness platform. With a 265% spike in usage from March to April, these organizations did more Assessments (4220% increase) to understand the knowledge and skills of their sellers and baseline their competencies for additional training. Additionally, they're shifting their classroom-based training online with a 2624% increase in vILT. Tech companies are shifting to remote training, online field communications and virtual skills development as evidenced by a 243% increase in vILT usage since February, more Quick Updates for microlearning and field alignment, and nearly a 50% increase in Missions virtual role play and skills development. Companies in the Healthcare and Life Sciences space, consisting of Pharmaceutical, BioTech and MedTech organizations, rolled out more coaching (5532% increase) after greater than 200% increases in longer format Courses, Quick Updates for microlearning and field communications, and Assessments to understand rep competencies. Companies are establishing new sales enablement and readiness strategies, and relying on proven platforms to develop and improve knowledge, hard and soft skills, and behaviors that foster positive customer experiences, drive revenue and build brand value. Previously, virtual training and coaching was viewed by many organizations as supplemental or optional. However, this is no longer possible with recent travel restrictions, work from home mandates and the updated restrictions that will be in place for the foreseeable future. Customers are leveraging MindTickle to prepare customer-facing employees for in-person or, as currently mandated, virtual person-to-person interactions through: Remote Onboarding and Re-boarding Field organization initiatives like Virtual Quarterly Business Reviews and Sales Kick-Offs Remote field communications for alignment and messaging consistency Remote skills development and coaching Measuring remote seller readiness with reporting and analytics insights "It is more important than ever for organizations to consistently deliver the 'right' message to effectively engage customers and prospects, while executing on task, whether in a web conference, email or phone call," said Gopkiran Rao, chief strategy and marketing officer at MindTickle."As companies adapt to the new normal, a platform for virtual enablement and training that incorporates a systematic approach to ongoing readiness is no longer optional -- it's mandatory. Some companies have needed to retrain their customer-facing teams that have traditionally engaged with customers in-person and face-to-face, to be more effective in using teleconferencing and engaging customers in digital real estate -- screens measured in square inches. Others are accelerating plans they had already had in place and reacting to a renewed sense of urgency in assessing and addressing the competencies and capabilities of their teams." MindTickle has developed numerousresources to assist organizations in effectively keeping their remote employees trained, connected and updated to handle any customer interaction. Additional information: Learn more about MindTickle's applications See MindTickle'scustomer stories Connect withMindTickleon LinkedIn About MindTickle MindTickle provides a comprehensive, data-driven solution for sales readiness and enablement that fuels revenue growth and brand value for dozens of Fortune 500 and Global 2000 companies, and hundreds of the world's most recognized companies across technology, life sciences, financial services, manufacturing and service sectors. With purpose-built applications, proven methodologies, and best practices designed to drive effective sales onboarding and ongoing readiness, MindTickle enables company leaders and sellers to continually assess, diagnose and develop the knowledge, skills, and behaviors required to effectively engage customers and drive growth. MindTickle has been recognized by leading industry analyst and research firms and has been ranked on G2's Best Software 2020 lists as the #1 Enterprise Software Product and the 5th ranked software product for sales. For more information visit www.MindTickle.com or find us on LinkedIn, Facebook and Twitter. CONTACT: Public Relations at MindTickle, [emailprotected] SOURCE MindTickle Related Links https://www.mindtickle.com/
|
edtsum5672
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: INDIANA, Pa., Oct. 1, 2020 /PRNewswire/ --S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, with operations in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio, and Upstate New York, announced today that a conference call detailing the company's third quarter 2020 earnings will be held live over the Internet at 1:00 p.m. ET on Thursday, October 22, 2020. Todd D. Brice, chief executive officer, David G. Antolik, president, and Mark Kochvar, chief financial officer, will conduct the conference call. The public is invited to listen. S&T Bancorp, Inc. intends to release its third quarter earnings before the market opens on Thursday, October 22, 2020. PERTINENT USER INFORMATION: What: S&T Bancorp, Inc. 3rd Quarter Earnings Conference Call When: 1:00 p.m. ET, Thursday, October 22, 2020 Where: S&T Bank's Investor Relations webpage www.stbancorp.com How: Live over the Internet To access the webcast, go to S&T Bancorp's webpage at the address listed above and click on "Events &Presentations." Select "3rd Quarter 2020 Conference Call" and follow the instructions. Participants are asked to access the webcast approximately five minutes prior to the beginning of the discussion. After the live presentation, the webcast will be archived on this website for at least 90 days. A replay of the call will also be available until October 29, 2020, by dialing 1.877.481.4010; the Conference ID is 37817. To Ask Questions:Prior to the webcast, please email questions to [emailprotected]. Also, participants who log into the conference call will have an opportunity to email their questions directly from the webpage beginning at 12:55 p.m. ET until the conclusion of the presentation. Third Quarter 2020 Earnings Release:The S&T Bancorp, Inc. Third Quarter Earnings Press Release can be accessed on Thursday, October 22, 2020 at www.stbancorp.com. Click on "Press Releases." About S&T Bancorp, Inc. and S&T Bank:S&T Bancorp, Inc. is a $9.5 billion bank holding company that is headquartered in Indiana, Pennsylvania and trades on the NASDAQ Global Select Market under the symbol STBA. Its principal subsidiary, S&T Bank, was recently ranked #1 in customer satisfaction with retail banking in the Mid-Atlantic including best in communication and advice by J.D. Power. Established in 1902, S&T Bank operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio, and Upstate New York. For more information visit stbancorp.com, stbank.com, and follow us on Facebook, Instagram, and LinkedIn. SOURCE S&T Bancorp, Inc. Related Links http://www.stbank.com
Answer:
|
S&T Bancorp to Webcast Third Quarter Earnings Conference Call
|
INDIANA, Pa., Oct. 1, 2020 /PRNewswire/ --S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, with operations in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio, and Upstate New York, announced today that a conference call detailing the company's third quarter 2020 earnings will be held live over the Internet at 1:00 p.m. ET on Thursday, October 22, 2020. Todd D. Brice, chief executive officer, David G. Antolik, president, and Mark Kochvar, chief financial officer, will conduct the conference call. The public is invited to listen. S&T Bancorp, Inc. intends to release its third quarter earnings before the market opens on Thursday, October 22, 2020. PERTINENT USER INFORMATION: What: S&T Bancorp, Inc. 3rd Quarter Earnings Conference Call When: 1:00 p.m. ET, Thursday, October 22, 2020 Where: S&T Bank's Investor Relations webpage www.stbancorp.com How: Live over the Internet To access the webcast, go to S&T Bancorp's webpage at the address listed above and click on "Events &Presentations." Select "3rd Quarter 2020 Conference Call" and follow the instructions. Participants are asked to access the webcast approximately five minutes prior to the beginning of the discussion. After the live presentation, the webcast will be archived on this website for at least 90 days. A replay of the call will also be available until October 29, 2020, by dialing 1.877.481.4010; the Conference ID is 37817. To Ask Questions:Prior to the webcast, please email questions to [emailprotected]. Also, participants who log into the conference call will have an opportunity to email their questions directly from the webpage beginning at 12:55 p.m. ET until the conclusion of the presentation. Third Quarter 2020 Earnings Release:The S&T Bancorp, Inc. Third Quarter Earnings Press Release can be accessed on Thursday, October 22, 2020 at www.stbancorp.com. Click on "Press Releases." About S&T Bancorp, Inc. and S&T Bank:S&T Bancorp, Inc. is a $9.5 billion bank holding company that is headquartered in Indiana, Pennsylvania and trades on the NASDAQ Global Select Market under the symbol STBA. Its principal subsidiary, S&T Bank, was recently ranked #1 in customer satisfaction with retail banking in the Mid-Atlantic including best in communication and advice by J.D. Power. Established in 1902, S&T Bank operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio, and Upstate New York. For more information visit stbancorp.com, stbank.com, and follow us on Facebook, Instagram, and LinkedIn. SOURCE S&T Bancorp, Inc. Related Links http://www.stbank.com
|
edtsum5689
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, Aug. 3, 2020 /PRNewswire/ -- The GlobalUV-C Robot Marketis forecast to reach USD 1.46 Billion by 2027, according to a new report by Reports and Data. UV-C robots are autonomous robots that emit ample energy to shred the RNA or DNA of microorganisms. They have emerged as a powerful tool amidst the coronavirus pandemic, where physical distancing among people is crucial. Even though most countries have declared themselves free of the virus, there is a huge risk of the second wave among asymptotic patients. Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/3376 These robots were initially developed to sanitize hospitals where the risk of infection is greater, but with a rise in infectious viruses, multiple sectors are using these hospitals to sanitize their environment. According to WHO, infectious diseases account for the death of more than 17 million people every year. Approximately 50,000 male and female populations die every day, owing to infectious diseases. Several nations are facing huge losses in terms of lost income (in foreign currency) from tourism and food trade due to epidemics of plague, and cholera, among others. All these factors are causative of the rising demand for UV-C robots. The COVID-19 impact: With the outbreak of the coronavirus, the WHO encourages people to take more aggressive steps to prevent the widespread of the virus, especially in hospitals or places where the infected patients are being treated. The UVD-Robots developed by Blue Ocean Robotics operate autonomously and move around COVID-19 patients' operating theatres and rooms, covering crucial surfaces with the virus and bacteria-killing UV light. The market has witnessed a high demand during the epidemic and is anticipated to grow in the coming years due to the growth in automation and high adoption of robotics. To identify the key trends in the industry, click on the link below:https://www.reportsanddata.com/report-detail/uv-c-robot-market Further key findings from the report suggest The software segment held a significant share in the market owing to the demand for sophisticated software required in the robotics. It is a set of complicated codes that make the UV-C robots functional. Several frameworks and software have been proposed to make the programming of these products easier. Surface disinfection is likely to grow at the fastest rate in the forecast period. Infections acquired in hospitals and healthcare places are a significant cause of avertible death across the globe. The physical environment plays a crucial role in the transmission of disease, and novel technologies are being presented into healthcare facilities to decrease the environmental route of transmission of disease. Ultraviolet surface disinfection is considered to be one of the new technologies with substantial potential. Portable robotics witness high demand as these products can move around from room to room to sanitize and can guide itself around the organization without help. They have self-direction sensors, and they also help in eliminating HAIs or hospital-acquired diseases by limiting physical contact. Hospitals in the commercial sector are the major end-users of the market. With the rise in infection and an increasing incidence of diseases, most of the hospitals are adopting UV-C robots to sanitize their surroundings and surfaces. North America has the highest adoption rate in the market. This is due to the availability of advanced technology and the financial ability of the institutions to deploy and maintain expensive robots. Moreover, the presence of key market players in the region is also an encouraging market driver. Key participants include Finsen Technologies, OTSAW, RobotLab, UVD Robots, Omron, Blue Ocean Robotics, Hipac, Skytron, Xenex Disinfection Services LLC, and Tru-D SmartUVC, among others. Order Now: https://www.reportsanddata.com/checkout-form/3376 For the purpose of this report, Reports and Data has segmented the global UV-C Robot Market on the basis of component, type, end-users, application, distribution channel, and region: Component Outlook (Revenue, USD Billion; 2017-2027) Software Hardware Type Outlook (Revenue, USD Billion; 2017-2027) Stationary Portable End-users Outlook (Revenue, USD Billion; 2017-2027) Residential Commercial Industrial Application Outlook (Revenue, USD Billion; 2017-2027) Air Surface Others Distribution Channel Outlook (Revenue, USD Billion; 2017-2027) Online Offline Regional Outlook (Revenue, USD Billion; 2017-2027) North America U.S Canada Europe Germany U.K France Benelux Rest of Europe Asia Pacific China Japan South Korea Rest of APAC Latin America Brazil Rest of LATAM Middle East & Africa Saudi Arabia UAE Rest of MEA Browse more similar reports on Roboticscategory by Reports And Data Agricultural Robots MarketBy Offerings (Hardware, Software, Services), By Type (Unmanned Aerial Vehicles (UAVs), Milking Robots, Driverless Tractors, Automated Harvesting Systems, Other Robots), And By Farm, By Farming, By Application, Forecasts To 2027 Collaborative Robot (Cobot) Market By Type (Liquid Ring Compressors, Centrifugal Compressors and Others), By Application (Energy and Power, Manufacturing, Healthcare), And Region- Global Forecasts To 2027 Vision Guided Robotics Software MarketAnalysis, By Robot Type (Fixed and Mobile), By Technology (2d Vision, 3D Vision), By Application (Navigation, Assembly), By Verticals (Automotive, Healthcare, Aerospace) By Region, Forecasts to 2026 About Reports and Data Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us:John WHead of Business DevelopmentReports And Data | Web: www.reportsanddata.comDirect Line: +1-212-710-1370E-mail: [emailprotected]LinkedIn | Twitter | Blogs SOURCE Reports And Data
Answer:
|
UV-C Robot Market to Reach USD 1.46 Billion by 2027 | Reports And Data
|
NEW YORK, Aug. 3, 2020 /PRNewswire/ -- The GlobalUV-C Robot Marketis forecast to reach USD 1.46 Billion by 2027, according to a new report by Reports and Data. UV-C robots are autonomous robots that emit ample energy to shred the RNA or DNA of microorganisms. They have emerged as a powerful tool amidst the coronavirus pandemic, where physical distancing among people is crucial. Even though most countries have declared themselves free of the virus, there is a huge risk of the second wave among asymptotic patients. Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/3376 These robots were initially developed to sanitize hospitals where the risk of infection is greater, but with a rise in infectious viruses, multiple sectors are using these hospitals to sanitize their environment. According to WHO, infectious diseases account for the death of more than 17 million people every year. Approximately 50,000 male and female populations die every day, owing to infectious diseases. Several nations are facing huge losses in terms of lost income (in foreign currency) from tourism and food trade due to epidemics of plague, and cholera, among others. All these factors are causative of the rising demand for UV-C robots. The COVID-19 impact: With the outbreak of the coronavirus, the WHO encourages people to take more aggressive steps to prevent the widespread of the virus, especially in hospitals or places where the infected patients are being treated. The UVD-Robots developed by Blue Ocean Robotics operate autonomously and move around COVID-19 patients' operating theatres and rooms, covering crucial surfaces with the virus and bacteria-killing UV light. The market has witnessed a high demand during the epidemic and is anticipated to grow in the coming years due to the growth in automation and high adoption of robotics. To identify the key trends in the industry, click on the link below:https://www.reportsanddata.com/report-detail/uv-c-robot-market Further key findings from the report suggest The software segment held a significant share in the market owing to the demand for sophisticated software required in the robotics. It is a set of complicated codes that make the UV-C robots functional. Several frameworks and software have been proposed to make the programming of these products easier. Surface disinfection is likely to grow at the fastest rate in the forecast period. Infections acquired in hospitals and healthcare places are a significant cause of avertible death across the globe. The physical environment plays a crucial role in the transmission of disease, and novel technologies are being presented into healthcare facilities to decrease the environmental route of transmission of disease. Ultraviolet surface disinfection is considered to be one of the new technologies with substantial potential. Portable robotics witness high demand as these products can move around from room to room to sanitize and can guide itself around the organization without help. They have self-direction sensors, and they also help in eliminating HAIs or hospital-acquired diseases by limiting physical contact. Hospitals in the commercial sector are the major end-users of the market. With the rise in infection and an increasing incidence of diseases, most of the hospitals are adopting UV-C robots to sanitize their surroundings and surfaces. North America has the highest adoption rate in the market. This is due to the availability of advanced technology and the financial ability of the institutions to deploy and maintain expensive robots. Moreover, the presence of key market players in the region is also an encouraging market driver. Key participants include Finsen Technologies, OTSAW, RobotLab, UVD Robots, Omron, Blue Ocean Robotics, Hipac, Skytron, Xenex Disinfection Services LLC, and Tru-D SmartUVC, among others. Order Now: https://www.reportsanddata.com/checkout-form/3376 For the purpose of this report, Reports and Data has segmented the global UV-C Robot Market on the basis of component, type, end-users, application, distribution channel, and region: Component Outlook (Revenue, USD Billion; 2017-2027) Software Hardware Type Outlook (Revenue, USD Billion; 2017-2027) Stationary Portable End-users Outlook (Revenue, USD Billion; 2017-2027) Residential Commercial Industrial Application Outlook (Revenue, USD Billion; 2017-2027) Air Surface Others Distribution Channel Outlook (Revenue, USD Billion; 2017-2027) Online Offline Regional Outlook (Revenue, USD Billion; 2017-2027) North America U.S Canada Europe Germany U.K France Benelux Rest of Europe Asia Pacific China Japan South Korea Rest of APAC Latin America Brazil Rest of LATAM Middle East & Africa Saudi Arabia UAE Rest of MEA Browse more similar reports on Roboticscategory by Reports And Data Agricultural Robots MarketBy Offerings (Hardware, Software, Services), By Type (Unmanned Aerial Vehicles (UAVs), Milking Robots, Driverless Tractors, Automated Harvesting Systems, Other Robots), And By Farm, By Farming, By Application, Forecasts To 2027 Collaborative Robot (Cobot) Market By Type (Liquid Ring Compressors, Centrifugal Compressors and Others), By Application (Energy and Power, Manufacturing, Healthcare), And Region- Global Forecasts To 2027 Vision Guided Robotics Software MarketAnalysis, By Robot Type (Fixed and Mobile), By Technology (2d Vision, 3D Vision), By Application (Navigation, Assembly), By Verticals (Automotive, Healthcare, Aerospace) By Region, Forecasts to 2026 About Reports and Data Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us:John WHead of Business DevelopmentReports And Data | Web: www.reportsanddata.comDirect Line: +1-212-710-1370E-mail: [emailprotected]LinkedIn | Twitter | Blogs SOURCE Reports And Data
|
edtsum5695
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, April 1, 2020 /PRNewswire/ -- Overview:This report assesses the market for IoT authentication and authorization by technology, solutions, and industry verticals with forecasts from 2020 to 2025. The report analyzes IoT authentication an authorization market drivers and opportunities. The report also assesses IoT authentication and authorization infrastructure requirements.Read the full report: https://www.reportlinker.com/p05878515/?utm_source=PRN IoT authentication and authorization solutions are important in support of IoT data management including access and management with a Data as a Service (DaaS) model, which is defined as any service offered wherein users can access vendor provided databases or host their own databases on vendor managed systems.IoT Data as a Service (IoTDaaS) offers convenient and cost-effective solutions to enterprises of various sizes and domain. IoTDaaS constitutes retrieving, storing and analyzing information and provide customer either of the three or integrated service package depending on the budget and the requirement. Acquiring (capturing and/or licensing), storing, processing, and distributing IoT data is anticipated to become a multi-billion-dollar business by 2025.IoT authentication and authorization solutions are also important in support of the "things" involved in IoT, which vary from devices used to detect, actuate, signal, engage, and more. IoT things also involve everything from gateways, modules, and sensors to hardware and embedded software within products and equipment and other consumer, enterprise, and industrial assets. The IoT ecosystem could easily become highly cumbersome with so many different "things" to consider as part of IoT provisioning, activation, administration and other management functions.More specifically, IoT authentication and authorization solutions are important in support of IoT device management in concert with the expanding scope of devices by volume, type, purpose, role and importance. Authentication ensures proper IoT device security, which goes beyond access (to device, network/system, etc.) and includes data security/privacy as well as securing proper decisions (e.g. ensuring that autonomous processes are carried forth in a manner that is not detrimental).Target Audience: Network service providers Systems integration companies IoT and wireless device manufacturers Network and device security companies Data management and analytics companiesReport Benefits: Identify market opportunities for IoT authentication solutions Understand IoT authorization and authentication infrastructure Understand the role an importance of AAA in IoT networks and systems Recognize the relationship between AAA and IoT service level agreements Understand the difference between authentication and authorization in IoTReport Findings: IoT authentication and authorization is crucial for IoT SLAs Asia Pacific is the largest region followed by North America and Europe Healthcare is the largest industry vertical for IoT authentication and authorization Aerospace is the fastest-growing industry vertical for IoT authentication and authorization IoT authentication and authorization in edge networks will be a $1.3B opportunity by 2025Read the full report: https://www.reportlinker.com/p05878515/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com
Answer:
|
IoT Authentication and Authorization by Technology, Solutions, and Industry Verticals 2020 - 2025
|
NEW YORK, April 1, 2020 /PRNewswire/ -- Overview:This report assesses the market for IoT authentication and authorization by technology, solutions, and industry verticals with forecasts from 2020 to 2025. The report analyzes IoT authentication an authorization market drivers and opportunities. The report also assesses IoT authentication and authorization infrastructure requirements.Read the full report: https://www.reportlinker.com/p05878515/?utm_source=PRN IoT authentication and authorization solutions are important in support of IoT data management including access and management with a Data as a Service (DaaS) model, which is defined as any service offered wherein users can access vendor provided databases or host their own databases on vendor managed systems.IoT Data as a Service (IoTDaaS) offers convenient and cost-effective solutions to enterprises of various sizes and domain. IoTDaaS constitutes retrieving, storing and analyzing information and provide customer either of the three or integrated service package depending on the budget and the requirement. Acquiring (capturing and/or licensing), storing, processing, and distributing IoT data is anticipated to become a multi-billion-dollar business by 2025.IoT authentication and authorization solutions are also important in support of the "things" involved in IoT, which vary from devices used to detect, actuate, signal, engage, and more. IoT things also involve everything from gateways, modules, and sensors to hardware and embedded software within products and equipment and other consumer, enterprise, and industrial assets. The IoT ecosystem could easily become highly cumbersome with so many different "things" to consider as part of IoT provisioning, activation, administration and other management functions.More specifically, IoT authentication and authorization solutions are important in support of IoT device management in concert with the expanding scope of devices by volume, type, purpose, role and importance. Authentication ensures proper IoT device security, which goes beyond access (to device, network/system, etc.) and includes data security/privacy as well as securing proper decisions (e.g. ensuring that autonomous processes are carried forth in a manner that is not detrimental).Target Audience: Network service providers Systems integration companies IoT and wireless device manufacturers Network and device security companies Data management and analytics companiesReport Benefits: Identify market opportunities for IoT authentication solutions Understand IoT authorization and authentication infrastructure Understand the role an importance of AAA in IoT networks and systems Recognize the relationship between AAA and IoT service level agreements Understand the difference between authentication and authorization in IoTReport Findings: IoT authentication and authorization is crucial for IoT SLAs Asia Pacific is the largest region followed by North America and Europe Healthcare is the largest industry vertical for IoT authentication and authorization Aerospace is the fastest-growing industry vertical for IoT authentication and authorization IoT authentication and authorization in edge networks will be a $1.3B opportunity by 2025Read the full report: https://www.reportlinker.com/p05878515/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com
|
edtsum5701
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceuticals Industries Limited (Teva or the Company) (NYSE: TEVA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 29, 2015 and August 18, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before November 23, 2020. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected]. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Teva made kickback payments to charities as part of a scheme to cover Medicare co-payments for patients taking Copaxone. A portion of the Companys Copaxone revenue was derived from this illegal scheme. Based on these facts, the Companys public statements were false and materially misleading throughout the class period. When the market learned the truth about Teva, investors suffered damages. Join the case to recover your losses. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Answer:
|
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
|
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceuticals Industries Limited (Teva or the Company) (NYSE: TEVA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 29, 2015 and August 18, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before November 23, 2020. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected]. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Teva made kickback payments to charities as part of a scheme to cover Medicare co-payments for patients taking Copaxone. A portion of the Companys Copaxone revenue was derived from this illegal scheme. Based on these facts, the Companys public statements were false and materially misleading throughout the class period. When the market learned the truth about Teva, investors suffered damages. Join the case to recover your losses. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
|
edtsum5712
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN JOSE, Calif., April 14, 2021 /PRNewswire/ --Harmonic (NASDAQ: HLIT) today announced that Mowies, a LATAM-based on-demand media platform, with a unique revenue model for creators of feature films, documentaries, TV series, theatrical performances, concerts and other original content, is optimizing its workflow with Harmonic's VOS360 cloud streaming offering. Based on a pay-as-you-grow business model, Harmonic's VOS360 SaaS is helping Mowies expand its offering, which uniquely allows consumers to purchase on-demand content directly from filmmakers, musicians and storytellers. The VOS360 SaaSprovides Mowies with an easy-to-use, end-to-end solution for media processing and delivery, optimizing bandwidth usage and enabling an exceptional viewing experience for viewers. Harmonic VOS360 Cloud Streaming Offering "As a recent entrant to the streaming market, Mowies is growing rapidly as more creators and users come onboard every day," said Alejo Arango, CEO at Mowies. "Harmonic's VOS360 SaaS gives us the ability to scale based on our growing viewership, without requiring investments in infrastructure. Thanks to Harmonic, we have a streamlined solution from source to screen, and we can confidently keep adding new content and gaining much needed visibility for content creators." Harmonic's VOS360 SaaS supports the entire streaming workflow from ingest to delivery, allowing simpler on-demand streaming with easy control through a rich API. Mowies has improved the streaming quality and lowered overall streaming costs with Harmonic's EyeQ AI-based encoding technology on the VOS360 platform. EyeQ encoding reduces Mowies' storage and CDN requirements by up to 50% compared with traditional encoding methods. Harmonic's worldwide team of DevOps experts provides 24/7 monitoring and assistance to ensure the highest service availability for Mowies at all times. "Mowies required a fast time-to-market, and that's an area where the VOS360 platform really shines. With its flexible cloud-based architecture, the VOS360 platform was up and running in weeks," said Alvaro Martin, vice president, sales and services, Latin America, at Harmonic. "With the VOS360 solution powering their streaming workflow, Mowies can deliver content from independent content creators and Hollywood filmmakers via a single, end-to-end platform, reducing their operating costs and decreasing complexity."Further information about Harmonic and the company's solutions is available at www.harmonicinc.com. About HarmonicHarmonic (NASDAQ: HLIT), the worldwide leader in virtualized cable access and video delivery solutions, enables media companies and service providers to deliver ultra-high-quality video streaming and broadcast services to consumers globally. The company revolutionized cable access networking via the industry's first virtualized cable access solution, enabling cable operators to more flexibly deploy gigabit internet service to consumers' homes and mobile devices. Whether simplifying OTT video delivery via innovative cloud and software platforms, or powering the delivery of gigabit internet cable services, Harmonic is changing the way media companies and service providers monetize live and on-demand content on every screen. More information is available at www.harmonicinc.com. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements concerning Harmonic's business and the anticipated capabilities, advantages, reliability, efficiency, market acceptance, market growth, specifications and benefits of Harmonic products, services and technology are forward-looking statements. These statements are based on our current expectations and beliefs and are subject to risks and uncertainties, including the risks and uncertainties more fully described in Harmonic's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended Dec. 31, 2020, its Quarterly Reports on Form 10-Q and its Current Reports on Form 8-K. The forward-looking statements in this press release are based on information available to Harmonic as of the date hereof, and Harmonic disclaims any obligation to update any forward-looking statements.Harmonic, the Harmonic logo and other Harmonic marks are owned by Harmonic Inc. or its affiliates. All other trademarks referenced herein are the property of their respective owners.SOURCE Harmonic Inc. Related Links https://www.harmonicinc.com/
Answer:
|
Mowies Expands On-Demand Platform with Harmonic's VOS Cloud Streaming SaaS
|
SAN JOSE, Calif., April 14, 2021 /PRNewswire/ --Harmonic (NASDAQ: HLIT) today announced that Mowies, a LATAM-based on-demand media platform, with a unique revenue model for creators of feature films, documentaries, TV series, theatrical performances, concerts and other original content, is optimizing its workflow with Harmonic's VOS360 cloud streaming offering. Based on a pay-as-you-grow business model, Harmonic's VOS360 SaaS is helping Mowies expand its offering, which uniquely allows consumers to purchase on-demand content directly from filmmakers, musicians and storytellers. The VOS360 SaaSprovides Mowies with an easy-to-use, end-to-end solution for media processing and delivery, optimizing bandwidth usage and enabling an exceptional viewing experience for viewers. Harmonic VOS360 Cloud Streaming Offering "As a recent entrant to the streaming market, Mowies is growing rapidly as more creators and users come onboard every day," said Alejo Arango, CEO at Mowies. "Harmonic's VOS360 SaaS gives us the ability to scale based on our growing viewership, without requiring investments in infrastructure. Thanks to Harmonic, we have a streamlined solution from source to screen, and we can confidently keep adding new content and gaining much needed visibility for content creators." Harmonic's VOS360 SaaS supports the entire streaming workflow from ingest to delivery, allowing simpler on-demand streaming with easy control through a rich API. Mowies has improved the streaming quality and lowered overall streaming costs with Harmonic's EyeQ AI-based encoding technology on the VOS360 platform. EyeQ encoding reduces Mowies' storage and CDN requirements by up to 50% compared with traditional encoding methods. Harmonic's worldwide team of DevOps experts provides 24/7 monitoring and assistance to ensure the highest service availability for Mowies at all times. "Mowies required a fast time-to-market, and that's an area where the VOS360 platform really shines. With its flexible cloud-based architecture, the VOS360 platform was up and running in weeks," said Alvaro Martin, vice president, sales and services, Latin America, at Harmonic. "With the VOS360 solution powering their streaming workflow, Mowies can deliver content from independent content creators and Hollywood filmmakers via a single, end-to-end platform, reducing their operating costs and decreasing complexity."Further information about Harmonic and the company's solutions is available at www.harmonicinc.com. About HarmonicHarmonic (NASDAQ: HLIT), the worldwide leader in virtualized cable access and video delivery solutions, enables media companies and service providers to deliver ultra-high-quality video streaming and broadcast services to consumers globally. The company revolutionized cable access networking via the industry's first virtualized cable access solution, enabling cable operators to more flexibly deploy gigabit internet service to consumers' homes and mobile devices. Whether simplifying OTT video delivery via innovative cloud and software platforms, or powering the delivery of gigabit internet cable services, Harmonic is changing the way media companies and service providers monetize live and on-demand content on every screen. More information is available at www.harmonicinc.com. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements concerning Harmonic's business and the anticipated capabilities, advantages, reliability, efficiency, market acceptance, market growth, specifications and benefits of Harmonic products, services and technology are forward-looking statements. These statements are based on our current expectations and beliefs and are subject to risks and uncertainties, including the risks and uncertainties more fully described in Harmonic's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended Dec. 31, 2020, its Quarterly Reports on Form 10-Q and its Current Reports on Form 8-K. The forward-looking statements in this press release are based on information available to Harmonic as of the date hereof, and Harmonic disclaims any obligation to update any forward-looking statements.Harmonic, the Harmonic logo and other Harmonic marks are owned by Harmonic Inc. or its affiliates. All other trademarks referenced herein are the property of their respective owners.SOURCE Harmonic Inc. Related Links https://www.harmonicinc.com/
|
edtsum5714
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SEATTLE and VANCOUVER, BC, Nov. 12, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced third quarter 2020 financial results and provided an update on the cytisinicline clinical development program. Recent Events & Highlights Initiated the Phase 3 ORCA-2 clinical trial evaluating the efficacy and safety of 3 mg cytisinicline dosed 3 times daily compared to placebo in 750 adult smokers at 15 clinical sites in the United States Promoted John Bencich to Chief Executive Officer and Dr. Cindy Jacobs to President Presented successful results from the RAUORA, head-to-head non-inferiority clinical trial comparing cytisinicline and Chantix (varenicline), at the Society for Research on Nicotine and Tobacco European (SRNT-E) Annual Meeting Presented mechanism of action data comparing 5-HT3 receptor activity of cytisinicline vs. Chantix at SRNT-E, providing rationale for differentiated side effect profile of smoking cessation treatments Announced smoking cessation Key Opinion Leader Virtual Roundtable to be held on November 17, 2020 "With the initiation of the Phase 3 ORCA-2 trial and the breakthrough evidence, both mechanistically and clinically, in support of cytisinicline in comparison to Chantix, the third quarter of 2020 has undeniably been the most pivotal in the history of our company," commented John Bencich, Chief Executive Officer of Achieve. "Our primary focus in the coming months will be enrollment and execution of ORCA-2, while continuing to explore opportunities for commercialization and expansion into new therapeutic indications, digital health technologies, and audiences who may benefit from cytisinicline, specifically, users of vapes or e-cigarettes." Phase 3 ORCA-2 Trial Initiation Achieve's first Phase 3 ORCA-2 trial was initiated in October 2020 and will randomize 750 U.S. smokers to one of three study arms to determine the efficacy and safety of cytisinicline administered for either 6 or 12 weeks, compared to placebo. The primary endpoint is biochemically verified continuous abstinence during the last 4 weeks of treatment in the 6 and 12-week cytisinicline treatment arms compared to placebo. Each treatment arm will be compared independently to the placebo arm and the trial will be determined to be successful if either or both of the cytisinicline treatment arms show a statistical benefit compared to placebo. Management Team UpdateIn September, the Company announced the promotion of John Bencich to Chief Executive Officer and Dr. Cindy Jacobs to President. Mr. Bencich has been serving as Achieve's Chief Financial and Operating Officer since 2017 and will join the Board of Directors in his role. Dr. Jacobs has been serving as the Chief Medical Officer of Achieve since 2017 and will continue in her role leading the regulatory and clinical development efforts for cytisinicline. Rick Stewart will remain with Achieve as the Executive Chairman of the Board of Directors and Dr. Anthony Clark will remain in his role as Chief Scientific Officer. RAUORA: Significantly Fewer Adverse Events and Higher Quits Rates for Cytisinicline vs ChantixFinal results from the New Zealand RAUORA Phase 3 non-inferiority clinical trial comparing cytisinicline to varenicline (Chantix) in Mori (indigenous New Zealanders) and whnau (family) of Mori were presented at the SRNT-E Annual Meeting in September 2020. Results showed that cytisinicline met the pre-specified non-inferiority endpoint and was trending towards superiority demonstrating a 4.29% improvement in quit rates in favor of cytisinicline. Subjects in the cytisinicline arm were approximately one and a half times more likely to have quit smoking at 6 months compared to subjects who received varenicline. Importantly, significantly fewer overall adverse events (AEs) were reported in cytisinicline-treated subjects. Of the subjects who experienced AEs (111 in the cytisinicline arm compared to 138 in the varenicline arm), there was significantly less nausea and vivid dreams. MOA Data Explaining Reduced Nausea and Vomiting with Cytisinicline Presented at SRNT-EData presented at the SRNT-E Annual Meeting in September 2020 provides a rationale based on detailed receptor pharmacology to explain why the incidence of nausea and vomiting associated with cytisinicline appears to be consistently lower than that seen with Chantix. The preclinical study, conducted at the University of Cambridge Department of Biochemistry, was designed to examine the in vitro binding characteristics of cytisinicline compared to varenicline at the human 5-HT3 receptor. The study reported an IC50 of 0.50 mM for cytisinicline and 0.25 M for varenicline, representing a 2000-greater fold agonist binding affinity to the 5-HT3 receptor for varenicline compared to cytisinicline. Virtual Smoking Cessation KOL Roundtable to be Held November 17, 2020 Achieve announced plans to host a virtual roundtable on cytisinicline and smoking cessation on Tuesday, November 17, 2020, at 12:00PM EST. Five esteemed experts in the field of smoking cessation will discuss the ongoing ORCA-2 trial, review recent cytisinicline data, and discuss the importance of smoking cessation in the midst of the COVID-19 pandemic. Visit http://ir.achievelifesciences.com/events-and-webcasts for additional informationand click here to register for the event. Financial ResultsAs of September 30, 2020, the company's cash, cash equivalents, and restricted cash was $22.4 million. Total operating expenses for the three and nine months ended September 30, 2020 were $3.8 million and $10.0 million, respectively. Total net loss for the three and nine months ended September 30, 2020 was $3.8 million and $10.0 million, respectively. As of November 12, 2020, Achieve had 3,617,664 shares outstanding. Conference Call Details Achieve will host a conference call at 4:30pm Eastern time today, Thursday, November 12, 2020. To access the webcast, log on to the investor relations page of the Achieve website at http://ir.achievelifesciences.com/events-and-webcasts. Alternatively, access to the live conference call is available by dialing (877) 472-9809 (U.S. &Canada) or (629) 228-0791 (International) and referencing conference ID 8047128. A webcast replay will be available approximately two hours after the call and will be archived onthe websitefor 90 days. About Achieve and CytisiniclineTobacco use is currently the leading cause of preventable death that is responsible for more than eight million deaths worldwide and nearly half a million deaths in the U.S. annually.1,2More than 87% of lung cancer deaths, 61% of all pulmonary disease deaths, and 32% of all deaths from coronary heart disease are attributable to smoking and exposure to secondhand smoke.2Achieve's focus is to address the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline. Cytisinicline is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor. It is believed to aid in smoking cessation by interacting with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms and by reducing the reward and satisfaction associated with smoking. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the timing and nature of cytisinicline clinical development and commercialization activities,the potential market size for cytisinicline, the potential benefits of cytisinicline, the ability to discover and develop new uses for cytisinicline, including but not limited to as an e-cigarette cessation product, and the development and effectiveness of new treatments. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Achieve may not actually achieve its plans or product development goals in a timely manner, if at all, or otherwise carry out its intentions or meet its expectations or projections disclosed in these forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including, among others, the risk that cytisinicline may not demonstrate the hypothesized or expected benefits; the risk that Achieve may not be able to obtain additional financing to fund the development of cytisinicline; the risk that cytisinicline will not receive regulatory approval or be successfully commercialized; the risk that new developments in the smoking cessation landscape require changes in business strategy or clinical development plans; the risk that Achieve's intellectual property may not be adequately protected; general business and economic conditions; risks related to the impact on our business of the COVID-19 pandemic or similar public health crisesand the other factors described in the risk factors set forth in Achieve's filings with the Securities and Exchange Commission from time to time, including Achieve's Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. Achieve undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable. Media ContactGlenn Silver[emailprotected](646)871-8485 Investor Relations ContactJason Wong[emailprotected](415) 375-3340 ext. 4 References1World Health Organization. WHO Report on the Global Tobacco Epidemic, 2019. Geneva: World Health Organization, 2017.2U.S. Department of Health and Human Services. The Health Consequences of Smoking 50 Years of Progress. A Report of the Surgeon General, 2014. Chantix is a registered trademark of Pfizer Inc. Consolidated Statements of Loss (In thousands, except per share and share data) Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Operating expenses: Research and development 1,891 1,824 4,535 7,911 General and administrative 1,863 1,893 5,494 5,408 Total operating expenses 3,754 3,717 10,029 13,319 Loss from operations (3,754) (3,717) (10,029) (13,319) Other income (expense) (10) 44 23 118 Net loss $ (3,764) $ (3,673) $ (10,006) $ (13,201) Basic and diluted net loss per share $ (1.14) $ (9.07) $ (4.55) $ (35.96) Weighted average number of basic and diluted common shares 3,289,252 405,012 2,197,368 367,103 Consolidated Balance Sheets (In thousands) September 30, December 31, 2020 2019 Assets: Cash, cash equivalents, short term investments and restricted cash $ 22,443 $ 16,714 Prepaid expenses and other current assets 1,669 670 Property, equipment and other assets 358 244 Right-of-use assets 193 329 License agreement 1,920 2,087 Goodwill 1,034 1,034 Total assets $ 27,617 $ 21,078 Liabilities and stockholders' equity: Accounts payable and accrued liabilities $ 1,719 $ 2,666 Current portion of long-term obligations 129 203 Long-term obligations 94 159 Stockholders' equity 25,675 18,050 Total liabilities and stockholders' equity $ 27,617 $ 21,078 SOURCE Achieve Life Sciences, Inc. Related Links www.achievelifesciences.com
Answer:
|
Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update
|
SEATTLE and VANCOUVER, BC, Nov. 12, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced third quarter 2020 financial results and provided an update on the cytisinicline clinical development program. Recent Events & Highlights Initiated the Phase 3 ORCA-2 clinical trial evaluating the efficacy and safety of 3 mg cytisinicline dosed 3 times daily compared to placebo in 750 adult smokers at 15 clinical sites in the United States Promoted John Bencich to Chief Executive Officer and Dr. Cindy Jacobs to President Presented successful results from the RAUORA, head-to-head non-inferiority clinical trial comparing cytisinicline and Chantix (varenicline), at the Society for Research on Nicotine and Tobacco European (SRNT-E) Annual Meeting Presented mechanism of action data comparing 5-HT3 receptor activity of cytisinicline vs. Chantix at SRNT-E, providing rationale for differentiated side effect profile of smoking cessation treatments Announced smoking cessation Key Opinion Leader Virtual Roundtable to be held on November 17, 2020 "With the initiation of the Phase 3 ORCA-2 trial and the breakthrough evidence, both mechanistically and clinically, in support of cytisinicline in comparison to Chantix, the third quarter of 2020 has undeniably been the most pivotal in the history of our company," commented John Bencich, Chief Executive Officer of Achieve. "Our primary focus in the coming months will be enrollment and execution of ORCA-2, while continuing to explore opportunities for commercialization and expansion into new therapeutic indications, digital health technologies, and audiences who may benefit from cytisinicline, specifically, users of vapes or e-cigarettes." Phase 3 ORCA-2 Trial Initiation Achieve's first Phase 3 ORCA-2 trial was initiated in October 2020 and will randomize 750 U.S. smokers to one of three study arms to determine the efficacy and safety of cytisinicline administered for either 6 or 12 weeks, compared to placebo. The primary endpoint is biochemically verified continuous abstinence during the last 4 weeks of treatment in the 6 and 12-week cytisinicline treatment arms compared to placebo. Each treatment arm will be compared independently to the placebo arm and the trial will be determined to be successful if either or both of the cytisinicline treatment arms show a statistical benefit compared to placebo. Management Team UpdateIn September, the Company announced the promotion of John Bencich to Chief Executive Officer and Dr. Cindy Jacobs to President. Mr. Bencich has been serving as Achieve's Chief Financial and Operating Officer since 2017 and will join the Board of Directors in his role. Dr. Jacobs has been serving as the Chief Medical Officer of Achieve since 2017 and will continue in her role leading the regulatory and clinical development efforts for cytisinicline. Rick Stewart will remain with Achieve as the Executive Chairman of the Board of Directors and Dr. Anthony Clark will remain in his role as Chief Scientific Officer. RAUORA: Significantly Fewer Adverse Events and Higher Quits Rates for Cytisinicline vs ChantixFinal results from the New Zealand RAUORA Phase 3 non-inferiority clinical trial comparing cytisinicline to varenicline (Chantix) in Mori (indigenous New Zealanders) and whnau (family) of Mori were presented at the SRNT-E Annual Meeting in September 2020. Results showed that cytisinicline met the pre-specified non-inferiority endpoint and was trending towards superiority demonstrating a 4.29% improvement in quit rates in favor of cytisinicline. Subjects in the cytisinicline arm were approximately one and a half times more likely to have quit smoking at 6 months compared to subjects who received varenicline. Importantly, significantly fewer overall adverse events (AEs) were reported in cytisinicline-treated subjects. Of the subjects who experienced AEs (111 in the cytisinicline arm compared to 138 in the varenicline arm), there was significantly less nausea and vivid dreams. MOA Data Explaining Reduced Nausea and Vomiting with Cytisinicline Presented at SRNT-EData presented at the SRNT-E Annual Meeting in September 2020 provides a rationale based on detailed receptor pharmacology to explain why the incidence of nausea and vomiting associated with cytisinicline appears to be consistently lower than that seen with Chantix. The preclinical study, conducted at the University of Cambridge Department of Biochemistry, was designed to examine the in vitro binding characteristics of cytisinicline compared to varenicline at the human 5-HT3 receptor. The study reported an IC50 of 0.50 mM for cytisinicline and 0.25 M for varenicline, representing a 2000-greater fold agonist binding affinity to the 5-HT3 receptor for varenicline compared to cytisinicline. Virtual Smoking Cessation KOL Roundtable to be Held November 17, 2020 Achieve announced plans to host a virtual roundtable on cytisinicline and smoking cessation on Tuesday, November 17, 2020, at 12:00PM EST. Five esteemed experts in the field of smoking cessation will discuss the ongoing ORCA-2 trial, review recent cytisinicline data, and discuss the importance of smoking cessation in the midst of the COVID-19 pandemic. Visit http://ir.achievelifesciences.com/events-and-webcasts for additional informationand click here to register for the event. Financial ResultsAs of September 30, 2020, the company's cash, cash equivalents, and restricted cash was $22.4 million. Total operating expenses for the three and nine months ended September 30, 2020 were $3.8 million and $10.0 million, respectively. Total net loss for the three and nine months ended September 30, 2020 was $3.8 million and $10.0 million, respectively. As of November 12, 2020, Achieve had 3,617,664 shares outstanding. Conference Call Details Achieve will host a conference call at 4:30pm Eastern time today, Thursday, November 12, 2020. To access the webcast, log on to the investor relations page of the Achieve website at http://ir.achievelifesciences.com/events-and-webcasts. Alternatively, access to the live conference call is available by dialing (877) 472-9809 (U.S. &Canada) or (629) 228-0791 (International) and referencing conference ID 8047128. A webcast replay will be available approximately two hours after the call and will be archived onthe websitefor 90 days. About Achieve and CytisiniclineTobacco use is currently the leading cause of preventable death that is responsible for more than eight million deaths worldwide and nearly half a million deaths in the U.S. annually.1,2More than 87% of lung cancer deaths, 61% of all pulmonary disease deaths, and 32% of all deaths from coronary heart disease are attributable to smoking and exposure to secondhand smoke.2Achieve's focus is to address the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline. Cytisinicline is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor. It is believed to aid in smoking cessation by interacting with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms and by reducing the reward and satisfaction associated with smoking. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the timing and nature of cytisinicline clinical development and commercialization activities,the potential market size for cytisinicline, the potential benefits of cytisinicline, the ability to discover and develop new uses for cytisinicline, including but not limited to as an e-cigarette cessation product, and the development and effectiveness of new treatments. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Achieve may not actually achieve its plans or product development goals in a timely manner, if at all, or otherwise carry out its intentions or meet its expectations or projections disclosed in these forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including, among others, the risk that cytisinicline may not demonstrate the hypothesized or expected benefits; the risk that Achieve may not be able to obtain additional financing to fund the development of cytisinicline; the risk that cytisinicline will not receive regulatory approval or be successfully commercialized; the risk that new developments in the smoking cessation landscape require changes in business strategy or clinical development plans; the risk that Achieve's intellectual property may not be adequately protected; general business and economic conditions; risks related to the impact on our business of the COVID-19 pandemic or similar public health crisesand the other factors described in the risk factors set forth in Achieve's filings with the Securities and Exchange Commission from time to time, including Achieve's Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. Achieve undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable. Media ContactGlenn Silver[emailprotected](646)871-8485 Investor Relations ContactJason Wong[emailprotected](415) 375-3340 ext. 4 References1World Health Organization. WHO Report on the Global Tobacco Epidemic, 2019. Geneva: World Health Organization, 2017.2U.S. Department of Health and Human Services. The Health Consequences of Smoking 50 Years of Progress. A Report of the Surgeon General, 2014. Chantix is a registered trademark of Pfizer Inc. Consolidated Statements of Loss (In thousands, except per share and share data) Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Operating expenses: Research and development 1,891 1,824 4,535 7,911 General and administrative 1,863 1,893 5,494 5,408 Total operating expenses 3,754 3,717 10,029 13,319 Loss from operations (3,754) (3,717) (10,029) (13,319) Other income (expense) (10) 44 23 118 Net loss $ (3,764) $ (3,673) $ (10,006) $ (13,201) Basic and diluted net loss per share $ (1.14) $ (9.07) $ (4.55) $ (35.96) Weighted average number of basic and diluted common shares 3,289,252 405,012 2,197,368 367,103 Consolidated Balance Sheets (In thousands) September 30, December 31, 2020 2019 Assets: Cash, cash equivalents, short term investments and restricted cash $ 22,443 $ 16,714 Prepaid expenses and other current assets 1,669 670 Property, equipment and other assets 358 244 Right-of-use assets 193 329 License agreement 1,920 2,087 Goodwill 1,034 1,034 Total assets $ 27,617 $ 21,078 Liabilities and stockholders' equity: Accounts payable and accrued liabilities $ 1,719 $ 2,666 Current portion of long-term obligations 129 203 Long-term obligations 94 159 Stockholders' equity 25,675 18,050 Total liabilities and stockholders' equity $ 27,617 $ 21,078 SOURCE Achieve Life Sciences, Inc. Related Links www.achievelifesciences.com
|
edtsum5717
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: JACKSONVILLE, Fla., March 23, 2021 /PRNewswire/ --Black Knight, Inc. (NYSE: BKI) reports the following "first look" at February 2021 month-end mortgage performance statistics derived from its loan-level database representing the majority of the national mortgage market. Total U.S. loan delinquency rate (loans 30 or more days past due, but not in foreclosure): 6.00%Month-over-month change: 2.61%Year-over-year change: 83.03% Total U.S. foreclosure pre-sale inventory rate: 0.32%Month-over-month change: -1.15%Year-over-year change: -29.90% Total U.S. foreclosure starts: 3,900Month-over-month change: -33.90%Year-over-year change: -87.93% Monthly prepayment rate (SMM): 2.85%Month-over-month change: 8.41%Year-over-year change: 110.35% Foreclosure sales as % of 90+: 0.09%Month-over-month change: 8.18%Year-over-year change: -93.88% Number of properties that are 30 or more days past due, but not in foreclosure: 3,186,000Month-over-month change: 56,000Year-over-year change: 1,449,000 Number of properties that are 90 or more days past due, but not in foreclosure: 2,075,000Month-over-month change: -15,000Year-over-year change: 1,666,000 Number of properties in foreclosure pre-sale inventory: 168,000Month-over-month change: -3,000Year-over-year change: -71,000 Number of properties that are 30 or more days past due or in foreclosure: 3,354,000Month-over-month change: 53,000Year-over-year change: 1,378,000 Top 5 States by Non-Current* Percentage Mississippi: 10.79%Louisiana: 10.29%Hawaii: 8.87%Oklahoma: 8.35%Maryland: 8.01% Bottom 5 States by Non-Current* Percentage Oregon: 4.16%Utah: 4.05%Washington: 3.85%Colorado: 3.83%Idaho: 3.29% Top 5 States by 90+ Days Delinquent Percentage Mississippi: 6.26%Louisiana: 6.22%Hawaii: 5.69%Nevada:5.58%Maryland: 5.11% Top 5 States by 6-Month Improvement in Non-Current* PercentageAlaska: -21.69%Utah: -20.33%New Jersey: -19.95%Colorado: -18.38%Florida: -17.58% Top 5 States by 6-Month Deterioration in Non-Current* Percentage Oklahoma: 1.82%Arkansas: 0.01%Nebraska: -3.11%Minnesota: -3.11%Iowa:-3.70% *Non-current totals combine foreclosures and delinquencies as a percent of active loans in that state.Notes:1) Totals are extrapolated based on Black Knight's loan-level database of mortgage assets.2) All whole numbers are rounded to the nearest thousand, except foreclosure starts, which are rounded to the nearest hundred. For a more detailed view of this month's "first look" data, please visit the Black Knight newsroom. The company will provide a more in-depth review of this data in its monthly Mortgage Monitor report, which includes an analysis of data supplemented by detailed charts and graphs that reflect trend and point-in-time observations. The Mortgage Monitor report will be available online at https://www.blackknightinc.com/data-reports/ by April 5, 2021. For more information about gaining access to Black Knight's loan-level database, please send an email to [emailprotected]. About Black Knight Black Knight, Inc. (NYSE:BKI) is an award-winning software, data and analytics company that drives innovation in the mortgage lending and servicing and real estate industries, as well as the capital and secondary markets. Businesses leverage our robust, integrated solutions across the entire homeownership life cycle to help retain existing customers, gain new customers, mitigate risk and operate more effectively. Our clients rely on our proven, comprehensive, scalable products and our unwavering commitment to delivering superior client support to achieve their strategic goals and better serve their customers. For more information on Black Knight, please visitwww.blackknightinc.com. SOURCE Black Knight, Inc. Related Links www.blackknightinc.com
Answer:
|
Black Knight's First Look: Mortgage Delinquencies Rise for the First Time in Nine Months; Increase Largely Calendar-Driven But Bears Watching
|
JACKSONVILLE, Fla., March 23, 2021 /PRNewswire/ --Black Knight, Inc. (NYSE: BKI) reports the following "first look" at February 2021 month-end mortgage performance statistics derived from its loan-level database representing the majority of the national mortgage market. Total U.S. loan delinquency rate (loans 30 or more days past due, but not in foreclosure): 6.00%Month-over-month change: 2.61%Year-over-year change: 83.03% Total U.S. foreclosure pre-sale inventory rate: 0.32%Month-over-month change: -1.15%Year-over-year change: -29.90% Total U.S. foreclosure starts: 3,900Month-over-month change: -33.90%Year-over-year change: -87.93% Monthly prepayment rate (SMM): 2.85%Month-over-month change: 8.41%Year-over-year change: 110.35% Foreclosure sales as % of 90+: 0.09%Month-over-month change: 8.18%Year-over-year change: -93.88% Number of properties that are 30 or more days past due, but not in foreclosure: 3,186,000Month-over-month change: 56,000Year-over-year change: 1,449,000 Number of properties that are 90 or more days past due, but not in foreclosure: 2,075,000Month-over-month change: -15,000Year-over-year change: 1,666,000 Number of properties in foreclosure pre-sale inventory: 168,000Month-over-month change: -3,000Year-over-year change: -71,000 Number of properties that are 30 or more days past due or in foreclosure: 3,354,000Month-over-month change: 53,000Year-over-year change: 1,378,000 Top 5 States by Non-Current* Percentage Mississippi: 10.79%Louisiana: 10.29%Hawaii: 8.87%Oklahoma: 8.35%Maryland: 8.01% Bottom 5 States by Non-Current* Percentage Oregon: 4.16%Utah: 4.05%Washington: 3.85%Colorado: 3.83%Idaho: 3.29% Top 5 States by 90+ Days Delinquent Percentage Mississippi: 6.26%Louisiana: 6.22%Hawaii: 5.69%Nevada:5.58%Maryland: 5.11% Top 5 States by 6-Month Improvement in Non-Current* PercentageAlaska: -21.69%Utah: -20.33%New Jersey: -19.95%Colorado: -18.38%Florida: -17.58% Top 5 States by 6-Month Deterioration in Non-Current* Percentage Oklahoma: 1.82%Arkansas: 0.01%Nebraska: -3.11%Minnesota: -3.11%Iowa:-3.70% *Non-current totals combine foreclosures and delinquencies as a percent of active loans in that state.Notes:1) Totals are extrapolated based on Black Knight's loan-level database of mortgage assets.2) All whole numbers are rounded to the nearest thousand, except foreclosure starts, which are rounded to the nearest hundred. For a more detailed view of this month's "first look" data, please visit the Black Knight newsroom. The company will provide a more in-depth review of this data in its monthly Mortgage Monitor report, which includes an analysis of data supplemented by detailed charts and graphs that reflect trend and point-in-time observations. The Mortgage Monitor report will be available online at https://www.blackknightinc.com/data-reports/ by April 5, 2021. For more information about gaining access to Black Knight's loan-level database, please send an email to [emailprotected]. About Black Knight Black Knight, Inc. (NYSE:BKI) is an award-winning software, data and analytics company that drives innovation in the mortgage lending and servicing and real estate industries, as well as the capital and secondary markets. Businesses leverage our robust, integrated solutions across the entire homeownership life cycle to help retain existing customers, gain new customers, mitigate risk and operate more effectively. Our clients rely on our proven, comprehensive, scalable products and our unwavering commitment to delivering superior client support to achieve their strategic goals and better serve their customers. For more information on Black Knight, please visitwww.blackknightinc.com. SOURCE Black Knight, Inc. Related Links www.blackknightinc.com
|
edtsum5722
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, Aug. 6, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors ofFirstEnergy Corporation("FirstEnergy" or the "Company")(NYSE:FE). Such investors are advised to contact Robert S. Willoughby at [emailprotected] or 888-476-6529, ext. 7980. The investigation concerns whether FirstEnergy and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On July 21, 2020, the Federal Bureau of Investigation agents arrested Ohio House Speaker Larry Householder in connection with an alleged illegal scheme involving bribery in return for Householder's championing of a state-funded bailout of two nuclear power plants formerly owned by FirstEnergy. On this news, FirstEnergy's stock price fell $7.01 per share, or 16.99%, to close at $34.25 per share on July 21, 2020. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com. CONTACT:Robert S. WilloughbyPomerantz LLP [emailprotected]888-476-6529 ext. 7980 SOURCE Pomerantz LLP Related Links www.pomerantzlaw.com
Answer:
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FirstEnergy Corporation - FE
|
NEW YORK, Aug. 6, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors ofFirstEnergy Corporation("FirstEnergy" or the "Company")(NYSE:FE). Such investors are advised to contact Robert S. Willoughby at [emailprotected] or 888-476-6529, ext. 7980. The investigation concerns whether FirstEnergy and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On July 21, 2020, the Federal Bureau of Investigation agents arrested Ohio House Speaker Larry Householder in connection with an alleged illegal scheme involving bribery in return for Householder's championing of a state-funded bailout of two nuclear power plants formerly owned by FirstEnergy. On this news, FirstEnergy's stock price fell $7.01 per share, or 16.99%, to close at $34.25 per share on July 21, 2020. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com. CONTACT:Robert S. WilloughbyPomerantz LLP [emailprotected]888-476-6529 ext. 7980 SOURCE Pomerantz LLP Related Links www.pomerantzlaw.com
|
edtsum5725
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)--British company iProov has today announced that European digital identity leader, itsme, has selected iProovs Genuine Presence Assurance technology to support its global expansion. Launched in 2017 by qualified trust service provider, Belgian Mobile ID, itsme is Belgium's digital identity app. It is currently used by more than 35% of the Belgian population and is relied on by more than 150 companies in the private sector (banks, insurance companies etc) and by the Belgian government. From now, users in the Netherlands will also have access to itsmes trusted ID solution and will be able to securely authenticate themselves and onboard to digital services. iProov will verify the faces of new users, whatever their mobile device. We needed a technology partner to support our mission to make secure digital identities available to everyone. iProov was the obvious choice. They hold privacy and security in the highest regard and offer the future-proof, cutting-edge technology that will enable us to identify users internationally, Stephanie De Bruyne, CEO at itsme, said. Onboarding for an eIDAS level high or qualified signature has to meet very demanding, independently audited and certified international standards. Previously, these could only be met by an in-person meeting or video calling. itsme avoids these expensive and tedious methods by using iProovs faster, more convenient, less costly and more secure solution. iProovs Genuine Presence Assurance technology enables users to onboard to the itsme service in a way that is both secure and effortless to use. A user scans their identity document using their mobile device. They then scan their face in a process that takes a few brief seconds. iProov technology ensures that the user is the right person, matching the identity in the document, that they are a real person, and that they are authenticating right now. The iProov process maximizes inclusiveness by eliminating the need for users to follow instructions to move or read out words. Andrew Bud, Founder and CEO of iProov, said: We are delighted to be working with itsme, a true pioneer in the provision of digital identity trust services. I have huge respect for how itsme has successfully driven the uptake of digital identity in Belgium, so its a pleasure and privilege to be partnering on a solution for the Netherlands. This is yet another demonstration that iProov is the technology of choice for Europes leading eIDAS providers. itsme enables identification, secure onboarding, authentication on website or app, confirmation of transactions and qualified electronic signatures, all to the highest level of security. itsme was granted accreditation by the Belgian government as an official form of digital identity in 2018 and on a European level in 2019 (LOA high eIDAS). About iProov Founded in 2012, iProov is the world leader in online facial biometric authentication, working with governments, banks and other enterprises to securely verify customer identity. Used for effortless onboarding and authentication, customers include the U.S. Department of Homeland Security, the UK Home Office, the UK National Health Service (NHS), the Australian Taxation Office, GovTech Singapore, Rabobank, ING, and others. iProovs technologies include Liveness Assurance and Genuine Presence Assurance, which ensures that an online customer is the right person, a real person, and is authenticating right now. This protects against spoof attacks from photos, videos, masks and digital injection attacks and the emerging threat of deepfakes. iProov was recognized as a Gartner Cool Vendor 2020 in Identity Access Management & Fraud Detection. For more information, please see www.iproov.com or follow us on LinkedIn or Twitter. About itsme Since its launch in 2017, the itsme app has become the widely accepted simple and secure standard for mobile identification and the protection of privacy in the digital world. itsme enables the following: identification (creating a new online account and sharing identity details), authentication (secure, personal access to a website or application), confirmation of a transaction (approval of an order or bank payment) and, finally, the legally binding electronic signing of documents (qualified electronic signature with the highest level of security). itsme was granted accreditation by the Belgian government as an official form of digital identity in January 2018 and on a European level in December 2019 (LOA high eIDAS). The itsme app is used extensively in the financial sector among others because it complies with PSD2, FATF and GDPR guidelines. It has also been awarded ISO27001 certification. itsme was developed by the Belgian Mobile ID consortium, which combines the seven Belgian market leaders from the banking and telecommunications sectors: Belfius, BNP Paribas Fortis, CBC/KBC & ING, on the one hand, and Orange Belgium, Proximus and Telenet on the other. itsme takes the security of the electronic identity card to the world of mobile.
Answer:
|
iProov Face Verification Selected by itsme to Support Global Expansion
|
LONDON--(BUSINESS WIRE)--British company iProov has today announced that European digital identity leader, itsme, has selected iProovs Genuine Presence Assurance technology to support its global expansion. Launched in 2017 by qualified trust service provider, Belgian Mobile ID, itsme is Belgium's digital identity app. It is currently used by more than 35% of the Belgian population and is relied on by more than 150 companies in the private sector (banks, insurance companies etc) and by the Belgian government. From now, users in the Netherlands will also have access to itsmes trusted ID solution and will be able to securely authenticate themselves and onboard to digital services. iProov will verify the faces of new users, whatever their mobile device. We needed a technology partner to support our mission to make secure digital identities available to everyone. iProov was the obvious choice. They hold privacy and security in the highest regard and offer the future-proof, cutting-edge technology that will enable us to identify users internationally, Stephanie De Bruyne, CEO at itsme, said. Onboarding for an eIDAS level high or qualified signature has to meet very demanding, independently audited and certified international standards. Previously, these could only be met by an in-person meeting or video calling. itsme avoids these expensive and tedious methods by using iProovs faster, more convenient, less costly and more secure solution. iProovs Genuine Presence Assurance technology enables users to onboard to the itsme service in a way that is both secure and effortless to use. A user scans their identity document using their mobile device. They then scan their face in a process that takes a few brief seconds. iProov technology ensures that the user is the right person, matching the identity in the document, that they are a real person, and that they are authenticating right now. The iProov process maximizes inclusiveness by eliminating the need for users to follow instructions to move or read out words. Andrew Bud, Founder and CEO of iProov, said: We are delighted to be working with itsme, a true pioneer in the provision of digital identity trust services. I have huge respect for how itsme has successfully driven the uptake of digital identity in Belgium, so its a pleasure and privilege to be partnering on a solution for the Netherlands. This is yet another demonstration that iProov is the technology of choice for Europes leading eIDAS providers. itsme enables identification, secure onboarding, authentication on website or app, confirmation of transactions and qualified electronic signatures, all to the highest level of security. itsme was granted accreditation by the Belgian government as an official form of digital identity in 2018 and on a European level in 2019 (LOA high eIDAS). About iProov Founded in 2012, iProov is the world leader in online facial biometric authentication, working with governments, banks and other enterprises to securely verify customer identity. Used for effortless onboarding and authentication, customers include the U.S. Department of Homeland Security, the UK Home Office, the UK National Health Service (NHS), the Australian Taxation Office, GovTech Singapore, Rabobank, ING, and others. iProovs technologies include Liveness Assurance and Genuine Presence Assurance, which ensures that an online customer is the right person, a real person, and is authenticating right now. This protects against spoof attacks from photos, videos, masks and digital injection attacks and the emerging threat of deepfakes. iProov was recognized as a Gartner Cool Vendor 2020 in Identity Access Management & Fraud Detection. For more information, please see www.iproov.com or follow us on LinkedIn or Twitter. About itsme Since its launch in 2017, the itsme app has become the widely accepted simple and secure standard for mobile identification and the protection of privacy in the digital world. itsme enables the following: identification (creating a new online account and sharing identity details), authentication (secure, personal access to a website or application), confirmation of a transaction (approval of an order or bank payment) and, finally, the legally binding electronic signing of documents (qualified electronic signature with the highest level of security). itsme was granted accreditation by the Belgian government as an official form of digital identity in January 2018 and on a European level in December 2019 (LOA high eIDAS). The itsme app is used extensively in the financial sector among others because it complies with PSD2, FATF and GDPR guidelines. It has also been awarded ISO27001 certification. itsme was developed by the Belgian Mobile ID consortium, which combines the seven Belgian market leaders from the banking and telecommunications sectors: Belfius, BNP Paribas Fortis, CBC/KBC & ING, on the one hand, and Orange Belgium, Proximus and Telenet on the other. itsme takes the security of the electronic identity card to the world of mobile.
|
edtsum5733
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, April 29, 2021 /PRNewswire/ -- The "Avian Influenza (Infectious Disease) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com's offering. Avian Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Avian Influenza pipeline landscape.The report provides comprehensive information on the therapeutics under development for Avian Influenza, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Avian Influenza and features dormant and discontinued projects.The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.The report is built using data and information sourced from the publisher' proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.Scope of the report: The report provides a snapshot of the Global Therapeutic Landscape of Avian Influenza (Infectious Disease). The report reviews pipeline therapeutics for Avian Influenza (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources. The report covers pipeline products based on various stages of development ranging from discovery till pre-registration. The report features descriptive drug profiles for the pipeline products which includes, Product Description, Descriptive MoA, R&D Brief, Licensing and Collaboration details & Other Developmental Activities. The report reviews key players involved in the development of Avian Influenza (Infectious Disease) therapeutics and enlists all their major and minor projects. The report assesses Avian Influenza (Infectious Disease) therapeutics based on Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report summarizes all the dormant and discontinued pipeline projects. The report reviews latest news related to pipeline therapeutics for Avian Influenza (Infectious Disease). Key Topics Covered: Indication - Overview Indication - Therapeutics Development Pipeline Overview Pipeline by Companies Pipeline by Universities/Institutes Products under Development by Companies Products under Development by Universities/Institutes Indication - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Indication - Companies Involved in Therapeutics Development Indication - Drug Profiles R&D Progress Indication - Dormant Projects Indication - Discontinued Products Indication - Product Development Milestones Featured News & Press Releases For more information about this report visit https://www.researchandmarkets.com/r/gj3l7a About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer:
|
Global Therapeutic Landscape of Avian Influenza Drugs in Development 2021
|
DUBLIN, April 29, 2021 /PRNewswire/ -- The "Avian Influenza (Infectious Disease) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com's offering. Avian Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Avian Influenza pipeline landscape.The report provides comprehensive information on the therapeutics under development for Avian Influenza, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Avian Influenza and features dormant and discontinued projects.The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.The report is built using data and information sourced from the publisher' proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.Scope of the report: The report provides a snapshot of the Global Therapeutic Landscape of Avian Influenza (Infectious Disease). The report reviews pipeline therapeutics for Avian Influenza (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources. The report covers pipeline products based on various stages of development ranging from discovery till pre-registration. The report features descriptive drug profiles for the pipeline products which includes, Product Description, Descriptive MoA, R&D Brief, Licensing and Collaboration details & Other Developmental Activities. The report reviews key players involved in the development of Avian Influenza (Infectious Disease) therapeutics and enlists all their major and minor projects. The report assesses Avian Influenza (Infectious Disease) therapeutics based on Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report summarizes all the dormant and discontinued pipeline projects. The report reviews latest news related to pipeline therapeutics for Avian Influenza (Infectious Disease). Key Topics Covered: Indication - Overview Indication - Therapeutics Development Pipeline Overview Pipeline by Companies Pipeline by Universities/Institutes Products under Development by Companies Products under Development by Universities/Institutes Indication - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Indication - Companies Involved in Therapeutics Development Indication - Drug Profiles R&D Progress Indication - Dormant Projects Indication - Discontinued Products Indication - Product Development Milestones Featured News & Press Releases For more information about this report visit https://www.researchandmarkets.com/r/gj3l7a About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
|
edtsum5735
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: KENNESAW, Ga.--(BUSINESS WIRE)--Kennesaw State University has received a $9 million gift from real estate executive Norman J. Radow and his wife Lindy to benefit the College of Humanities and Social Sciences. It is rare for a public College of Humanities and Social Sciences to be the beneficiary of this level of philanthropy from a single donor. In recognition of the gift, the Board of Regents of the University System of Georgia has approved the naming of the College as the Norman J. Radow College of Humanities and Social Sciences. The gift, one of the largest contributions from a single donor in Kennesaw State Universitys history, includes $2 million to establish the Lindy Radow Humanities and Social Sciences Honors Scholarship Endowment Fund. The Lindy Radow Scholarship will be matched by funds from the KSU Journey Honors Scholarship, to create a Humanities-Honors Scholarship Endowment of $5 million. In addition to his many years of service to Kennesaw State University and the KSU Foundation, countless hours of volunteerism and vision, Radow has also been a generous donor to other parts of the University. He has personally endowed three named scholarships in the past, including one to benefit students in the Southern Polytechnic College of Engineering and Engineering Technology, in honor of his father, Paul Radow. The Lindy Radow Scholarship and the Paul Radow Scholarship represent two of the largest student endowments from a single donor in the history of the University. The generosity of Norman Radow for the University is already well-established, and this gift will have a tremendous impact for years to come, said KSU President Pamela Whitten. His dedication to providing life-changing opportunities to students has made Kennesaw State what it is today, and we are thankful for everything he has done and continues to do for the University. Kennesaw States College of Humanities and Social Sciences is the largest college at the University, offering more than 80 programs of study for 7,000 of the more than 41,000 graduate and undergraduate students enrolled at the University. Shawn Long, dean of the College of Humanities and Social Sciences, said, It is very rare for a College of Humanities to be named through an endowed gift, and we are grateful to Norman and Lindy Radow for their support to help propel our students and the College to new and exciting heights. We look forward to a rolling out an ambitious program of educational opportunities for students and groundbreaking research for faculty. Norman Radow is the founder and chief executive officer of The RADCO Companies, one of the most respected turnaround real estate companies in the United States. He also served as the chairman of the Kennesaw State University Foundation Board of Trustees. With his direct influence as a trustee and chairman of the board, KSU saw an unprecedented period of expansion, including the development of multiple on-campus residences, building of several parking facilities, acquisition and expansion of office buildings around campus, expansion of The Commons dining facility, development of the football program and expansion of the Sports & Recreation Park. Providing new opportunities to students in the College of Humanities and Social Sciences will help them become the future leaders of a changing world, Radow said. I am grateful to President Whitten and the Board of Regents for honoring me and celebrating my passion for KSU by attaching my name to one of the largest Colleges of Humanities and Social Sciences in the Southeast. A leader in innovative teaching and learning, Kennesaw State University offers more than 150 undergraduate, graduate and doctoral degrees to its more than 41,000 students. With 11 colleges on two metro Atlanta campuses, Kennesaw State is a member of the University System of Georgia and the second-largest university in the state. The universitys vibrant campus culture, diverse population, strong global ties and entrepreneurial spirit draw students from throughout the region and from 126 countries across the globe. Kennesaw State is a Carnegie-designated doctoral research institution (R2), placing it among an elite group of only 6 percent of U.S. colleges and universities with an R1 or R2 status. For more information, visit kennesaw.edu.
Answer:
|
KSU Receives Multi-Million Dollar Gift to Name Radow College of Humanities and Social Sciences
|
KENNESAW, Ga.--(BUSINESS WIRE)--Kennesaw State University has received a $9 million gift from real estate executive Norman J. Radow and his wife Lindy to benefit the College of Humanities and Social Sciences. It is rare for a public College of Humanities and Social Sciences to be the beneficiary of this level of philanthropy from a single donor. In recognition of the gift, the Board of Regents of the University System of Georgia has approved the naming of the College as the Norman J. Radow College of Humanities and Social Sciences. The gift, one of the largest contributions from a single donor in Kennesaw State Universitys history, includes $2 million to establish the Lindy Radow Humanities and Social Sciences Honors Scholarship Endowment Fund. The Lindy Radow Scholarship will be matched by funds from the KSU Journey Honors Scholarship, to create a Humanities-Honors Scholarship Endowment of $5 million. In addition to his many years of service to Kennesaw State University and the KSU Foundation, countless hours of volunteerism and vision, Radow has also been a generous donor to other parts of the University. He has personally endowed three named scholarships in the past, including one to benefit students in the Southern Polytechnic College of Engineering and Engineering Technology, in honor of his father, Paul Radow. The Lindy Radow Scholarship and the Paul Radow Scholarship represent two of the largest student endowments from a single donor in the history of the University. The generosity of Norman Radow for the University is already well-established, and this gift will have a tremendous impact for years to come, said KSU President Pamela Whitten. His dedication to providing life-changing opportunities to students has made Kennesaw State what it is today, and we are thankful for everything he has done and continues to do for the University. Kennesaw States College of Humanities and Social Sciences is the largest college at the University, offering more than 80 programs of study for 7,000 of the more than 41,000 graduate and undergraduate students enrolled at the University. Shawn Long, dean of the College of Humanities and Social Sciences, said, It is very rare for a College of Humanities to be named through an endowed gift, and we are grateful to Norman and Lindy Radow for their support to help propel our students and the College to new and exciting heights. We look forward to a rolling out an ambitious program of educational opportunities for students and groundbreaking research for faculty. Norman Radow is the founder and chief executive officer of The RADCO Companies, one of the most respected turnaround real estate companies in the United States. He also served as the chairman of the Kennesaw State University Foundation Board of Trustees. With his direct influence as a trustee and chairman of the board, KSU saw an unprecedented period of expansion, including the development of multiple on-campus residences, building of several parking facilities, acquisition and expansion of office buildings around campus, expansion of The Commons dining facility, development of the football program and expansion of the Sports & Recreation Park. Providing new opportunities to students in the College of Humanities and Social Sciences will help them become the future leaders of a changing world, Radow said. I am grateful to President Whitten and the Board of Regents for honoring me and celebrating my passion for KSU by attaching my name to one of the largest Colleges of Humanities and Social Sciences in the Southeast. A leader in innovative teaching and learning, Kennesaw State University offers more than 150 undergraduate, graduate and doctoral degrees to its more than 41,000 students. With 11 colleges on two metro Atlanta campuses, Kennesaw State is a member of the University System of Georgia and the second-largest university in the state. The universitys vibrant campus culture, diverse population, strong global ties and entrepreneurial spirit draw students from throughout the region and from 126 countries across the globe. Kennesaw State is a Carnegie-designated doctoral research institution (R2), placing it among an elite group of only 6 percent of U.S. colleges and universities with an R1 or R2 status. For more information, visit kennesaw.edu.
|
edtsum5738
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MILAN--(BUSINESS WIRE)--Intesa Sanpaolo has signed a memorandum of understanding with Kyriba, a global fintech leader in supply chain finance solutions, to create and make available an innovative Dynamic Discounting service for global businesses. This new service enables large buyers with significant excess liquidity to offer suppliers advanced payment of invoices with a discount on the price that has been previously agreed upon. Kyribas Dynamic Discounting solution is a user-friendly web-based software that connects with Enterprise Resource Planning systems (ERPs) to automatically update company accounts. The partnership with Kyriba enables critical functionality as part of the activities implemented by Intesa Sanpaolo to strengthen its Supply Chain Finance Program. The program aims to enhance Italian production chains, considered key drivers to help relaunch the Italian economy and catalyze development, employment and investment. The agreement with Kyriba, which also envisages a partnership in other areas focused on cash and treasury management, was established as a result of the cooperation with the Global Transaction Banking Department, which reports to the IMI Corporate & Investment Banking Division led by Mauro Micillo, and the Innovation Head Office Department, within the Chief IT Digital Innovation Officer Area led by Massimo Proverbio. Kyribas Dynamic Discounting solution offers buyers the opportunity to optimize excess liquidity cycles and, at the same time, improve corporate margins, simplify supplier management, and integrate flows and payments with their ERP systems, said Stefano Favale, Head of Global Transaction Banking at Intesa Sanpaolo. Companies can access the service directly from Intesa Sanpaolos Inbiz platform, acknowledged for its user experience and as a digital portal designed for a comprehensive interaction with the Bank. The agreement with Kyriba forms part of the measures we are endorsing to accelerate the digital transformation of our Group, said Paola Papanicolaou, Head of the Innovation Department at Intesa Sanpaolo. The partnership with international fintech players that are selected on the basis of an in-depth analysis allows us to constantly expand advanced digital financial services and always offer our customers distinctive and innovative solutions. Kyribas partnership with Intesa Sanpaolo opens new opportunities to serve CFOs and treasury leaders worldwide with active liquidity management solutions to help them better navigate the new normal, said Jean-Luc Robert, Chairman and CEO of Kyriba. We see growing demand for supply chain finance solutions to help corporations optimize liquidity and drive growth. Dynamic Discounting is becoming a critical solution set for modern finance leaders who are aiming to optimize liquidity, said Edi Poloniato, Global Head of Working Capital Solutions at Kyriba. Supplier onboarding automation and supplier financing flexibility in a localized solution across the Intesa Sanpaolo platform gives Italian companies a significant advantage at a time when it is most needed. Intesa Sanpaolo is one of the soundest and most profitable banks in Europe. It offers commercial, corporate investment banking, asset management and insurance services. It is the leading Bank in Italy, with approximately 11.8 million customers who are assisted through both digital and traditional channels. The Groups international subsidiary banks serve 7.2 million customers across Eastern Europe, the Middle East and North Africa. Intesa Sanpaolo is considered one of the most sustainable banks in the world. For the Group, creating value means being a driver for growth, for the benefit of both society and the economy. As regards the environment, the Group has set up a 5-billion-euro fund for the circular economy. Intesa Sanpaolo supports major economic inclusion and poverty reduction projects, including an impact fund of 1.2 billion euro for loans available to social groups who struggle to access credit. Intesa Sanpaolo has a high level of involvement in cultural initiatives, organised by the Bank or in collaboration with other entities in Italy and further afield. These include permanent and temporary exhibitions showcasing the Banks impressive artistic heritage at the Gallerie dItalia, the Groups museums located in Milan, Naples, Vicenza and soon Turin. Website: group.intesasanpaolo.com | News: https://www.intesasanpaolo.com/it/news.html Twitter: @intesasanpaolo | Facebook: @intesasanpaolo | LinkedIn: https://www.linkedin.com/company/intesa-sanpaolo | Instagram: @intesasanpaolo About Kyriba Corp.: Kyriba empowers CFOs and their IT counterparts to transform how they optimize financial technology solutions, de-risk ERP cloud migration, and activate liquidity as a dynamic, real-time vehicle for growth and value creation. With 2,000 clients worldwide, including more than 100 of Fortune 500 companies, Kyribas pioneering Active Liquidity Network connects internal applications for treasury, risk, payments and working capital with vital external sources such as banks, ERPs, trading platforms, and market data providers. Based on a secure, scalable SaaS platform that leverages artificial intelligence, Kyriba enables thousands of companies worldwide to maximize growth opportunities, protect against loss from fraud and financial risk, and reduce costs through advanced automation. Kyriba is headquartered in San Diego, with offices in New York, Paris, London, Frankfurt, Tokyo, Dubai, Singapore, Shanghai and other major locations. For more information, visit www.kyriba.com.
Answer:
|
Intesa Sanpaolo Strengthens Its Supply Chain Finance Program With an Innovative Dynamic Discounting Service Now Available to Businesses Thanks to the Agreement With Kyriba Large buyers with significant excess liquidity can now offer suppliers advanced payment of invoices with a discount on the price that has been previously agreed upon. This new capability opens opportunities to optimize excess liquidity cycles while improving corporate margins, thereby simplifying supplier management and integrating flows and payments. Companies can now access the new service directly from Intesa Sanpaolos Inbiz platform.
|
MILAN--(BUSINESS WIRE)--Intesa Sanpaolo has signed a memorandum of understanding with Kyriba, a global fintech leader in supply chain finance solutions, to create and make available an innovative Dynamic Discounting service for global businesses. This new service enables large buyers with significant excess liquidity to offer suppliers advanced payment of invoices with a discount on the price that has been previously agreed upon. Kyribas Dynamic Discounting solution is a user-friendly web-based software that connects with Enterprise Resource Planning systems (ERPs) to automatically update company accounts. The partnership with Kyriba enables critical functionality as part of the activities implemented by Intesa Sanpaolo to strengthen its Supply Chain Finance Program. The program aims to enhance Italian production chains, considered key drivers to help relaunch the Italian economy and catalyze development, employment and investment. The agreement with Kyriba, which also envisages a partnership in other areas focused on cash and treasury management, was established as a result of the cooperation with the Global Transaction Banking Department, which reports to the IMI Corporate & Investment Banking Division led by Mauro Micillo, and the Innovation Head Office Department, within the Chief IT Digital Innovation Officer Area led by Massimo Proverbio. Kyribas Dynamic Discounting solution offers buyers the opportunity to optimize excess liquidity cycles and, at the same time, improve corporate margins, simplify supplier management, and integrate flows and payments with their ERP systems, said Stefano Favale, Head of Global Transaction Banking at Intesa Sanpaolo. Companies can access the service directly from Intesa Sanpaolos Inbiz platform, acknowledged for its user experience and as a digital portal designed for a comprehensive interaction with the Bank. The agreement with Kyriba forms part of the measures we are endorsing to accelerate the digital transformation of our Group, said Paola Papanicolaou, Head of the Innovation Department at Intesa Sanpaolo. The partnership with international fintech players that are selected on the basis of an in-depth analysis allows us to constantly expand advanced digital financial services and always offer our customers distinctive and innovative solutions. Kyribas partnership with Intesa Sanpaolo opens new opportunities to serve CFOs and treasury leaders worldwide with active liquidity management solutions to help them better navigate the new normal, said Jean-Luc Robert, Chairman and CEO of Kyriba. We see growing demand for supply chain finance solutions to help corporations optimize liquidity and drive growth. Dynamic Discounting is becoming a critical solution set for modern finance leaders who are aiming to optimize liquidity, said Edi Poloniato, Global Head of Working Capital Solutions at Kyriba. Supplier onboarding automation and supplier financing flexibility in a localized solution across the Intesa Sanpaolo platform gives Italian companies a significant advantage at a time when it is most needed. Intesa Sanpaolo is one of the soundest and most profitable banks in Europe. It offers commercial, corporate investment banking, asset management and insurance services. It is the leading Bank in Italy, with approximately 11.8 million customers who are assisted through both digital and traditional channels. The Groups international subsidiary banks serve 7.2 million customers across Eastern Europe, the Middle East and North Africa. Intesa Sanpaolo is considered one of the most sustainable banks in the world. For the Group, creating value means being a driver for growth, for the benefit of both society and the economy. As regards the environment, the Group has set up a 5-billion-euro fund for the circular economy. Intesa Sanpaolo supports major economic inclusion and poverty reduction projects, including an impact fund of 1.2 billion euro for loans available to social groups who struggle to access credit. Intesa Sanpaolo has a high level of involvement in cultural initiatives, organised by the Bank or in collaboration with other entities in Italy and further afield. These include permanent and temporary exhibitions showcasing the Banks impressive artistic heritage at the Gallerie dItalia, the Groups museums located in Milan, Naples, Vicenza and soon Turin. Website: group.intesasanpaolo.com | News: https://www.intesasanpaolo.com/it/news.html Twitter: @intesasanpaolo | Facebook: @intesasanpaolo | LinkedIn: https://www.linkedin.com/company/intesa-sanpaolo | Instagram: @intesasanpaolo About Kyriba Corp.: Kyriba empowers CFOs and their IT counterparts to transform how they optimize financial technology solutions, de-risk ERP cloud migration, and activate liquidity as a dynamic, real-time vehicle for growth and value creation. With 2,000 clients worldwide, including more than 100 of Fortune 500 companies, Kyribas pioneering Active Liquidity Network connects internal applications for treasury, risk, payments and working capital with vital external sources such as banks, ERPs, trading platforms, and market data providers. Based on a secure, scalable SaaS platform that leverages artificial intelligence, Kyriba enables thousands of companies worldwide to maximize growth opportunities, protect against loss from fraud and financial risk, and reduce costs through advanced automation. Kyriba is headquartered in San Diego, with offices in New York, Paris, London, Frankfurt, Tokyo, Dubai, Singapore, Shanghai and other major locations. For more information, visit www.kyriba.com.
|
edtsum5739
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: KANSAS CITY, Mo., Nov. 16, 2020 /PRNewswire/ --In October 2020, Impact Communications, a leading marketing and PR strategy firm focused exclusively on the financial advisory industry, conducted a survey on Conversations That Matter: Addressing Client Concerns, Hopes and Dreams During Uncertain Times. The survey asked hundreds of independent financial advisors to weigh in on how they have adjusted to the challenges posed by the Covid Crisis and Coronavirus Crash. Continue Reading Results will be revealed during November 20th webinar "Conversations That Matter: Addressing Client Concerns, Hopes and Dreams During Uncertain Times" "The survey was an opportunity for independent financial advisors to weigh in on 2020's pandemic realities and share their stories on how they adjusted when the COVID-19 lockdowns, market turbulence and business realities became apparent," said Marie Swift, president and CEO of Impact Communications. "From the survey we've also learned where advisors have gone the extra mile, what their clients valued most, and whether or not they are getting new business. The survey has given us important insights into the state of today's financial advisors and how they are adjusting their businesses in these uncertain times." WEBINAR VIA RIA CHANNEL The results of the survey will be revealed during a webinar via RIAChannel.com on Friday, Nov. 20, 2020, at 1:00 pm ET. The Conversations That Matter survey results, which will be presented by Swift, will be followed by comments and observations from three panelists: Bob Veresof Inside Information / Insider's Forum Shannon Stoneof DHR Investment Counsel, LTD Heather Kellyof Allianz Life Insurance Company of North America Swift and the panelists will provide insights on how financial advisors can: Build demand for their services and expertise Bridge communication gaps with current and prospective clients Shift their marketing efforts to align with changes in consumer sentiment and client perceptions Prepare their clients for future lifestyle, market and economic shocks Consider new and innovative solutions to help their clients Click here to sign up to attend the Conversations That Matter webinar:https://www.riachannel.com/conversations-that-matter-addressing-client-concerns-hopes-and-dreams-during-uncertain-times-allianz-life-11-20-20BONUS VIDEO AVAILABLE NOWMarie Swift interviewed Heather Kelly during the early stages of the Conversations That Matter project. Click here to watch the Swift Chat with Heather Kelly.SPECIAL REPORT AVAILABILITYFollowing the webinar on Nov. 20, 2020, all registrants will receive a corresponding special report, in which Swift provides additional color and comments from dozens of financial industry experts, behavioral finance academics and independent financial advisors. Readers will glean fresh insights from experts such as Dr. Meir Statman, Dr. Sonya Lutter, Carl Richards, Bob Veres and Joel Bruckenstein, as well as tales-from-the-trenches stories from independent financial advisors such as Bonnie Sewell, Melanie Housden, John Enright, Shannon Stone, Carolyn McClanahan and more.A free download link will be provided to anyone interested on Monday, Nov. 23, 2020. Watch for Swift's blog post on www.MarieSwift.comand/or follow @MarieSwift on social media for a link to the Conversations That Matter special report.ABOUT IMPACT COMMUNICATIONS, INC.Founded in 1993 by Marie Swift, who prior to Impact Communications was Director of Corporate Communications for a nationally-known wealth management firm and regional office for one of the largest independent broker/dealers in the country, Impact Communications works with a select group of fintech companies, financial institutions such as custodians and independent broker/dealers, RIA networks and membership organizations, OSJs, allied consulting entities, wealth management firms and independent advisors. Private coaching, on-camera training, branding and customized websites, content creation, and personalized media strategies enable Impact clients to reach their overarching goals. A prolific writer and respected consultant in the financial planning profession, Swift has appeared on NPR and numerous video interviews. Her quotes and articles have been published by Forbes, MarketWatch, Barron's and dozens of financial services trade publications. She profiles interesting people in the financial services industry on her blog, Best Practices in the Financial Services Industry, and in her new Swift Chat video interview series. For more information about Impact Communication and its services, please visit www.ImpactCommunications.org.CONTACT: Corrine Smith or Grace VogelzangImpact Communications, Inc.913-649-5009 | 800-974-7753[emailprotected][emailprotected]Related Imagesnew-survey-explores-how-financial.png SOURCE Impact Communications
Answer:
|
New Survey Explores How Financial Advisors Have Responded to the Covid Crisis and Coronavirus Crash Results will be revealed during November 20th webinar "Conversations That Matter: Addressing Client Concerns, Hopes and Dreams During Uncertain Times"
|
KANSAS CITY, Mo., Nov. 16, 2020 /PRNewswire/ --In October 2020, Impact Communications, a leading marketing and PR strategy firm focused exclusively on the financial advisory industry, conducted a survey on Conversations That Matter: Addressing Client Concerns, Hopes and Dreams During Uncertain Times. The survey asked hundreds of independent financial advisors to weigh in on how they have adjusted to the challenges posed by the Covid Crisis and Coronavirus Crash. Continue Reading Results will be revealed during November 20th webinar "Conversations That Matter: Addressing Client Concerns, Hopes and Dreams During Uncertain Times" "The survey was an opportunity for independent financial advisors to weigh in on 2020's pandemic realities and share their stories on how they adjusted when the COVID-19 lockdowns, market turbulence and business realities became apparent," said Marie Swift, president and CEO of Impact Communications. "From the survey we've also learned where advisors have gone the extra mile, what their clients valued most, and whether or not they are getting new business. The survey has given us important insights into the state of today's financial advisors and how they are adjusting their businesses in these uncertain times." WEBINAR VIA RIA CHANNEL The results of the survey will be revealed during a webinar via RIAChannel.com on Friday, Nov. 20, 2020, at 1:00 pm ET. The Conversations That Matter survey results, which will be presented by Swift, will be followed by comments and observations from three panelists: Bob Veresof Inside Information / Insider's Forum Shannon Stoneof DHR Investment Counsel, LTD Heather Kellyof Allianz Life Insurance Company of North America Swift and the panelists will provide insights on how financial advisors can: Build demand for their services and expertise Bridge communication gaps with current and prospective clients Shift their marketing efforts to align with changes in consumer sentiment and client perceptions Prepare their clients for future lifestyle, market and economic shocks Consider new and innovative solutions to help their clients Click here to sign up to attend the Conversations That Matter webinar:https://www.riachannel.com/conversations-that-matter-addressing-client-concerns-hopes-and-dreams-during-uncertain-times-allianz-life-11-20-20BONUS VIDEO AVAILABLE NOWMarie Swift interviewed Heather Kelly during the early stages of the Conversations That Matter project. Click here to watch the Swift Chat with Heather Kelly.SPECIAL REPORT AVAILABILITYFollowing the webinar on Nov. 20, 2020, all registrants will receive a corresponding special report, in which Swift provides additional color and comments from dozens of financial industry experts, behavioral finance academics and independent financial advisors. Readers will glean fresh insights from experts such as Dr. Meir Statman, Dr. Sonya Lutter, Carl Richards, Bob Veres and Joel Bruckenstein, as well as tales-from-the-trenches stories from independent financial advisors such as Bonnie Sewell, Melanie Housden, John Enright, Shannon Stone, Carolyn McClanahan and more.A free download link will be provided to anyone interested on Monday, Nov. 23, 2020. Watch for Swift's blog post on www.MarieSwift.comand/or follow @MarieSwift on social media for a link to the Conversations That Matter special report.ABOUT IMPACT COMMUNICATIONS, INC.Founded in 1993 by Marie Swift, who prior to Impact Communications was Director of Corporate Communications for a nationally-known wealth management firm and regional office for one of the largest independent broker/dealers in the country, Impact Communications works with a select group of fintech companies, financial institutions such as custodians and independent broker/dealers, RIA networks and membership organizations, OSJs, allied consulting entities, wealth management firms and independent advisors. Private coaching, on-camera training, branding and customized websites, content creation, and personalized media strategies enable Impact clients to reach their overarching goals. A prolific writer and respected consultant in the financial planning profession, Swift has appeared on NPR and numerous video interviews. Her quotes and articles have been published by Forbes, MarketWatch, Barron's and dozens of financial services trade publications. She profiles interesting people in the financial services industry on her blog, Best Practices in the Financial Services Industry, and in her new Swift Chat video interview series. For more information about Impact Communication and its services, please visit www.ImpactCommunications.org.CONTACT: Corrine Smith or Grace VogelzangImpact Communications, Inc.913-649-5009 | 800-974-7753[emailprotected][emailprotected]Related Imagesnew-survey-explores-how-financial.png SOURCE Impact Communications
|
edtsum5741
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON, Aug. 20, 2020 /PRNewswire/ -- Asset tracking is one of the highest growth application segments for the Internet of Things (IoT). According to a new report by global tech market advisory firm, ABI Research, asset tracking device shipments will see a 51% year-on-year device shipment growth rate through 2024. Expanding LPWAN coverage, technological maturity, and the associated miniaturization of sophisticated devices are key to moving asset tracking from traditionally high-value markets to low-value high-volume markets, which will account for most of the tracker connection and shipment numbers. "Hardware devices for the asset tracking market are primarily dominated by the need to balance power consumption, form factor, and device cost. Balance and compromise between these three must be achieved based on the use-case and are dictated by the business case and possible return on investment for the customer," said Tancred Taylor, Research Analyst at ABI Research. "As these constraints are marginalized by greater volumes of adoption, by emerging technologies like eSIM or System-on-Chip, and by increasingly low-power components and connectivity, so too will the limitations on the business case." Expanding technological and network foundations drive the number of use-cases, and OEMs are responding by diversifying their hardware offerings. Some OEMs such as CoreKinect, Particle, Mobilogix, or Starcom Systems are innovating in this space by taking a reference-architecture or modular approach to device design for personalized solutions. Others are going to market with off-the-shelf or vertically-focused devices for quickly scalable deployments such as BeWhere, Roambee, Sony, or FFLY4U. Early adoption of asset tracking was in the fleet, container, and logistics industries to provide basic data on the location and condition of assets in transit. The total addressable market for these industries remains extensive, particularly as the solutions trickle down from the largest enterprises to small- and medium-sized companies. Increased device functionality combined with component miniaturization is key to driving the next generation of low-cost tracking devices. This will enable granular tracking at the pallet, package, or item level, and open new markets and device categories, such as disposable trackers. Emerson, Sensitech, CoreKinect, and Bayer are among companies driving innovation in this field. Innovation among product offerings is accompanied by variations in business models and go-to-market approaches. Mobile Network Operators (MNOs) are playing a significant role in driving adoption through increased verticalization, with Verizon, AT&T, and Orange among those offering subscription models for end-to-end solutions comprising device, connectivity, software, and managed service offerings. This model is additionally gaining traction among OEMs, with Roambee an early adopter for a subscription-only model, and others such as Mobilogix following suit. This service-based model will gain additional traction as OEMs move down the value-chain by developing in-house capabilities or partner networks to simplify the ecosystem and consumer's solution. "While there is extensive work to be done on the hardware side to make low-cost trackers that can be simply attached to any 'thing', many OEMs are shifting from a hardware-only model to more of a consultative approach to a customer's requirements and deliver personalized end-to-end solutions. Flexibility, simplicity, and cost are crucial to gain enterprise traction," Taylor concluded. These findings are from ABI Research's IoT Asset Tracking Device Evolution: Technologies and Features Driving the Next Stage of Growthapplication analysis report.This report is part of the company'sM2M, IoT, and IoEresearch service, which includes research, data, and analyst insights. Based on extensive primary interviews, Application Analysisreports present in-depth analysis on key market trends and factors for a specific technology. About ABI ResearchABI Research provides strategic guidance to visionaries, delivering actionable intelligence on the transformative technologies that are dramatically reshaping industries, economies, and workforces across the world. ABI Research's global team of analysts publish groundbreaking studies often years ahead of other technology advisory firms, empowering our clients to stay ahead of their markets and their competitors. ABI Research1990 For more information about ABI Research's services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific or visit www.abiresearch.com. Contact Info: GlobalDeborah PetraraTel: +1.516.624.2558[emailprotected] SOURCE ABI Research Related Links http://www.abiresearch.com
Answer:
|
Asset Tracking Device Shipments Drive IoT Expansion and Grow 51% Year-on-Year Through 2024 Growing technological and network maturity opens the door to new addressable markets
|
LONDON, Aug. 20, 2020 /PRNewswire/ -- Asset tracking is one of the highest growth application segments for the Internet of Things (IoT). According to a new report by global tech market advisory firm, ABI Research, asset tracking device shipments will see a 51% year-on-year device shipment growth rate through 2024. Expanding LPWAN coverage, technological maturity, and the associated miniaturization of sophisticated devices are key to moving asset tracking from traditionally high-value markets to low-value high-volume markets, which will account for most of the tracker connection and shipment numbers. "Hardware devices for the asset tracking market are primarily dominated by the need to balance power consumption, form factor, and device cost. Balance and compromise between these three must be achieved based on the use-case and are dictated by the business case and possible return on investment for the customer," said Tancred Taylor, Research Analyst at ABI Research. "As these constraints are marginalized by greater volumes of adoption, by emerging technologies like eSIM or System-on-Chip, and by increasingly low-power components and connectivity, so too will the limitations on the business case." Expanding technological and network foundations drive the number of use-cases, and OEMs are responding by diversifying their hardware offerings. Some OEMs such as CoreKinect, Particle, Mobilogix, or Starcom Systems are innovating in this space by taking a reference-architecture or modular approach to device design for personalized solutions. Others are going to market with off-the-shelf or vertically-focused devices for quickly scalable deployments such as BeWhere, Roambee, Sony, or FFLY4U. Early adoption of asset tracking was in the fleet, container, and logistics industries to provide basic data on the location and condition of assets in transit. The total addressable market for these industries remains extensive, particularly as the solutions trickle down from the largest enterprises to small- and medium-sized companies. Increased device functionality combined with component miniaturization is key to driving the next generation of low-cost tracking devices. This will enable granular tracking at the pallet, package, or item level, and open new markets and device categories, such as disposable trackers. Emerson, Sensitech, CoreKinect, and Bayer are among companies driving innovation in this field. Innovation among product offerings is accompanied by variations in business models and go-to-market approaches. Mobile Network Operators (MNOs) are playing a significant role in driving adoption through increased verticalization, with Verizon, AT&T, and Orange among those offering subscription models for end-to-end solutions comprising device, connectivity, software, and managed service offerings. This model is additionally gaining traction among OEMs, with Roambee an early adopter for a subscription-only model, and others such as Mobilogix following suit. This service-based model will gain additional traction as OEMs move down the value-chain by developing in-house capabilities or partner networks to simplify the ecosystem and consumer's solution. "While there is extensive work to be done on the hardware side to make low-cost trackers that can be simply attached to any 'thing', many OEMs are shifting from a hardware-only model to more of a consultative approach to a customer's requirements and deliver personalized end-to-end solutions. Flexibility, simplicity, and cost are crucial to gain enterprise traction," Taylor concluded. These findings are from ABI Research's IoT Asset Tracking Device Evolution: Technologies and Features Driving the Next Stage of Growthapplication analysis report.This report is part of the company'sM2M, IoT, and IoEresearch service, which includes research, data, and analyst insights. Based on extensive primary interviews, Application Analysisreports present in-depth analysis on key market trends and factors for a specific technology. About ABI ResearchABI Research provides strategic guidance to visionaries, delivering actionable intelligence on the transformative technologies that are dramatically reshaping industries, economies, and workforces across the world. ABI Research's global team of analysts publish groundbreaking studies often years ahead of other technology advisory firms, empowering our clients to stay ahead of their markets and their competitors. ABI Research1990 For more information about ABI Research's services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific or visit www.abiresearch.com. Contact Info: GlobalDeborah PetraraTel: +1.516.624.2558[emailprotected] SOURCE ABI Research Related Links http://www.abiresearch.com
|
edtsum5742
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BOSTON--(BUSINESS WIRE)--Black Friday sales researchers at The Consumer Post have tracked the latest Alienware 4K, 1440p & 1080p monitor laptop deals for Black Friday & Cyber Monday, together with sales on Alienware Aurora, Alienware 15, Stealth and more gaming laptops. Links to the best deals are listed below. Best Alienware Deals: Best Gaming Laptop Deals: In need of some more deals? Check out Walmarts Black Friday & Cyber Monday sale and Amazons Black Friday & Cyber Monday sale to view more live discounts. The Consumer Post earns commissions from purchases made using the links provided. About The Consumer Post: The Consumer Post shares news for online shoppers. As an Amazon Associate and affiliate The Consumer Post earns from qualifying purchases.
Answer:
|
Black Friday & Cyber Monday Alienware Deals 2020: Alienware Aurora, M15 & More Savings Monitored by The Consumer Post Alienware deals for Black Friday & Cyber Monday, including Alienware m15, m17 and more deals
|
BOSTON--(BUSINESS WIRE)--Black Friday sales researchers at The Consumer Post have tracked the latest Alienware 4K, 1440p & 1080p monitor laptop deals for Black Friday & Cyber Monday, together with sales on Alienware Aurora, Alienware 15, Stealth and more gaming laptops. Links to the best deals are listed below. Best Alienware Deals: Best Gaming Laptop Deals: In need of some more deals? Check out Walmarts Black Friday & Cyber Monday sale and Amazons Black Friday & Cyber Monday sale to view more live discounts. The Consumer Post earns commissions from purchases made using the links provided. About The Consumer Post: The Consumer Post shares news for online shoppers. As an Amazon Associate and affiliate The Consumer Post earns from qualifying purchases.
|
edtsum5750
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN DIEGO, Feb. 5, 2021 /PRNewswire/ -- Angiocrine Bioscience Inc., a clinical-stage biopharmaceutical company today announced that the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) has selected Angiocrine's AB-205 Phase 1b/2 study results for an oral presentation.Intravenous AB-205 is being developed to treat diffuse damage of vascular niches of multiple organs caused by off-target cytotoxicity from high-dose chemotherapy (HDT) in the course of conditioning patients undergoing autologous hematopoietic cell transplantation to effect a cure of aggressive lymphomas.Treating the damaged vascular niches enable prompt repair of multiple organs.In case of HDT, the most severely and frequently affected organ systems are oral-gastrointestinal and hematopoietic.By enabling multi-organ repair, AB-205 has the potential of substantially reducing the incidence of severe transplant-related complications that can be life-threatening and prolong hospitalization. "Our investigators and Angiocrine are honored to be selected by ASTCT & CIBMTR to present at its annual meeting this February," commented Paul Finnegan, MD, Angiocrine's CEO. "We look forward to Dr. Lihua Budde's presentation of AB-205's efficacy and safety results from our Phase 1b/2 study as well as preparing for the upcoming Phase 3 registration study for this indication." Session Name: Oral Abstract - Session D - Acute Regimen-Related Toxicity and Supportive Care Title of Abstract: Results of an Open Label Dose Escalation Trial of AB-205 (E-CELcells) in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) Session Date: Monday, February 8, 2021 Session Time: 2:30 PM - 4:00 PM CSTPresentation Time: 3:00 PM CST About Severe Toxicities and Complications during High-Dose Chemotherapy (HDT) and Autologous Hematopoietic Cell Transplant (AHCT)HDT followed by AHCT is considered a standard-of-care consolidative treatment to cure patients with aggressive systemic lymphoma who have failed 1st-line chemotherapy and respond to chemotherapy induction. Although highly effective in eradicating aggressive cancer cells, HDT also causes collateral damage to healthy tissue, which can lead to severe toxicities and serious, costly complications.The most affected organ system is the lining of the oral-gastrointestinal (GI) tract. The oral GI tract renews its mucosal lining every 3 to 7 days. Because of the collateral damage from HDT, the oral GI tract loses its ability to renew its lining, leading to inflammation (mucositis) and breakdown. The patient suffers from debilitating nausea, vomiting and diarrhea, refractory to medications and prolonging hospitalization.Severe oral GI complications can occur as frequently as 50% and cause profound misery.The rates and severity increase with age and, thus, many older patients are turned away from this potentially curative therapy due to concerns over complication risks. About AB-205AB-205 represents a new and unique approach to repairing damaged tissues through advanced cell-and-gene therapy. AB-205 consists of allogeneic (off-the shelf) 'universal' E-CEL (human engineered cord endothelial) cells. Intravenous AB-205 is given after completion of HDT and on the same day as AHCT.AB-205's immediate action repairs damaged tissue and thereby prevents (reduces) the extent of breakdown of tissues, which is the root cause of severe toxicities experienced by patients. Reducing or preventing severe toxicities can lead to better quality of life and shorter stay in the hospitali.e., savings to the healthcare system. AB-205 was recently granted both the Regenerative Medicine Advanced Therapy (RMAT) Designation and Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA). Angiocrine is currently advancing intravenous AB-205 into a multi-center single registration Phase 3 trial. About Angiocrine Bioscience, Inc.Angiocrine Bioscience is a clinical-stage biotechnology company developing a radically new way to biologically repair damaged and diseased tissues and organs. Based on its novel and proprietary E-CEL platform, Angiocrine is developing multiple E-CEL therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system; immune diseases that attack vessels and tissues; and ischemic diseases involving soft tissue, central nervous system and the heart. For additional information, please contact: Angiocrine Bioscience, Inc.John R. Jaskowiak(877) 784-8496[emailprotected] SOURCE Angiocrine Bioscience, Inc. Related Links www.angiocrinebioscience.com
Answer:
|
Angiocrine Bioscience Announces Oral Presentation of Intravenous AB-205 Data during the Annual Transplantation & Cellular Therapy Meetings of ASCT and CIBMTR
|
SAN DIEGO, Feb. 5, 2021 /PRNewswire/ -- Angiocrine Bioscience Inc., a clinical-stage biopharmaceutical company today announced that the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) has selected Angiocrine's AB-205 Phase 1b/2 study results for an oral presentation.Intravenous AB-205 is being developed to treat diffuse damage of vascular niches of multiple organs caused by off-target cytotoxicity from high-dose chemotherapy (HDT) in the course of conditioning patients undergoing autologous hematopoietic cell transplantation to effect a cure of aggressive lymphomas.Treating the damaged vascular niches enable prompt repair of multiple organs.In case of HDT, the most severely and frequently affected organ systems are oral-gastrointestinal and hematopoietic.By enabling multi-organ repair, AB-205 has the potential of substantially reducing the incidence of severe transplant-related complications that can be life-threatening and prolong hospitalization. "Our investigators and Angiocrine are honored to be selected by ASTCT & CIBMTR to present at its annual meeting this February," commented Paul Finnegan, MD, Angiocrine's CEO. "We look forward to Dr. Lihua Budde's presentation of AB-205's efficacy and safety results from our Phase 1b/2 study as well as preparing for the upcoming Phase 3 registration study for this indication." Session Name: Oral Abstract - Session D - Acute Regimen-Related Toxicity and Supportive Care Title of Abstract: Results of an Open Label Dose Escalation Trial of AB-205 (E-CELcells) in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) Session Date: Monday, February 8, 2021 Session Time: 2:30 PM - 4:00 PM CSTPresentation Time: 3:00 PM CST About Severe Toxicities and Complications during High-Dose Chemotherapy (HDT) and Autologous Hematopoietic Cell Transplant (AHCT)HDT followed by AHCT is considered a standard-of-care consolidative treatment to cure patients with aggressive systemic lymphoma who have failed 1st-line chemotherapy and respond to chemotherapy induction. Although highly effective in eradicating aggressive cancer cells, HDT also causes collateral damage to healthy tissue, which can lead to severe toxicities and serious, costly complications.The most affected organ system is the lining of the oral-gastrointestinal (GI) tract. The oral GI tract renews its mucosal lining every 3 to 7 days. Because of the collateral damage from HDT, the oral GI tract loses its ability to renew its lining, leading to inflammation (mucositis) and breakdown. The patient suffers from debilitating nausea, vomiting and diarrhea, refractory to medications and prolonging hospitalization.Severe oral GI complications can occur as frequently as 50% and cause profound misery.The rates and severity increase with age and, thus, many older patients are turned away from this potentially curative therapy due to concerns over complication risks. About AB-205AB-205 represents a new and unique approach to repairing damaged tissues through advanced cell-and-gene therapy. AB-205 consists of allogeneic (off-the shelf) 'universal' E-CEL (human engineered cord endothelial) cells. Intravenous AB-205 is given after completion of HDT and on the same day as AHCT.AB-205's immediate action repairs damaged tissue and thereby prevents (reduces) the extent of breakdown of tissues, which is the root cause of severe toxicities experienced by patients. Reducing or preventing severe toxicities can lead to better quality of life and shorter stay in the hospitali.e., savings to the healthcare system. AB-205 was recently granted both the Regenerative Medicine Advanced Therapy (RMAT) Designation and Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA). Angiocrine is currently advancing intravenous AB-205 into a multi-center single registration Phase 3 trial. About Angiocrine Bioscience, Inc.Angiocrine Bioscience is a clinical-stage biotechnology company developing a radically new way to biologically repair damaged and diseased tissues and organs. Based on its novel and proprietary E-CEL platform, Angiocrine is developing multiple E-CEL therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system; immune diseases that attack vessels and tissues; and ischemic diseases involving soft tissue, central nervous system and the heart. For additional information, please contact: Angiocrine Bioscience, Inc.John R. Jaskowiak(877) 784-8496[emailprotected] SOURCE Angiocrine Bioscience, Inc. Related Links www.angiocrinebioscience.com
|
edtsum5752
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BOSTON--(BUSINESS WIRE)--MFS Investment Management (MFS) released today the distribution income sources for six of its closed-end funds for August 2020: MFS Charter Income Trust (NYSE: MCR), MFS Government Markets Income Trust (NYSE: MGF), MFS Intermediate High Income Fund (NYSE: CIF), MFS Intermediate Income Trust (NYSE: MIN), MFS Multimarket Income Trust (NYSE: MMT) and MFS Special Value Trust (NYSE: MFV). This information also can be obtained by visiting MFS.com by clicking on Products & Strategies > Closed End Funds > Dividend Source Information. MFS Charter Income Trust Distribution period: August 2020 Distribution amount per share: $ 0.05825 The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The funds fiscal year begins each December 1st. All amounts are expressed per common share. Total cumulative distributions for the fiscal year to date % Breakdown of the total cumulative distributions for the fiscal year to date Current distribution % Breakdown of current distribution Net Investment Income $ 0.03356 58% $ 0.27996 54% Net Realized ST Cap Gains 0.00000 0% 0.00000 0% Net Realized LT Cap Gains 0.00000 0% 0.00000 0% Return of Capital or Other Capital Source 0.02469 42% 0.24117 46% Total (per common share) $ 0.05825 100% $ 0.52113 100% Average annual total return (in relation to NAV) for the five years ended 7-31-2020 7.24% Annualized current distribution rate expressed as a percentage of month end NAV as of 7-31-2020 7.87% Cumulative total return (in relation to NAV) for the fiscal year through 7-31-2020 7.77% Cumulative fiscal year distributions as a percentage of NAV as of 7-31-2020 5.87% MFS Government Markets Income Trust Distribution period: August 2020 Distribution amount per share: $ 0.02938 The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The funds fiscal year begins each December 1st. All amounts are expressed per common share. Total cumulative distributions for the fiscal year to date % Breakdown of the total cumulative distributions for the fiscal year to date Current distribution % Breakdown of current distribution Net Investment Income $ 0.00964 33% $ 0.08070 31% Net Realized ST Cap Gains 0.00000 0% 0.00000 0% Net Realized LT Cap Gains 0.00000 0% 0.00000 0% Return of Capital or Other Capital Source 0.01974 67% 0.17999 69% Total (per common share) $ 0.02938 100% $ 0.26069 100% Average annual total return (in relation to NAV) for the five years ended 7-31-2020 4.26% Annualized current distribution rate expressed as a percentage of month end NAV as of 7-31-2020 7.22% Cumulative total return (in relation to NAV) for the fiscal year through 7-31-2020 12.16% Cumulative fiscal year distributions as a percentage of NAV as of 7-31-2020 5.34% MFS Intermediate High Income Fund Distribution period: August 2020 Distribution amount per share: $ 0.01884 The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The funds fiscal year begins each December 1st. All amounts are expressed per common share. Total cumulative distributions for the fiscal year to date % Breakdown of the total cumulative distributions for the fiscal year to date Current distribution % Breakdown of current distribution Net Investment Income $ 0.01199 64% $ 0.10411 61% Net Realized ST Cap Gains 0.00000 0% 0.00000 0% Net Realized LT Cap Gains 0.00000 0% 0.00000 0% Return of Capital or Other Capital Source 0.00685 36% 0.06795 39% Total (per common share) $ 0.01884 100% $ 0.17206 100% Average annual total return (in relation to NAV) for the five years ended 7-31-2020 6.55% Annualized current distribution rate expressed as a percentage of month end NAV as of 7-31-2020 9.23% Cumulative total return (in relation to NAV) for the fiscal year through 7-31-2020 3.32% Cumulative fiscal year distributions as a percentage of NAV as of 7-31-2020 7.02% MFS Intermediate Income Trust Distribution period: August 2020 Distribution amount per share: $ 0.02856 The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The funds fiscal year begins each November 1st. All amounts are expressed per common share. Total cumulative distributions for the fiscal year to date % Breakdown of the total cumulative distributions for the fiscal year to date Current distribution % Breakdown of current distribution Net Investment Income $ 0.00757 27% $ 0.07747 27% Net Realized ST Cap Gains 0.00000 0% 0.01087 4% Net Realized LT Cap Gains 0.00445 16% 0.02582 9% Return of Capital or Other Capital Source 0.01654 57% 0.16914 60% Total (per common share) $ 0.02856 100% $ 0.28330 100% Average annual total return (in relation to NAV) for the five years ended 7-31-2020 4.40% Annualized current distribution rate expressed as a percentage of month end NAV as of 7-31-2020 8.48% Cumulative total return (in relation to NAV) for the fiscal year through 7-31-2020 9.38% Cumulative fiscal year distributions as a percentage of NAV as of 7-31-2020 7.01% MFS Multimarket Income Trust Distribution period: August 2020 Distribution amount per share: $ 0.04124 The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The funds fiscal year begins each November 1st. All amounts are expressed per common share. Total cumulative distributions for the fiscal year to date % Breakdown of the total cumulative distributions for the fiscal year to date Current distribution % Breakdown of current distribution Net Investment Income $ 0.02545 62% $ 0.24170 59% Net Realized ST Cap Gains 0.00000 0% 0.00000 0% Net Realized LT Cap Gains 0.00000 0% 0.00000 0% Return of Capital or Other Capital Source 0.01579 38% 0.16837 41% Total (per common share) $ 0.04124 100% $ 0.41007 100% Average annual total return (in relation to NAV) for the five years ended 7-31-2020 7.03% Annualized current distribution rate expressed as a percentage of month end NAV as of 7-31-2020 7.83% Cumulative total return (in relation to NAV) for the fiscal year through 7-31-2020 7.55% Cumulative fiscal year distributions as a percentage of NAV as of 7-31-2020 6.49% MFS Special Value Trust Distribution period: August 2020 Distribution amount per share: $ 0.04323 The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The funds fiscal year begins each November 1st. All amounts are expressed per common share. Total cumulative distributions for the fiscal year to date % Breakdown of the total cumulative distributions for the fiscal year to date Current distribution % Breakdown of current distribution Net Investment Income $ 0.01134 26% $ 0.12214 27% Net Realized ST Cap Gains 0.00000 0% 0.00000 0% Net Realized LT Cap Gains 0.02032 47% 0.31122 70% Return of Capital or Other Capital Source 0.01157 27% 0.01157 3% Total (per common share) $ 0.04323 100% $ 0.44493 100% Average annual total return (in relation to NAV) for the five years ended 7-31-2020 6.62% Annualized current distribution rate expressed as a percentage of month end NAV as 7-31-2020 9.84% Cumulative total return (in relation to NAV) for the fiscal year through 7-31-2020 1.66% Cumulative fiscal year distributions as a percentage of NAV as of 7-31-2020 8.44% The above funds have adopted a managed distribution plan. Under a managed distribution plan, to the extent that sufficient investment income is not available on a monthly basis, the fund will distribute long-term capital gains and/or return of capital in order to maintain its managed distribution level. Investors should not draw any conclusions about the funds investment performance from the amount of the funds distributions or from the terms of the funds managed distribution plan. The Board of the fund may amend the terms of the plan or terminate the plan at any time without prior notice to the fund's shareholders. The amendment or termination of a plan could have an adverse effect on the market price of the funds common shares. The plan will be subject to periodic review by the Board. With each distribution that does not consist solely of net investment income, the fund will issue a notice to shareholders and an accompanying press release which will provide detailed information regarding the amount and estimated composition of the distribution and other related information. The amounts and sources of distributions reported above are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the funds investment experience during its full fiscal year and may be subject to changes based on tax regulations. The fund will send shareholders a Form 1099-DIV for the calendar year that will tell them how to report these distributions for federal income tax purposes. The fund may at times distribute more than its net investment income and net realized capital gains; therefore, a portion of the distribution may result in a return of capital. A return of capital may occur, for example, when some or all of the money that shareholders invested in the fund is paid back to them. A return of capital does not necessarily reflect a funds investment performance and should not be confused with yield or income. Any such returns of capital will decrease the fund's total assets and, therefore, could have the effect of increasing the fund's expense ratio. In addition, in order to make the level of distributions called for under its plan, the fund may have to sell portfolio securities at a less than opportune time. About MFS Investment Management In 1924, MFS launched the first US open-end mutual fund, opening the door to the markets for millions of everyday investors. Today, as a full-service global investment manager serving financial advisors, intermediaries and institutional clients, MFS still serves a single purpose: to create long-term value for clients by allocating capital responsibly. That takes our powerful investment approach combining collective expertise, thoughtful risk management and long-term discipline. Supported by our culture of shared values and collaboration, our teams of diverse thinkers actively debate ideas and assess material risks to uncover what we believe are the best investment opportunities in the market. As of July 31, 2020, MFS manages US$531.9 billion in assets on behalf of individual and institutional investors worldwide. Please visit mfs.com for more information. The Funds are closed-end Funds. Common shares of the Funds are only available for purchase/sale on the NYSE at the current market price (NYSE American for MFS California Municipal Fund). Shares may trade at a discount to NAV. MFS Investment Management 111 Huntington Ave., Boston, MA 02199 15668.143
Answer:
|
MFS Releases Closed-End Fund Income Distribution Sources for Certain Funds
|
BOSTON--(BUSINESS WIRE)--MFS Investment Management (MFS) released today the distribution income sources for six of its closed-end funds for August 2020: MFS Charter Income Trust (NYSE: MCR), MFS Government Markets Income Trust (NYSE: MGF), MFS Intermediate High Income Fund (NYSE: CIF), MFS Intermediate Income Trust (NYSE: MIN), MFS Multimarket Income Trust (NYSE: MMT) and MFS Special Value Trust (NYSE: MFV). This information also can be obtained by visiting MFS.com by clicking on Products & Strategies > Closed End Funds > Dividend Source Information. MFS Charter Income Trust Distribution period: August 2020 Distribution amount per share: $ 0.05825 The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The funds fiscal year begins each December 1st. All amounts are expressed per common share. Total cumulative distributions for the fiscal year to date % Breakdown of the total cumulative distributions for the fiscal year to date Current distribution % Breakdown of current distribution Net Investment Income $ 0.03356 58% $ 0.27996 54% Net Realized ST Cap Gains 0.00000 0% 0.00000 0% Net Realized LT Cap Gains 0.00000 0% 0.00000 0% Return of Capital or Other Capital Source 0.02469 42% 0.24117 46% Total (per common share) $ 0.05825 100% $ 0.52113 100% Average annual total return (in relation to NAV) for the five years ended 7-31-2020 7.24% Annualized current distribution rate expressed as a percentage of month end NAV as of 7-31-2020 7.87% Cumulative total return (in relation to NAV) for the fiscal year through 7-31-2020 7.77% Cumulative fiscal year distributions as a percentage of NAV as of 7-31-2020 5.87% MFS Government Markets Income Trust Distribution period: August 2020 Distribution amount per share: $ 0.02938 The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The funds fiscal year begins each December 1st. All amounts are expressed per common share. Total cumulative distributions for the fiscal year to date % Breakdown of the total cumulative distributions for the fiscal year to date Current distribution % Breakdown of current distribution Net Investment Income $ 0.00964 33% $ 0.08070 31% Net Realized ST Cap Gains 0.00000 0% 0.00000 0% Net Realized LT Cap Gains 0.00000 0% 0.00000 0% Return of Capital or Other Capital Source 0.01974 67% 0.17999 69% Total (per common share) $ 0.02938 100% $ 0.26069 100% Average annual total return (in relation to NAV) for the five years ended 7-31-2020 4.26% Annualized current distribution rate expressed as a percentage of month end NAV as of 7-31-2020 7.22% Cumulative total return (in relation to NAV) for the fiscal year through 7-31-2020 12.16% Cumulative fiscal year distributions as a percentage of NAV as of 7-31-2020 5.34% MFS Intermediate High Income Fund Distribution period: August 2020 Distribution amount per share: $ 0.01884 The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The funds fiscal year begins each December 1st. All amounts are expressed per common share. Total cumulative distributions for the fiscal year to date % Breakdown of the total cumulative distributions for the fiscal year to date Current distribution % Breakdown of current distribution Net Investment Income $ 0.01199 64% $ 0.10411 61% Net Realized ST Cap Gains 0.00000 0% 0.00000 0% Net Realized LT Cap Gains 0.00000 0% 0.00000 0% Return of Capital or Other Capital Source 0.00685 36% 0.06795 39% Total (per common share) $ 0.01884 100% $ 0.17206 100% Average annual total return (in relation to NAV) for the five years ended 7-31-2020 6.55% Annualized current distribution rate expressed as a percentage of month end NAV as of 7-31-2020 9.23% Cumulative total return (in relation to NAV) for the fiscal year through 7-31-2020 3.32% Cumulative fiscal year distributions as a percentage of NAV as of 7-31-2020 7.02% MFS Intermediate Income Trust Distribution period: August 2020 Distribution amount per share: $ 0.02856 The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The funds fiscal year begins each November 1st. All amounts are expressed per common share. Total cumulative distributions for the fiscal year to date % Breakdown of the total cumulative distributions for the fiscal year to date Current distribution % Breakdown of current distribution Net Investment Income $ 0.00757 27% $ 0.07747 27% Net Realized ST Cap Gains 0.00000 0% 0.01087 4% Net Realized LT Cap Gains 0.00445 16% 0.02582 9% Return of Capital or Other Capital Source 0.01654 57% 0.16914 60% Total (per common share) $ 0.02856 100% $ 0.28330 100% Average annual total return (in relation to NAV) for the five years ended 7-31-2020 4.40% Annualized current distribution rate expressed as a percentage of month end NAV as of 7-31-2020 8.48% Cumulative total return (in relation to NAV) for the fiscal year through 7-31-2020 9.38% Cumulative fiscal year distributions as a percentage of NAV as of 7-31-2020 7.01% MFS Multimarket Income Trust Distribution period: August 2020 Distribution amount per share: $ 0.04124 The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The funds fiscal year begins each November 1st. All amounts are expressed per common share. Total cumulative distributions for the fiscal year to date % Breakdown of the total cumulative distributions for the fiscal year to date Current distribution % Breakdown of current distribution Net Investment Income $ 0.02545 62% $ 0.24170 59% Net Realized ST Cap Gains 0.00000 0% 0.00000 0% Net Realized LT Cap Gains 0.00000 0% 0.00000 0% Return of Capital or Other Capital Source 0.01579 38% 0.16837 41% Total (per common share) $ 0.04124 100% $ 0.41007 100% Average annual total return (in relation to NAV) for the five years ended 7-31-2020 7.03% Annualized current distribution rate expressed as a percentage of month end NAV as of 7-31-2020 7.83% Cumulative total return (in relation to NAV) for the fiscal year through 7-31-2020 7.55% Cumulative fiscal year distributions as a percentage of NAV as of 7-31-2020 6.49% MFS Special Value Trust Distribution period: August 2020 Distribution amount per share: $ 0.04323 The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The funds fiscal year begins each November 1st. All amounts are expressed per common share. Total cumulative distributions for the fiscal year to date % Breakdown of the total cumulative distributions for the fiscal year to date Current distribution % Breakdown of current distribution Net Investment Income $ 0.01134 26% $ 0.12214 27% Net Realized ST Cap Gains 0.00000 0% 0.00000 0% Net Realized LT Cap Gains 0.02032 47% 0.31122 70% Return of Capital or Other Capital Source 0.01157 27% 0.01157 3% Total (per common share) $ 0.04323 100% $ 0.44493 100% Average annual total return (in relation to NAV) for the five years ended 7-31-2020 6.62% Annualized current distribution rate expressed as a percentage of month end NAV as 7-31-2020 9.84% Cumulative total return (in relation to NAV) for the fiscal year through 7-31-2020 1.66% Cumulative fiscal year distributions as a percentage of NAV as of 7-31-2020 8.44% The above funds have adopted a managed distribution plan. Under a managed distribution plan, to the extent that sufficient investment income is not available on a monthly basis, the fund will distribute long-term capital gains and/or return of capital in order to maintain its managed distribution level. Investors should not draw any conclusions about the funds investment performance from the amount of the funds distributions or from the terms of the funds managed distribution plan. The Board of the fund may amend the terms of the plan or terminate the plan at any time without prior notice to the fund's shareholders. The amendment or termination of a plan could have an adverse effect on the market price of the funds common shares. The plan will be subject to periodic review by the Board. With each distribution that does not consist solely of net investment income, the fund will issue a notice to shareholders and an accompanying press release which will provide detailed information regarding the amount and estimated composition of the distribution and other related information. The amounts and sources of distributions reported above are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the funds investment experience during its full fiscal year and may be subject to changes based on tax regulations. The fund will send shareholders a Form 1099-DIV for the calendar year that will tell them how to report these distributions for federal income tax purposes. The fund may at times distribute more than its net investment income and net realized capital gains; therefore, a portion of the distribution may result in a return of capital. A return of capital may occur, for example, when some or all of the money that shareholders invested in the fund is paid back to them. A return of capital does not necessarily reflect a funds investment performance and should not be confused with yield or income. Any such returns of capital will decrease the fund's total assets and, therefore, could have the effect of increasing the fund's expense ratio. In addition, in order to make the level of distributions called for under its plan, the fund may have to sell portfolio securities at a less than opportune time. About MFS Investment Management In 1924, MFS launched the first US open-end mutual fund, opening the door to the markets for millions of everyday investors. Today, as a full-service global investment manager serving financial advisors, intermediaries and institutional clients, MFS still serves a single purpose: to create long-term value for clients by allocating capital responsibly. That takes our powerful investment approach combining collective expertise, thoughtful risk management and long-term discipline. Supported by our culture of shared values and collaboration, our teams of diverse thinkers actively debate ideas and assess material risks to uncover what we believe are the best investment opportunities in the market. As of July 31, 2020, MFS manages US$531.9 billion in assets on behalf of individual and institutional investors worldwide. Please visit mfs.com for more information. The Funds are closed-end Funds. Common shares of the Funds are only available for purchase/sale on the NYSE at the current market price (NYSE American for MFS California Municipal Fund). Shares may trade at a discount to NAV. MFS Investment Management 111 Huntington Ave., Boston, MA 02199 15668.143
|
edtsum5753
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PROCEEDS WILL BE USED TO INCREASE FLORIDA CULTIVATION CAPACITY, ACCELERATE DISPENSARY OPENINGS AND ACCELERATE GROWTH IN CORE FLORIDA MARKET Capital Will Also Fund Improvements to Michigan Cultivation Facility MIAMI, April 5, 2021 /PRNewswire/ -Cansortium Inc. ("Cansortium" or the "Company") (CSE: TIUM.U), (OTCQB: CNTMF), is pleased to announce the closing of the sale of approximately US$12 million of units ("Units") at a purchase price of US$0.70 per Unit (the"Private Placement"). The Private Placement, originally contemplated as a US$10 million financing, was increased by the Company due to investor demand, and a subsequent closing is expected in the next few days. Each Unit consists of one common share of the Company (each, a "Share") and one-half of one common share purchase warrant (each whole warrant, a "Warrant"). Each Warrant will entitle the holder thereof to purchase one common share of the Company (a "Warrant Share") for a period of 24 months following the closing date at an exercise price per Warrant Share equal to US$0.90. Proceeds from the Private Placement will provide the necessary capital to accelerate the Company's growth initiatives in both Florida and Michigan. In Florida, where the Company currently operates two cultivation facilities and 24 retail dispensaries (with 3 more to be opened shortly), the proceeds from the Private Placement will be used to: (i) immediately complete Phase 2 of the Company's new Sweetwater cultivation facility, more than doubling that facility's annual production capacity from 3,000 lbs. to more than 6,000 lbs. of high quality flower, (ii) construct a new building at the Sweetwater facility to more efficiently trim, process and package the increased flower supply; and (iii) create four additional grow rooms in the Tampa cultivation facility to increase the supply of flower and biomass by approximately 2,400 lbs. annually and to improve operating efficiencies In addition, proceeds from the Private Placement will help accelerate opening two new dispensaries in Pennsylvania and an additional two in Florida by year-end, thereby increasing the Company's dispensary footprint to 31 locations. In Michigan, the Company will expand its existing cultivation facility and construct additional support infrastructure to capitalize on the strong demand for recreational cannabis throughout the state. "I am pleased with the tremendous progress that we have made since I have become Cansortium's CEO and we are now in a position to focus on expansion and growth", said Robert Beasley, Chief Executive Officer. "Cansortium's future has never been brighter and management is focused on executing our operating plan and continuing to capitalize on our strong asset base." Neal Hochberg, Chairman, added, "The Private Placement is another milestone for the Company delivering important growth and expansion capital. We are confident that we will refinance our short-term maturities, which will simplify our balance sheet and provide additional growth and working capital. The Board has tremendous confidence in our management team and the successful completion of the Private Placement further enables them to create additional value for all of our stakeholders." Canaccord Genuity acted as Financial Advisor to Cansortium on the Private Placement. No securities regulatory authority has either approved or disapproved of the contents of this news release. The Shares and Warrants and any underlying securities shall be subject to a four month hold period from the closing date for Canadian investors. The securities being offered have not been, nor will they be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws. Accordingly, these securities may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of Cansortium in any jurisdiction in which such offer, solicitation or sale would be unlawful. About Cansortium Inc. Headquartered in Miami, Florida, and operating under the Fluent brand, Cansortium is focused on being the highest quality cannabis company in the State of Florida driven by an unrelenting commitment to operational excellence from seed to sale. Cansortium has developed strong proficiencies in each of cultivation, processing, retail, and distribution activities, resulting in successfully operating in the highly regulated cannabis industry. In addition to Florida, Cansortium seeks to create significant shareholder value in the attractive markets of Texas, Michigan, and Pennsylvania, where the Company has secured licenses and established operations. Cansortium Inc.'s common shares trade on the CSE under the symbol "TIUM.U" and on the OTCQB Venture Market under the symbol (OTCQB: CNTMF). Investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcmarkets.com. Forward-Looking Information Certain information in this news release may constitute forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates, and projections regarding future events.Forward-looking information is necessarily based on many opinions, assumptions, and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in the public documents of the Company available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law. SOURCE Cansortium Inc Related Links www.cansortium.com
Answer:
|
Cansortium Closes US$12 Million Private Placement
|
PROCEEDS WILL BE USED TO INCREASE FLORIDA CULTIVATION CAPACITY, ACCELERATE DISPENSARY OPENINGS AND ACCELERATE GROWTH IN CORE FLORIDA MARKET Capital Will Also Fund Improvements to Michigan Cultivation Facility MIAMI, April 5, 2021 /PRNewswire/ -Cansortium Inc. ("Cansortium" or the "Company") (CSE: TIUM.U), (OTCQB: CNTMF), is pleased to announce the closing of the sale of approximately US$12 million of units ("Units") at a purchase price of US$0.70 per Unit (the"Private Placement"). The Private Placement, originally contemplated as a US$10 million financing, was increased by the Company due to investor demand, and a subsequent closing is expected in the next few days. Each Unit consists of one common share of the Company (each, a "Share") and one-half of one common share purchase warrant (each whole warrant, a "Warrant"). Each Warrant will entitle the holder thereof to purchase one common share of the Company (a "Warrant Share") for a period of 24 months following the closing date at an exercise price per Warrant Share equal to US$0.90. Proceeds from the Private Placement will provide the necessary capital to accelerate the Company's growth initiatives in both Florida and Michigan. In Florida, where the Company currently operates two cultivation facilities and 24 retail dispensaries (with 3 more to be opened shortly), the proceeds from the Private Placement will be used to: (i) immediately complete Phase 2 of the Company's new Sweetwater cultivation facility, more than doubling that facility's annual production capacity from 3,000 lbs. to more than 6,000 lbs. of high quality flower, (ii) construct a new building at the Sweetwater facility to more efficiently trim, process and package the increased flower supply; and (iii) create four additional grow rooms in the Tampa cultivation facility to increase the supply of flower and biomass by approximately 2,400 lbs. annually and to improve operating efficiencies In addition, proceeds from the Private Placement will help accelerate opening two new dispensaries in Pennsylvania and an additional two in Florida by year-end, thereby increasing the Company's dispensary footprint to 31 locations. In Michigan, the Company will expand its existing cultivation facility and construct additional support infrastructure to capitalize on the strong demand for recreational cannabis throughout the state. "I am pleased with the tremendous progress that we have made since I have become Cansortium's CEO and we are now in a position to focus on expansion and growth", said Robert Beasley, Chief Executive Officer. "Cansortium's future has never been brighter and management is focused on executing our operating plan and continuing to capitalize on our strong asset base." Neal Hochberg, Chairman, added, "The Private Placement is another milestone for the Company delivering important growth and expansion capital. We are confident that we will refinance our short-term maturities, which will simplify our balance sheet and provide additional growth and working capital. The Board has tremendous confidence in our management team and the successful completion of the Private Placement further enables them to create additional value for all of our stakeholders." Canaccord Genuity acted as Financial Advisor to Cansortium on the Private Placement. No securities regulatory authority has either approved or disapproved of the contents of this news release. The Shares and Warrants and any underlying securities shall be subject to a four month hold period from the closing date for Canadian investors. The securities being offered have not been, nor will they be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws. Accordingly, these securities may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of Cansortium in any jurisdiction in which such offer, solicitation or sale would be unlawful. About Cansortium Inc. Headquartered in Miami, Florida, and operating under the Fluent brand, Cansortium is focused on being the highest quality cannabis company in the State of Florida driven by an unrelenting commitment to operational excellence from seed to sale. Cansortium has developed strong proficiencies in each of cultivation, processing, retail, and distribution activities, resulting in successfully operating in the highly regulated cannabis industry. In addition to Florida, Cansortium seeks to create significant shareholder value in the attractive markets of Texas, Michigan, and Pennsylvania, where the Company has secured licenses and established operations. Cansortium Inc.'s common shares trade on the CSE under the symbol "TIUM.U" and on the OTCQB Venture Market under the symbol (OTCQB: CNTMF). Investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcmarkets.com. Forward-Looking Information Certain information in this news release may constitute forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates, and projections regarding future events.Forward-looking information is necessarily based on many opinions, assumptions, and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in the public documents of the Company available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law. SOURCE Cansortium Inc Related Links www.cansortium.com
|
edtsum5762
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Retail Execution Software Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Enterprise Size and Application, and Geography" report has been added to ResearchAndMarkets.com's offering. Machine Learning to Revolutionize Retail Execution Business and Act as a Trend for Retail Execution Software Market during 2020-2027 Retail Execution Software Market was valued at US$ 198.39 million in 2019 and is projected to reach US$ 303.26 million by 2027; it is expected to grow at a CAGR of 7.2% from 2020 to 2027. In the retail industry, several challenges occur due to an imbalance between demand and resource availability, as well as inadequate area mapping. Machine learning, an application of artificial intelligence, is the foundation of the next-gen of technologies. It offers systems the ability to learn from recorded data and experiences with the use of algorithms, patterns, and predictive insights. Moreover, with the capabilities of machine learning, online retailers can swiftly acknowledge and identify customers who have been disconnected from their services. Additionally, retailers can ensure customer retention by reminding customers to reorder perishable products or share exclusive deals. The on-demand retail industry continues to grow, with technology playing a major role in automating services to ensure better customer experience. In the US, the number of online grocery shoppers has increased by 35 million, which proves that on-demand retail execution is a trend and a new wave of consumer behavior. By utilizing the advantages of machine learning, vendors in the market can automate and streamline the retail execution process. Thus, this trend is projected to boost the demand for retail execution software during the forecast period. Geographically, North America led the retail execution software market in 2019 owing to the relatively high density of consumer electronic devices, such as smartphones. Further, it represents ~33% of the global e-commerce purchases. High penetration of smartphone and internet drives the demand for e-commerce in North America, which, in turn, propels the need for retail execution software for faster retail execution. There are more than 3 million retail outlets in the US, contributing US$ 2.6 trillion to its GDP. Furthermore, the retail vendors are providing distinct types of services such as product grading and assortment, packaging, mobile applications, and e-mail and SMS alerts sending. The rise in focus on providing such value-added services in retail execution is one of the latest trends contributing to the growth of the market in North America. Wal-Mart, The Home Depot, Costco, Kroger, and Target are among the enterprises having their origins in North America. With well-established retail sector, the presence of key retail execution software market players - such as Mobisoft Infotech LLC, POPProbe, Spring Mobile Solutions, and TRAX IMAGE RECOGNITION - is also supporting the market growth in this region. Also, the adoption of Software-as-a-Service (SaaS) is more prevalent in the manufacturing, BFSI, and retail sectors across North America. SaaS incorporated with AI, and machine learning is changing North American customer services. The market is expected to witness a slight decline in growth over the next few quarters due to the COVID-19 pandemic; however, it is expected to rise again at a healthy pace post pandemic. Impact of COVID-19 Pandemic on Retail Execution Software Market According to the latest report from World Health Organization (WHO), the US, Spain, Italy, France, Germany, the UK, Russia, Turkey, Brazil, Iran, and China are among the worst affected countries due to the COVID-19 outbreak. The crisis is adversely affecting the industries worldwide. The global economy took the worst hit in 2020, and it is likely to continue in 2021. The outbreak has created significant disruptions in primary industries such as logistics, retail, and e-commerce. The sharp decline in the international logistics business industry is restraining the growth of the global retail execution software market. Bizom (Mobisy Technologies Private Limited); EdgeCG (StayinFront, Inc.); Intelligence Retail; Mobisoft; POPProbe; Spring Mobile Solutions, Inc.; Trax Technology Solutions Pte Ltd.; Valomnia; WINIT; and Kantar Group are among the companies operating in the retail execution software market. Key Topics Covered: 1. Introduction 2. Key Takeaways 3. Research Methodology 4. Retail Execution Software Market Landscape 4.1 Market Overview 4.2 PEST Analysis 4.3 Ecosystem Analysis 4.4 Expert Opinion 5. Retail Execution Software Market - Key Market Dynamics 5.1 Market Drivers 5.1.1 Growing Preference for Retail and E-Commerce Platforms 5.1.2 Increasing Integration of Payment Gateways with Retail Execution Software 5.2 Market Restraints 5.2.1 Growing Security Concerns 5.3 Market Opportunities 5.3.1 Integration of Big Data Analytics Technology in Retail Industry 5.4 Future Trends 5.4.1 Machine Learning to Revolutionize Retail Execution Business 5.5 Impact Analysis of Drivers and Restraints 6. Retail Execution Software Market - Global Market Analysis 6.1 Global Retail Execution Software Market Overview 6.2 Retail Execution Software Market - Revenue and Forecast to 2027 (US$ Million) 6.3 Market Positioning - Five Key Players 7. Retail Execution Software Market Analysis - By Enterprise Size 7.1 Overview 7.2 Retail execution software Market, By Enterprise Size (2019 and 2027) 7.3 SMEs 7.4 Large Enterprises 8. Retail Execution Software Market Analysis - By Application 8.1 Overview 8.2 Retail Execution Software Market Breakdown, by Belt Enterprise Size, 2019 & 2027 8.3 Retail Operations 8.4 Field Service Management 8.5 Mobile Forms Automation 8.6 Field Sales 8.7 Trade Promotion Management 8.8 Employee Engagement 9. Retail Execution Software Market - Geographic Analysis 10. Impact of COVID-19 Pandemic on Retail Execution Software Market 10.1 Overview 11. Industry Landscape 11.1 Overview 11.2 Market Initiative 11.3 New Product Development 11.4 Merger and Acquisition 12. Company Profiles 12.1 Key Facts 12.2 Business Description 12.3 Products and Services 12.4 Financial Overview 12.5 SWOT Analysis 12.6 Key Developments For more information about this report visit https://www.researchandmarkets.com/r/us3rzm
Answer:
|
Global Retail Execution Software Market Forecast Report 2021-2027: Machine Learning to Revolutionize Retail Execution Business - ResearchAndMarkets.com
|
DUBLIN--(BUSINESS WIRE)--The "Retail Execution Software Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Enterprise Size and Application, and Geography" report has been added to ResearchAndMarkets.com's offering. Machine Learning to Revolutionize Retail Execution Business and Act as a Trend for Retail Execution Software Market during 2020-2027 Retail Execution Software Market was valued at US$ 198.39 million in 2019 and is projected to reach US$ 303.26 million by 2027; it is expected to grow at a CAGR of 7.2% from 2020 to 2027. In the retail industry, several challenges occur due to an imbalance between demand and resource availability, as well as inadequate area mapping. Machine learning, an application of artificial intelligence, is the foundation of the next-gen of technologies. It offers systems the ability to learn from recorded data and experiences with the use of algorithms, patterns, and predictive insights. Moreover, with the capabilities of machine learning, online retailers can swiftly acknowledge and identify customers who have been disconnected from their services. Additionally, retailers can ensure customer retention by reminding customers to reorder perishable products or share exclusive deals. The on-demand retail industry continues to grow, with technology playing a major role in automating services to ensure better customer experience. In the US, the number of online grocery shoppers has increased by 35 million, which proves that on-demand retail execution is a trend and a new wave of consumer behavior. By utilizing the advantages of machine learning, vendors in the market can automate and streamline the retail execution process. Thus, this trend is projected to boost the demand for retail execution software during the forecast period. Geographically, North America led the retail execution software market in 2019 owing to the relatively high density of consumer electronic devices, such as smartphones. Further, it represents ~33% of the global e-commerce purchases. High penetration of smartphone and internet drives the demand for e-commerce in North America, which, in turn, propels the need for retail execution software for faster retail execution. There are more than 3 million retail outlets in the US, contributing US$ 2.6 trillion to its GDP. Furthermore, the retail vendors are providing distinct types of services such as product grading and assortment, packaging, mobile applications, and e-mail and SMS alerts sending. The rise in focus on providing such value-added services in retail execution is one of the latest trends contributing to the growth of the market in North America. Wal-Mart, The Home Depot, Costco, Kroger, and Target are among the enterprises having their origins in North America. With well-established retail sector, the presence of key retail execution software market players - such as Mobisoft Infotech LLC, POPProbe, Spring Mobile Solutions, and TRAX IMAGE RECOGNITION - is also supporting the market growth in this region. Also, the adoption of Software-as-a-Service (SaaS) is more prevalent in the manufacturing, BFSI, and retail sectors across North America. SaaS incorporated with AI, and machine learning is changing North American customer services. The market is expected to witness a slight decline in growth over the next few quarters due to the COVID-19 pandemic; however, it is expected to rise again at a healthy pace post pandemic. Impact of COVID-19 Pandemic on Retail Execution Software Market According to the latest report from World Health Organization (WHO), the US, Spain, Italy, France, Germany, the UK, Russia, Turkey, Brazil, Iran, and China are among the worst affected countries due to the COVID-19 outbreak. The crisis is adversely affecting the industries worldwide. The global economy took the worst hit in 2020, and it is likely to continue in 2021. The outbreak has created significant disruptions in primary industries such as logistics, retail, and e-commerce. The sharp decline in the international logistics business industry is restraining the growth of the global retail execution software market. Bizom (Mobisy Technologies Private Limited); EdgeCG (StayinFront, Inc.); Intelligence Retail; Mobisoft; POPProbe; Spring Mobile Solutions, Inc.; Trax Technology Solutions Pte Ltd.; Valomnia; WINIT; and Kantar Group are among the companies operating in the retail execution software market. Key Topics Covered: 1. Introduction 2. Key Takeaways 3. Research Methodology 4. Retail Execution Software Market Landscape 4.1 Market Overview 4.2 PEST Analysis 4.3 Ecosystem Analysis 4.4 Expert Opinion 5. Retail Execution Software Market - Key Market Dynamics 5.1 Market Drivers 5.1.1 Growing Preference for Retail and E-Commerce Platforms 5.1.2 Increasing Integration of Payment Gateways with Retail Execution Software 5.2 Market Restraints 5.2.1 Growing Security Concerns 5.3 Market Opportunities 5.3.1 Integration of Big Data Analytics Technology in Retail Industry 5.4 Future Trends 5.4.1 Machine Learning to Revolutionize Retail Execution Business 5.5 Impact Analysis of Drivers and Restraints 6. Retail Execution Software Market - Global Market Analysis 6.1 Global Retail Execution Software Market Overview 6.2 Retail Execution Software Market - Revenue and Forecast to 2027 (US$ Million) 6.3 Market Positioning - Five Key Players 7. Retail Execution Software Market Analysis - By Enterprise Size 7.1 Overview 7.2 Retail execution software Market, By Enterprise Size (2019 and 2027) 7.3 SMEs 7.4 Large Enterprises 8. Retail Execution Software Market Analysis - By Application 8.1 Overview 8.2 Retail Execution Software Market Breakdown, by Belt Enterprise Size, 2019 & 2027 8.3 Retail Operations 8.4 Field Service Management 8.5 Mobile Forms Automation 8.6 Field Sales 8.7 Trade Promotion Management 8.8 Employee Engagement 9. Retail Execution Software Market - Geographic Analysis 10. Impact of COVID-19 Pandemic on Retail Execution Software Market 10.1 Overview 11. Industry Landscape 11.1 Overview 11.2 Market Initiative 11.3 New Product Development 11.4 Merger and Acquisition 12. Company Profiles 12.1 Key Facts 12.2 Business Description 12.3 Products and Services 12.4 Financial Overview 12.5 SWOT Analysis 12.6 Key Developments For more information about this report visit https://www.researchandmarkets.com/r/us3rzm
|
edtsum5775
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN DIEGO--(BUSINESS WIRE)--The Bumble Bee Seafood Company today announced that it has been awarded a 2020 Top Workplace honor by the San Diego Union-Tribune. Company employees cited strong values, a positive, friendly and motivating culture, and a passionate senior management team as key company attributes. The Union-Tribunes annual Top Workplaces list is based solely on employee feedback gathered through an anonymous survey administered by third-party research partner, Energage. Ninety-four percent of Bumble Bee employees participated in the survey, 17 percent higher than the industry average for food and beverage, as benchmarked by Energage. The highest-scored and most improved area was employee agreement with the statement I believe Bumble Bee is going in the right direction. Our employees are the epitome of what enables Bumble Bee to continue to be a thriving company even in this challenging environment, said Jan Tharp, President and Chief Executive Officer for The Bumble Bee Seafood Company. I am incredibly proud of our organization and very thankful to our employees for this recognition. The Union-Tribune award comes on the heels of a series of key announcements made by the iconic seafood brand over the past 12 months, including the sale of the company to long-time partner FCF CO., LTD., the announcement of a joint venture with Gathered Foods Corporation, a $40 million commitment to sustainability efforts, and a ground-breaking new television and digital advertising campaign known as Yes! Bumble Bee! The Bumble Bee Seafood Company employs more than 1,250 people, including nearly 120 at the San Diego headquarters. ABOUT THE BUMBLE BEE SEAFOOD COMPANY The Bumble Bee Seafood Company is passionately pursuing its purpose of feeding peoples lives through the power of the ocean. The iconic 120-year-old fishing company consistently aims to deliver delicious, healthy and affordable food to consumers while working hard to find new ways to protect the ocean and those that rely on it. Bumble Bee is firmly anchored in a commitment to connect the world to the ocean by re-defining sourcing, producing and enjoying products from and inspired by the ocean. Bumble Bees full line of seafood and specialty protein products are marketed in the U.S., Canada and over 50 markets globally under leading brands including Bumble Bee, Brunswick, Clover Leaf, Snows, Wild Selectionsand Beach Cliff. For more information about the company, visit TheBumbleBeeCompany.com. For product information, visit www.BumbleBee.com.
Answer:
|
The Bumble Bee Seafood Company Named A 2020 Top Workplace by the San Diego Union-Tribune
|
SAN DIEGO--(BUSINESS WIRE)--The Bumble Bee Seafood Company today announced that it has been awarded a 2020 Top Workplace honor by the San Diego Union-Tribune. Company employees cited strong values, a positive, friendly and motivating culture, and a passionate senior management team as key company attributes. The Union-Tribunes annual Top Workplaces list is based solely on employee feedback gathered through an anonymous survey administered by third-party research partner, Energage. Ninety-four percent of Bumble Bee employees participated in the survey, 17 percent higher than the industry average for food and beverage, as benchmarked by Energage. The highest-scored and most improved area was employee agreement with the statement I believe Bumble Bee is going in the right direction. Our employees are the epitome of what enables Bumble Bee to continue to be a thriving company even in this challenging environment, said Jan Tharp, President and Chief Executive Officer for The Bumble Bee Seafood Company. I am incredibly proud of our organization and very thankful to our employees for this recognition. The Union-Tribune award comes on the heels of a series of key announcements made by the iconic seafood brand over the past 12 months, including the sale of the company to long-time partner FCF CO., LTD., the announcement of a joint venture with Gathered Foods Corporation, a $40 million commitment to sustainability efforts, and a ground-breaking new television and digital advertising campaign known as Yes! Bumble Bee! The Bumble Bee Seafood Company employs more than 1,250 people, including nearly 120 at the San Diego headquarters. ABOUT THE BUMBLE BEE SEAFOOD COMPANY The Bumble Bee Seafood Company is passionately pursuing its purpose of feeding peoples lives through the power of the ocean. The iconic 120-year-old fishing company consistently aims to deliver delicious, healthy and affordable food to consumers while working hard to find new ways to protect the ocean and those that rely on it. Bumble Bee is firmly anchored in a commitment to connect the world to the ocean by re-defining sourcing, producing and enjoying products from and inspired by the ocean. Bumble Bees full line of seafood and specialty protein products are marketed in the U.S., Canada and over 50 markets globally under leading brands including Bumble Bee, Brunswick, Clover Leaf, Snows, Wild Selectionsand Beach Cliff. For more information about the company, visit TheBumbleBeeCompany.com. For product information, visit www.BumbleBee.com.
|
edtsum5776
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "CNG, RNG, and Hydrogen Tanks Market by Gas Type (CNG, RNG, Hydrogen), Material Type (Metal, Carbon, Glass), Tank Type (Type 1, Type 2, Type 3, Type 4), Application (Fuel, Transportation) and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global CNG, RNG, and hydrogen tanks market size is projected to grow from USD 1.8 billion in 2020 to USD 2.7 billion by 2025, at a compound annual growth rate (CAGR) of 8.1% between 2020 and 2025. CNG, RNG, and hydrogen tanks are durable, cheaper, and most importantly eco-friendly. It is used in various applications in the fuel tank, and transportation tank. CNG, RNG, and hydrogen tanks can be majorly classified into tank types, depending on the material used during manufacturing. However, the negative impact of the COVID-19 pandemic on the automotive industry has affected the CNG, RNG, and hydrogen tanks market adversely. "RNG gas is the fastest-growing segment in the CNG, RNG, and hydrogen tanks market in terms of both value and volume." RNG gas is projected to register the highest CAGR in terms of value between 2020 and 2025. RNG can be used as a transportation fuel in the form of compressed natural gas (CNG) or liquefied natural gas (LNG). RNG is qualified advanced biofuel under the Renewable Fuel Standard. RNG is widely used in transportation and fuel applications. Europe has the presence of various upgraded operating biogas plants, 195 in Germany, 92 in UK, 70 in Sweden, 44 in France, and 34 in Netherlands. "Metal is the largest material type of CNG, RNG, and hydrogen tanks in terms of value and volume." Various metals (steel, aluminum, and metal alloys) are used in manufacturing of CNG, RNG, and hydrogen tanks. Steel is used in Type 1, Type 2 & Type 3 cylinders. The metal used in CNG, RNG, and hydrogen tanks increases the weight of the CNG, RNG, and hydrogen cylinders but at the same time it provides adequate protection to the cylinders. For metal and metal-lined cylinders, the life cycle of these depends on the rate of fatigue crack growth "Type 1 tank is the largest used tank type of CNG, RNG, and hydrogen tanks in terms of both value and volume." Type 1 CNG, RNG, and hydrogen tanks are entirely made from metal made either from steel or aluminum and are designed in the shape of cylinders. These cylinders are seamless steel cylinders are used for the storage of CNG, RNG, and hydrogen on vehicles. The production cost for Type 1 CNG, RNG, and hydrogen cylinders tank is comparatively lower which makes these cylinders affordable and cost-effective. "Fuel tank is the largest application of CNG, RNG, and hydrogen tanks in terms of both value and volume." CNG, RNG, and hydrogen are widely used in fuel tank application. The fuel tank is an alternative fuel for the automobiles running on petrol and diesel. The various advantages of CNG, RNG, and hydrogen fuel tank being extremely durable, cheaper, emission of lesser CO2 has increased the demand for these fuel tanks in automotive industry. The natural gas fuel tank driven vehicles are cheaper compared to the diesel-driven cars. The fuel tanks These tanks are widely used in Light-duty vehicles, Medium-duty vehicles, and Heavy-duty vehicles. "APAC is the leading CNG, RNG, and hydrogen tanks market in terms of both value and volume." APAC is the largest CNG, RNG, and hydrogen tanks market in terms of both value and volume. The growth of the CNG, RNG, and hydrogen tanks market in APAC is driven by its increasing consumption in various applications, such as transportation tanks, and fuel tanks. This is because of the high industrial growth in countries, such as China, India, Pakistan, and Thailand. China has become the largest consumer of CNG, RNG, and hydrogen tanks in the automobile sector and is expected to strengthen its position further. The high focus of Indian and Chinese government on reducing air pollution by promoting the use of natural gas vehicles is driving the growth of the CNG, RNG, and hydrogen tanks market in these countries. APAC governments are focusing on increasing the use of alternative fuels and reducing emissions in cities, which is expected to help in the growth CNG, RNG, and hydrogen tanks market in the region. The key reason for this growth includes the demand for.(MEA)-10%, Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 CNG, RNG, and Hydrogen Tanks Market, by Gas Type 7 CNG, RNG, and Hydrogen Tanks Market, by Material 8 CNG, RNG, and Hydrogen Tanks Market, by Tank Type 9 CNG, RNG, and Hydrogen Tanks Market, by Application 10 CNG, RNG, and Hydrogen Tanks Market, by Region 11 Competitive Landscape 12 Company Profiles Other Companies For more information about this report visit https://www.researchandmarkets.com/r/u9ezho
Answer:
|
Global CNG, RNG, and Hydrogen Tanks Markets, 2020-2025 by Material Type (Metal, Carbon, Glass), Tank Type (Type 1, Type 2, Type 3, Type 4), & Application (Fuel, Transportation) - ResearchAndMarkets.com
|
DUBLIN--(BUSINESS WIRE)--The "CNG, RNG, and Hydrogen Tanks Market by Gas Type (CNG, RNG, Hydrogen), Material Type (Metal, Carbon, Glass), Tank Type (Type 1, Type 2, Type 3, Type 4), Application (Fuel, Transportation) and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global CNG, RNG, and hydrogen tanks market size is projected to grow from USD 1.8 billion in 2020 to USD 2.7 billion by 2025, at a compound annual growth rate (CAGR) of 8.1% between 2020 and 2025. CNG, RNG, and hydrogen tanks are durable, cheaper, and most importantly eco-friendly. It is used in various applications in the fuel tank, and transportation tank. CNG, RNG, and hydrogen tanks can be majorly classified into tank types, depending on the material used during manufacturing. However, the negative impact of the COVID-19 pandemic on the automotive industry has affected the CNG, RNG, and hydrogen tanks market adversely. "RNG gas is the fastest-growing segment in the CNG, RNG, and hydrogen tanks market in terms of both value and volume." RNG gas is projected to register the highest CAGR in terms of value between 2020 and 2025. RNG can be used as a transportation fuel in the form of compressed natural gas (CNG) or liquefied natural gas (LNG). RNG is qualified advanced biofuel under the Renewable Fuel Standard. RNG is widely used in transportation and fuel applications. Europe has the presence of various upgraded operating biogas plants, 195 in Germany, 92 in UK, 70 in Sweden, 44 in France, and 34 in Netherlands. "Metal is the largest material type of CNG, RNG, and hydrogen tanks in terms of value and volume." Various metals (steel, aluminum, and metal alloys) are used in manufacturing of CNG, RNG, and hydrogen tanks. Steel is used in Type 1, Type 2 & Type 3 cylinders. The metal used in CNG, RNG, and hydrogen tanks increases the weight of the CNG, RNG, and hydrogen cylinders but at the same time it provides adequate protection to the cylinders. For metal and metal-lined cylinders, the life cycle of these depends on the rate of fatigue crack growth "Type 1 tank is the largest used tank type of CNG, RNG, and hydrogen tanks in terms of both value and volume." Type 1 CNG, RNG, and hydrogen tanks are entirely made from metal made either from steel or aluminum and are designed in the shape of cylinders. These cylinders are seamless steel cylinders are used for the storage of CNG, RNG, and hydrogen on vehicles. The production cost for Type 1 CNG, RNG, and hydrogen cylinders tank is comparatively lower which makes these cylinders affordable and cost-effective. "Fuel tank is the largest application of CNG, RNG, and hydrogen tanks in terms of both value and volume." CNG, RNG, and hydrogen are widely used in fuel tank application. The fuel tank is an alternative fuel for the automobiles running on petrol and diesel. The various advantages of CNG, RNG, and hydrogen fuel tank being extremely durable, cheaper, emission of lesser CO2 has increased the demand for these fuel tanks in automotive industry. The natural gas fuel tank driven vehicles are cheaper compared to the diesel-driven cars. The fuel tanks These tanks are widely used in Light-duty vehicles, Medium-duty vehicles, and Heavy-duty vehicles. "APAC is the leading CNG, RNG, and hydrogen tanks market in terms of both value and volume." APAC is the largest CNG, RNG, and hydrogen tanks market in terms of both value and volume. The growth of the CNG, RNG, and hydrogen tanks market in APAC is driven by its increasing consumption in various applications, such as transportation tanks, and fuel tanks. This is because of the high industrial growth in countries, such as China, India, Pakistan, and Thailand. China has become the largest consumer of CNG, RNG, and hydrogen tanks in the automobile sector and is expected to strengthen its position further. The high focus of Indian and Chinese government on reducing air pollution by promoting the use of natural gas vehicles is driving the growth of the CNG, RNG, and hydrogen tanks market in these countries. APAC governments are focusing on increasing the use of alternative fuels and reducing emissions in cities, which is expected to help in the growth CNG, RNG, and hydrogen tanks market in the region. The key reason for this growth includes the demand for.(MEA)-10%, Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 CNG, RNG, and Hydrogen Tanks Market, by Gas Type 7 CNG, RNG, and Hydrogen Tanks Market, by Material 8 CNG, RNG, and Hydrogen Tanks Market, by Tank Type 9 CNG, RNG, and Hydrogen Tanks Market, by Application 10 CNG, RNG, and Hydrogen Tanks Market, by Region 11 Competitive Landscape 12 Company Profiles Other Companies For more information about this report visit https://www.researchandmarkets.com/r/u9ezho
|
edtsum5783
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LAVAL, Quebec, Jan. 27, 2021 /PRNewswire/ --Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its fourth-quarter and full-year 2020 financial results on Wednesday, Feb. 24, 2021. Bausch Health will host a conference call and live web cast at 8:00 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call. Conference Call Details Date: Wednesday, Feb. 24, 2021 Time: 8:00 a.m. ET Webcast: http://ir.bauschhealth.com/events-and-presentations Participant Event Dial-in: +1 (888) 317-6003 (United States) +1 (412) 317-6061 (International) +1 (866) 284-3684 (Canada) Participant Passcode: 2735891 Replay Dial-in: +1 (877) 344-7529 (United States) +1 (412) 317-0088 (International) +1 (855) 669-9658 (Canada) Replay Passcode: 10150375 (replay available until March 3, 2021) About Bausch HealthBausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com. Investor Contact: Media Contact: Arthur Shannon Lainie Keller [emailprotected] [emailprotected] (514) 856-3855 (908) 927-1198 (877) 281-6642 (toll free) SOURCE Bausch Health Companies Inc.
Answer:
|
Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2020 Financial Results On February 24
|
LAVAL, Quebec, Jan. 27, 2021 /PRNewswire/ --Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its fourth-quarter and full-year 2020 financial results on Wednesday, Feb. 24, 2021. Bausch Health will host a conference call and live web cast at 8:00 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call. Conference Call Details Date: Wednesday, Feb. 24, 2021 Time: 8:00 a.m. ET Webcast: http://ir.bauschhealth.com/events-and-presentations Participant Event Dial-in: +1 (888) 317-6003 (United States) +1 (412) 317-6061 (International) +1 (866) 284-3684 (Canada) Participant Passcode: 2735891 Replay Dial-in: +1 (877) 344-7529 (United States) +1 (412) 317-0088 (International) +1 (855) 669-9658 (Canada) Replay Passcode: 10150375 (replay available until March 3, 2021) About Bausch HealthBausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com. Investor Contact: Media Contact: Arthur Shannon Lainie Keller [emailprotected] [emailprotected] (514) 856-3855 (908) 927-1198 (877) 281-6642 (toll free) SOURCE Bausch Health Companies Inc.
|
edtsum5784
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), will announce its fourth-quarter and full-year 2020 financial results before the market opens on Wednesday, February 10, 2021. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to the event and view the presentation slides via webcast, join from the IQVIA Investor Relations website at http://ir.iqvia.com. To participate in the conference call, interested parties must register in advance by clicking on this link. Following registration, participants will receive a confirmation email containing details on how to join the conference call, including the dial-in and a unique passcode and registrant ID. At the time of the live event, registered participants connect to the call using the information provided in the confirmation email and will be placed directly into the call. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the webcast recording, visit http://ir.iqvia.com. About IQVIA IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIAs insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. IQVIAFIN
Answer:
|
IQVIA to Announce Fourth-Quarter and Full-Year 2020 Results on February 10, 2021
|
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), will announce its fourth-quarter and full-year 2020 financial results before the market opens on Wednesday, February 10, 2021. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to the event and view the presentation slides via webcast, join from the IQVIA Investor Relations website at http://ir.iqvia.com. To participate in the conference call, interested parties must register in advance by clicking on this link. Following registration, participants will receive a confirmation email containing details on how to join the conference call, including the dial-in and a unique passcode and registrant ID. At the time of the live event, registered participants connect to the call using the information provided in the confirmation email and will be placed directly into the call. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the webcast recording, visit http://ir.iqvia.com. About IQVIA IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIAs insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. IQVIAFIN
|
edtsum5785
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Global Filter Regulator Market by Type, by Application, by Geographic Scope And Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The global filter regulator market was valued at USD 6.91 Billion in 2019 and is projected to reach USD 10.12 Billion by 2027, growing at a CAGR of 4.89% from 2020 to 2027. Downtime in the industrial plant is very expensive; most of the time it is the outcome of the contaminated & very poorly maintained compressed air systems. Filter regulators are also used to address the Oil and Gas industry's specific need for the robust performance and also at the same time minimizing the energy cost and the downtime. Therefore, the growing demand for the global oil & gas industry is expected to drive the market for filter regulators. The Global Filter Regulators market is segmented on the basis of type, application, and geography. On the basis of end-use industry, the market is bifurcated into Oil & Gas, Chemical, Process and Industrial, Water & Wastewater and Others. The major key players in the Filter Regulator Market are ARO, Aventics, AVS Group, Easto Pneumatic Private Limited, Norgren, Parker Hannifin, Pneumatic Components Limited (PCL), Reed Manufacturing, Rotex Automation Limited, XMC Pneumatic. Key Topics Covered: 1 Introduction of Global Filter Regulator Market 2 Executive Summary 3 Research Methodology 4 Global Filter Regulator Market Outlook 4.1 Overview 4.2 Market Dynamics 4.3 Porters Five Force Model 5 Global Filter Regulator Market, by Type 5.1 Overview 5.2 Filter 5.3 Regulator 5.4 Lubricator 6 Global Filter Regulator Market, by Application 6.1 Overview 6.2 Oil & Gas 6.3 Food & Beverage 6.4 Pharmaceutical 6.5 Automotive 6.6 Others 7 Global Filter Regulator Market, by Geography 8 Global Filter Regulator Market Competitive Landscape 8.1 Overview 8.2 Company Market Ranking 8.3 Key Development Strategies 9 Company Profiles 9.1 ARO 9.2 Aventics 9.3 AVS Group 9.4 Easto Pneumatic Private Limited 9.5 Norgren 9.6 Parker Hannifin 9.7 Pneumatic Components Limited (Pcl) 9.8 Reed Manufacturing 9.9 Rotex Automation Limited 9.10 XMC Pneumatic For more information about this report visit https://www.researchandmarkets.com/r/ifa04z About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Answer:
|
Global Filter Regulator Market Analysis and Forecast to 2026 - World Market Projected to Reach $10.12 Billion by 2027 - ResearchAndMarkets.com
|
DUBLIN--(BUSINESS WIRE)--The "Global Filter Regulator Market by Type, by Application, by Geographic Scope And Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The global filter regulator market was valued at USD 6.91 Billion in 2019 and is projected to reach USD 10.12 Billion by 2027, growing at a CAGR of 4.89% from 2020 to 2027. Downtime in the industrial plant is very expensive; most of the time it is the outcome of the contaminated & very poorly maintained compressed air systems. Filter regulators are also used to address the Oil and Gas industry's specific need for the robust performance and also at the same time minimizing the energy cost and the downtime. Therefore, the growing demand for the global oil & gas industry is expected to drive the market for filter regulators. The Global Filter Regulators market is segmented on the basis of type, application, and geography. On the basis of end-use industry, the market is bifurcated into Oil & Gas, Chemical, Process and Industrial, Water & Wastewater and Others. The major key players in the Filter Regulator Market are ARO, Aventics, AVS Group, Easto Pneumatic Private Limited, Norgren, Parker Hannifin, Pneumatic Components Limited (PCL), Reed Manufacturing, Rotex Automation Limited, XMC Pneumatic. Key Topics Covered: 1 Introduction of Global Filter Regulator Market 2 Executive Summary 3 Research Methodology 4 Global Filter Regulator Market Outlook 4.1 Overview 4.2 Market Dynamics 4.3 Porters Five Force Model 5 Global Filter Regulator Market, by Type 5.1 Overview 5.2 Filter 5.3 Regulator 5.4 Lubricator 6 Global Filter Regulator Market, by Application 6.1 Overview 6.2 Oil & Gas 6.3 Food & Beverage 6.4 Pharmaceutical 6.5 Automotive 6.6 Others 7 Global Filter Regulator Market, by Geography 8 Global Filter Regulator Market Competitive Landscape 8.1 Overview 8.2 Company Market Ranking 8.3 Key Development Strategies 9 Company Profiles 9.1 ARO 9.2 Aventics 9.3 AVS Group 9.4 Easto Pneumatic Private Limited 9.5 Norgren 9.6 Parker Hannifin 9.7 Pneumatic Components Limited (Pcl) 9.8 Reed Manufacturing 9.9 Rotex Automation Limited 9.10 XMC Pneumatic For more information about this report visit https://www.researchandmarkets.com/r/ifa04z About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
|
edtsum5792
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAVANNAH, Ga., Feb. 3, 2021 /PRNewswire/ --Red One Medical, a proven government contractor providing best-in-class medical supplies to the VA and DoD, has exclusively partnered with ALG Health one of the few face mask manufacturers in America. In 2020, Americans faced pandemic-related healthcare supply shortages unlike ever before. While retailers and distributors did their best to supply citizens with masks, 95 percent of surgical masks and 70 percent of respirators like N95 masks are made overseas, according to the US Department of Health and Human Services.* Continue Reading Red One Medical ALG Health ALG Health rose to the challenge, determined to shift manufacturing back to the US to meet rising demand. The company made a significant investment in their state-of-the art facility in Ohio, which is making N95 masks that are "100% Made in the USA" from start to finish and approved by the National Institute for Occupational Safety and Health (NIOSH). The company recently received FDA-approval for their foldable N95 to be used as a surgical mask. They're scaling rapidlyand at full capacitywill be able to produce 1 million masks/day. Red One Medical will provide these masks, which meet Buy American and Berry Amendment mandates, to America's veterans and military service members. "We're proud to partner with Red Onea leading government contractor," said Adam Harmon, ALG Health's President and CEO. "Together, we're committed to providing better access to N95 NIOSH-approved respirators that are 100% US-made and Berry Amendment-compliant."ALG Health is creating much-needed manufacturing jobs in NW Ohio that "help local residents rebuild their families and future," said Doug Soper, ALG Health's VP of Sales and Distribution. The company is committed to serving underserved and at-risk local communities. "Red One is excited to team with a company whose vision of 'protecting those who protect us' aligns with our core values," said Red One's CEO Charles Pollak. "ALG Health is a reliable, scalable source of American-made masks for the VA healthcare workers who need them."In 2020, Red One Medical donated 10,000 KN95 face masks to VA hospitals to support healthcare workers, veterans and their families. The company also partnered with Maersk to deliver mission critical medical supplies to help combat COVID-19, including delivering 29 million masks to the government of Alberta, Canada, which distributed the masks to its citizens for free. About ALG HealthALG Health's state-of-the-art manufacturing facility in Bryan, Ohio makes 100% Made in the USA NIOSH-approved N95 masks. In 2020, the COVID-19 epidemic exposed a huge shortage of personal protective equipment (PPE) in the US, especially high quality, American-made PPE. We saw the need and rose to the challenge, determined to change the future of PPE manufacturing in America. We're proud to serve the American medical community, first responders, military, government, schools, volunteers, and fellow US manufacturers.About Red One MedicalRed One Medicalidentifies and delivers advanced medical and pharmaceutical technologies that transform care for America's veterans and military service members. Located in Savannah, GA, Red One Medical is a CVE-certified Service Disabled Veteran Owned Business (SDVOSB).It donates a portion of profits to charities that support veterans, military families and their communities.*Source: How Decades of Offshoring Led to a Mask Shortage in a Pandemic by Tim Simonite, Wired. March 29, 2020. https://www.wired.com/story/decades-offshoring-led-mask-shortage-pandemic/Contact:Rachael Post, Red One Medical[emailprotected]917-757-5841SOURCE Red One Medical Related Links https://redonemedical.com
Answer:
|
Red One Medical Partners with ALG Health to Provide 100% Made in the USA N95 NIOSH-Approved Face Masks to Veterans and Military Service Members
|
SAVANNAH, Ga., Feb. 3, 2021 /PRNewswire/ --Red One Medical, a proven government contractor providing best-in-class medical supplies to the VA and DoD, has exclusively partnered with ALG Health one of the few face mask manufacturers in America. In 2020, Americans faced pandemic-related healthcare supply shortages unlike ever before. While retailers and distributors did their best to supply citizens with masks, 95 percent of surgical masks and 70 percent of respirators like N95 masks are made overseas, according to the US Department of Health and Human Services.* Continue Reading Red One Medical ALG Health ALG Health rose to the challenge, determined to shift manufacturing back to the US to meet rising demand. The company made a significant investment in their state-of-the art facility in Ohio, which is making N95 masks that are "100% Made in the USA" from start to finish and approved by the National Institute for Occupational Safety and Health (NIOSH). The company recently received FDA-approval for their foldable N95 to be used as a surgical mask. They're scaling rapidlyand at full capacitywill be able to produce 1 million masks/day. Red One Medical will provide these masks, which meet Buy American and Berry Amendment mandates, to America's veterans and military service members. "We're proud to partner with Red Onea leading government contractor," said Adam Harmon, ALG Health's President and CEO. "Together, we're committed to providing better access to N95 NIOSH-approved respirators that are 100% US-made and Berry Amendment-compliant."ALG Health is creating much-needed manufacturing jobs in NW Ohio that "help local residents rebuild their families and future," said Doug Soper, ALG Health's VP of Sales and Distribution. The company is committed to serving underserved and at-risk local communities. "Red One is excited to team with a company whose vision of 'protecting those who protect us' aligns with our core values," said Red One's CEO Charles Pollak. "ALG Health is a reliable, scalable source of American-made masks for the VA healthcare workers who need them."In 2020, Red One Medical donated 10,000 KN95 face masks to VA hospitals to support healthcare workers, veterans and their families. The company also partnered with Maersk to deliver mission critical medical supplies to help combat COVID-19, including delivering 29 million masks to the government of Alberta, Canada, which distributed the masks to its citizens for free. About ALG HealthALG Health's state-of-the-art manufacturing facility in Bryan, Ohio makes 100% Made in the USA NIOSH-approved N95 masks. In 2020, the COVID-19 epidemic exposed a huge shortage of personal protective equipment (PPE) in the US, especially high quality, American-made PPE. We saw the need and rose to the challenge, determined to change the future of PPE manufacturing in America. We're proud to serve the American medical community, first responders, military, government, schools, volunteers, and fellow US manufacturers.About Red One MedicalRed One Medicalidentifies and delivers advanced medical and pharmaceutical technologies that transform care for America's veterans and military service members. Located in Savannah, GA, Red One Medical is a CVE-certified Service Disabled Veteran Owned Business (SDVOSB).It donates a portion of profits to charities that support veterans, military families and their communities.*Source: How Decades of Offshoring Led to a Mask Shortage in a Pandemic by Tim Simonite, Wired. March 29, 2020. https://www.wired.com/story/decades-offshoring-led-mask-shortage-pandemic/Contact:Rachael Post, Red One Medical[emailprotected]917-757-5841SOURCE Red One Medical Related Links https://redonemedical.com
|
edtsum5802
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, Feb. 3, 2021 /PRNewswire/ -- Veea Inc., a pioneer in smart edge connectivity and computing, announced today that they have entered into an agreement with Realty Times, Inc. and Bring It Home Communities to co-develop and co-market edge-powered solutions for the real estate industry. In almost every real estate transaction, agents must communicate with buyers, sellers, lenders, lawyers, inspectors, and government workers. Dozens and dozens of pages of documents must be signed and managed. The pandemic has essentially changed our expectations of how people and businesses operate, creating substantial challenges for real estate brokers and agents and opportunities for those willing to embrace virtual operations. Real-estate firms and their agents need a virtual office with comprehensive, secure, reliable, and flexible communications within an environment that supports their activities while also providing tangible customer benefits that set them apart from legacy real-estate operators. The edge computing-based solution will support new, virtualized capabilities such as virtual meetings for brokers, agents, and clients; virtual tours and virtual open houses with augmented reality capabilities that enable buyers to see properties like they are physically there on a variety of devices such as smartphones, tablets, laptops and desktops; rich media advertising by firms that want to reach home buyers supported by Veea's AdEdge advertising platform; and support for online learning and certification for agents and brokers. "This solution provides tremendous value to the entire real estate community," said John Giaimo, CEO of Bring it Home Communities, Inc, and Realty Times. "It helps local realtors and brokers easily service buyers and sellers virtually, yet with the all-important personal touch." Real estate offices in key markets will begin participating in pilot tests beginning in March. "VeeaHub Smart Edge Nodes integrate the secure connectivity, application processing power, and simplicity required to support virtual offices that can easily be deployed and centrally managed from the cloud," said Mark Tubinis, Veea's Chief Commercial Officer. "The solution is perfect for creating Virtual Real Estate offices that need to satisfy the demands of renters, buyers, sellers, lenders, lawyers, and anyone else that influences property transactions". About Veea, Inc. Veea is redefining and simplifying highly secure edge computing while improving application responsiveness, reducing bandwidth costs and overcoming central cloud dependency and latency. VeeaHub Smart Edge Nodes integrate a full range of connectivity solutions, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud. Veea's Edge Services run across this application mesh to deliver secure remote access, IoT/IIoT/AIoT, and a wide range of smart applications. These elements comprise the Veea Edge Platform, serving the needs of a large number of enterprise and public customers ranging from Secure Access Service Edge (SASE)-basedwork or study from home, Smart Buildings, Smart Energy, Smart Cities, Smart Construction, Smart Farming to Smart Retail. For more information, visit www.veea.com.Follow us on TwitterandLinkedIn.Embrace Your Edge About Bring it Home Communities Bring it Home community portals provide local real estate listings, articles, lifestyle and content specific to the community. Proudly supporting local businesses through the Bring it Home Ad Network, powered by Ad Persistence Visit https://bringithomecommunities.com/ About Realty Times One of America's largest and most trusted real estate news organizations, Realty Times has connected buyers, sellers, brokers and agents with everything real estate related. Visit http://www.RealtyTimes.com/ SOURCE Veea Inc. Related Links www.veea.com
Answer:
|
Veea Collaborates with Bring It Home Communities and Realty Times to Develop Virtual Offices for Real Estate Agents and Brokers
|
NEW YORK, Feb. 3, 2021 /PRNewswire/ -- Veea Inc., a pioneer in smart edge connectivity and computing, announced today that they have entered into an agreement with Realty Times, Inc. and Bring It Home Communities to co-develop and co-market edge-powered solutions for the real estate industry. In almost every real estate transaction, agents must communicate with buyers, sellers, lenders, lawyers, inspectors, and government workers. Dozens and dozens of pages of documents must be signed and managed. The pandemic has essentially changed our expectations of how people and businesses operate, creating substantial challenges for real estate brokers and agents and opportunities for those willing to embrace virtual operations. Real-estate firms and their agents need a virtual office with comprehensive, secure, reliable, and flexible communications within an environment that supports their activities while also providing tangible customer benefits that set them apart from legacy real-estate operators. The edge computing-based solution will support new, virtualized capabilities such as virtual meetings for brokers, agents, and clients; virtual tours and virtual open houses with augmented reality capabilities that enable buyers to see properties like they are physically there on a variety of devices such as smartphones, tablets, laptops and desktops; rich media advertising by firms that want to reach home buyers supported by Veea's AdEdge advertising platform; and support for online learning and certification for agents and brokers. "This solution provides tremendous value to the entire real estate community," said John Giaimo, CEO of Bring it Home Communities, Inc, and Realty Times. "It helps local realtors and brokers easily service buyers and sellers virtually, yet with the all-important personal touch." Real estate offices in key markets will begin participating in pilot tests beginning in March. "VeeaHub Smart Edge Nodes integrate the secure connectivity, application processing power, and simplicity required to support virtual offices that can easily be deployed and centrally managed from the cloud," said Mark Tubinis, Veea's Chief Commercial Officer. "The solution is perfect for creating Virtual Real Estate offices that need to satisfy the demands of renters, buyers, sellers, lenders, lawyers, and anyone else that influences property transactions". About Veea, Inc. Veea is redefining and simplifying highly secure edge computing while improving application responsiveness, reducing bandwidth costs and overcoming central cloud dependency and latency. VeeaHub Smart Edge Nodes integrate a full range of connectivity solutions, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud. Veea's Edge Services run across this application mesh to deliver secure remote access, IoT/IIoT/AIoT, and a wide range of smart applications. These elements comprise the Veea Edge Platform, serving the needs of a large number of enterprise and public customers ranging from Secure Access Service Edge (SASE)-basedwork or study from home, Smart Buildings, Smart Energy, Smart Cities, Smart Construction, Smart Farming to Smart Retail. For more information, visit www.veea.com.Follow us on TwitterandLinkedIn.Embrace Your Edge About Bring it Home Communities Bring it Home community portals provide local real estate listings, articles, lifestyle and content specific to the community. Proudly supporting local businesses through the Bring it Home Ad Network, powered by Ad Persistence Visit https://bringithomecommunities.com/ About Realty Times One of America's largest and most trusted real estate news organizations, Realty Times has connected buyers, sellers, brokers and agents with everything real estate related. Visit http://www.RealtyTimes.com/ SOURCE Veea Inc. Related Links www.veea.com
|
edtsum5820
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NORTH CHICAGO, Ill., Aug. 25, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has submitted an application for a new indication to the U.S. Food and Drug Administration (FDA) for RINVOQ (upadacitinib; 15 mg, once daily), a selective and reversible JAK inhibitor, for the treatment of adult patients with active ankylosing spondylitis. AbbVie also submitted an application to the European Medicines Agency (EMA) for RINVOQ earlier this year for the treatment of adult patients with active ankylosing spondylitis who have responded inadequately to conventional therapy. "Ankylosing spondylitis is a debilitating disease that can cause severe pain, restricted mobility and lasting structural damage. With limited treatment options, innovation is crucial to help more patients living with active ankylosing spondylitis reach their treatment goals," said Michael Severino, M.D., vice chairman and president, AbbVie. "RINVOQ has the potential to improve care by helping to provide disease control, addressing pain and improving function. We look forward to working with regulatory authorities and hope to bring this important treatment option to patients." The applications to the FDA and EMA are supported by data from SELECT-AXIS 1, a Phase 2/3 study in which RINVOQ demonstrated significant improvements in signs and symptoms in patients with active ankylosing spondylitis.1 In this study, twice as many patients receiving RINVOQ (52 percent) met the primary endpoint of Assessment of SpondyloArthritis International Society (ASAS) 40 response versus placebo (26 percent) at week 14 (p<0.001).1 The safety profile of RINVOQ in ankylosing spondylitis was consistent with previously reported studies across therapeutic areas, including rheumatoid arthritis, atopic dermatitis and psoriatic arthritis, with no new significant safety risks detected.2-4 Ankylosing spondylitis is a chronic, progressive, inflammatory musculoskeletal disease impacting more than five million people worldwide.5,6 The range of symptoms pose significant physical, psychological and economic burden on individuals impacted by the disease.5,7-9 About RINVOQ (upadacitinib) Discovered and developed by AbbVie scientists, RINVOQ is a selective and reversible JAK inhibitor that is being studied in several immune-mediated inflammatory diseases.10-17 In August 2019, RINVOQ received U.S. FDA approval for adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. In December 2019, RINVOQ was approved by the European Commission for the treatment of adult patients with moderate to severe active rheumatoid arthritis who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. The approved dose for RINVOQ in rheumatoid arthritis is 15 mg. Phase 3 trials of RINVOQ in psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, Crohn's disease, atopic dermatitis, ulcerative colitis and giant cell arteritis are ongoing.12-17 Use of RINVOQ in ankylosing spondylitis is not approved and its safety and efficacy have not been established by regulatory authorities. Important Safety Information about RINVOQ (upadacitinib)18 RINVOQ is a prescription medicine used to treat adults with moderate to severe rheumatoid arthritis in whom methotrexate did not work well or could not be tolerated. It is not known if RINVOQ is safe and effective in children under 18 years of age. What is the most important information I should know about RINVOQ?RINVOQ is a medicine that can lower the ability of your immune system to fight infections. You should not start taking RINVOQ if you have any kind of infection unless your healthcare provider (HCP) tells you it is okay. Serious infections have happened in some people taking RINVOQ, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections.Your HCP should test you for TB before starting RINVOQ and check you closely for signs and symptoms of TB during treatment with RINVOQ. You may be at higher risk of developing shingles (herpes zoster). Lymphoma and other cancers, including skin cancers, can happen in people taking RINVOQ. Blood clots in the veins of the legs or lungs and arteries are possible in some people taking RINVOQ. This may be life-threatening and cause death. Tears in the stomach or intestines and changes in certain laboratory tests can happen. Your HCP should do blood tests before you start taking RINVOQ and while you take it. Your HCP may stop your RINVOQ treatment for a period of time if needed because of changes in these blood test results. What should I tell my HCP BEFORE starting RINVOQ?Tell your HCP if you: Are being treated for an infection, have an infection that won't go away or keeps coming back, or have symptoms of an infection such as: Fever, sweating, or chills Shortness of breath Warm, red, or painful skin or sores on your body Muscle aches Feeling tired Blood in phlegm Diarrhea or stomach pain Cough Weight loss Burning when urinating or urinating more often than normal Have TB or have been in close contact with someone with TB. Have had any type of cancer, hepatitis B or C, shingles (herpes zoster), or blood clots in the veins of your legs or lungs, diverticulitis (inflammation in parts of the large intestine), or ulcers in your stomach or intestines. Have other medical conditions including liver problems, low blood cell counts, diabetes, chronic lung disease, HIV, or a weak immune system. Live, have lived, or have traveled to parts of the country that increase your risk of getting certain kinds of fungal infections, such as the Ohio and Mississippi River valleys and the Southwest. If you are unsure if you've been to these areas, ask your HCP. Have recently received or are scheduled to receive a vaccine. People who take RINVOQ should not receive live vaccines. Are pregnant or plan to become pregnant. Based on animal studies, RINVOQ may harm your unborn baby. Your HCP will check whether or not you are pregnant before you start RINVOQ. You should use effective birth control (contraception) to avoid becoming pregnant while taking RINVOQ and for at least 4 weeks after your last dose. Are breastfeeding or plan to breastfeed. RINVOQ may pass into your breast milk. You should not breastfeed while taking RINVOQ and for at least 6 days after your last dose. Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. RINVOQ and other medicines may affect each other, causing side effects. Especially tell your HCP if you take: Medicines for fungal or bacterial infections Rifampicin or phenytoin Medicines that affect your immune system Ask your HCP or pharmacist if you are not sure if you are taking any of these medicines. What should I tell my HCP AFTER starting RINVOQ?Tell your HCP right away if you: Have any symptoms of an infection. RINVOQ can make you more likely to get infections or make any infections you have worse. Have any signs or symptoms of blood clots during treatment with RINVOQ, including: Swelling Pain or tenderness in the leg Sudden unexplained chest pain Shortness of breath Have a fever or stomach-area pain that does not go away, and a change in your bowel habits. What are the common side effects of RINVOQ?These include: upper respiratory tract infections (common cold, sinus infections), nausea, cough, and fever. These are not all the possible side effects of RINVOQ. RINVOQ is taken once a day with or without food. Do not split, break, crush, or chew the tablet. Take RINVOQ exactly as your HCP tells you to use it. This is the most important information to know about RINVOQ. For more information, talk to your HCP. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more. Please click here for theFull Prescribing InformationandMedication Guide. Globally, prescribing information varies; refer to the individual country product label for complete information. About AbbVie in Rheumatology For more than 20 years, AbbVie has been dedicated to improving care for people living with rheumatic diseases. Our longstanding commitment to discovering and delivering transformative therapies is underscored by our pursuit of cutting-edge science that improves our understanding of promising new pathways and targets in order to help more people living with rheumatic diseases reach their treatment goals. For more information on AbbVie in rheumatology, visit https://www.abbvie.com/our-science/therapeutic-focus-areas/immunology/immunology-focus-areas/rheumatology.html. About AbbVie AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us atwww.abbvie.com. Follow @abbvie on Twitter,Facebook,Instagram,YouTubeandLinkedIn. Forward-Looking Statements Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "project" and similar expressions, among others, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, failure to realize the expected benefits from AbbVie's acquisition of Allergan plc ("Allergan"), failure to promptly and effectively integrate Allergan's businesses, competition from other products, challenges to intellectual property, difficulties inherent in the research and development process, adverse litigation or government action, changes to laws and regulations applicable to our industry and the impact of public health outbreaks, epidemics or pandemics, such as COVID-19. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2019 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its subsequent Quarterly Reports on Form 10-Q. AbbVie undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law. References: Van der Heijde D, et al. Efficacy and Safety of Upadacitinib in a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2/3 Clinical Study of Patients With Active Ankylosing Spondylitis. 2019 ACR/ARP; 2728. Cohen S, et al. Safety profile of upadacitinib in Rheumatoid Arthritis: Integrated analysis from the SELECT Phase 3 Clinical Program. EULAR 2019; THU0167. McInnes I, et al. Efficacy and Safety of Upadacitinib Versus Placebo and Adalimumab in Patients With Active Psoriatic Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Anti-Rheumatic Drugs (SELECT-PsA-1): a Double-Blind, Randomized Controlled Phase 3 Trial. 2020 EULAR E-Congress; LB0001. Guttman-Yassky, E et al. ePoster #P0236. 27th European Academy of Dermatology and Venerology (EADV) Congress. September 2018. Dean, LE, et al. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford). 2014 Apr;53(4):650-7. doi: 10.1093/rheumatology/ket387. Epub 2013 Dec 9. Sieper J, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002 Nov; 61(Suppl 3): iii8iii18. doi: 10.1136/ard.61.suppl_3.iii8. Ozgul, A., et al. Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clin Rheumatol. 2006 Mar;25(2):168-74. Epub 2005 Aug 10. Martindale, J., et al. Disease and psychological status in ankylosing spondylitis. Rheumatology (Oxford). 2006 Oct;45(10):1288-93. Epub 2006 Apr 4. Boonen, A., et al. The burden of ankylosing spondylitis. J Rheumatol Suppl. 2006 Sep;78:4-11. Pipeline Our Science | AbbVie. AbbVie. 2019. Available at:https://www.abbvie.com/our-science/pipeline.html. Accessed on August 17, 2020. Burmester G.R., et al. Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018 Jun 23;391(10139):2503-2512. doi: 10.1016/S0140-6736(18)31115-2. Epub 2018 Jun 18. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy. ClinicalTrials.gov. 2020. Available at:https://clinicaltrials.gov/ct2/show/NCT02365649. Accessed on August 17, 2020 A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis. ClinicalTrials.gov. 2020. Available at:https://clinicaltrials.gov/ct2/show/NCT02819635. Accessed on August 17, 2020. A Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects With Active Ankylosing Spondylitis (SELECT Axis 1). ClinicalTrials.gov. 2020. Available at:https://clinicaltrials.gov/ct2/show/study/NCT03178487. Accessed on August 17, 2020. A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis (SELECT-GCA). ClinicalTrials.gov. 2020. Available at:https://clinicaltrials.gov/ct2/show/NCT03725202. Accessed onAugust 17, 2020. A Study to Evaluate Upadacitinib in Adolescent and Adult Subjects With Moderate to Severe Atopic Dermatitis. ClinicalTrials.gov. 2020. Available at:https://clinicaltrials.gov/ct2/show/record/NCT03607422. Accessed onAugust 17, 2020. A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (SELECT - PsA 1). ClinicalTrials.gov. 2020. Available at: https://clinicaltrials.gov/ct2/show/NCT03104400. Accessed on August 17, 2020. RINVOQ (upadacitinib) [Package Insert]. North Chicago, Ill.: AbbVie Inc. SOURCE AbbVie Related Links abbvie.com
Answer:
|
AbbVie Submits Regulatory Application to FDA for RINVOQ (upadacitinib) for the Treatment of Adults with Active Ankylosing Spondylitis
|
NORTH CHICAGO, Ill., Aug. 25, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has submitted an application for a new indication to the U.S. Food and Drug Administration (FDA) for RINVOQ (upadacitinib; 15 mg, once daily), a selective and reversible JAK inhibitor, for the treatment of adult patients with active ankylosing spondylitis. AbbVie also submitted an application to the European Medicines Agency (EMA) for RINVOQ earlier this year for the treatment of adult patients with active ankylosing spondylitis who have responded inadequately to conventional therapy. "Ankylosing spondylitis is a debilitating disease that can cause severe pain, restricted mobility and lasting structural damage. With limited treatment options, innovation is crucial to help more patients living with active ankylosing spondylitis reach their treatment goals," said Michael Severino, M.D., vice chairman and president, AbbVie. "RINVOQ has the potential to improve care by helping to provide disease control, addressing pain and improving function. We look forward to working with regulatory authorities and hope to bring this important treatment option to patients." The applications to the FDA and EMA are supported by data from SELECT-AXIS 1, a Phase 2/3 study in which RINVOQ demonstrated significant improvements in signs and symptoms in patients with active ankylosing spondylitis.1 In this study, twice as many patients receiving RINVOQ (52 percent) met the primary endpoint of Assessment of SpondyloArthritis International Society (ASAS) 40 response versus placebo (26 percent) at week 14 (p<0.001).1 The safety profile of RINVOQ in ankylosing spondylitis was consistent with previously reported studies across therapeutic areas, including rheumatoid arthritis, atopic dermatitis and psoriatic arthritis, with no new significant safety risks detected.2-4 Ankylosing spondylitis is a chronic, progressive, inflammatory musculoskeletal disease impacting more than five million people worldwide.5,6 The range of symptoms pose significant physical, psychological and economic burden on individuals impacted by the disease.5,7-9 About RINVOQ (upadacitinib) Discovered and developed by AbbVie scientists, RINVOQ is a selective and reversible JAK inhibitor that is being studied in several immune-mediated inflammatory diseases.10-17 In August 2019, RINVOQ received U.S. FDA approval for adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. In December 2019, RINVOQ was approved by the European Commission for the treatment of adult patients with moderate to severe active rheumatoid arthritis who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. The approved dose for RINVOQ in rheumatoid arthritis is 15 mg. Phase 3 trials of RINVOQ in psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, Crohn's disease, atopic dermatitis, ulcerative colitis and giant cell arteritis are ongoing.12-17 Use of RINVOQ in ankylosing spondylitis is not approved and its safety and efficacy have not been established by regulatory authorities. Important Safety Information about RINVOQ (upadacitinib)18 RINVOQ is a prescription medicine used to treat adults with moderate to severe rheumatoid arthritis in whom methotrexate did not work well or could not be tolerated. It is not known if RINVOQ is safe and effective in children under 18 years of age. What is the most important information I should know about RINVOQ?RINVOQ is a medicine that can lower the ability of your immune system to fight infections. You should not start taking RINVOQ if you have any kind of infection unless your healthcare provider (HCP) tells you it is okay. Serious infections have happened in some people taking RINVOQ, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections.Your HCP should test you for TB before starting RINVOQ and check you closely for signs and symptoms of TB during treatment with RINVOQ. You may be at higher risk of developing shingles (herpes zoster). Lymphoma and other cancers, including skin cancers, can happen in people taking RINVOQ. Blood clots in the veins of the legs or lungs and arteries are possible in some people taking RINVOQ. This may be life-threatening and cause death. Tears in the stomach or intestines and changes in certain laboratory tests can happen. Your HCP should do blood tests before you start taking RINVOQ and while you take it. Your HCP may stop your RINVOQ treatment for a period of time if needed because of changes in these blood test results. What should I tell my HCP BEFORE starting RINVOQ?Tell your HCP if you: Are being treated for an infection, have an infection that won't go away or keeps coming back, or have symptoms of an infection such as: Fever, sweating, or chills Shortness of breath Warm, red, or painful skin or sores on your body Muscle aches Feeling tired Blood in phlegm Diarrhea or stomach pain Cough Weight loss Burning when urinating or urinating more often than normal Have TB or have been in close contact with someone with TB. Have had any type of cancer, hepatitis B or C, shingles (herpes zoster), or blood clots in the veins of your legs or lungs, diverticulitis (inflammation in parts of the large intestine), or ulcers in your stomach or intestines. Have other medical conditions including liver problems, low blood cell counts, diabetes, chronic lung disease, HIV, or a weak immune system. Live, have lived, or have traveled to parts of the country that increase your risk of getting certain kinds of fungal infections, such as the Ohio and Mississippi River valleys and the Southwest. If you are unsure if you've been to these areas, ask your HCP. Have recently received or are scheduled to receive a vaccine. People who take RINVOQ should not receive live vaccines. Are pregnant or plan to become pregnant. Based on animal studies, RINVOQ may harm your unborn baby. Your HCP will check whether or not you are pregnant before you start RINVOQ. You should use effective birth control (contraception) to avoid becoming pregnant while taking RINVOQ and for at least 4 weeks after your last dose. Are breastfeeding or plan to breastfeed. RINVOQ may pass into your breast milk. You should not breastfeed while taking RINVOQ and for at least 6 days after your last dose. Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. RINVOQ and other medicines may affect each other, causing side effects. Especially tell your HCP if you take: Medicines for fungal or bacterial infections Rifampicin or phenytoin Medicines that affect your immune system Ask your HCP or pharmacist if you are not sure if you are taking any of these medicines. What should I tell my HCP AFTER starting RINVOQ?Tell your HCP right away if you: Have any symptoms of an infection. RINVOQ can make you more likely to get infections or make any infections you have worse. Have any signs or symptoms of blood clots during treatment with RINVOQ, including: Swelling Pain or tenderness in the leg Sudden unexplained chest pain Shortness of breath Have a fever or stomach-area pain that does not go away, and a change in your bowel habits. What are the common side effects of RINVOQ?These include: upper respiratory tract infections (common cold, sinus infections), nausea, cough, and fever. These are not all the possible side effects of RINVOQ. RINVOQ is taken once a day with or without food. Do not split, break, crush, or chew the tablet. Take RINVOQ exactly as your HCP tells you to use it. This is the most important information to know about RINVOQ. For more information, talk to your HCP. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more. Please click here for theFull Prescribing InformationandMedication Guide. Globally, prescribing information varies; refer to the individual country product label for complete information. About AbbVie in Rheumatology For more than 20 years, AbbVie has been dedicated to improving care for people living with rheumatic diseases. Our longstanding commitment to discovering and delivering transformative therapies is underscored by our pursuit of cutting-edge science that improves our understanding of promising new pathways and targets in order to help more people living with rheumatic diseases reach their treatment goals. For more information on AbbVie in rheumatology, visit https://www.abbvie.com/our-science/therapeutic-focus-areas/immunology/immunology-focus-areas/rheumatology.html. About AbbVie AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us atwww.abbvie.com. Follow @abbvie on Twitter,Facebook,Instagram,YouTubeandLinkedIn. Forward-Looking Statements Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "project" and similar expressions, among others, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, failure to realize the expected benefits from AbbVie's acquisition of Allergan plc ("Allergan"), failure to promptly and effectively integrate Allergan's businesses, competition from other products, challenges to intellectual property, difficulties inherent in the research and development process, adverse litigation or government action, changes to laws and regulations applicable to our industry and the impact of public health outbreaks, epidemics or pandemics, such as COVID-19. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2019 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its subsequent Quarterly Reports on Form 10-Q. AbbVie undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law. References: Van der Heijde D, et al. Efficacy and Safety of Upadacitinib in a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2/3 Clinical Study of Patients With Active Ankylosing Spondylitis. 2019 ACR/ARP; 2728. Cohen S, et al. Safety profile of upadacitinib in Rheumatoid Arthritis: Integrated analysis from the SELECT Phase 3 Clinical Program. EULAR 2019; THU0167. McInnes I, et al. Efficacy and Safety of Upadacitinib Versus Placebo and Adalimumab in Patients With Active Psoriatic Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Anti-Rheumatic Drugs (SELECT-PsA-1): a Double-Blind, Randomized Controlled Phase 3 Trial. 2020 EULAR E-Congress; LB0001. Guttman-Yassky, E et al. ePoster #P0236. 27th European Academy of Dermatology and Venerology (EADV) Congress. September 2018. Dean, LE, et al. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford). 2014 Apr;53(4):650-7. doi: 10.1093/rheumatology/ket387. Epub 2013 Dec 9. Sieper J, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002 Nov; 61(Suppl 3): iii8iii18. doi: 10.1136/ard.61.suppl_3.iii8. Ozgul, A., et al. Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clin Rheumatol. 2006 Mar;25(2):168-74. Epub 2005 Aug 10. Martindale, J., et al. Disease and psychological status in ankylosing spondylitis. Rheumatology (Oxford). 2006 Oct;45(10):1288-93. Epub 2006 Apr 4. Boonen, A., et al. The burden of ankylosing spondylitis. J Rheumatol Suppl. 2006 Sep;78:4-11. Pipeline Our Science | AbbVie. AbbVie. 2019. Available at:https://www.abbvie.com/our-science/pipeline.html. Accessed on August 17, 2020. Burmester G.R., et al. Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018 Jun 23;391(10139):2503-2512. doi: 10.1016/S0140-6736(18)31115-2. Epub 2018 Jun 18. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy. ClinicalTrials.gov. 2020. Available at:https://clinicaltrials.gov/ct2/show/NCT02365649. Accessed on August 17, 2020 A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis. ClinicalTrials.gov. 2020. Available at:https://clinicaltrials.gov/ct2/show/NCT02819635. Accessed on August 17, 2020. A Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects With Active Ankylosing Spondylitis (SELECT Axis 1). ClinicalTrials.gov. 2020. Available at:https://clinicaltrials.gov/ct2/show/study/NCT03178487. Accessed on August 17, 2020. A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis (SELECT-GCA). ClinicalTrials.gov. 2020. Available at:https://clinicaltrials.gov/ct2/show/NCT03725202. Accessed onAugust 17, 2020. A Study to Evaluate Upadacitinib in Adolescent and Adult Subjects With Moderate to Severe Atopic Dermatitis. ClinicalTrials.gov. 2020. Available at:https://clinicaltrials.gov/ct2/show/record/NCT03607422. Accessed onAugust 17, 2020. A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (SELECT - PsA 1). ClinicalTrials.gov. 2020. Available at: https://clinicaltrials.gov/ct2/show/NCT03104400. Accessed on August 17, 2020. RINVOQ (upadacitinib) [Package Insert]. North Chicago, Ill.: AbbVie Inc. SOURCE AbbVie Related Links abbvie.com
|
edtsum5828
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: WASHINGTON, Jan. 12, 2021 Climate researchers from NASA and the National Oceanic and Atmospheric Administration (NOAA) will release their annual assessment of global temperatures and discuss the major climate trends of 2020 during a media teleconference at 1 p.m. EST Thursday, Jan. 14. The briefing will take place at the 101st American Meteorological Society Annual Meeting, which is virtual this year. The teleconference participants are: Gavin Schmidt, director of NASA's Goddard Institute for Space Studies in New York Russ Vose, chief of the analysis and synthesis branch of NOAA's National Centers for Environmental Information in Asheville, North Carolina The American Meteorological Society is hosting the teleconference via Zoom. Media may join the call via browser at: https://go.nasa.gov/35zGWkH Access to the presentation also will be available as a dial-in number when the event begins, and the link above will be updated with that information.Audience questions will be possible through the meeting link only. Audio of the briefing will stream live at: www.nasa.gov/live NASA and NOAA are two keepers of the world's temperature data and independently produce a record of Earth's surface temperatures and changes based on historical observations over oceans and land. For more information about NASA's Earth science programs, visit: www.nasa.gov/earth SOURCE NASA Related Links http://www.nasa.gov
Answer:
|
NASA, NOAA to Announce 2020 Global Temperatures, Climate Conditions
|
WASHINGTON, Jan. 12, 2021 Climate researchers from NASA and the National Oceanic and Atmospheric Administration (NOAA) will release their annual assessment of global temperatures and discuss the major climate trends of 2020 during a media teleconference at 1 p.m. EST Thursday, Jan. 14. The briefing will take place at the 101st American Meteorological Society Annual Meeting, which is virtual this year. The teleconference participants are: Gavin Schmidt, director of NASA's Goddard Institute for Space Studies in New York Russ Vose, chief of the analysis and synthesis branch of NOAA's National Centers for Environmental Information in Asheville, North Carolina The American Meteorological Society is hosting the teleconference via Zoom. Media may join the call via browser at: https://go.nasa.gov/35zGWkH Access to the presentation also will be available as a dial-in number when the event begins, and the link above will be updated with that information.Audience questions will be possible through the meeting link only. Audio of the briefing will stream live at: www.nasa.gov/live NASA and NOAA are two keepers of the world's temperature data and independently produce a record of Earth's surface temperatures and changes based on historical observations over oceans and land. For more information about NASA's Earth science programs, visit: www.nasa.gov/earth SOURCE NASA Related Links http://www.nasa.gov
|
edtsum5834
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOS ALTOS, Calif., July 21, 2020 /PRNewswire/ --Bioz, Inc., a Silicon Valley software AI company, and New England Biolabs (NEB), a world leader in the discovery and production of enzymes for molecular biology applications, today announce the launch of a new stand-alone Bioz Search Tool to guide scientists towards the most current SARS-CoV-2-related research, including experimental protocols and best practices. Continue Reading Bioz, Inc. Bioz and NEB are committed to supporting ongoing research towards the development of diagnostics and vaccines for SARS-CoV-2. This new tool provides product-specific article recommendations to guide researchers towards reliable techniques, ultimately saving time spent exploring publications, optimizing protocols and establishing best practices. The Bioz Search Tool is a sophisticated content-hub that facilitates and integrates smart searching through all of NEB's product citations structured data and taxonomy with filtering by technique, by product nameand by COVID-19 related terms, all within an intuitive web interface. The Bioz Search Tool enriches NEB's website with objective information to support its customers' buying process while improving the product selection experience. Moreover, the new Bioz tool is dynamic in nature and automatically updates its scientific data to include the most recent published peer-reviewed articles and, for the first time, preprints. Dr. Karin Lachmi, founder and CSO of Bioz, states, "As we speak, members of the global scientific community are working tirelessly to find new ways to fight this pandemic. Working fast and effectively is critical for these global efforts to succeedand the new Bioz Search Tool provides researchers with a wealth of knowledge to catalyze their discovery." Dr. Lachmi added,"Together with NEB, we are committed to supporting faster research using advanced AI technology to provide researchers with the tools they need to better evaluate products and to win the battle against emerging pathogens like what we are facing today."Andy Bertera, NEB's Executive Director of Marketing & Sales, states, "We are excited to integrate the live-streamed product validation data contained within the new Bioz Search Tool to support our customers' research as they select protocols and techniques for their COVID-19-related experiments." Bertera added, "Including free text search capability, as well as access to preprints, will also facilitate the identification of the products neededand, ultimately, speed up the discovery process."Suggested Tweet:.@NEBLeverages@BiozAI software to Catalyze #COVID19 related Research in the Life Sciences. https://bit.ly/3jcwi8J Link to the New Tool Bioz NEB COVID-19 Search Tool Additional Helpful Links About Bioz Bioz Search Engine Bioz Stars Bioz Business Solutions Bioz Badge on NEB's Website About NEB NEB Website To learn more about the Bioz Partner Program and Bioz Badges, please reach out to [emailprotected]. For more information about New England Biolabs, visit www.neb.com. NEW ENGLAND BIOLABS and NEBare registered trademarks of New England Biolabs, Inc.Bioz Media Contact: Daniel Levitt, CEO Bioz, Inc. [emailprotected] NEB Media Contact: Deana D. Martin, Ph.D. Associate Director, Marketing Communications New England Biolabs Tel: 978-380-7464 Email: [emailprotected]Related Imagesimage1.png Related LinksBioz Badges Bioz Stars SOURCE Bioz, Inc. Related Links https://www.bioz.com
Answer:
|
Bioz Has Partnered With New England Biolabs to Empower Life Science Researchers Around COVID-19 Discovery
|
LOS ALTOS, Calif., July 21, 2020 /PRNewswire/ --Bioz, Inc., a Silicon Valley software AI company, and New England Biolabs (NEB), a world leader in the discovery and production of enzymes for molecular biology applications, today announce the launch of a new stand-alone Bioz Search Tool to guide scientists towards the most current SARS-CoV-2-related research, including experimental protocols and best practices. Continue Reading Bioz, Inc. Bioz and NEB are committed to supporting ongoing research towards the development of diagnostics and vaccines for SARS-CoV-2. This new tool provides product-specific article recommendations to guide researchers towards reliable techniques, ultimately saving time spent exploring publications, optimizing protocols and establishing best practices. The Bioz Search Tool is a sophisticated content-hub that facilitates and integrates smart searching through all of NEB's product citations structured data and taxonomy with filtering by technique, by product nameand by COVID-19 related terms, all within an intuitive web interface. The Bioz Search Tool enriches NEB's website with objective information to support its customers' buying process while improving the product selection experience. Moreover, the new Bioz tool is dynamic in nature and automatically updates its scientific data to include the most recent published peer-reviewed articles and, for the first time, preprints. Dr. Karin Lachmi, founder and CSO of Bioz, states, "As we speak, members of the global scientific community are working tirelessly to find new ways to fight this pandemic. Working fast and effectively is critical for these global efforts to succeedand the new Bioz Search Tool provides researchers with a wealth of knowledge to catalyze their discovery." Dr. Lachmi added,"Together with NEB, we are committed to supporting faster research using advanced AI technology to provide researchers with the tools they need to better evaluate products and to win the battle against emerging pathogens like what we are facing today."Andy Bertera, NEB's Executive Director of Marketing & Sales, states, "We are excited to integrate the live-streamed product validation data contained within the new Bioz Search Tool to support our customers' research as they select protocols and techniques for their COVID-19-related experiments." Bertera added, "Including free text search capability, as well as access to preprints, will also facilitate the identification of the products neededand, ultimately, speed up the discovery process."Suggested Tweet:.@NEBLeverages@BiozAI software to Catalyze #COVID19 related Research in the Life Sciences. https://bit.ly/3jcwi8J Link to the New Tool Bioz NEB COVID-19 Search Tool Additional Helpful Links About Bioz Bioz Search Engine Bioz Stars Bioz Business Solutions Bioz Badge on NEB's Website About NEB NEB Website To learn more about the Bioz Partner Program and Bioz Badges, please reach out to [emailprotected]. For more information about New England Biolabs, visit www.neb.com. NEW ENGLAND BIOLABS and NEBare registered trademarks of New England Biolabs, Inc.Bioz Media Contact: Daniel Levitt, CEO Bioz, Inc. [emailprotected] NEB Media Contact: Deana D. Martin, Ph.D. Associate Director, Marketing Communications New England Biolabs Tel: 978-380-7464 Email: [emailprotected]Related Imagesimage1.png Related LinksBioz Badges Bioz Stars SOURCE Bioz, Inc. Related Links https://www.bioz.com
|
edtsum5839
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)--The parking management solutions market is expected to grow by USD 3.42 billion, progressing at a CAGR of over 8% during the forecast period. Click & Get Free Sample Report in Minutes The growth in smart parking deployment projects is one of the major factors propelling market growth. However, factors such as lack of integration among siloed parking technologies will hamper the market growth. More details: https://www.technavio.com/report/parking-management-solutions-market-industry-analysis Parking Management Solutions Market: Type Landscape Off-street parking refers to the parking of vehicles in parking facilities such as garages and lots. The growing focus on improving city infrastructure and the rising number of malls, restaurants, and SMEs globally are driving the construction of off-street parking facilities. Off-street parking facilities are primarily built by private business enterprises for their customers. These facilities are integrated with advanced technologies. This is a major contributor to the off-street parking management solution market segment. Parking Management Solutions Market: Geographic Landscape North America was the largest parking management solutions market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The increase in the requirement of traffic management will significantly drive parking management solutions market growth in this region over the forecast period. 32% of the markets growth will originate from North America during the forecast period. The US and Canada are the key markets for parking management solutions in North America. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Related Reports on Information Technology Include: Intelligent Parking Systems Market by Type and Region - Forecast and Analysis 2020-2024: The intelligent parking systems market size has the potential to grow by USD 5.2 bn during 2020-2024, and the markets growth momentum will accelerate during the forecast period. To get extensive research insights: Click and Get FREE Sample Report in Minutes! Smart Parking Market by Type and Geography - Forecast and Analysis 2020-2024: The smart parking market size has the potential to grow by USD 5.22 billion during 2020-2024, and the markets growth momentum will accelerate during the forecast period. To get extensive research insights: Click and Get FREE Sample Report in Minutes! Companies Covered: What our reports offer: Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Product Market Segmentation by Type Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Answer:
|
Parking Management Solutions Market by Type (off-street parking and on-street parking), Product, and Region - Global Forecast to 2024 |Technavio
|
LONDON--(BUSINESS WIRE)--The parking management solutions market is expected to grow by USD 3.42 billion, progressing at a CAGR of over 8% during the forecast period. Click & Get Free Sample Report in Minutes The growth in smart parking deployment projects is one of the major factors propelling market growth. However, factors such as lack of integration among siloed parking technologies will hamper the market growth. More details: https://www.technavio.com/report/parking-management-solutions-market-industry-analysis Parking Management Solutions Market: Type Landscape Off-street parking refers to the parking of vehicles in parking facilities such as garages and lots. The growing focus on improving city infrastructure and the rising number of malls, restaurants, and SMEs globally are driving the construction of off-street parking facilities. Off-street parking facilities are primarily built by private business enterprises for their customers. These facilities are integrated with advanced technologies. This is a major contributor to the off-street parking management solution market segment. Parking Management Solutions Market: Geographic Landscape North America was the largest parking management solutions market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The increase in the requirement of traffic management will significantly drive parking management solutions market growth in this region over the forecast period. 32% of the markets growth will originate from North America during the forecast period. The US and Canada are the key markets for parking management solutions in North America. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Related Reports on Information Technology Include: Intelligent Parking Systems Market by Type and Region - Forecast and Analysis 2020-2024: The intelligent parking systems market size has the potential to grow by USD 5.2 bn during 2020-2024, and the markets growth momentum will accelerate during the forecast period. To get extensive research insights: Click and Get FREE Sample Report in Minutes! Smart Parking Market by Type and Geography - Forecast and Analysis 2020-2024: The smart parking market size has the potential to grow by USD 5.22 billion during 2020-2024, and the markets growth momentum will accelerate during the forecast period. To get extensive research insights: Click and Get FREE Sample Report in Minutes! Companies Covered: What our reports offer: Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Product Market Segmentation by Type Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
|
edtsum5841
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOS ANGELES, June 19, 2020 /PRNewswire/ --Caring Brands International ("CBI"), a portfolio company of Levine Leichtman Capital Partners ("LLCP"), announced today that it has successfully completed the acquisition of its Bluebird Care Master Franchise in the Republic of Ireland. Through the acquisition, CBI adds direct franchising rights in the Republic of Ireland, which it serves through its Bluebird Care brand, and 26 franchise locations to its portfolio of over 550 locations across the United States, United Kingdom, and Australia. The franchisees in the Republic of Ireland will now have direct access to the wide-ranging support and services of Bluebird Care, one of the United Kingdom's largest homecare providers, and CBI. Founded in 1966, CBI is the largest franchisor of home healthcare services globally and produces approximately $1.1 billion of annual systemwide sales across its brands. CBI offers franchises under three brands: Interim HealthCare (United States), Bluebird Care (United Kingdom and Republic of Ireland) and Just Better Care (Australia). CBI's franchisees offer individuals a full continuum of care at home including skilled nursing, assistance with daily living activities and end-of-life hospice care. Jennifer Sheets, CEO and President of Caring Brands International, commented, "I look forward to supporting our Irish franchisees as they continue to grow their businesses and enhance their market leadership. We are very eager to extend our award-winning support services to the team in the Republic of Ireland, so that they can continue to provide the highest standard of care to customers in their own homes, now during COVID-19, and in the future." Matthew Frankel, a Partner at LLCP, stated, "This acquisition demonstrates the continued support of our CBI investment. We remain focused on building value for the benefit of all CBI's stakeholders, including franchise owners, patients, caregivers, and investors. We are excited to partner with the Irish franchisees on their next stage of growth." CBI is a portfolio company of Levine Leichtman Capital Partners Fund V, L.P. About Levine Leichtman Capital Partners Levine Leichtman Capital Partners, LLC is a middle-market private equity firm with a 36-year track record of successfully investing across various targeted sectors, including franchising, professional services, education and engineered products. LLCP utilizes a differentiated Structured Equity investment strategy, combining debt and equity capital investments in portfolio companies. This unique structure provides a less dilutive solution for management teams and entrepreneurs, while delivering growth and income with a significantly lower risk profile. LLCP's global team of dedicated investment professionals is led by seven partners who have worked together for an average of 21 years. Since inception, LLCP has managed over $10.8 billion of institutional capital across 14 investment funds and has invested in over 85 portfolio companies. LLCP currently manages $6.9 billion of assets including its most recent flagship fund, Levine Leichtman Capital Partners VI, L.P., which closed in 2018 with $2.5 billion of committed capital and has offices in Los Angeles, New York, Dallas, Chicago, Charlotte, Miami, London, Stockholm and The Hague. Media Contact:Mark Semer or Ross Lovern Kekst CNC[emailprotected], [emailprotected] (212) 521-4800 SOURCE Levine Leichtman Capital Partners
Answer:
|
Levine Leichtman Capital Partners Portfolio Company Caring Brands International Acquires Master Franchise in the Republic of Ireland
|
LOS ANGELES, June 19, 2020 /PRNewswire/ --Caring Brands International ("CBI"), a portfolio company of Levine Leichtman Capital Partners ("LLCP"), announced today that it has successfully completed the acquisition of its Bluebird Care Master Franchise in the Republic of Ireland. Through the acquisition, CBI adds direct franchising rights in the Republic of Ireland, which it serves through its Bluebird Care brand, and 26 franchise locations to its portfolio of over 550 locations across the United States, United Kingdom, and Australia. The franchisees in the Republic of Ireland will now have direct access to the wide-ranging support and services of Bluebird Care, one of the United Kingdom's largest homecare providers, and CBI. Founded in 1966, CBI is the largest franchisor of home healthcare services globally and produces approximately $1.1 billion of annual systemwide sales across its brands. CBI offers franchises under three brands: Interim HealthCare (United States), Bluebird Care (United Kingdom and Republic of Ireland) and Just Better Care (Australia). CBI's franchisees offer individuals a full continuum of care at home including skilled nursing, assistance with daily living activities and end-of-life hospice care. Jennifer Sheets, CEO and President of Caring Brands International, commented, "I look forward to supporting our Irish franchisees as they continue to grow their businesses and enhance their market leadership. We are very eager to extend our award-winning support services to the team in the Republic of Ireland, so that they can continue to provide the highest standard of care to customers in their own homes, now during COVID-19, and in the future." Matthew Frankel, a Partner at LLCP, stated, "This acquisition demonstrates the continued support of our CBI investment. We remain focused on building value for the benefit of all CBI's stakeholders, including franchise owners, patients, caregivers, and investors. We are excited to partner with the Irish franchisees on their next stage of growth." CBI is a portfolio company of Levine Leichtman Capital Partners Fund V, L.P. About Levine Leichtman Capital Partners Levine Leichtman Capital Partners, LLC is a middle-market private equity firm with a 36-year track record of successfully investing across various targeted sectors, including franchising, professional services, education and engineered products. LLCP utilizes a differentiated Structured Equity investment strategy, combining debt and equity capital investments in portfolio companies. This unique structure provides a less dilutive solution for management teams and entrepreneurs, while delivering growth and income with a significantly lower risk profile. LLCP's global team of dedicated investment professionals is led by seven partners who have worked together for an average of 21 years. Since inception, LLCP has managed over $10.8 billion of institutional capital across 14 investment funds and has invested in over 85 portfolio companies. LLCP currently manages $6.9 billion of assets including its most recent flagship fund, Levine Leichtman Capital Partners VI, L.P., which closed in 2018 with $2.5 billion of committed capital and has offices in Los Angeles, New York, Dallas, Chicago, Charlotte, Miami, London, Stockholm and The Hague. Media Contact:Mark Semer or Ross Lovern Kekst CNC[emailprotected], [emailprotected] (212) 521-4800 SOURCE Levine Leichtman Capital Partners
|
edtsum5844
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: THIEF RIVER FALLS, Minn., March 31, 2020 /PRNewswire/ -- Digi-Key Electronics, a global electronic components distributor, announced that it now offers a free eBook on the benefits of implementing Application Programming Interface (API) solutions, as well as a new ROI calculator to see the return on investment that implementing APIs can deliver. Digi-Key Electronics now offers a free eBook on the benefits of implementing API solutions, as well as a new ROI calculator. Digi-Key's APIs have long provided a complete digital platform for customers to automate and streamline procurement processes while providing real-time product information to procurement, engineering and design teams. Digi-Key's APIs are free to use, and digitally connect customers' systems with the Digi-Key system to provide automated, real-time product search, price and availability, quoting and ordering, barcode, product change notifications and more. Customers who have utilized Digi-Key's API calculator have seen an average of $50,000 to $100,000 in cost savings by implementing API solutions. "Speed and access to information and data are critical in all forms of electronic product design and procurement, and an organization's time-to-market can mean the difference between a successful and marginal product acceptance," said Nathan Pray, senior digital product owner for Digi-Key. "Digi-Key's API solutions provide a competitive advantage to customers by streamlining the purchasing process and enabling procurement, engineering and design teams to all receive critical real-time information on products they need at lightning speed because it's automated through machine-to-machine connections. Customers using Digi-Key's API solutions save time so they can bring products to market faster and more efficiently, which boosts revenue." Fremont, Calif.-based Sonic Manufacturing Technologies provides in-house board layout, prototyping and New Product Introduction (NPI) through full production in as little as five to 10 days. That speed to market necessitates a digital procurement strategy that not only enables a streamlined supply chain, but also supports good internal communication and collaboration. Every week, Sonic orders about 1 million parts to support its production line. Using Digi-Key's APIs and cloud-based procurement platform, Sonic has been able to automate 50% of its purchasing activity without adding staff. The team now focuses on more high-value activities such as selecting the best sources for the 60,000 line items the company buys annually; coordinating with engineering and design departments; and maintaining high customer service levels. Using Digi-Key's APIs and cloud-based platform, Sonic's cost to place an order (total landed cost) was reduced from a previous $40 to a current $9. While not every company will achieve 60% savings, even 20 to 30% savings on procurement costs of $400,000 each year will result in significant savings.For more information on Digi-Key's API solutions, visit the Digi-Key API Solutions resources page. Users can also access the free eBook and ROI calculator, which shows companies how much they can save in one year by implementing Digi-Key's price and availability and ordering APIs. About Digi-Key ElectronicsDigi-Key Electronics, headquartered in Thief River Falls, Minn., USA, is a B2B global, full-service, authorized distributor of both prototype/design and production quantities of electronic components, offering more than 10 million products, with over 2.2 million products in stock and available for immediate shipment, from over 800 quality name-brand manufacturers. Digi-Key ensures timely delivery with over 99.5% of orders being shipped the same day. The company also offers robust EDI, API and XML solutions. Additional information and access to Digi-Key's broad product offering is available at www.digikey.com and on Facebook, Twitter, YouTube, Instagram,and LinkedIn.Editorial ContactShelli LissickBellmont Partners+1 651 276 6922[emailprotected]SOURCE Digi-Key Electronics Related Links http://www.digikey.com
Answer:
|
Digi-Key Electronics Launches Calculator and eBook for API Solutions to Streamline Procurement and Prove Cost Savings
|
THIEF RIVER FALLS, Minn., March 31, 2020 /PRNewswire/ -- Digi-Key Electronics, a global electronic components distributor, announced that it now offers a free eBook on the benefits of implementing Application Programming Interface (API) solutions, as well as a new ROI calculator to see the return on investment that implementing APIs can deliver. Digi-Key Electronics now offers a free eBook on the benefits of implementing API solutions, as well as a new ROI calculator. Digi-Key's APIs have long provided a complete digital platform for customers to automate and streamline procurement processes while providing real-time product information to procurement, engineering and design teams. Digi-Key's APIs are free to use, and digitally connect customers' systems with the Digi-Key system to provide automated, real-time product search, price and availability, quoting and ordering, barcode, product change notifications and more. Customers who have utilized Digi-Key's API calculator have seen an average of $50,000 to $100,000 in cost savings by implementing API solutions. "Speed and access to information and data are critical in all forms of electronic product design and procurement, and an organization's time-to-market can mean the difference between a successful and marginal product acceptance," said Nathan Pray, senior digital product owner for Digi-Key. "Digi-Key's API solutions provide a competitive advantage to customers by streamlining the purchasing process and enabling procurement, engineering and design teams to all receive critical real-time information on products they need at lightning speed because it's automated through machine-to-machine connections. Customers using Digi-Key's API solutions save time so they can bring products to market faster and more efficiently, which boosts revenue." Fremont, Calif.-based Sonic Manufacturing Technologies provides in-house board layout, prototyping and New Product Introduction (NPI) through full production in as little as five to 10 days. That speed to market necessitates a digital procurement strategy that not only enables a streamlined supply chain, but also supports good internal communication and collaboration. Every week, Sonic orders about 1 million parts to support its production line. Using Digi-Key's APIs and cloud-based procurement platform, Sonic has been able to automate 50% of its purchasing activity without adding staff. The team now focuses on more high-value activities such as selecting the best sources for the 60,000 line items the company buys annually; coordinating with engineering and design departments; and maintaining high customer service levels. Using Digi-Key's APIs and cloud-based platform, Sonic's cost to place an order (total landed cost) was reduced from a previous $40 to a current $9. While not every company will achieve 60% savings, even 20 to 30% savings on procurement costs of $400,000 each year will result in significant savings.For more information on Digi-Key's API solutions, visit the Digi-Key API Solutions resources page. Users can also access the free eBook and ROI calculator, which shows companies how much they can save in one year by implementing Digi-Key's price and availability and ordering APIs. About Digi-Key ElectronicsDigi-Key Electronics, headquartered in Thief River Falls, Minn., USA, is a B2B global, full-service, authorized distributor of both prototype/design and production quantities of electronic components, offering more than 10 million products, with over 2.2 million products in stock and available for immediate shipment, from over 800 quality name-brand manufacturers. Digi-Key ensures timely delivery with over 99.5% of orders being shipped the same day. The company also offers robust EDI, API and XML solutions. Additional information and access to Digi-Key's broad product offering is available at www.digikey.com and on Facebook, Twitter, YouTube, Instagram,and LinkedIn.Editorial ContactShelli LissickBellmont Partners+1 651 276 6922[emailprotected]SOURCE Digi-Key Electronics Related Links http://www.digikey.com
|
edtsum5853
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN FRANCISCO, March 3, 2021 /PRNewswire/ -- Today Brave announced the acquisition of Tailcat, the open search engine developed by the team formerly responsible for the privacy search and browser products at Cliqz, a holding of Hubert Burda Media. Tailcat will become the foundation of Brave Search. Brave Search and the Brave browser constitute the industry's first independent, privacy-preserving alternative to Google Chrome and Google Search, which rely on tracking users across sites and have 70 percent and 92 percent market share, respectively. Under the hood, nearly all of today's search engines are either built by, or rely on, results from Big Tech companies. In contrast, the Tailcat search engine is built on top of a completely independent index, capable of delivering the quality people expect, but without compromising their privacy. Tailcat does not collect IP addresses or use personally identifiable information to improve search results. Brave Search & the Brave browser constitute the industry's first independent, privacy-preserving alternative to Big Tech Tweet this Brave Search will join the family of privacy-preserving Brave products as consumers are increasingly demanding user-first alternatives to Big Tech. The Brave browser saw unprecedented growth in 2021, reaching over 25 million monthly active users. This mirrored the impressive migration to Signal, the privacy messaging platform, after WhatsApp announced a change to their privacy policies requiring data-sharing with Facebook. Privacy is becoming mainstream. The Brave browser provides the stringent protections users demand, and Brave Search is being developed according to the same principles: Brave Search is private: it does not track or profile users. Brave Search is user-first: Brave serves the user first, not the advertising and data industries. Brave Search offers choice: We will provide options for ad-free paid search and ad-supported search. We are working on bringing private ads to search, as we've done for Brave user ads. Brave Search is independent: We will rely on anonymized contributions from the community to improve and refine Brave Search. Prior to this innovation, producing quality results could be achieved only by Big Tech companies, which took many years and tens of billions of dollars to crawl the entire Web continually. Brave Search is transparent: we will not use secret methods or algorithms to bias results. We will explore multiple community-curated open ranking models to ensure diversity, and prevent algorithmic biases and outright censorship. Brave Search is seamless: we will offer best-in-class integration between the browser and search without compromising privacy, from personalization to instant results as the user types. Brave Search is open: we do not believe in walled gardens and, as such, we will offer Brave Search to power other search engines. With Brave Search, users can choose a default search engine that works seamlessly with the Brave browser to provide a complete privacy-respecting experience. Brave will also explore blockchain-based options and new developments, including for e-commerce uses."Brave has grown significantly over the past year, from 11 million monthly active users to over 25 million. We expect to see even greater demand for Brave in 2021 as more and more users demand real privacy solutions to escape Big Tech's invasive practices," said Brendan Eich, CEO and co-founder of Brave Software. "Brave's mission is to put the user first, and integrating privacy-preserving search into our platform is a necessary step to ensure that user privacy is not plundered to fuel the surveillance economy." "We are very happy that our technology is being used at Brave and that, as a result, a genuine, privacy-friendly alternative to Google is being created in the core web functions of browsing and searching," added Paul-Bernhard Kallen, CEO ofHubert Burda Media. "As a Brave stakeholder we will continue to be involved in this exciting project.""The only way to counter Big Tech with its bad habit of collecting personal data is to develop a robust, independent, and privacy-preserving search engine that delivers the quality users have come to expect. People should not be forced to choose between privacy and quality," said Dr. Josep M. Pujol, head of the Tailcat project. "The team is excited to be working on the only real private search/browser alternative to Big Tech available on the market."Brave already offers a privacy-preserving ad platform with Brave Ads,which has delivered nearly 3,000 private ad campaigns in 200 countries with major advertisers such as Verizon, The Home Depot, The New York Times, Progressive Insurance, Chipotle, PayPal, Amazon, Harry's Razors, CBS, and KIND Snacks. Brave recently launched a privacy-preserving news reader, Brave Today, as well as a Firewall+VPN service, and is testing Brave Together, a privacy-preserving video-conferencing service. With the addition of privacy-preserving search, Brave is further expanding its browser into a super app to give users the control they deserve over their online experience.Users interested in testing Brave Search can sign up via the waitlist atbrave.com/search/. About Brave: Brave Software's fast, privacy-oriented browser, combined with its blockchain-based digital advertising platform, is reinventing the Web for users, publishers, and advertisers. Users get a private, speedier web experience with much longer battery life, publishers increase their revenue share, and advertisers achieve better conversion. Users can opt into privacy-respecting ads that reward them with the Basic Attention Token (BAT), a frequent flyer-like token they can redeem or use to tip or contribute to publishers and other content creators. The Brave solution is a win-win for everyone who has a stake in the open Web and who is weary of giving up privacy and revenue to the ad-tech intermediaries. Brave currently has over 25 million monthly active users and over 1 million Verified Publishers. Brave Software was co-founded by Brendan Eich, creator of JavaScript and co-founder of Mozilla (Firefox), and Brian Bondy, formerly of Khan Academy and Mozilla.For more information, visithttps://brave.com/or follow the company on [email protected] Brave Software Related Links https://www.brave.com
Answer:
|
Brave acquires search engine to offer the first private alternative to Google Search and Google Chrome on both mobile and desktop Brave Search is coming just as millions are migrating from Big Tech platforms to more private and secure solutions
|
SAN FRANCISCO, March 3, 2021 /PRNewswire/ -- Today Brave announced the acquisition of Tailcat, the open search engine developed by the team formerly responsible for the privacy search and browser products at Cliqz, a holding of Hubert Burda Media. Tailcat will become the foundation of Brave Search. Brave Search and the Brave browser constitute the industry's first independent, privacy-preserving alternative to Google Chrome and Google Search, which rely on tracking users across sites and have 70 percent and 92 percent market share, respectively. Under the hood, nearly all of today's search engines are either built by, or rely on, results from Big Tech companies. In contrast, the Tailcat search engine is built on top of a completely independent index, capable of delivering the quality people expect, but without compromising their privacy. Tailcat does not collect IP addresses or use personally identifiable information to improve search results. Brave Search & the Brave browser constitute the industry's first independent, privacy-preserving alternative to Big Tech Tweet this Brave Search will join the family of privacy-preserving Brave products as consumers are increasingly demanding user-first alternatives to Big Tech. The Brave browser saw unprecedented growth in 2021, reaching over 25 million monthly active users. This mirrored the impressive migration to Signal, the privacy messaging platform, after WhatsApp announced a change to their privacy policies requiring data-sharing with Facebook. Privacy is becoming mainstream. The Brave browser provides the stringent protections users demand, and Brave Search is being developed according to the same principles: Brave Search is private: it does not track or profile users. Brave Search is user-first: Brave serves the user first, not the advertising and data industries. Brave Search offers choice: We will provide options for ad-free paid search and ad-supported search. We are working on bringing private ads to search, as we've done for Brave user ads. Brave Search is independent: We will rely on anonymized contributions from the community to improve and refine Brave Search. Prior to this innovation, producing quality results could be achieved only by Big Tech companies, which took many years and tens of billions of dollars to crawl the entire Web continually. Brave Search is transparent: we will not use secret methods or algorithms to bias results. We will explore multiple community-curated open ranking models to ensure diversity, and prevent algorithmic biases and outright censorship. Brave Search is seamless: we will offer best-in-class integration between the browser and search without compromising privacy, from personalization to instant results as the user types. Brave Search is open: we do not believe in walled gardens and, as such, we will offer Brave Search to power other search engines. With Brave Search, users can choose a default search engine that works seamlessly with the Brave browser to provide a complete privacy-respecting experience. Brave will also explore blockchain-based options and new developments, including for e-commerce uses."Brave has grown significantly over the past year, from 11 million monthly active users to over 25 million. We expect to see even greater demand for Brave in 2021 as more and more users demand real privacy solutions to escape Big Tech's invasive practices," said Brendan Eich, CEO and co-founder of Brave Software. "Brave's mission is to put the user first, and integrating privacy-preserving search into our platform is a necessary step to ensure that user privacy is not plundered to fuel the surveillance economy." "We are very happy that our technology is being used at Brave and that, as a result, a genuine, privacy-friendly alternative to Google is being created in the core web functions of browsing and searching," added Paul-Bernhard Kallen, CEO ofHubert Burda Media. "As a Brave stakeholder we will continue to be involved in this exciting project.""The only way to counter Big Tech with its bad habit of collecting personal data is to develop a robust, independent, and privacy-preserving search engine that delivers the quality users have come to expect. People should not be forced to choose between privacy and quality," said Dr. Josep M. Pujol, head of the Tailcat project. "The team is excited to be working on the only real private search/browser alternative to Big Tech available on the market."Brave already offers a privacy-preserving ad platform with Brave Ads,which has delivered nearly 3,000 private ad campaigns in 200 countries with major advertisers such as Verizon, The Home Depot, The New York Times, Progressive Insurance, Chipotle, PayPal, Amazon, Harry's Razors, CBS, and KIND Snacks. Brave recently launched a privacy-preserving news reader, Brave Today, as well as a Firewall+VPN service, and is testing Brave Together, a privacy-preserving video-conferencing service. With the addition of privacy-preserving search, Brave is further expanding its browser into a super app to give users the control they deserve over their online experience.Users interested in testing Brave Search can sign up via the waitlist atbrave.com/search/. About Brave: Brave Software's fast, privacy-oriented browser, combined with its blockchain-based digital advertising platform, is reinventing the Web for users, publishers, and advertisers. Users get a private, speedier web experience with much longer battery life, publishers increase their revenue share, and advertisers achieve better conversion. Users can opt into privacy-respecting ads that reward them with the Basic Attention Token (BAT), a frequent flyer-like token they can redeem or use to tip or contribute to publishers and other content creators. The Brave solution is a win-win for everyone who has a stake in the open Web and who is weary of giving up privacy and revenue to the ad-tech intermediaries. Brave currently has over 25 million monthly active users and over 1 million Verified Publishers. Brave Software was co-founded by Brendan Eich, creator of JavaScript and co-founder of Mozilla (Firefox), and Brian Bondy, formerly of Khan Academy and Mozilla.For more information, visithttps://brave.com/or follow the company on [email protected] Brave Software Related Links https://www.brave.com
|
edtsum5858
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PITTSBURGH, April 17, 2020 /PRNewswire/ --"As a salon professional for 36 years and a salon owner for 21, I felt that there was a huge void when it comes to protecting the client while shampooing their hair," said an inventor from Palm Harbor, Fla. "You would not cut someone's hair without draping them with a cutting cape to protect them. Well, you should never shampoo their hair, especially if you're removing color or other chemicals, without protecting them and their clothes. That's why I developed the patent pending SALON COLOR SHIELD. I was tired of having seeing our greatest asset in the beauty industry - our clients - get upset because their clothes had been ruined or soiled from shampooing color or other chemical processes from their hair." He created a prototype for the SALON COLOR SHIELD to protect the client's skin and clothing while hair is shampooed. The accessory creates a watertight seal for maximum effectiveness. It safeguards the client from water, hair coloring, perm solution and other chemicals. This offers added peace of mind to clients. Additionally, the invention is designed to be cheap and affordable, as well as easy to use. The original design was submitted to the Tampa sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 18-TPA-2917, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com
Answer:
|
InventHelp Presents Protective Accessory for Hair-Styling Appointments (TPA-2917)
|
PITTSBURGH, April 17, 2020 /PRNewswire/ --"As a salon professional for 36 years and a salon owner for 21, I felt that there was a huge void when it comes to protecting the client while shampooing their hair," said an inventor from Palm Harbor, Fla. "You would not cut someone's hair without draping them with a cutting cape to protect them. Well, you should never shampoo their hair, especially if you're removing color or other chemicals, without protecting them and their clothes. That's why I developed the patent pending SALON COLOR SHIELD. I was tired of having seeing our greatest asset in the beauty industry - our clients - get upset because their clothes had been ruined or soiled from shampooing color or other chemical processes from their hair." He created a prototype for the SALON COLOR SHIELD to protect the client's skin and clothing while hair is shampooed. The accessory creates a watertight seal for maximum effectiveness. It safeguards the client from water, hair coloring, perm solution and other chemicals. This offers added peace of mind to clients. Additionally, the invention is designed to be cheap and affordable, as well as easy to use. The original design was submitted to the Tampa sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 18-TPA-2917, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com
|
edtsum5860
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SHANGHAI, April 22, 2020 /PRNewswire/ -- On April 20, 2020, the first phase of Connell Chemical Industry Ltd.'s 600 KTA MTO complex, a 300 KTA MTO plant, successfully startedup and produced on-spec ethylene and propylene. This plant was built by Wison Engineering (SEHK stock code: 2236) through an EPC contract. This project is the first large-size chemical project brought online during period when China is in the process of restarting the economy while fighting COVID-19 pandemic. The MTO plant started feed-in at 8:18 AM on April 15, produced on-spec propylene at 7:00 AM on April 18, and produced on-spec ethylene at 4:00 AM on April 20. This plant is deployed with Honeywell UOP's advanced MTO/OCP reaction technologies and Wison Engineering's olefin recovery and separation technology "Pre-cutting + Oil Absorption" process. The project was built by Wison Engineering through an EPC contract. The integrated process with UOP MTO/OCP technology and Wison Engineering's olefin recovery and separation technology is the most advanced MTO process in the world, featured by advantages of high feedstock yield and low catalyst consumption. This commercialization is the 10th successful commercial application for Wison Engineering's olefin recovery and separation technology. This successful startup has once again proved the reliability of this olefin separation technology and Wison Engineering's leading capability in MTO technology and engineering. Timeline In July 2016, Wison Engineering was awarded an EPC contract for Connell Chemical Industry's 300 KTA MTO project. At the same time, Wison Engineering and Connell also signed a licensing agreement on process design package (PDP) contract for Wison's proprietary olefin separation technology. Wison Engineering was responsible for engineering design, procurement and construction of MTO reaction and concentration unit, olefin separation unit, olefin cracking unit and additional auxiliaries. Following the contract signing, site construction started in the same month. In October 2016, Honeywell UOP and Connell signed the licensing agreement on MTO+OCP technology. In September 2017, the project handover ceremony for 300 KTA MTO plant was successfully held at project site. On April 20, 2020, 300 KTA MTO plant successfully started up and produced on-spec ethylene and propylene. About Wison Engineering Wison Engineering (SEHK Stock Code: 2236) is a global leading service provider for energy and chemical industry, including oil refining, petrochemical, syngas chemical, oil and gas field services, LNG and power generation. From technology selection, project planning and consultation to engineering, procurement and construction management, as well as commissioning and start-up services, we can provide customized solutions covering entire project cycle with flexible service approaches. Our business has already covered more than 20 countries and regions. For more information, please visit: www.wison-engineering.com, or follow us on LinkedIn @ Wison Engineering Ltd. Contact: Media RelationsHOPE HUANGTel: (86) 21-2030 6967Email: [emailprotected] Investor RelationsCHARLES CHANTel: (852) 2116 4313Email: [emailprotected] SOURCE Wison Engineering Related Links http://www.wison-engineering.com
Answer:
|
MTO Plant Built by Wison Engineering Successfully Starts up
|
SHANGHAI, April 22, 2020 /PRNewswire/ -- On April 20, 2020, the first phase of Connell Chemical Industry Ltd.'s 600 KTA MTO complex, a 300 KTA MTO plant, successfully startedup and produced on-spec ethylene and propylene. This plant was built by Wison Engineering (SEHK stock code: 2236) through an EPC contract. This project is the first large-size chemical project brought online during period when China is in the process of restarting the economy while fighting COVID-19 pandemic. The MTO plant started feed-in at 8:18 AM on April 15, produced on-spec propylene at 7:00 AM on April 18, and produced on-spec ethylene at 4:00 AM on April 20. This plant is deployed with Honeywell UOP's advanced MTO/OCP reaction technologies and Wison Engineering's olefin recovery and separation technology "Pre-cutting + Oil Absorption" process. The project was built by Wison Engineering through an EPC contract. The integrated process with UOP MTO/OCP technology and Wison Engineering's olefin recovery and separation technology is the most advanced MTO process in the world, featured by advantages of high feedstock yield and low catalyst consumption. This commercialization is the 10th successful commercial application for Wison Engineering's olefin recovery and separation technology. This successful startup has once again proved the reliability of this olefin separation technology and Wison Engineering's leading capability in MTO technology and engineering. Timeline In July 2016, Wison Engineering was awarded an EPC contract for Connell Chemical Industry's 300 KTA MTO project. At the same time, Wison Engineering and Connell also signed a licensing agreement on process design package (PDP) contract for Wison's proprietary olefin separation technology. Wison Engineering was responsible for engineering design, procurement and construction of MTO reaction and concentration unit, olefin separation unit, olefin cracking unit and additional auxiliaries. Following the contract signing, site construction started in the same month. In October 2016, Honeywell UOP and Connell signed the licensing agreement on MTO+OCP technology. In September 2017, the project handover ceremony for 300 KTA MTO plant was successfully held at project site. On April 20, 2020, 300 KTA MTO plant successfully started up and produced on-spec ethylene and propylene. About Wison Engineering Wison Engineering (SEHK Stock Code: 2236) is a global leading service provider for energy and chemical industry, including oil refining, petrochemical, syngas chemical, oil and gas field services, LNG and power generation. From technology selection, project planning and consultation to engineering, procurement and construction management, as well as commissioning and start-up services, we can provide customized solutions covering entire project cycle with flexible service approaches. Our business has already covered more than 20 countries and regions. For more information, please visit: www.wison-engineering.com, or follow us on LinkedIn @ Wison Engineering Ltd. Contact: Media RelationsHOPE HUANGTel: (86) 21-2030 6967Email: [emailprotected] Investor RelationsCHARLES CHANTel: (852) 2116 4313Email: [emailprotected] SOURCE Wison Engineering Related Links http://www.wison-engineering.com
|
edtsum5862
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOS ANGELES, Oct. 27, 2020 /PRNewswire/ --Angie Hospitalityby Nomadix, the leading provider of voice-activated and contactless technology solutions for hotels, today announced new subscription-based pricing as part of its commitment to help in the recovery of the hospitality industry. With the drastic shift in hotel requirements caused by COVID-19, the new pricing model enables hotels to make safety and other necessary upgrades without the up-front, per-room hardware investment typically required in this market. Hotels face increasing demand to incorporate contactless technologies that address new safety requirements and guest expectations. Angie helps hoteliers with those efforts by taking the upfront hardware costs out of the equation and upgrading each hotel room with technology that provides a safe and convenient next-generation experience for guests. "When I served as a hotel general manager, it wasn't always possible to upgrade guest-facing equipment when other operational expenses took priority. With the new pain points our industry is facing, we are shifting our models to reduce costs for hotels to make those necessary upgrades affordable," said David Millili, CEO of Angie Hospitality. "We are in this together and are working closely with our partners and customers to help the industry with its recovery initiatives." With minimal costs to install, hoteliers can modernize the guest experience by adding Angie's in-room guest assistants to fulfill common hotel requests, offer recommendations and share hotel information, which alleviates some of the stress on hotel staff. The devices also offer smart hotel room functionality to control lighting, adjust thermostats, close curtains and more. The operational efficiencies are an added benefit to increase guest satisfaction. The company earlier this month introduced Angie PBX, a cloud phone service that has drastically reduced telephony costs for hotel customers. Hotels can replace outdated in-room phones with Angie voice-enabled digital assistants and still meet emergency calling requirements. Additionally, Angie Casting and the mobile guest app enhance the hotel stay without straining budgets. All of these offerings can be implemented under the subscription option. Angie Hospitality will demo its new solutions at Cyber HITEC October 27-29, 2020, at booth #829 in the Clean to Cleaner Pavilion. About Angie HospitalityAngie Hospitality by Nomadix delivers contactless technology for hotels. The company offers patented voice and touchscreen capabilities with their purpose-built solutions for the hotel environment. Products include the world's first 24-hour interactive guest room assistant, mobile app, casting, and PBX solutions for hoteliers looking to increase guest satisfaction, improve staff efficiencies and maximize revenue opportunities. For more information, visit angie.ai. Media Contacts:Aubrey CogginsDirector of Marketing[emailprotected] Sami StansberryPR for Angie[emailprotected]312-481-6251 SOURCE Angie Hospitality
Answer:
|
Angie Hospitality Offers New Subscription-Based Pricing, Helps Hotels with Budget and Safety Changes Updates Equipment and Reduces Costs to Aid in Hospitality's Recovery Efforts
|
LOS ANGELES, Oct. 27, 2020 /PRNewswire/ --Angie Hospitalityby Nomadix, the leading provider of voice-activated and contactless technology solutions for hotels, today announced new subscription-based pricing as part of its commitment to help in the recovery of the hospitality industry. With the drastic shift in hotel requirements caused by COVID-19, the new pricing model enables hotels to make safety and other necessary upgrades without the up-front, per-room hardware investment typically required in this market. Hotels face increasing demand to incorporate contactless technologies that address new safety requirements and guest expectations. Angie helps hoteliers with those efforts by taking the upfront hardware costs out of the equation and upgrading each hotel room with technology that provides a safe and convenient next-generation experience for guests. "When I served as a hotel general manager, it wasn't always possible to upgrade guest-facing equipment when other operational expenses took priority. With the new pain points our industry is facing, we are shifting our models to reduce costs for hotels to make those necessary upgrades affordable," said David Millili, CEO of Angie Hospitality. "We are in this together and are working closely with our partners and customers to help the industry with its recovery initiatives." With minimal costs to install, hoteliers can modernize the guest experience by adding Angie's in-room guest assistants to fulfill common hotel requests, offer recommendations and share hotel information, which alleviates some of the stress on hotel staff. The devices also offer smart hotel room functionality to control lighting, adjust thermostats, close curtains and more. The operational efficiencies are an added benefit to increase guest satisfaction. The company earlier this month introduced Angie PBX, a cloud phone service that has drastically reduced telephony costs for hotel customers. Hotels can replace outdated in-room phones with Angie voice-enabled digital assistants and still meet emergency calling requirements. Additionally, Angie Casting and the mobile guest app enhance the hotel stay without straining budgets. All of these offerings can be implemented under the subscription option. Angie Hospitality will demo its new solutions at Cyber HITEC October 27-29, 2020, at booth #829 in the Clean to Cleaner Pavilion. About Angie HospitalityAngie Hospitality by Nomadix delivers contactless technology for hotels. The company offers patented voice and touchscreen capabilities with their purpose-built solutions for the hotel environment. Products include the world's first 24-hour interactive guest room assistant, mobile app, casting, and PBX solutions for hoteliers looking to increase guest satisfaction, improve staff efficiencies and maximize revenue opportunities. For more information, visit angie.ai. Media Contacts:Aubrey CogginsDirector of Marketing[emailprotected] Sami StansberryPR for Angie[emailprotected]312-481-6251 SOURCE Angie Hospitality
|
edtsum5875
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CALGARY, April 30, 2020 /PRNewswire/ - Today, WestJet announcedit has reached an agreementwith the Airline Pilot Association (ALPA), tosave more than 1,000pilot jobsatWestJet, WestJet Encore and Swoopamidst the COVID-19 crisis.The airline had previously confirmed that1,700 pilots across WestJet, WestJet Encore and Swoop had received layoff notifications, effective either May 1 or June 1, 2020. "I'm pleased thatALPA and WestJet, throughrobust negotiations and collaborationhave come together tominimize the impact of theunprecedentedCOVID-19 pandemicon our pilot groups," said Jeff Martin, WestJet Executive Vice-President,and Chief Operating Officer."We thank ALPAforthe joint effort in working with us to assist our airline in remainingflexibleandcompetitive. Our pilots will be a critical element of our recovery andretaining theseimportant rolesleavesus better positioned to recover strongly andreturnWestJet to a global airline." SaidALPAMECChair, representing WestJet and Swoop, Captain DaveColquhoun, "The agreement we have reached is due to the dedication of the WestJet executive and the WestJet pilots, in a time where everyone is making sacrifices to protect our airline. ALPA's elected leadership appreciates the time and effort that was involved in working together to minimize the impact to our members and we look forward to the time when all of our pilots, and many of the other WestJetters who are casualties of this crisis, are back to work at WestJet." Said ALPA MEC Chair, representing WestJet Encore, Captain Ryan Leier, "On behalf of WestJet Encore pilots,I am pleased we were able to successfully reach an agreement.We recognize that these are uncharted skies as we deal with the effects of COVID-19and this agreementwill help ourpilots and the airline get through this together." The agreement allows the WestJet Group of Companies to retainpilotsacross the three groups, through theamendmentof termstothe currentagreements. WestJet continues to work collaboratively with its employee andlabourgroups as well as all levels of government to minimize the impactof the COVID-19 crisisto the airline and its employees. WestJet is utilizing the Government of Canada's Canada Emergency WageSubsidy(CEWS)to assist in navigating this pandemicwhile work is not availabledue to the downturn in demand for air travel.Where it is of benefit tothe employee,WestJet willuse CEWSto keep the inactive employee on thepayroll to ensure they remain connected to the company. ALPA will communicate specific details to WestJet, WestJet Encore and SwoopPilots and WestJet will not be providing further information. Connect with WestJet on Facebook atfacebook.com/westjetFollow WestJet on Twitter attwitter.com/westjetFollow WestJet on Instagraminstagram.com/westjet/Subscribe to WestJet on YouTube atyoutube.com/westjetRead the WestJet blog atblog.westjet.com SOURCE WESTJET, an Alberta Partnership Related Links http://www.westjet.com
Answer:
|
WestJet saves 1,000 pilot jobs through ALPA agreements
|
CALGARY, April 30, 2020 /PRNewswire/ - Today, WestJet announcedit has reached an agreementwith the Airline Pilot Association (ALPA), tosave more than 1,000pilot jobsatWestJet, WestJet Encore and Swoopamidst the COVID-19 crisis.The airline had previously confirmed that1,700 pilots across WestJet, WestJet Encore and Swoop had received layoff notifications, effective either May 1 or June 1, 2020. "I'm pleased thatALPA and WestJet, throughrobust negotiations and collaborationhave come together tominimize the impact of theunprecedentedCOVID-19 pandemicon our pilot groups," said Jeff Martin, WestJet Executive Vice-President,and Chief Operating Officer."We thank ALPAforthe joint effort in working with us to assist our airline in remainingflexibleandcompetitive. Our pilots will be a critical element of our recovery andretaining theseimportant rolesleavesus better positioned to recover strongly andreturnWestJet to a global airline." SaidALPAMECChair, representing WestJet and Swoop, Captain DaveColquhoun, "The agreement we have reached is due to the dedication of the WestJet executive and the WestJet pilots, in a time where everyone is making sacrifices to protect our airline. ALPA's elected leadership appreciates the time and effort that was involved in working together to minimize the impact to our members and we look forward to the time when all of our pilots, and many of the other WestJetters who are casualties of this crisis, are back to work at WestJet." Said ALPA MEC Chair, representing WestJet Encore, Captain Ryan Leier, "On behalf of WestJet Encore pilots,I am pleased we were able to successfully reach an agreement.We recognize that these are uncharted skies as we deal with the effects of COVID-19and this agreementwill help ourpilots and the airline get through this together." The agreement allows the WestJet Group of Companies to retainpilotsacross the three groups, through theamendmentof termstothe currentagreements. WestJet continues to work collaboratively with its employee andlabourgroups as well as all levels of government to minimize the impactof the COVID-19 crisisto the airline and its employees. WestJet is utilizing the Government of Canada's Canada Emergency WageSubsidy(CEWS)to assist in navigating this pandemicwhile work is not availabledue to the downturn in demand for air travel.Where it is of benefit tothe employee,WestJet willuse CEWSto keep the inactive employee on thepayroll to ensure they remain connected to the company. ALPA will communicate specific details to WestJet, WestJet Encore and SwoopPilots and WestJet will not be providing further information. Connect with WestJet on Facebook atfacebook.com/westjetFollow WestJet on Twitter attwitter.com/westjetFollow WestJet on Instagraminstagram.com/westjet/Subscribe to WestJet on YouTube atyoutube.com/westjetRead the WestJet blog atblog.westjet.com SOURCE WESTJET, an Alberta Partnership Related Links http://www.westjet.com
|
edtsum5879
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DECATUR, Ga., Nov. 16, 2020 /PRNewswire/ --Today at the annual meeting of the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD), the Neglected Tropical Diseases Support Center announced Doctors Massitan Dembl and Yao Sodahlon as co-winners of the 2020 Kyelem Prize. "The Kyelem Prize recognizes special people in our field who have been particularly effective in bringing together those who implement neglected tropical disease control and elimination programs and those who support or conduct research to address those programs' needs," said Eric Ottesen, former director and special advisor to the Neglected Tropical Diseases Support Center. A Living Legacy The Kyelem Prize is named for the late Dr. Dominique Kyelem (1962-2013). As program director of the Lymphatic Filariasis Support Center (now the Neglected Tropical Diseases Support Center) at The Task Force for Global Health, after an illustrious career as Program Manager for lymphatic filariasis in Burkina Faso, Dr. Kyelem personified the spirit and mission of COR-NTD bringing together partners from both the program implementation and research communities to work on shared goals to optimize NTD control and elimination globally. "As rich as his CV and list of scientific publications were, it was Dominique's personal warmth that made him truly special everyone's friend, everyone's go-to person for help and advice, and the source of everyone's favorite smile and positivity," said Ottesen."Indeed, it was his wonderful personal attributes that we now celebrate in the individuals selected each year to receive the Kyelem Prize competence and effectiveness, collegiality and sincerity, unquenchable determination and optimism." Two Winners Selected Massitan Dembl and Yao Sodahlon were selected by their peers as co-winners of the 2020 Kyelem Prize. Dr. Dembl is the focal point for neglected tropical diseases for Mali's Ministry of Health."Massitan is a fighter at heart, ready to take on challenges at any level technical or policy to make her programs better and more effective for the populations she serves," said Ottesen. Dr. Sodahlon directs the Mectizan Donation Program, having worked previously as a neglected tropical disease program manager in Togo. "Working at the interface of the public and private sectors has its own special hazards, but Yao has not only managed these abundant challenges effectively but has also brought everyone closer together including, especially, the field teams and the communities whose engagement is, without doubt, essential for the success of the global lymphatic filariasis and onchocerciasis programs," said Ottesen. Each year, the COR-NTD Secretariat solicits nominations for the Kyelem Prize from the more than 1,000 researchers, program implementers, donors and World Health Organization representatives invited to attend the annual meeting. A selection committee representative of this community votes anonymously to select a winner. This year, the voting results were so close that two winners were selected. "For both our Prize winners today, a defining characteristic is their truly hands-on engagement with the communities they care for and the research they carry out," said Ottesen. About the Kyelem Prize:The Kyelem Prize is given annually in honor of Dr. Dominique Kyelem at the COR-NTD meeting. After beginning his career as a district medical officer in Burkina Faso, Dr. Kyelem earned his PhD at Liverpool School of Tropical Medicine. He then became program manager for lymphatic filariasis in Burkina Faso, and later served as director of programs in the Lymphatic Filariasis Support Center (now the Neglected Tropical Diseases Support Center) at The Task Force for Global Health until his death in 2013. In addition to his professional legacy which includes being among the first to pilot mass drug administration for lymphatic filariasis he is remembered for his unyielding positivity.Past awardees include Dr. Julie Jacobson (2015), Dr. Vasanthapuram Kumaraswami (2016), Professor David Molyneux (2017), Dr. Mwele Malecela (2017), Professor Alan Fenwick (2018) and Professor John Owusu Gyapong (2019). About COR-NTD:The Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD) is a forum for researchers, program implementers and their supporters with the shared goal of optimizing NTD control and elimination globally. Supported by grants from the Bill & Melinda Gates Foundation, the U.S. Agency for International Development, and the U.K. Agency for International Development, the Neglected Tropical Diseases Support Center at the Task Force for Global Health serves as the Coalition Secretariat. The aim of COR-NTD is to promote new synergies within the operational research community for NTDs and align that research with the program needs and World Health Organization guidelines. For more information, press only: Chelsea Toledo+1 404 592 1466[emailprotected] SOURCE The Task Force for Global Health Related Links www.taskforce.org
Answer:
|
Massitan Dembl and Yao Sodahlon Win 2020 Kyelem Prize Award recognizes technical, programmatic and personal contributions to the control and elimination of neglected tropical diseases
|
DECATUR, Ga., Nov. 16, 2020 /PRNewswire/ --Today at the annual meeting of the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD), the Neglected Tropical Diseases Support Center announced Doctors Massitan Dembl and Yao Sodahlon as co-winners of the 2020 Kyelem Prize. "The Kyelem Prize recognizes special people in our field who have been particularly effective in bringing together those who implement neglected tropical disease control and elimination programs and those who support or conduct research to address those programs' needs," said Eric Ottesen, former director and special advisor to the Neglected Tropical Diseases Support Center. A Living Legacy The Kyelem Prize is named for the late Dr. Dominique Kyelem (1962-2013). As program director of the Lymphatic Filariasis Support Center (now the Neglected Tropical Diseases Support Center) at The Task Force for Global Health, after an illustrious career as Program Manager for lymphatic filariasis in Burkina Faso, Dr. Kyelem personified the spirit and mission of COR-NTD bringing together partners from both the program implementation and research communities to work on shared goals to optimize NTD control and elimination globally. "As rich as his CV and list of scientific publications were, it was Dominique's personal warmth that made him truly special everyone's friend, everyone's go-to person for help and advice, and the source of everyone's favorite smile and positivity," said Ottesen."Indeed, it was his wonderful personal attributes that we now celebrate in the individuals selected each year to receive the Kyelem Prize competence and effectiveness, collegiality and sincerity, unquenchable determination and optimism." Two Winners Selected Massitan Dembl and Yao Sodahlon were selected by their peers as co-winners of the 2020 Kyelem Prize. Dr. Dembl is the focal point for neglected tropical diseases for Mali's Ministry of Health."Massitan is a fighter at heart, ready to take on challenges at any level technical or policy to make her programs better and more effective for the populations she serves," said Ottesen. Dr. Sodahlon directs the Mectizan Donation Program, having worked previously as a neglected tropical disease program manager in Togo. "Working at the interface of the public and private sectors has its own special hazards, but Yao has not only managed these abundant challenges effectively but has also brought everyone closer together including, especially, the field teams and the communities whose engagement is, without doubt, essential for the success of the global lymphatic filariasis and onchocerciasis programs," said Ottesen. Each year, the COR-NTD Secretariat solicits nominations for the Kyelem Prize from the more than 1,000 researchers, program implementers, donors and World Health Organization representatives invited to attend the annual meeting. A selection committee representative of this community votes anonymously to select a winner. This year, the voting results were so close that two winners were selected. "For both our Prize winners today, a defining characteristic is their truly hands-on engagement with the communities they care for and the research they carry out," said Ottesen. About the Kyelem Prize:The Kyelem Prize is given annually in honor of Dr. Dominique Kyelem at the COR-NTD meeting. After beginning his career as a district medical officer in Burkina Faso, Dr. Kyelem earned his PhD at Liverpool School of Tropical Medicine. He then became program manager for lymphatic filariasis in Burkina Faso, and later served as director of programs in the Lymphatic Filariasis Support Center (now the Neglected Tropical Diseases Support Center) at The Task Force for Global Health until his death in 2013. In addition to his professional legacy which includes being among the first to pilot mass drug administration for lymphatic filariasis he is remembered for his unyielding positivity.Past awardees include Dr. Julie Jacobson (2015), Dr. Vasanthapuram Kumaraswami (2016), Professor David Molyneux (2017), Dr. Mwele Malecela (2017), Professor Alan Fenwick (2018) and Professor John Owusu Gyapong (2019). About COR-NTD:The Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD) is a forum for researchers, program implementers and their supporters with the shared goal of optimizing NTD control and elimination globally. Supported by grants from the Bill & Melinda Gates Foundation, the U.S. Agency for International Development, and the U.K. Agency for International Development, the Neglected Tropical Diseases Support Center at the Task Force for Global Health serves as the Coalition Secretariat. The aim of COR-NTD is to promote new synergies within the operational research community for NTDs and align that research with the program needs and World Health Organization guidelines. For more information, press only: Chelsea Toledo+1 404 592 1466[emailprotected] SOURCE The Task Force for Global Health Related Links www.taskforce.org
|
edtsum5882
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, Aug. 17, 2020 /PRNewswire/ -- Read the full report: https://www.reportlinker.com/p05181598/?utm_source=PRN The global edge computing market is projected to grow from USD 3.6 billion in 2020 to USD 15.7 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 34.1% during the forecast period. The edge computingmarket is growing rapidlywith thegrowing adoption of Internet of Things (IoT)across industries; rising demand for low-latency processing and real-time, automated decision-making solutions; and the need for surmounting exponent3ially increasing data volumes and network traffic. However, a reluctance among Small and Medium-sized Enterprises (SMEs)to adopt edge computing solutions owing to initial Capital Expenditure (CAPEX) for infrastructureis projected tolimit the growth of the market.Industrial Internet of Things application segment to grow at the highest CAGR during the forecast periodThe implementation of IoT across industries has increased rapidly, which drives companies to implement solutions that could enhance IoT deployments through data processing closer to the source.By infusing edge computing in Industrial Internet of Things (IIoT) processes, companies could achieve an improved network communication and cooperative coordination with the cloud connected to the system. Further, it helps organizations to reduce workloads by facilitating lost-cost, low-power, and high bandwidth networks.Manufacturing vertical to hold the largest market size during the forecast periodEdge computing facilitates localized processing which helps reduce latency issues and enables smart and intelligent manufacturing through predictive analytics. With the rise in IoT deployment, manufacturing companies have been rapidly adopting edge computing to improve interoperability among IoT devices, reduce unforeseen downtime issues, and improve production efficiency.Edge computing market in Asia Pacific to grow at the highest CAGR during the forecast periodThe high growth of the market in Asia Pacific (APAC)is attributed to the pervasive use of mobile devices, growing data volumes, andincreasingassimilationof workload-centric Information Technology (IT) infrastructure in the region with the rising need of businesses to remain globally competitive.Furthermore, the inclination of countries across the region toward emerging technologies,such as cloud computing, IoT, 5G, and Artificial Intelligence (AI), is also expected to fuel the growth of the edge computingmarket.However, limited technology sophistication among SMEs, privacy issues, and limited technical expertise in advanced technologies remains the biggest hurdle in the edge computing adoption across APAC.Regional technological advances and increasing awareness of edge computing benefits to minimizeinfrastructure complexities and installation costsopens new avenues for the growth of edge computingmarket in the region.Further, in-depth interviews were conducted with the Chief Executive Officers (CEOs), Chief Marketing Officers (CMO), Chief Technology Officers (CTOs), Chief Operating Officers (COOs), Vice Presidents (VPs), Managing Directors (MDs), technology and innovation directors, and related key executives from various key companies and organizations operating in the edge computing market. By Company Tier 133%, Tier 227%, and Tier 340% By Designation C-Level48%, Director Level22%,and Others30% By Region North America42%, Europe28%, andAPAC25%, RoW 5%The edge computing market comprises major solution providers, such asCisco (US), HPE (US), Huawei (China), IBM (US), Dell Technologies (US), Nokia (Finland), Litmus Automation (US), AWS (US), FogHorn Systems (US), SixSq (Switzerland), MachineShop (US), Saguna Networks (Israel), Vapor IO (US), ADLINK (Taiwan), Altran (France), Axellio (US), GE Digital (US), Moxa (Taiwan), Sierra wireless (Canada), Digi International (US), Juniper Networks (US), Clearblade (US), EdgeConneX (US), Edge Intelligence (US), and Edgeworx (US).The study includes an in-depth competitive analysis of these key players in the edge computing market with their company profiles, recent developments, and key market strategies.Research CoverageThe edge computing market revenue is primarily classified into revenues from hardware,platform, and services.Hardware revenue is associated with hardware offerings, such as local data centers, edge gateways, and edge devices, whileplatform revenue is associated with edge computing tools and software.Further, services' revenue is associated with various support and maintenance, consultingand training, and integration services. The market is also segmentedon the basis ofapplication, organization size,vertical, and region.Key benefits of the reportThe report would help the market leaders/new entrants in this market with the information on the closest approximations of the revenue numbers for the overall edge computing market and the subsegments.This report would help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies.The report also helps stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities.Read the full report: https://www.reportlinker.com/p05181598/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com
Answer:
|
The global edge computing market is projected to grow from USD 3.6 billion in 2020 to USD 15.7 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 34.1% Rising focus of enterprises on increasing speed, ensuring resiliency and security, and eliminating outage issues in minimal time, to drive the growth of edge computingmarket
|
NEW YORK, Aug. 17, 2020 /PRNewswire/ -- Read the full report: https://www.reportlinker.com/p05181598/?utm_source=PRN The global edge computing market is projected to grow from USD 3.6 billion in 2020 to USD 15.7 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 34.1% during the forecast period. The edge computingmarket is growing rapidlywith thegrowing adoption of Internet of Things (IoT)across industries; rising demand for low-latency processing and real-time, automated decision-making solutions; and the need for surmounting exponent3ially increasing data volumes and network traffic. However, a reluctance among Small and Medium-sized Enterprises (SMEs)to adopt edge computing solutions owing to initial Capital Expenditure (CAPEX) for infrastructureis projected tolimit the growth of the market.Industrial Internet of Things application segment to grow at the highest CAGR during the forecast periodThe implementation of IoT across industries has increased rapidly, which drives companies to implement solutions that could enhance IoT deployments through data processing closer to the source.By infusing edge computing in Industrial Internet of Things (IIoT) processes, companies could achieve an improved network communication and cooperative coordination with the cloud connected to the system. Further, it helps organizations to reduce workloads by facilitating lost-cost, low-power, and high bandwidth networks.Manufacturing vertical to hold the largest market size during the forecast periodEdge computing facilitates localized processing which helps reduce latency issues and enables smart and intelligent manufacturing through predictive analytics. With the rise in IoT deployment, manufacturing companies have been rapidly adopting edge computing to improve interoperability among IoT devices, reduce unforeseen downtime issues, and improve production efficiency.Edge computing market in Asia Pacific to grow at the highest CAGR during the forecast periodThe high growth of the market in Asia Pacific (APAC)is attributed to the pervasive use of mobile devices, growing data volumes, andincreasingassimilationof workload-centric Information Technology (IT) infrastructure in the region with the rising need of businesses to remain globally competitive.Furthermore, the inclination of countries across the region toward emerging technologies,such as cloud computing, IoT, 5G, and Artificial Intelligence (AI), is also expected to fuel the growth of the edge computingmarket.However, limited technology sophistication among SMEs, privacy issues, and limited technical expertise in advanced technologies remains the biggest hurdle in the edge computing adoption across APAC.Regional technological advances and increasing awareness of edge computing benefits to minimizeinfrastructure complexities and installation costsopens new avenues for the growth of edge computingmarket in the region.Further, in-depth interviews were conducted with the Chief Executive Officers (CEOs), Chief Marketing Officers (CMO), Chief Technology Officers (CTOs), Chief Operating Officers (COOs), Vice Presidents (VPs), Managing Directors (MDs), technology and innovation directors, and related key executives from various key companies and organizations operating in the edge computing market. By Company Tier 133%, Tier 227%, and Tier 340% By Designation C-Level48%, Director Level22%,and Others30% By Region North America42%, Europe28%, andAPAC25%, RoW 5%The edge computing market comprises major solution providers, such asCisco (US), HPE (US), Huawei (China), IBM (US), Dell Technologies (US), Nokia (Finland), Litmus Automation (US), AWS (US), FogHorn Systems (US), SixSq (Switzerland), MachineShop (US), Saguna Networks (Israel), Vapor IO (US), ADLINK (Taiwan), Altran (France), Axellio (US), GE Digital (US), Moxa (Taiwan), Sierra wireless (Canada), Digi International (US), Juniper Networks (US), Clearblade (US), EdgeConneX (US), Edge Intelligence (US), and Edgeworx (US).The study includes an in-depth competitive analysis of these key players in the edge computing market with their company profiles, recent developments, and key market strategies.Research CoverageThe edge computing market revenue is primarily classified into revenues from hardware,platform, and services.Hardware revenue is associated with hardware offerings, such as local data centers, edge gateways, and edge devices, whileplatform revenue is associated with edge computing tools and software.Further, services' revenue is associated with various support and maintenance, consultingand training, and integration services. The market is also segmentedon the basis ofapplication, organization size,vertical, and region.Key benefits of the reportThe report would help the market leaders/new entrants in this market with the information on the closest approximations of the revenue numbers for the overall edge computing market and the subsegments.This report would help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies.The report also helps stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities.Read the full report: https://www.reportlinker.com/p05181598/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com
|
edtsum5886
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN FRANCISCO, Jan. 7, 2021 /PRNewswire/ -- Former US Secretary of State, George P. Shultz, who celebrated his 100th birthday on December 13, 2020, holds the first annual "Voices Youth Award" named in his honor and also in honor of Mikhail Gorbachev, former president of the USSR. It will be presented to youth activist Kehkashan Basu of Toronto, Canada. Continue Reading Former US Secretary of State, George P. Shultz, holds the first Voices Youth Award named in his honor and also in honor of Mikhail Gorbachev, former president of the USSR. Photo Credit: David Fedor. Youth Activist Kehkashan Basu of Toronto, Canada, the first recipient of the Voices Youth Award." A new international youth peace award for nuclear disarmament is bridging an eighty-year age gap between its first recipient and one of the two elder statesmen to whom it is dedicated. Former US Secretary of State, George P. Shultz, celebrated his 100th birthday on December 13, 2020. Kehkashan Basu, the first recipient of the "Voices Youth Award," is 20 years old. Shultz and US President Ronald Reagan came close to an agreement with Gorbachev at the 1986 Reykjavik Summit in Iceland to abolish nuclear weapons. Shultz and Gorbachev have remained friends and are honored together for their "Nuclear Weapons Legacy." The selection of Kehkashan Basu to receive the first annual "Voices Youth Award" was a part of this year's commemoration of the 75th anniversary of the atomic bombings of Hiroshima and Nagasaki, Japan, in August 1945. She received the newly mintedaward on January 6, 2021.Basu has been an advocate for the rights of children and young people since the age of 12. She is the founder and president of Green Hope Foundation, an initiative that promotes peace, nuclear disarmament and sustainable development through education. Voices for a World Free of Nuclear Weapons is part of United Religions Initiative (URI) the largest grassroots interfaith network in the world: building bridges of compassion and understanding between people of different religious and cultural traditions. URI currently has 1,056 Cooperation Circles in 112 countries with over one million members.Every year URI impacts over 50 million people globally. Nominations are being invited for the Second Annual "Voices Youth Award" from individuals or organizations promoting the abolition of nuclear weapons. Submission guidelines will be available on January 28, 2021 on the Voices for a World Free of Nuclear Weapons website, www.voices-uri.org. The winner of the. Second Annual "Voices Youth Award" will be selected and announced by August 1, 2021 ahead of the anniversary of the Hiroshima and Nagasaki bombings on August 6 and 9. For more information: Julie SchellingEmail: [emailprotected]Website: www.voices-URI.org SOURCE Voices for a World Free of Nuclear Weapons (URI) Related Links https://www.voices-uri.org/
Answer:
|
Age Passes the Baton to Youth Voices for a World Free of Nuclear Weapons announces annual "Voices Youth Award"
|
SAN FRANCISCO, Jan. 7, 2021 /PRNewswire/ -- Former US Secretary of State, George P. Shultz, who celebrated his 100th birthday on December 13, 2020, holds the first annual "Voices Youth Award" named in his honor and also in honor of Mikhail Gorbachev, former president of the USSR. It will be presented to youth activist Kehkashan Basu of Toronto, Canada. Continue Reading Former US Secretary of State, George P. Shultz, holds the first Voices Youth Award named in his honor and also in honor of Mikhail Gorbachev, former president of the USSR. Photo Credit: David Fedor. Youth Activist Kehkashan Basu of Toronto, Canada, the first recipient of the Voices Youth Award." A new international youth peace award for nuclear disarmament is bridging an eighty-year age gap between its first recipient and one of the two elder statesmen to whom it is dedicated. Former US Secretary of State, George P. Shultz, celebrated his 100th birthday on December 13, 2020. Kehkashan Basu, the first recipient of the "Voices Youth Award," is 20 years old. Shultz and US President Ronald Reagan came close to an agreement with Gorbachev at the 1986 Reykjavik Summit in Iceland to abolish nuclear weapons. Shultz and Gorbachev have remained friends and are honored together for their "Nuclear Weapons Legacy." The selection of Kehkashan Basu to receive the first annual "Voices Youth Award" was a part of this year's commemoration of the 75th anniversary of the atomic bombings of Hiroshima and Nagasaki, Japan, in August 1945. She received the newly mintedaward on January 6, 2021.Basu has been an advocate for the rights of children and young people since the age of 12. She is the founder and president of Green Hope Foundation, an initiative that promotes peace, nuclear disarmament and sustainable development through education. Voices for a World Free of Nuclear Weapons is part of United Religions Initiative (URI) the largest grassroots interfaith network in the world: building bridges of compassion and understanding between people of different religious and cultural traditions. URI currently has 1,056 Cooperation Circles in 112 countries with over one million members.Every year URI impacts over 50 million people globally. Nominations are being invited for the Second Annual "Voices Youth Award" from individuals or organizations promoting the abolition of nuclear weapons. Submission guidelines will be available on January 28, 2021 on the Voices for a World Free of Nuclear Weapons website, www.voices-uri.org. The winner of the. Second Annual "Voices Youth Award" will be selected and announced by August 1, 2021 ahead of the anniversary of the Hiroshima and Nagasaki bombings on August 6 and 9. For more information: Julie SchellingEmail: [emailprotected]Website: www.voices-URI.org SOURCE Voices for a World Free of Nuclear Weapons (URI) Related Links https://www.voices-uri.org/
|
edtsum5888
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, July 24, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.WeissLaw LLP1500 Broadway, 16th FloorNew York, NY 10036(212)682-3025(888) 593-4771[emailprotected] resTORbio, Inc. (NASDAQ: TORC) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of resTORbio, Inc. (NASDAQ: TORC) in connection with the proposed merger of the company with privately-held biopharmaceutical company Adicet Bio, Inc. ("Adicet"). Under the terms of the merger agreement, Adicet will merge with a wholly-owned subsidiary of TORC in an all-stock transaction, with the equityholders of Adicet becoming owners of 75% of the outstanding common stock of TORC upon the close of the merger. The remaining 25% of the combined surviving company will be owned by former TORC shareholders. If you own TORC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/restorbio-inc/ Vivint Solar, Inc. (NYSE: VSLR) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Vivint Solar, Inc. (NYSE: VSLR)in connection with the proposed acquisition of the company by Sunrun, Inc. ("RUN"). Under the terms of the agreement, VSLR shareholders will be entitled to receive 0.55 shares of RUN common stock for each VSLR share that they own, representing implied per-share merger consideration of $23.35 based upon RUN's July 23, 2020 closing price of $42.46. If you own VSLR shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/vslr-inc/ SOURCE WeissLaw LLP Related Links http://weisslawllp.com
Answer:
|
SHAREHOLDER ALERT: WeissLaw LLP Reminds TORC and VSLR Shareholders About Its Ongoing Investigations
|
NEW YORK, July 24, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.WeissLaw LLP1500 Broadway, 16th FloorNew York, NY 10036(212)682-3025(888) 593-4771[emailprotected] resTORbio, Inc. (NASDAQ: TORC) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of resTORbio, Inc. (NASDAQ: TORC) in connection with the proposed merger of the company with privately-held biopharmaceutical company Adicet Bio, Inc. ("Adicet"). Under the terms of the merger agreement, Adicet will merge with a wholly-owned subsidiary of TORC in an all-stock transaction, with the equityholders of Adicet becoming owners of 75% of the outstanding common stock of TORC upon the close of the merger. The remaining 25% of the combined surviving company will be owned by former TORC shareholders. If you own TORC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/restorbio-inc/ Vivint Solar, Inc. (NYSE: VSLR) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Vivint Solar, Inc. (NYSE: VSLR)in connection with the proposed acquisition of the company by Sunrun, Inc. ("RUN"). Under the terms of the agreement, VSLR shareholders will be entitled to receive 0.55 shares of RUN common stock for each VSLR share that they own, representing implied per-share merger consideration of $23.35 based upon RUN's July 23, 2020 closing price of $42.46. If you own VSLR shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/vslr-inc/ SOURCE WeissLaw LLP Related Links http://weisslawllp.com
|
edtsum5889
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: Converge announces its intention to begin offering the Converge TrustBuilder Platform, a blockchain-based solution toolkit, to help customers create secure trust ecosystems. TORONTO andGATINEAU, QC, May 19, 2020 /PRNewswire/ -Converge Technology Solutions Corp. ("Converge" or "the Company") (TSXV:CTS)(FSE:0ZB) (OTCQX:CTSDF) a national platform of regionally focused Hybrid IT solution providers ("ITSPs") in the U.S. and Canada has announced, in connection with PROMPT, the creation of a trust ecosystem builder toolkit to be marketed as the Converge TrustBuilder Platform. This was made possible by Becker-Carroll, a Converge Company's successful submission of its application for the platform to the Quebec Cybersecurity Innovation Program. The Converge TrustBuilder Platform utilizes the new W3C verifiable credential standard and allows customers to create, manage, and monetize trust ecosystems. The Company is working closely with In-Sec-M (a national cybersecurity cluster), the Digital Identity Laboratory of Canada, and the Digital Identity and Authentication Council of Canada (DIACC) to ensure adherence to emerging industry standards and the Pan-Canadian Trust Framework (PCTF). "With the discussion of a potential demand for digital passports due to the COVID-19 pandemic, this technology is now a priority, and we are proud to be contributing to its development. The Converge national platform, along with its approximate 200 sales professionals remain agreat channel for ourselves and our vendors to launch new products. It is my opinion that we are uniquely qualified to solve the biggest problem that all highly innovative solutions face, and that is getting early adopters on-board and proving the value of the technology by building successes for them," said Shaun Maine, Chief Executive Officer of Converge. "We would also like to thank the City of Gatineau, In-Sec-M, PROMPT, and the Quebec Government for creating this incredible innovation-fostering environment. We are thrilled to be a part of it, and we are dedicated to helping it succeed." "PROMPT is proud to support such a foundational project for Quebec in the strategic area of cybersecurity and digital identity. PROMPT's mission is to generate innovation through collaboration and research and, in doing so, propel the emergence of world-class economic and technological leaders. The project submitted by Becker-Carroll is among the most promising and visionary, and it will certainly contribute to reinforcing Quebec's position in the cybersecurity domain," commented Luc Sirois, General Manager of PROMPT. About PROMPTPROMPT is a leading organization whose primary objective is to increase Qubec's Information and Communications Technologies (ICT) industry's competitiveness by stimulating R&D partnerships. PROMPT is responsible for managing the Quebec Cybersecurity Innovation Program. For more information, visit promptinnov.com/en. About Converge Converge Technology Solutions Corp. is a North American IT Solution Provider focused on delivering industry leading solutions and services. Converge's regional sales and services organizations deliver advanced analytics, cloud, cybersecurity, and managed services offerings to clients across various industries. The Company supports these solutions with talent expertise and digital infrastructure offerings across all major IT vendors in the marketplace.This multi-faceted approach enables Converge to address the unique business and technology requirements for all clients in the public and private sectors. For more information, visit convergetp.com. SOURCE Converge Technology Solutions Corp. Related Links https://convergetp.com/
Answer:
|
Converge Technology Solutions Corp. Announces New TrustBuilder Platform
|
Converge announces its intention to begin offering the Converge TrustBuilder Platform, a blockchain-based solution toolkit, to help customers create secure trust ecosystems. TORONTO andGATINEAU, QC, May 19, 2020 /PRNewswire/ -Converge Technology Solutions Corp. ("Converge" or "the Company") (TSXV:CTS)(FSE:0ZB) (OTCQX:CTSDF) a national platform of regionally focused Hybrid IT solution providers ("ITSPs") in the U.S. and Canada has announced, in connection with PROMPT, the creation of a trust ecosystem builder toolkit to be marketed as the Converge TrustBuilder Platform. This was made possible by Becker-Carroll, a Converge Company's successful submission of its application for the platform to the Quebec Cybersecurity Innovation Program. The Converge TrustBuilder Platform utilizes the new W3C verifiable credential standard and allows customers to create, manage, and monetize trust ecosystems. The Company is working closely with In-Sec-M (a national cybersecurity cluster), the Digital Identity Laboratory of Canada, and the Digital Identity and Authentication Council of Canada (DIACC) to ensure adherence to emerging industry standards and the Pan-Canadian Trust Framework (PCTF). "With the discussion of a potential demand for digital passports due to the COVID-19 pandemic, this technology is now a priority, and we are proud to be contributing to its development. The Converge national platform, along with its approximate 200 sales professionals remain agreat channel for ourselves and our vendors to launch new products. It is my opinion that we are uniquely qualified to solve the biggest problem that all highly innovative solutions face, and that is getting early adopters on-board and proving the value of the technology by building successes for them," said Shaun Maine, Chief Executive Officer of Converge. "We would also like to thank the City of Gatineau, In-Sec-M, PROMPT, and the Quebec Government for creating this incredible innovation-fostering environment. We are thrilled to be a part of it, and we are dedicated to helping it succeed." "PROMPT is proud to support such a foundational project for Quebec in the strategic area of cybersecurity and digital identity. PROMPT's mission is to generate innovation through collaboration and research and, in doing so, propel the emergence of world-class economic and technological leaders. The project submitted by Becker-Carroll is among the most promising and visionary, and it will certainly contribute to reinforcing Quebec's position in the cybersecurity domain," commented Luc Sirois, General Manager of PROMPT. About PROMPTPROMPT is a leading organization whose primary objective is to increase Qubec's Information and Communications Technologies (ICT) industry's competitiveness by stimulating R&D partnerships. PROMPT is responsible for managing the Quebec Cybersecurity Innovation Program. For more information, visit promptinnov.com/en. About Converge Converge Technology Solutions Corp. is a North American IT Solution Provider focused on delivering industry leading solutions and services. Converge's regional sales and services organizations deliver advanced analytics, cloud, cybersecurity, and managed services offerings to clients across various industries. The Company supports these solutions with talent expertise and digital infrastructure offerings across all major IT vendors in the marketplace.This multi-faceted approach enables Converge to address the unique business and technology requirements for all clients in the public and private sectors. For more information, visit convergetp.com. SOURCE Converge Technology Solutions Corp. Related Links https://convergetp.com/
|
edtsum5891
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BROOKFIELD, Wis., July 7, 2020 /PRNewswire/ --More than half of funeral directors have experienced increased cremation rates due to the coronavirus pandemic, according to the 2020 Cremation and Burial Report, released by the National Funeral Directors Association(NFDA). The pandemic has forever changed the way families memorialize a loved one further solidifying cremation as the leading end-of-life preference, and funeral directors as unequivocal first responders in times of crisis. While the impact of COVID-19 has been both unprecedented and unpredictable, the shift toward cremation has been a forecasted pattern by NFDA. In 2015, the national cremation rate surpassed the burial rate for the first time in U.S. history. In 2020, the projected burial rate is 37.5% (down 7.7% from 2015) and projected cremation rate is 56.0% (up 8.1% from 2015). This preference is predicted to only strengthen, with projections for 2025 indicating that the burial rate will be 30.6% (down 14.6% from 2015) and the cremation rate 63.3% (up 15.4% from 2015). End-of-life services have looked different in 2020 due to COVID-19, starting with the sheer volume of deaths. An additional 200,000 U.S. deaths are estimated this year because of the pandemic, eight out of ten of which are adults 65 years and older, according to NFDA's 2020 Cremation and Burial Report. That means more families than usual are planning funerals. However, because of "safer-at-home" orders, social distancing rules and restrictions on gatherings, most have had to postpone or revise memorialization plans. In fact, 50% of NFDA-member funeral homes report families postponing a loved one's service due to COVID-19, with plans to hold some type of service with a funeral director's assistance in later months. The pandemic has also highlighted the importance of funeral directors, not only as leaders in their communities, but also as a vital network of often overlooked first responders during national and global crises. From natural disasters to mass tragedies, funeral directors are on the front lines helping families navigate uncharted territory it is no different with COVID-19. In fact, nearly 900 funeral professionals from across the country volunteered to assist funeral directors and others with respectfully caring for the dead in hotspots, like New York and Michigan, when they were experiencing spikes in COVID-related deaths. "Throughout the COVID-19 pandemic, funeral directors have been an invaluable part of the community, providing constant support and flexibility as families make already difficult decisions under seemingly impossible circumstances," said 2019-2020 NFDA president, Bryant Hightower, CFSP. "There was and is no road map for funeral directors during this unprecedented time, but they have undoubtedly risen to the occasion and adjusted their services to meet the moment." Ultimately, the changes funeral directors made to meet this moment will propel funeral service into the future. While COVID-19 restrictions have made it difficult or impossible for families to gather and grieve, it has highlighted the ability of funeral homes to meet every family's unique needs. For example, nearly half of NFDA-member funeral homes have started offering livestreaming options since the onset of COVID-19, offering widespread accessibility to loved ones who are unable to be physically present for a service. NFDA expects this trend to continue as social distancing becomes the norm for the foreseeable future. With families and funeral directors having to quickly pivot plans in recent months, it highlights both the uncertainty of death and the importance of preplanning. Whether families prefer burial or are considering cremation, like most Americans, they might not know where to start. Answering questions at all stages of planning, Remembering A Life(www.RememberingALife.com), NFDA's family outreach and education website, offers guidance on where to begin the planning process, the kinds of decisions that families can make, and the many options available to make a tribute personal and meaningful, especially during the time of COVID-19. Whether visitors are curious about their own affairs or need fast answers following the death of a loved one, the "Ask a Funeral Expert" tool gives families access to experienced professionals who can answer questions or refer them to a local funeral director. As the trusted leader and worldwide resource for the funeral service profession, NFDA lists Remembering A Life among their top resources providing helpful information about planning a meaningful service, as well as resources to help people understand their own and others' grief and loss. About the NFDA 2020 Cremation and Burial Report: The statistical projections contained in the 2020 NFDA Cremation and Burial Report were compiled by the University ofWisconsin-Madison Applied Population Laboratory Department of Community and EnvironmentalSociology. State-level deaths by method of disposition data were collected from state vital statistics departments or similar state regulatory agencies for the years 2002-18.Other findings presented in the report are from proprietary NFDA research studies, suchas the 2020 NFDA Consumer Awareness & Preferences Study. About National Funeral Directors Association (NFDA): NFDA is the world's leading and largest funeral service association, serving more than 20,000 individual members who represent nearly 11,000 funeral homes in the United States and 49 countries around the world. NFDA is the trusted leader, beacon for ethics and the strongest advocate for the profession. NFDA is the association of choice because it offers funeral professionals comprehensive educational resources, tools to manage successful businesses, guidance to become pillars in their communities and the expertise to foster future generations of funeral professionals. NFDA is headquartered in Brookfield, Wis., and has an office in Washington, D.C. For more information, please contact 800-228-6332 or visit https://www.nfda.org/. SOURCE National Funeral Directors Association
Answer:
|
The Future Of Funerals: COVID-19 Restrictions Force Funeral Directors To Adapt, Propelling Industry Forward NFDA 2020 Cremation and Burial Report Reveals Embrace Of Technology In Fifth Consecutive Year Of Growth For Cremation
|
BROOKFIELD, Wis., July 7, 2020 /PRNewswire/ --More than half of funeral directors have experienced increased cremation rates due to the coronavirus pandemic, according to the 2020 Cremation and Burial Report, released by the National Funeral Directors Association(NFDA). The pandemic has forever changed the way families memorialize a loved one further solidifying cremation as the leading end-of-life preference, and funeral directors as unequivocal first responders in times of crisis. While the impact of COVID-19 has been both unprecedented and unpredictable, the shift toward cremation has been a forecasted pattern by NFDA. In 2015, the national cremation rate surpassed the burial rate for the first time in U.S. history. In 2020, the projected burial rate is 37.5% (down 7.7% from 2015) and projected cremation rate is 56.0% (up 8.1% from 2015). This preference is predicted to only strengthen, with projections for 2025 indicating that the burial rate will be 30.6% (down 14.6% from 2015) and the cremation rate 63.3% (up 15.4% from 2015). End-of-life services have looked different in 2020 due to COVID-19, starting with the sheer volume of deaths. An additional 200,000 U.S. deaths are estimated this year because of the pandemic, eight out of ten of which are adults 65 years and older, according to NFDA's 2020 Cremation and Burial Report. That means more families than usual are planning funerals. However, because of "safer-at-home" orders, social distancing rules and restrictions on gatherings, most have had to postpone or revise memorialization plans. In fact, 50% of NFDA-member funeral homes report families postponing a loved one's service due to COVID-19, with plans to hold some type of service with a funeral director's assistance in later months. The pandemic has also highlighted the importance of funeral directors, not only as leaders in their communities, but also as a vital network of often overlooked first responders during national and global crises. From natural disasters to mass tragedies, funeral directors are on the front lines helping families navigate uncharted territory it is no different with COVID-19. In fact, nearly 900 funeral professionals from across the country volunteered to assist funeral directors and others with respectfully caring for the dead in hotspots, like New York and Michigan, when they were experiencing spikes in COVID-related deaths. "Throughout the COVID-19 pandemic, funeral directors have been an invaluable part of the community, providing constant support and flexibility as families make already difficult decisions under seemingly impossible circumstances," said 2019-2020 NFDA president, Bryant Hightower, CFSP. "There was and is no road map for funeral directors during this unprecedented time, but they have undoubtedly risen to the occasion and adjusted their services to meet the moment." Ultimately, the changes funeral directors made to meet this moment will propel funeral service into the future. While COVID-19 restrictions have made it difficult or impossible for families to gather and grieve, it has highlighted the ability of funeral homes to meet every family's unique needs. For example, nearly half of NFDA-member funeral homes have started offering livestreaming options since the onset of COVID-19, offering widespread accessibility to loved ones who are unable to be physically present for a service. NFDA expects this trend to continue as social distancing becomes the norm for the foreseeable future. With families and funeral directors having to quickly pivot plans in recent months, it highlights both the uncertainty of death and the importance of preplanning. Whether families prefer burial or are considering cremation, like most Americans, they might not know where to start. Answering questions at all stages of planning, Remembering A Life(www.RememberingALife.com), NFDA's family outreach and education website, offers guidance on where to begin the planning process, the kinds of decisions that families can make, and the many options available to make a tribute personal and meaningful, especially during the time of COVID-19. Whether visitors are curious about their own affairs or need fast answers following the death of a loved one, the "Ask a Funeral Expert" tool gives families access to experienced professionals who can answer questions or refer them to a local funeral director. As the trusted leader and worldwide resource for the funeral service profession, NFDA lists Remembering A Life among their top resources providing helpful information about planning a meaningful service, as well as resources to help people understand their own and others' grief and loss. About the NFDA 2020 Cremation and Burial Report: The statistical projections contained in the 2020 NFDA Cremation and Burial Report were compiled by the University ofWisconsin-Madison Applied Population Laboratory Department of Community and EnvironmentalSociology. State-level deaths by method of disposition data were collected from state vital statistics departments or similar state regulatory agencies for the years 2002-18.Other findings presented in the report are from proprietary NFDA research studies, suchas the 2020 NFDA Consumer Awareness & Preferences Study. About National Funeral Directors Association (NFDA): NFDA is the world's leading and largest funeral service association, serving more than 20,000 individual members who represent nearly 11,000 funeral homes in the United States and 49 countries around the world. NFDA is the trusted leader, beacon for ethics and the strongest advocate for the profession. NFDA is the association of choice because it offers funeral professionals comprehensive educational resources, tools to manage successful businesses, guidance to become pillars in their communities and the expertise to foster future generations of funeral professionals. NFDA is headquartered in Brookfield, Wis., and has an office in Washington, D.C. For more information, please contact 800-228-6332 or visit https://www.nfda.org/. SOURCE National Funeral Directors Association
|
edtsum5894
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, June 24, 2020 /PRNewswire/ -- McCann Health Managed Markets was named "Agency of The Year" for healthcare communications agencies $25M in size or smaller at the 2020 Manny Awards, awarded by Med Ad News. The magazine isthe leading pharmaceutical business and marketing publication and the awards celebrate the best in the healthcare communications industry. (PRNewsfoto/McCann Health) This represents the first time a managed markets agency has won an Agency of the Year award in this competition.McCann Health Managed Markets was also a finalist with two nominations for the Best Managed Markets Campaign category. The Mountain Lakes, NJ-based agency won this category for the third straight year with a win for Regeneron's 'Access Adventure.' McCann Health Managed Markets was recognized for growing the agency's business by 26 percent, overachieving both growth and revenue records. "We hired over 30 new people to handle our amazing growth and have become a talent destination for market access expertise," says McCann Health Managed Markets President Kim Wishnow-Per. "We have a great culture that people say is unique, and we're committed to programs that support professional growth and work-life balance. Identifying and growing that talent is critical to driving the right solutions for our clients." McCann Health Managed Markets is the cornerstone of the McCann Health network's access, value and evidence offering in the US. New business wins in 2019 with Janssen Immunology, Novartis and AstraZeneca helped fuel this record-breaking year. To support this new work, the agency also expanded its strategy department with seasoned market access experts and increased its Payer Consultancy Panel. Additionally, McCann Health Managed Markets expanded its Strategic Marketing Fellowship Program, which is part of the prestigious Rutgers Pharmaceutical Industry FellowshipProgram, and its academic partnerships by adding Purdue College of Pharmacy Advanced Pharmacy Practice Experience (APPE) PharmD program to its roster.As the spotlight on access to treatments intensifies, McCann Health Managed Markets understands that the fast-paced movement of the industry requires agility. With breakthrough achievements, the agency's momentum shows no signs of stopping. About McCann HealthMcCann Health, three-time Network of the Year winner at Cannes Lions Health and winner of an unprecedented twelve Network of the Year titles from the industry's top five creative award shows, is one of the world's most awarded global healthcare communications networks. Through combining science, creative and strategy we strive to deliver best-in-class services to our clients. Our 1,900+ employees in 60 offices across 20 countries and 6 continents are united by one vision: to help our clients play a meaningful role for healthier lives. McCann Health spans a range of global practices including strategic consulting, healthcare professional marketing, medical communications, consumer health and wellness, global health and specialty practices like pharmacy, payer and patient engagement. McCann Health is a part of McCann Worldgroup and the Interpublic Group (NYSE: IPG), a global leader in modern marketing solutions.SOURCE McCann Health
Answer:
|
McCann Health Managed Markets Named Agency Of The Year At Med Ad News' 2020 Manny Awards
|
NEW YORK, June 24, 2020 /PRNewswire/ -- McCann Health Managed Markets was named "Agency of The Year" for healthcare communications agencies $25M in size or smaller at the 2020 Manny Awards, awarded by Med Ad News. The magazine isthe leading pharmaceutical business and marketing publication and the awards celebrate the best in the healthcare communications industry. (PRNewsfoto/McCann Health) This represents the first time a managed markets agency has won an Agency of the Year award in this competition.McCann Health Managed Markets was also a finalist with two nominations for the Best Managed Markets Campaign category. The Mountain Lakes, NJ-based agency won this category for the third straight year with a win for Regeneron's 'Access Adventure.' McCann Health Managed Markets was recognized for growing the agency's business by 26 percent, overachieving both growth and revenue records. "We hired over 30 new people to handle our amazing growth and have become a talent destination for market access expertise," says McCann Health Managed Markets President Kim Wishnow-Per. "We have a great culture that people say is unique, and we're committed to programs that support professional growth and work-life balance. Identifying and growing that talent is critical to driving the right solutions for our clients." McCann Health Managed Markets is the cornerstone of the McCann Health network's access, value and evidence offering in the US. New business wins in 2019 with Janssen Immunology, Novartis and AstraZeneca helped fuel this record-breaking year. To support this new work, the agency also expanded its strategy department with seasoned market access experts and increased its Payer Consultancy Panel. Additionally, McCann Health Managed Markets expanded its Strategic Marketing Fellowship Program, which is part of the prestigious Rutgers Pharmaceutical Industry FellowshipProgram, and its academic partnerships by adding Purdue College of Pharmacy Advanced Pharmacy Practice Experience (APPE) PharmD program to its roster.As the spotlight on access to treatments intensifies, McCann Health Managed Markets understands that the fast-paced movement of the industry requires agility. With breakthrough achievements, the agency's momentum shows no signs of stopping. About McCann HealthMcCann Health, three-time Network of the Year winner at Cannes Lions Health and winner of an unprecedented twelve Network of the Year titles from the industry's top five creative award shows, is one of the world's most awarded global healthcare communications networks. Through combining science, creative and strategy we strive to deliver best-in-class services to our clients. Our 1,900+ employees in 60 offices across 20 countries and 6 continents are united by one vision: to help our clients play a meaningful role for healthier lives. McCann Health spans a range of global practices including strategic consulting, healthcare professional marketing, medical communications, consumer health and wellness, global health and specialty practices like pharmacy, payer and patient engagement. McCann Health is a part of McCann Worldgroup and the Interpublic Group (NYSE: IPG), a global leader in modern marketing solutions.SOURCE McCann Health
|
edtsum5912
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SARATOGA SPRINGS, N.Y. and CHARLOTTE, N.C., March 22, 2021 /PRNewswire/ --Fingerpaint, a full-service health and wellness marketing agency, has executed a strategic investment in Leaderboard Branding, a leading global naming and branding business headquartered in Charlotte, N.C., to grow its portfolio of companies. Details of the transaction were not disclosed. Brannon Cashion, Ed Mitzen Fingerpaint is known for its innovative and data-driven approach to providing integrated marketing services to a growing roster of healthcare clients, specifically in the pharmaceutical, rare disease, and gene therapy sectors. The investment in Leaderboard Branding is expected to increase Fingerpaint's global reach and expand services to better support clients in earlier stages of the commercialization process. As part of the transaction, Brannon Cashion, a Managing Partner at Leaderboard Branding, will join Fingerpaint's operating board. He brings over two decades of leadership experience in the global healthcare naming and strategic branding space. "Brannon and his team have built a best-in-class business that aligns with Fingerpaint's people-first values and mission, and we are pleased to welcome Leaderboard Branding to the Fingerpaint family," said Ed Mitzen, Founder of Fingerpaint. "Partnering with Leaderboard Branding is an investment in our never-ending commitment to continue adding services to meet the needs of our clients, allowing us to continue building out a world-class company within the healthcare marketing industry. ""We love the work Fingerpaint does and its people-first culture," said Mr. Cashion. "We are excited to align ourselves with a company with similar values that is doing innovative and exceptional work and can offer an expanded set of services to our clients. This is an opportunity to bring together two businesses that complement each other in unique ways." Knox Lane, a private equity firm based in San Francisco, is a strategic investor in Fingerpaint. Shamik Patel, Partner at Knox Lane, commented, "Leaderboard Branding supports the Fingerpaint team's continued commitment to being a best-in-class commercialization services provider for biopharma. We are confident the addition of Leaderboard Branding will accelerate Fingerpaint's growth initiatives and enhance its reputation as a value-added partner to its clients."Leaderboard Branding joins Fingerpaint companies 1798, a market access and commercialization firm that specializes in healthcare consulting services including patient and provider access services, financial impact analysis and analytics, competitive intelligence, and pull-through solutions; and Photo 51, a consultancy focused solely on advanced therapeutics, such as gene and cell therapies. About FingerpaintReset your expectations of a health and wellness agency. Independent by design and built on a foundation of empathy, Fingerpaint is biopharma's commercialization partner for integrated solutions. At its core is an award-winning global team of more than 450 people who are committed to creating and executing meaningful brand experiences for healthcare providers, care partners, and patients.In 2021, Fingerpaint made a strategic investment in Leaderboard Branding, a leading global naming and branding business. In 2020, Fingerpaint acquired 1798, a market access and commercialization firm located inLa Jolla, Calif., adding to its portfolio of services in support of biopharma customers. The agency also launched Photo 51, a gene therapy consultancy. Fingerpaint was named 2019 Agency of the Year by Med Ad News, and in 2018, it won the Heart Award from Med Ad News for its commitment to philanthropy and social causes. Additionally, it has been on Inc. Magazine's list of the 5,000 Fastest-Growing Companies for the past eight years. Visit us atFingerpaintand follow us on Facebook, Twitter, LinkedIn, and Instagram.About Leaderboard Branding Leaderboard Branding, a Fingerpaint company, is a global naming and branding firm that delivers strategic insights and world-class creativity to every client, on every engagement. Built on the tenets of put people first and take pride in your work, Leaderboard Branding has developed strong and strategic partnerships with healthcare, biopharma, consumer, and B2B companies.In the biopharma and healthcare space, Leaderboard Branding supports clients in the early phases of clinical development. The expert strategists at Leaderboard Branding have a unique ability to optimize a brand's commercial potential while mitigating safety concerns and aligning to regulatory guidelines. With expertise in nonproprietary naming, clinical trial branding, global trade name development, and visual design, Leaderboard Branding provides creative solutions through each phase of the drug development process. Leaderboard Branding's drug safety consulting and assessment capabilities help clients make crucial commercial decisions and regulatory submissions with confidence. Connect with us atLeaderboard Brandingand follow us onLinkedIn,Twitter, andFacebook.About Knox LaneFormed in 2019 and based inSan Francisco, Knox Lane is a middle-market investment firm led by and comprised of a team of accomplished investors and operators with a shared work history and a strong track record of partnering with leading companies to accelerate transformational growth. Knox Lane employs an investor-operator mindset and seeks to provide support across a number of business components, including human capital, brand management, end-to-end digital transformation, sourcing, supply chain and logistics, strategic acquisitions and business development.Media ContactJon Keehner / Julie HamiltonJoele Frank, Wilkinson Brimmer Katcher212-355-4449SOURCE Fingerpaint Related Links https://www.fingerpaint.com
Answer:
|
Fingerpaint Announces Strategic Investment in Leaderboard Branding Supports Fingerpaint's Continued Expansion of its World-Class Healthcare Commercialization Capabilities
|
SARATOGA SPRINGS, N.Y. and CHARLOTTE, N.C., March 22, 2021 /PRNewswire/ --Fingerpaint, a full-service health and wellness marketing agency, has executed a strategic investment in Leaderboard Branding, a leading global naming and branding business headquartered in Charlotte, N.C., to grow its portfolio of companies. Details of the transaction were not disclosed. Brannon Cashion, Ed Mitzen Fingerpaint is known for its innovative and data-driven approach to providing integrated marketing services to a growing roster of healthcare clients, specifically in the pharmaceutical, rare disease, and gene therapy sectors. The investment in Leaderboard Branding is expected to increase Fingerpaint's global reach and expand services to better support clients in earlier stages of the commercialization process. As part of the transaction, Brannon Cashion, a Managing Partner at Leaderboard Branding, will join Fingerpaint's operating board. He brings over two decades of leadership experience in the global healthcare naming and strategic branding space. "Brannon and his team have built a best-in-class business that aligns with Fingerpaint's people-first values and mission, and we are pleased to welcome Leaderboard Branding to the Fingerpaint family," said Ed Mitzen, Founder of Fingerpaint. "Partnering with Leaderboard Branding is an investment in our never-ending commitment to continue adding services to meet the needs of our clients, allowing us to continue building out a world-class company within the healthcare marketing industry. ""We love the work Fingerpaint does and its people-first culture," said Mr. Cashion. "We are excited to align ourselves with a company with similar values that is doing innovative and exceptional work and can offer an expanded set of services to our clients. This is an opportunity to bring together two businesses that complement each other in unique ways." Knox Lane, a private equity firm based in San Francisco, is a strategic investor in Fingerpaint. Shamik Patel, Partner at Knox Lane, commented, "Leaderboard Branding supports the Fingerpaint team's continued commitment to being a best-in-class commercialization services provider for biopharma. We are confident the addition of Leaderboard Branding will accelerate Fingerpaint's growth initiatives and enhance its reputation as a value-added partner to its clients."Leaderboard Branding joins Fingerpaint companies 1798, a market access and commercialization firm that specializes in healthcare consulting services including patient and provider access services, financial impact analysis and analytics, competitive intelligence, and pull-through solutions; and Photo 51, a consultancy focused solely on advanced therapeutics, such as gene and cell therapies. About FingerpaintReset your expectations of a health and wellness agency. Independent by design and built on a foundation of empathy, Fingerpaint is biopharma's commercialization partner for integrated solutions. At its core is an award-winning global team of more than 450 people who are committed to creating and executing meaningful brand experiences for healthcare providers, care partners, and patients.In 2021, Fingerpaint made a strategic investment in Leaderboard Branding, a leading global naming and branding business. In 2020, Fingerpaint acquired 1798, a market access and commercialization firm located inLa Jolla, Calif., adding to its portfolio of services in support of biopharma customers. The agency also launched Photo 51, a gene therapy consultancy. Fingerpaint was named 2019 Agency of the Year by Med Ad News, and in 2018, it won the Heart Award from Med Ad News for its commitment to philanthropy and social causes. Additionally, it has been on Inc. Magazine's list of the 5,000 Fastest-Growing Companies for the past eight years. Visit us atFingerpaintand follow us on Facebook, Twitter, LinkedIn, and Instagram.About Leaderboard Branding Leaderboard Branding, a Fingerpaint company, is a global naming and branding firm that delivers strategic insights and world-class creativity to every client, on every engagement. Built on the tenets of put people first and take pride in your work, Leaderboard Branding has developed strong and strategic partnerships with healthcare, biopharma, consumer, and B2B companies.In the biopharma and healthcare space, Leaderboard Branding supports clients in the early phases of clinical development. The expert strategists at Leaderboard Branding have a unique ability to optimize a brand's commercial potential while mitigating safety concerns and aligning to regulatory guidelines. With expertise in nonproprietary naming, clinical trial branding, global trade name development, and visual design, Leaderboard Branding provides creative solutions through each phase of the drug development process. Leaderboard Branding's drug safety consulting and assessment capabilities help clients make crucial commercial decisions and regulatory submissions with confidence. Connect with us atLeaderboard Brandingand follow us onLinkedIn,Twitter, andFacebook.About Knox LaneFormed in 2019 and based inSan Francisco, Knox Lane is a middle-market investment firm led by and comprised of a team of accomplished investors and operators with a shared work history and a strong track record of partnering with leading companies to accelerate transformational growth. Knox Lane employs an investor-operator mindset and seeks to provide support across a number of business components, including human capital, brand management, end-to-end digital transformation, sourcing, supply chain and logistics, strategic acquisitions and business development.Media ContactJon Keehner / Julie HamiltonJoele Frank, Wilkinson Brimmer Katcher212-355-4449SOURCE Fingerpaint Related Links https://www.fingerpaint.com
|
edtsum5917
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: Contact tracing critical to transitioning industry back from take-out to dine-inCALGARY,Alberta, May 19, 2020 /PRNewswire/ -- Patronscan, a leading manufacturer of I.D. scanning technology, has developed a contact tracing guest registry that can help the hospitality, sports and entertainment industry transition from an era of stay-at-home orders to open for business. "To restore economic growth and jobs, public healthcare experts are wrestling with how best to transition bars and restaurants from take-out to dine-in and how to reintroduce the public to gathering safely in public spaces as stay-at-home orders are relaxed," said Alberio Bathory-Frota, CEO of Patronscan, a worldwide I.D. scanning firm. "To assure customers that a place of business has social distancing protocols in place and that they will be notified of any potential health risk, Patronscan has developed an electronic guest registry that measures occupancy levels and makes contact tracing faster and safer. Guest registries are a powerful tool for businesses seeking to rebuild their customer base and to get workers back on payroll." Underscoring the challenge of getting people back to work, Bathory-Frota said, "Government agencies throughout the world are releasing COVID-19 guidelines so that restaurants, bars, movie theaters, sporting events and other public venues can open safely. Their challenge is how to restore economic activity and jobs without exposing customers and employees to potential health risks. An increasing number of public healthcare experts believe contact tracing and guest registries are part of the solution." New Zealand has adopted a national policy of requiring its hospitality industry to register all guests, a protocol to control occupancy and to reduce the spread of coronavirus through contact tracing. If a customer or employee contracts COVID-19, healthcare providers use the information to notify employees and customers of the need to be tested and/or seek medical care. The States of Washington, Maine and Rhode Island have similar policies,both mandatory and voluntary, as dothe cities of Austin, Texas and New Orleans, Louisiana. Patronscan can work with healthcare agencies and various business industries to customize software features to meet or exceed established social distancing protocols and to comply with privacy laws. The user-friendly technology allows businesses to quickly process, authenticate and store customer information in compliance with local privacy laws. The registry ensures that data is accurate, secured off-site, protected and then permanently deleted between 3-4 weeks, or as determined by government guidelines. The software uses iOS,Android devices,or Patronscan's I.D. scanner kiosks to scan/swipe government issued I.D.s. This is a safer alternative to registering guests on a notepad. Data is not shared with third parties or stored with government agencies. It is not designed to deny patrons entrance to an establishment, nor is it an app that tracks a patron's internet activities. The registry will be offered free to non-profit organizations and Patronscan's existing customers.For product information, www.patronscan.com/covid19-guest-registerSince 2005, Patronscan, a Canadian firm, has equipped businesses with technology that provides greater security for their guests, staff and property. Patronscan protects over 600 venues, spanning 200 cities worldwide, and has scanned over 100 million government issued identifications (I.D.s). Patronscan is a leader in bar and nightclub technology that identifies underaged drinkers and protects businesses and customers by identifying patrons with a history of property damage, violent behavior and sexual assault. Contact: Marko MlikotinRiver City Communications[emailprotected]916.799.7574 (PST)SOURCE Patronscan Related Links http://www.patronscan.com/
Answer:
|
COVID-19 Technology Could Accelerate Reopening of Hospitality Industry
|
Contact tracing critical to transitioning industry back from take-out to dine-inCALGARY,Alberta, May 19, 2020 /PRNewswire/ -- Patronscan, a leading manufacturer of I.D. scanning technology, has developed a contact tracing guest registry that can help the hospitality, sports and entertainment industry transition from an era of stay-at-home orders to open for business. "To restore economic growth and jobs, public healthcare experts are wrestling with how best to transition bars and restaurants from take-out to dine-in and how to reintroduce the public to gathering safely in public spaces as stay-at-home orders are relaxed," said Alberio Bathory-Frota, CEO of Patronscan, a worldwide I.D. scanning firm. "To assure customers that a place of business has social distancing protocols in place and that they will be notified of any potential health risk, Patronscan has developed an electronic guest registry that measures occupancy levels and makes contact tracing faster and safer. Guest registries are a powerful tool for businesses seeking to rebuild their customer base and to get workers back on payroll." Underscoring the challenge of getting people back to work, Bathory-Frota said, "Government agencies throughout the world are releasing COVID-19 guidelines so that restaurants, bars, movie theaters, sporting events and other public venues can open safely. Their challenge is how to restore economic activity and jobs without exposing customers and employees to potential health risks. An increasing number of public healthcare experts believe contact tracing and guest registries are part of the solution." New Zealand has adopted a national policy of requiring its hospitality industry to register all guests, a protocol to control occupancy and to reduce the spread of coronavirus through contact tracing. If a customer or employee contracts COVID-19, healthcare providers use the information to notify employees and customers of the need to be tested and/or seek medical care. The States of Washington, Maine and Rhode Island have similar policies,both mandatory and voluntary, as dothe cities of Austin, Texas and New Orleans, Louisiana. Patronscan can work with healthcare agencies and various business industries to customize software features to meet or exceed established social distancing protocols and to comply with privacy laws. The user-friendly technology allows businesses to quickly process, authenticate and store customer information in compliance with local privacy laws. The registry ensures that data is accurate, secured off-site, protected and then permanently deleted between 3-4 weeks, or as determined by government guidelines. The software uses iOS,Android devices,or Patronscan's I.D. scanner kiosks to scan/swipe government issued I.D.s. This is a safer alternative to registering guests on a notepad. Data is not shared with third parties or stored with government agencies. It is not designed to deny patrons entrance to an establishment, nor is it an app that tracks a patron's internet activities. The registry will be offered free to non-profit organizations and Patronscan's existing customers.For product information, www.patronscan.com/covid19-guest-registerSince 2005, Patronscan, a Canadian firm, has equipped businesses with technology that provides greater security for their guests, staff and property. Patronscan protects over 600 venues, spanning 200 cities worldwide, and has scanned over 100 million government issued identifications (I.D.s). Patronscan is a leader in bar and nightclub technology that identifies underaged drinkers and protects businesses and customers by identifying patrons with a history of property damage, violent behavior and sexual assault. Contact: Marko MlikotinRiver City Communications[emailprotected]916.799.7574 (PST)SOURCE Patronscan Related Links http://www.patronscan.com/
|
edtsum5919
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TOKYO, July 31, 2020 /PRNewswire/ -- In June 2020, the Ocean Policy Research Institute (OPRI) of the Sasakawa Peace Foundation (SPF) published "Selections: White Paper on the Oceans and Ocean Policy in Japan 2020." This annual publication features articles by OPRI researchers and other experts aiming to contribute to comprehensive and cross-sectoral collaboration to address ocean issues in Japan and around the world. The White Paper can be downloaded here:https://www.spf.org/en/global-data/opri/whitepaper2020-en.pdf OPRI is the only think tank in Japan that conducts comprehensive research on ocean policy issues. Since 2000, our experts have collaborated on a range of projects to encourage practical policymaking in Japan while also supporting international exchange to address the full array of challenges related to the world's oceans. OPRI has published the White Paper on the Oceans and Ocean Policy every year since 2004, with the first English edition published in 2018. Selections: White Paper on the Oceans and Ocean Policy in Japan 2020 Foreword by Atsushi Sunami, President of SPF and President of OPRI Interviews with Dr. Daichi Suzuki, Commissioner of the Japan Sports Agency, and Dr. Hiroshi Komiyama, Chairman of Urban Planning and Sustainability Committee of the Tokyo Organizing Committee of the Olympic and Paralympic Games Japan and World's Ocean Initiative: The Oceans and Climate Change The Nippon Foundation-GEBCO Seabed 2030 Promotion of Scientific Research in the Arctic New Development in Ocean Education New Developments in Japan's Marine Information Management SOURCE Sasakawa Peace Foundation Related Links http://www.spf.org
Answer:
|
Ocean Policy Research Institute publishes "Selections: White Paper on the Oceans and Ocean Policy in Japan 2020"
|
TOKYO, July 31, 2020 /PRNewswire/ -- In June 2020, the Ocean Policy Research Institute (OPRI) of the Sasakawa Peace Foundation (SPF) published "Selections: White Paper on the Oceans and Ocean Policy in Japan 2020." This annual publication features articles by OPRI researchers and other experts aiming to contribute to comprehensive and cross-sectoral collaboration to address ocean issues in Japan and around the world. The White Paper can be downloaded here:https://www.spf.org/en/global-data/opri/whitepaper2020-en.pdf OPRI is the only think tank in Japan that conducts comprehensive research on ocean policy issues. Since 2000, our experts have collaborated on a range of projects to encourage practical policymaking in Japan while also supporting international exchange to address the full array of challenges related to the world's oceans. OPRI has published the White Paper on the Oceans and Ocean Policy every year since 2004, with the first English edition published in 2018. Selections: White Paper on the Oceans and Ocean Policy in Japan 2020 Foreword by Atsushi Sunami, President of SPF and President of OPRI Interviews with Dr. Daichi Suzuki, Commissioner of the Japan Sports Agency, and Dr. Hiroshi Komiyama, Chairman of Urban Planning and Sustainability Committee of the Tokyo Organizing Committee of the Olympic and Paralympic Games Japan and World's Ocean Initiative: The Oceans and Climate Change The Nippon Foundation-GEBCO Seabed 2030 Promotion of Scientific Research in the Arctic New Development in Ocean Education New Developments in Japan's Marine Information Management SOURCE Sasakawa Peace Foundation Related Links http://www.spf.org
|
edtsum5921
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: Global Healthcare Industry Veteran Plans to Leverage Extensive Advocacy Experience, Rare Disease Expertise, and a History of Creating Important Public-Private Partnerships to Benefit ME/CFS Patients; Timing Could Not Be More CriticalLOS ANGELES, May 21, 2020 /PRNewswire/ -- Solve M.E., the leading, national non-profit organization solely dedicated to solving Myalgic Encephalomyelitis, formerly known as Chronic Fatigue Syndrome (ME/CFS), today announced that Oved Amitay has been named as President and Chief Executive Officer as of June 1, 2020. Maryellen Gleason, who has been acting as Interim President and CEO of Solve M.E. for the last year, will step down when Amitay's appointment begins. Oved Amitay, Newly Appointed CEO of Solve M.E. Throughout his career, Amitay has enjoyed extensive engagement with healthcare systems and patient advocacy organizations around the world, forging collaborations to address the needs of people affected by rare genetic diseases. Amitay will be leaving his position as Chief Business Officer at CENTOGENE, a global leader in the diagnostics of rare hereditary disorders where he has been responsible for the companys programs within the biotechnology and pharmaceutical industries. "We could not be more pleased to welcome Oved," said John Nicols, Solve M.E.'s board chair. "His extensive background in developing and commercializing therapies for a wide range of debilitating diseases will be a highly valuable asset for patients and for Solve M.E. These experiences have brought Oved to directly collaborate with patient advocate groups across a range of diseases, and he has played key roles to help bring therapeutic solutions to improve the lives of those patients. Potential links between COVID-19 and chronic, viral diseases such as ME/CFS are becoming more apparent, so Solve M.E.'s role as the leading advocacy and research organization in the world is critical." Prior to CENTOGENE, Amitay served as President and COO of Arrett Neuroscience, where he led the company's strategy for developing therapies for Rett syndrome. He also served as Vice President and Head of Commercial at Alnylam Pharmaceuticals, held a long tenure at Genzyme Corporation (now Sanofi Genzyme) as Vice President of Strategic Development, and served as General Manager of the Gaucher Disease and MPS Portfolios, where he was responsible for the flagship product Cerezyme. Amitay also oversaw the development of the drug Eliglustat, which was approved by the FDA and EMA for the treatment of Gaucher Disease.In addition to these accolades, Mr. Amitay is also a Founding Advisor of Splisense Therapeutics, Israel."My goal is to build on the remarkable work of Solve M.E. and cement the organization's position as the leading advocate of ME/CFS research," said Amitay. "We need to shorten the diagnostic odyssey of people affected by the disease, continue to support basic research, and build an infrastructure that includes the You + M.E. registry to enablenovel translational research and clinical studies. It's shocking to me that that this disease continues to be missed for long periods of time in terms of diagnosis, while having such a profound impact on every moment of a patient's life. This realization is a personal impetus for me to join and lead the fight to overcome ME /CFS."Amitay recognizes opportunities for Solve M.E. to evolve their work to include enabling public-private collaborations and expanding the connectivity within the ME/CFS communityboth in the U.S. and globally. Hisoverall vision for the organization includes a better understanding of ME/CFS as a disease, its underlying causes, personal variability, and the full scope of impact to ultimately arrive at the identification of targets for interventionandthe availability of therapies that can improve quality of life."Getting to know the patients and families affected by ME/CFS is truly a privilege," said Amitay. "Recognizing the potential for a wave of post-viral ME/CFS during the current COVID-19 pandemic creates a sense of urgency and personal commitment. Because COVID-19 could significantly swell the ME/CFS population, I believe Solve M.E. has a responsibility to create risk awareness." A link to Oved Amitay's full bio can be found here: Oved Amitay BioTo learn more about the Solve ME/CFS Initiative, visit www.solvecfs.org. Follow Solve ME/CFS on Facebook, Instagram, or Twitter.About the OrganizationThe Solve ME/CFS Initiative (Solve M.E.) is the leading, national non-profit organization solely dedicated to solving ME/CFS. We are committed to making ME/CFS understood, diagnosable, and treatable. Solve M.E. works to accelerate the discovery of safe and effective treatments, strives for an aggressive expansion of funding for research that will lead to a cure, and seeks to engage the entire ME/CFS community.MEDIA INQUIRIES ONLY CONTACT:Stephanie Worrell208-484-9470[emailprotected]ALL OTHER INQUIRIES, PLEASE CALL THE SOLVE ME/CFS INITIATIVE AT: 704-364-0016OR EMAIL [emailprotected]SOURCE Solve M.E. Related Links https://solvecfs.org/
Answer:
|
Solve M.E. Announces Oved Amitay as President and Chief Executive Officer English English
|
Global Healthcare Industry Veteran Plans to Leverage Extensive Advocacy Experience, Rare Disease Expertise, and a History of Creating Important Public-Private Partnerships to Benefit ME/CFS Patients; Timing Could Not Be More CriticalLOS ANGELES, May 21, 2020 /PRNewswire/ -- Solve M.E., the leading, national non-profit organization solely dedicated to solving Myalgic Encephalomyelitis, formerly known as Chronic Fatigue Syndrome (ME/CFS), today announced that Oved Amitay has been named as President and Chief Executive Officer as of June 1, 2020. Maryellen Gleason, who has been acting as Interim President and CEO of Solve M.E. for the last year, will step down when Amitay's appointment begins. Oved Amitay, Newly Appointed CEO of Solve M.E. Throughout his career, Amitay has enjoyed extensive engagement with healthcare systems and patient advocacy organizations around the world, forging collaborations to address the needs of people affected by rare genetic diseases. Amitay will be leaving his position as Chief Business Officer at CENTOGENE, a global leader in the diagnostics of rare hereditary disorders where he has been responsible for the companys programs within the biotechnology and pharmaceutical industries. "We could not be more pleased to welcome Oved," said John Nicols, Solve M.E.'s board chair. "His extensive background in developing and commercializing therapies for a wide range of debilitating diseases will be a highly valuable asset for patients and for Solve M.E. These experiences have brought Oved to directly collaborate with patient advocate groups across a range of diseases, and he has played key roles to help bring therapeutic solutions to improve the lives of those patients. Potential links between COVID-19 and chronic, viral diseases such as ME/CFS are becoming more apparent, so Solve M.E.'s role as the leading advocacy and research organization in the world is critical." Prior to CENTOGENE, Amitay served as President and COO of Arrett Neuroscience, where he led the company's strategy for developing therapies for Rett syndrome. He also served as Vice President and Head of Commercial at Alnylam Pharmaceuticals, held a long tenure at Genzyme Corporation (now Sanofi Genzyme) as Vice President of Strategic Development, and served as General Manager of the Gaucher Disease and MPS Portfolios, where he was responsible for the flagship product Cerezyme. Amitay also oversaw the development of the drug Eliglustat, which was approved by the FDA and EMA for the treatment of Gaucher Disease.In addition to these accolades, Mr. Amitay is also a Founding Advisor of Splisense Therapeutics, Israel."My goal is to build on the remarkable work of Solve M.E. and cement the organization's position as the leading advocate of ME/CFS research," said Amitay. "We need to shorten the diagnostic odyssey of people affected by the disease, continue to support basic research, and build an infrastructure that includes the You + M.E. registry to enablenovel translational research and clinical studies. It's shocking to me that that this disease continues to be missed for long periods of time in terms of diagnosis, while having such a profound impact on every moment of a patient's life. This realization is a personal impetus for me to join and lead the fight to overcome ME /CFS."Amitay recognizes opportunities for Solve M.E. to evolve their work to include enabling public-private collaborations and expanding the connectivity within the ME/CFS communityboth in the U.S. and globally. Hisoverall vision for the organization includes a better understanding of ME/CFS as a disease, its underlying causes, personal variability, and the full scope of impact to ultimately arrive at the identification of targets for interventionandthe availability of therapies that can improve quality of life."Getting to know the patients and families affected by ME/CFS is truly a privilege," said Amitay. "Recognizing the potential for a wave of post-viral ME/CFS during the current COVID-19 pandemic creates a sense of urgency and personal commitment. Because COVID-19 could significantly swell the ME/CFS population, I believe Solve M.E. has a responsibility to create risk awareness." A link to Oved Amitay's full bio can be found here: Oved Amitay BioTo learn more about the Solve ME/CFS Initiative, visit www.solvecfs.org. Follow Solve ME/CFS on Facebook, Instagram, or Twitter.About the OrganizationThe Solve ME/CFS Initiative (Solve M.E.) is the leading, national non-profit organization solely dedicated to solving ME/CFS. We are committed to making ME/CFS understood, diagnosable, and treatable. Solve M.E. works to accelerate the discovery of safe and effective treatments, strives for an aggressive expansion of funding for research that will lead to a cure, and seeks to engage the entire ME/CFS community.MEDIA INQUIRIES ONLY CONTACT:Stephanie Worrell208-484-9470[emailprotected]ALL OTHER INQUIRIES, PLEASE CALL THE SOLVE ME/CFS INITIATIVE AT: 704-364-0016OR EMAIL [emailprotected]SOURCE Solve M.E. Related Links https://solvecfs.org/
|
edtsum5922
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LAS VEGAS, March 22, 2021 /PRNewswire/ --Blending Eastern and Western food culture, Zouk Group, Singapore's leading nightlife and lifestyle brand, will introduce an Asian hawker-inspired food hall concept with authentic street food and cuisines from around the world to Resorts World Las Vegas, the Strip's new integrated resort opening this summer. Famous Foods Street Eats will be an interactive 24,000-square-foot street food destination, boasting 16 diverse food stalls from top chefs and restaurateurs and the only destination in the country with the most Michelin Plate and Bib Gourmand recognized concepts under one roof. In addition, Famous Foods will feature a vibrant 16-seat center bar and a picturesque speakeasy hidden within the depths of the food hall. Zouk Group Brings Famous Foods Street Eats to Resorts World Las Vegas Famous Foods will pay homage to the lively scene and culture that has been savored at Asia's most popular hawker centres for nearly a century. These centres, which originated in and are located throughout Southeast Asia, offer a wide array of culturally significant dishes that are locally and critically acclaimed, some even boasting Michelin Plates and Bib Gourmand Awards an award which originated as a way to honor restaurants that offer exceptional food at a reasonable price. To download high-resolution renderings, please click here Zouk Group's Executive Chairman Hui Lim and Chief Executive Officer Andrew Li not only took inspiration from these traditional hawker centres, but also recruited from them bringing Asia's top food hawkers to the U.S. for the very first time. Lim & Li traveled throughout Asia to personally taste test the different hawker cuisines and curated a selection of food stalls for Famous Foods complete with unique Asian recipes that have been passed down through family generations. The marketplace will offer food enthusiasts the authentic opportunity to "hawker-hop" and indulge in culturally traditional dishes, as well as stalls from craveable U.S. eateries and their respective celebrated chefs.The fun and energetic space, conveniently located right off the casino floor, is designed to offer an array of Instagrammable moments for a new-age dining experience, featuring vibrant neon signs and trinkets, and an open seating area with floor-to-ceiling views of the iconic Las Vegas Strip. With food "edutainment" at the forefront of the Famous Foods experience, guests can enjoy Michelin-awarded meals at an affordable price while learning about the different cultures and origins of these authentic cuisines. Famous Foods will also feature two commissioned art pieces by Red Hong Yi, a popular Chinese-Malaysian contemporary artist known for her mixed media interpretations. Anchoring the space will stand a 10-foot tall Lucky Cat sculpture made entirely of gold coins, while a distinct eight-tone mural made of 18,000 tea bags welcomes guests upon arrival."Famous Foods will transport guests to an authentic Asian hawker market - an experience that's never been replicated in the U.S.," said Andrew Li, Chief Executive Officer of Zouk Group. "After months of planning and carefully curating the perfect mix of partners, Zouk Group is thrilled to be able to unveil this special culinary concept to the city of Las Vegas, and equally as excited to bring it to the Strip's most anticipated new resort." "The addition of Famous Foods to Resorts World Las Vegas's culinary portfolio will bring a completely new kind of tasting experience to the Strip," said Bart Mahoney, Resorts World Las Vegas Vice President of Food & Beverage. "We look forward to welcoming many of these concepts to the U.S. for the first time and offering a truly unique dining lineup inspired by Asia's rich history, lifestyle and culture." Primed to be one of the top food experiences in the city, Famous Foods will feature the following eateries: Eastern Stalls Ah Chun Shandong Dumpling Serving traditional Shandong dumplings and hand-pulled noodle dishes made fresh daily, earning the Au Chun restaurant the Michelin Guide's Bib Gourmand recognition from 2013 to 2021. Boon Tong Kee With recipes originating in Singapore's Chinatown in 1979, the Boon Tong Kee food stall at Famous Foods will serve its traditional Hainanese chicken rice, featuring poached tender chicken paired with rice cooked in chicken broth. FUHU Shack FUHU Shack is a casual outpost of Zouk Group and Resorts World's vibe dining restaurant, FUHU, serving up a western reinterpretation of one of China's most desired dishes with Peking Duck Burritos. Geylang Claypot Rice Founded over 40 years ago and one of Singapore's favorite claypot eateries, Geylang Claypot Rice earned a Michelin Plate in 2016 and will serve up traditional Southeast Asian rice dishes slowly cooked in traditional claypots with a variety of savory ingredients. Googgle Man's Char Kuey Teow Using traditional charcoal-fired stoves, Chef Ah Guan ensures that every strand of noodle is expertly fried to produce a smoky aroma called 'wok hei' or 'dragon's breath.' The Char Kuey Teow food stall will serve rice and egg noodles delicately fried with fresh seafood, vegetables and more - a popular comfort food for many across parts of Southeast Asia. Pepita's Kitchen Creator and owner of Pepita's Kitchen, Dedet de la Fuente (or 'Lechon Diva' as she's affectionately known) quickly made her mark on Manila's local food scene with her exclusive 12-course private degustation dinners featuring her stuffed lechon creations that are commonly frequented by stars such as Martha Stewart and Adam Richman, and visited by the late Anthony Bourdain. Pepita's Kitchen food stall will offer a sampling of the Lechon Diva's delectable lechon staples. Springleaf Prata Place A family-themed concept from Singapore, Springleaf Prata Place offers authentic cuisine from South India. Roti canai masters use generational family recipes, earning the restaurant a Michelin Plate and the distinguished recognition as the Michelin Guide's only roti canai eatery. The Springleaf Prata Place food stall will serve delicious staples including Chicken Curry and Teh Tarik, a frothy, hot milk tea commonly enjoyed in Singapore. Ten Suns Braised Beef A legendary, family-run Thai beef noodle shop located in Bangkok Old Town that received a Bib Gourmand recognition from the Michelin Guide in 2019, 2020 and 2021. Tiger Sugar The Taiwanese bubble tea shop, best known for their famous Black Sugar Boba Milk, brings their signature syrup-streaked drinks to the Las Vegas Strip featuring a menu of cold black tea varieties. Dessert Serving an array of sweet treats from around the world, the dessert stall at Famous Foods will feature gourmet cookies, Instagrammable treats and pre-packaged goodies. Mamak Thetranslation for a sundry store in Singapore, Mamak will sell merchandise, unique snacks and keepsakes including take-home food kits, books and more for guests to commemorate their experience. Western Stalls Streetbird Las Vegas Streetbird Las Vegas is James Beard Award-winning Chef Marcus Samuelsson's love letter to one of America's favorite foods: fried chicken. Streetbird Las Vegas will highlight Samuelsson's take on comfort food classics including his famous Sweet & Spicy Fried Chicken, Hot Honey Chicken & Waffle, Wild Wild Wings, and Mac 'n Greens. Kuru Kuru Pa Yakitori Created by GRAMMY-nominated DJ and producer Steve Aoki and his restaurateur brother Kevin Aoki, this Japanese and anime-inspired concept will feature a variety of yakitori, kushiyaki and yaki onigiri along with a selection of signature drinks and mochi. Mozz Bar by James Trees An Italian food counter from James Beard Award finalist James Trees of Las Vegas favorite Esther's Kitchen offering fresh mozzarella and burrata, housemade bread, small bites and signature sandwiches including chicken and eggplant parmesan. Blood Bros. BBQ A critically acclaimed Houston hotspot that will serve up classic Texas barbecue with the occasional Chinese and Vietnamese twist. Nori Bar Nori Bar offers an authentic sushi experience, including signature made-to-order handrolls and sashimi using high-quality ingredients, warm seasoned rice, chilled seafood and crisp nori along with a menu of eclectic sakes, matcha green tea, seasonal teas and Japanese beer all on tap. Famous Foods Center Bar A high-energy 16-seat center bar featuring an innovative self-pour and automated beer system that will offer a rotating selection of dozens of beers from around the world, along with cocktails and wine on tap. Here Kitty Kitty Vice Den An elegantly grunge speakeasy discretely tucked away offering guests a laidback hangout and an expertly crafted mixology program. Resorts World Las Vegas and Zouk Group previously announced their partnership in November 2020 to bring multiple entertainment and lifestyle concepts to the 3,500-room integrated resort, including world-class nightclub and dayclub venues, Zouk Nightclub and AYU Dayclub; as well as RedTail, a new-style social gaming bar, and FUHU, a high-energy contemporary Asian dining venue. Additional food and beverage concepts opening at Resorts World Las Vegas will be announced in the coming weeks. About Resorts World Las Vegas Resorts World Las Vegas is being developed by Genting Berhad, a publicly traded Malaysian corporation registered with the Nevada Gaming Commission. The company has affiliated operations in the Americas, Malaysia, Singapore, the United Kingdom and the Bahamas. Resorts World Las Vegas is one of the largest hotel construction sites in the U.S., rapidly moving forward with over 3,000 construction workers on-site daily at the nearly 88-acre site. In partnership with Hilton Hotels & Resorts, Resorts World Las Vegas will integrate three of Hilton's premium brands into its resort campus, including Las Vegas Hilton, the resort's full-service brand; Conrad Las Vegas, Hilton's lifestyle luxury brand; and LXR, Hilton's network of independent luxury properties, which will operate as Crockfords Las Vegas, Genting's internationally renowned ultra-luxury brand. Resorts World Las Vegas will feature 3,500 guest rooms and suites, an innovative, next-generation gaming floor, world-class food and beverage options, a 5,000-capacity theatre, distinct nightlife venues, a curated retail collection of designer and boutique shops, and more. The integrated resort will weave time-honored traditions of the international Resorts World brand into the fabric of Las Vegas, introducing a bold, fresh take on hospitality to the city with stunning design, progressive technology and world-class guest service. Resorts World Las Vegas isSharecare Health Security VERIFIEDwithForbes Travel Guide,a verification that ensures the resort has appropriate health safety procedures in place.Formore information, visitrwlasvegas.comor find us onFacebook,LinkedIn,TwitterandInstagram.About Genting GroupGenting Group comprises Genting Berhad (KLSE: GENTING), the holding company, and its listed companies Genting Malaysia Berhad (KLSE: GENM), Genting Plantations Berhad (KLSE: GENP) and Genting Singapore Limited (SGX: G13). Genting Group collectively employs approximately 56,000 people and is involved in leisure and hospitality, palm oil plantations, power generation, oil and gas, property development, life sciences and biotechnology activities, with operations spanning across the globe, including in Malaysia, Singapore, Indonesia, India, China, the United States of America, Bahamas and the United Kingdom. Genting Group is a leader in the global gaming and hospitality industry. Founded in 1965, Genting Group has more than 50 years of experience in developing and operating destination resorts in the Americas,Malaysia,Singapore, the United Kingdom and the Bahamas, offering an unparalleled resort experience and iconic entertainment attractions to over 50 million visitors a year. For more information, visit www.genting.com.About Zouk GroupZouk Group is a global lifestyle company with establishments that span across nightlife, entertainment, and dining sectors. Its namesake, Zouk, is a 29-year-old nightlife brand known for pushing boundaries of dance music and propelling Singapore on the global map. Ranked Asia's best club on DJ Mag's annual Top 100 Clubs list since 2017 and top globally since 2010, Zouk is Singapore's foremost clubbing institution, delivering the freshest in dance music across genres, state-of-the-art sound and lighting systems, a constant roster of stellar international, regional and local residents, and top-notch service and hospitality.Zouk has since evolved into an all-encompassing global lifestyle brand that has expanded into the food & beverage sector with new brands like social gaming bar RedTail, vibe dining restaurant FUHU, and more concepts in the pipeline. Aside from club offerings, Zouk Group also owns ZoukOut, Asia's premier dawn-to-dusk music festival featuring world class DJs, which attracts a cosmopolitan mix of locals and tourists within and beyond Asia to the beachfront of Singapore. Zouk Group now oversees all club and lifestyle entities in Singapore, Genting Highlands in Malaysia, on board Genting-owned cruise ship, and soon to come, Las Vegas. The company also owns the franchise to Five Guys in Singapore and Malaysia.SOURCE Resorts World Las Vegas Related Links https://www.rwlasvegas.com
Answer:
|
Zouk Group Brings Famous Foods Street Eats to Resorts World Las Vegas The 16-stall culinary marketplace will introduce Michelin Plate and Bib Gourmand-recognized hawker stands from Southeast Asia to the U.S. for the first time alongside western concepts from celebrated chefs and restaurateurs including Marcus Samuelsson, James Trees and Blood Bros. BBQ
|
LAS VEGAS, March 22, 2021 /PRNewswire/ --Blending Eastern and Western food culture, Zouk Group, Singapore's leading nightlife and lifestyle brand, will introduce an Asian hawker-inspired food hall concept with authentic street food and cuisines from around the world to Resorts World Las Vegas, the Strip's new integrated resort opening this summer. Famous Foods Street Eats will be an interactive 24,000-square-foot street food destination, boasting 16 diverse food stalls from top chefs and restaurateurs and the only destination in the country with the most Michelin Plate and Bib Gourmand recognized concepts under one roof. In addition, Famous Foods will feature a vibrant 16-seat center bar and a picturesque speakeasy hidden within the depths of the food hall. Zouk Group Brings Famous Foods Street Eats to Resorts World Las Vegas Famous Foods will pay homage to the lively scene and culture that has been savored at Asia's most popular hawker centres for nearly a century. These centres, which originated in and are located throughout Southeast Asia, offer a wide array of culturally significant dishes that are locally and critically acclaimed, some even boasting Michelin Plates and Bib Gourmand Awards an award which originated as a way to honor restaurants that offer exceptional food at a reasonable price. To download high-resolution renderings, please click here Zouk Group's Executive Chairman Hui Lim and Chief Executive Officer Andrew Li not only took inspiration from these traditional hawker centres, but also recruited from them bringing Asia's top food hawkers to the U.S. for the very first time. Lim & Li traveled throughout Asia to personally taste test the different hawker cuisines and curated a selection of food stalls for Famous Foods complete with unique Asian recipes that have been passed down through family generations. The marketplace will offer food enthusiasts the authentic opportunity to "hawker-hop" and indulge in culturally traditional dishes, as well as stalls from craveable U.S. eateries and their respective celebrated chefs.The fun and energetic space, conveniently located right off the casino floor, is designed to offer an array of Instagrammable moments for a new-age dining experience, featuring vibrant neon signs and trinkets, and an open seating area with floor-to-ceiling views of the iconic Las Vegas Strip. With food "edutainment" at the forefront of the Famous Foods experience, guests can enjoy Michelin-awarded meals at an affordable price while learning about the different cultures and origins of these authentic cuisines. Famous Foods will also feature two commissioned art pieces by Red Hong Yi, a popular Chinese-Malaysian contemporary artist known for her mixed media interpretations. Anchoring the space will stand a 10-foot tall Lucky Cat sculpture made entirely of gold coins, while a distinct eight-tone mural made of 18,000 tea bags welcomes guests upon arrival."Famous Foods will transport guests to an authentic Asian hawker market - an experience that's never been replicated in the U.S.," said Andrew Li, Chief Executive Officer of Zouk Group. "After months of planning and carefully curating the perfect mix of partners, Zouk Group is thrilled to be able to unveil this special culinary concept to the city of Las Vegas, and equally as excited to bring it to the Strip's most anticipated new resort." "The addition of Famous Foods to Resorts World Las Vegas's culinary portfolio will bring a completely new kind of tasting experience to the Strip," said Bart Mahoney, Resorts World Las Vegas Vice President of Food & Beverage. "We look forward to welcoming many of these concepts to the U.S. for the first time and offering a truly unique dining lineup inspired by Asia's rich history, lifestyle and culture." Primed to be one of the top food experiences in the city, Famous Foods will feature the following eateries: Eastern Stalls Ah Chun Shandong Dumpling Serving traditional Shandong dumplings and hand-pulled noodle dishes made fresh daily, earning the Au Chun restaurant the Michelin Guide's Bib Gourmand recognition from 2013 to 2021. Boon Tong Kee With recipes originating in Singapore's Chinatown in 1979, the Boon Tong Kee food stall at Famous Foods will serve its traditional Hainanese chicken rice, featuring poached tender chicken paired with rice cooked in chicken broth. FUHU Shack FUHU Shack is a casual outpost of Zouk Group and Resorts World's vibe dining restaurant, FUHU, serving up a western reinterpretation of one of China's most desired dishes with Peking Duck Burritos. Geylang Claypot Rice Founded over 40 years ago and one of Singapore's favorite claypot eateries, Geylang Claypot Rice earned a Michelin Plate in 2016 and will serve up traditional Southeast Asian rice dishes slowly cooked in traditional claypots with a variety of savory ingredients. Googgle Man's Char Kuey Teow Using traditional charcoal-fired stoves, Chef Ah Guan ensures that every strand of noodle is expertly fried to produce a smoky aroma called 'wok hei' or 'dragon's breath.' The Char Kuey Teow food stall will serve rice and egg noodles delicately fried with fresh seafood, vegetables and more - a popular comfort food for many across parts of Southeast Asia. Pepita's Kitchen Creator and owner of Pepita's Kitchen, Dedet de la Fuente (or 'Lechon Diva' as she's affectionately known) quickly made her mark on Manila's local food scene with her exclusive 12-course private degustation dinners featuring her stuffed lechon creations that are commonly frequented by stars such as Martha Stewart and Adam Richman, and visited by the late Anthony Bourdain. Pepita's Kitchen food stall will offer a sampling of the Lechon Diva's delectable lechon staples. Springleaf Prata Place A family-themed concept from Singapore, Springleaf Prata Place offers authentic cuisine from South India. Roti canai masters use generational family recipes, earning the restaurant a Michelin Plate and the distinguished recognition as the Michelin Guide's only roti canai eatery. The Springleaf Prata Place food stall will serve delicious staples including Chicken Curry and Teh Tarik, a frothy, hot milk tea commonly enjoyed in Singapore. Ten Suns Braised Beef A legendary, family-run Thai beef noodle shop located in Bangkok Old Town that received a Bib Gourmand recognition from the Michelin Guide in 2019, 2020 and 2021. Tiger Sugar The Taiwanese bubble tea shop, best known for their famous Black Sugar Boba Milk, brings their signature syrup-streaked drinks to the Las Vegas Strip featuring a menu of cold black tea varieties. Dessert Serving an array of sweet treats from around the world, the dessert stall at Famous Foods will feature gourmet cookies, Instagrammable treats and pre-packaged goodies. Mamak Thetranslation for a sundry store in Singapore, Mamak will sell merchandise, unique snacks and keepsakes including take-home food kits, books and more for guests to commemorate their experience. Western Stalls Streetbird Las Vegas Streetbird Las Vegas is James Beard Award-winning Chef Marcus Samuelsson's love letter to one of America's favorite foods: fried chicken. Streetbird Las Vegas will highlight Samuelsson's take on comfort food classics including his famous Sweet & Spicy Fried Chicken, Hot Honey Chicken & Waffle, Wild Wild Wings, and Mac 'n Greens. Kuru Kuru Pa Yakitori Created by GRAMMY-nominated DJ and producer Steve Aoki and his restaurateur brother Kevin Aoki, this Japanese and anime-inspired concept will feature a variety of yakitori, kushiyaki and yaki onigiri along with a selection of signature drinks and mochi. Mozz Bar by James Trees An Italian food counter from James Beard Award finalist James Trees of Las Vegas favorite Esther's Kitchen offering fresh mozzarella and burrata, housemade bread, small bites and signature sandwiches including chicken and eggplant parmesan. Blood Bros. BBQ A critically acclaimed Houston hotspot that will serve up classic Texas barbecue with the occasional Chinese and Vietnamese twist. Nori Bar Nori Bar offers an authentic sushi experience, including signature made-to-order handrolls and sashimi using high-quality ingredients, warm seasoned rice, chilled seafood and crisp nori along with a menu of eclectic sakes, matcha green tea, seasonal teas and Japanese beer all on tap. Famous Foods Center Bar A high-energy 16-seat center bar featuring an innovative self-pour and automated beer system that will offer a rotating selection of dozens of beers from around the world, along with cocktails and wine on tap. Here Kitty Kitty Vice Den An elegantly grunge speakeasy discretely tucked away offering guests a laidback hangout and an expertly crafted mixology program. Resorts World Las Vegas and Zouk Group previously announced their partnership in November 2020 to bring multiple entertainment and lifestyle concepts to the 3,500-room integrated resort, including world-class nightclub and dayclub venues, Zouk Nightclub and AYU Dayclub; as well as RedTail, a new-style social gaming bar, and FUHU, a high-energy contemporary Asian dining venue. Additional food and beverage concepts opening at Resorts World Las Vegas will be announced in the coming weeks. About Resorts World Las Vegas Resorts World Las Vegas is being developed by Genting Berhad, a publicly traded Malaysian corporation registered with the Nevada Gaming Commission. The company has affiliated operations in the Americas, Malaysia, Singapore, the United Kingdom and the Bahamas. Resorts World Las Vegas is one of the largest hotel construction sites in the U.S., rapidly moving forward with over 3,000 construction workers on-site daily at the nearly 88-acre site. In partnership with Hilton Hotels & Resorts, Resorts World Las Vegas will integrate three of Hilton's premium brands into its resort campus, including Las Vegas Hilton, the resort's full-service brand; Conrad Las Vegas, Hilton's lifestyle luxury brand; and LXR, Hilton's network of independent luxury properties, which will operate as Crockfords Las Vegas, Genting's internationally renowned ultra-luxury brand. Resorts World Las Vegas will feature 3,500 guest rooms and suites, an innovative, next-generation gaming floor, world-class food and beverage options, a 5,000-capacity theatre, distinct nightlife venues, a curated retail collection of designer and boutique shops, and more. The integrated resort will weave time-honored traditions of the international Resorts World brand into the fabric of Las Vegas, introducing a bold, fresh take on hospitality to the city with stunning design, progressive technology and world-class guest service. Resorts World Las Vegas isSharecare Health Security VERIFIEDwithForbes Travel Guide,a verification that ensures the resort has appropriate health safety procedures in place.Formore information, visitrwlasvegas.comor find us onFacebook,LinkedIn,TwitterandInstagram.About Genting GroupGenting Group comprises Genting Berhad (KLSE: GENTING), the holding company, and its listed companies Genting Malaysia Berhad (KLSE: GENM), Genting Plantations Berhad (KLSE: GENP) and Genting Singapore Limited (SGX: G13). Genting Group collectively employs approximately 56,000 people and is involved in leisure and hospitality, palm oil plantations, power generation, oil and gas, property development, life sciences and biotechnology activities, with operations spanning across the globe, including in Malaysia, Singapore, Indonesia, India, China, the United States of America, Bahamas and the United Kingdom. Genting Group is a leader in the global gaming and hospitality industry. Founded in 1965, Genting Group has more than 50 years of experience in developing and operating destination resorts in the Americas,Malaysia,Singapore, the United Kingdom and the Bahamas, offering an unparalleled resort experience and iconic entertainment attractions to over 50 million visitors a year. For more information, visit www.genting.com.About Zouk GroupZouk Group is a global lifestyle company with establishments that span across nightlife, entertainment, and dining sectors. Its namesake, Zouk, is a 29-year-old nightlife brand known for pushing boundaries of dance music and propelling Singapore on the global map. Ranked Asia's best club on DJ Mag's annual Top 100 Clubs list since 2017 and top globally since 2010, Zouk is Singapore's foremost clubbing institution, delivering the freshest in dance music across genres, state-of-the-art sound and lighting systems, a constant roster of stellar international, regional and local residents, and top-notch service and hospitality.Zouk has since evolved into an all-encompassing global lifestyle brand that has expanded into the food & beverage sector with new brands like social gaming bar RedTail, vibe dining restaurant FUHU, and more concepts in the pipeline. Aside from club offerings, Zouk Group also owns ZoukOut, Asia's premier dawn-to-dusk music festival featuring world class DJs, which attracts a cosmopolitan mix of locals and tourists within and beyond Asia to the beachfront of Singapore. Zouk Group now oversees all club and lifestyle entities in Singapore, Genting Highlands in Malaysia, on board Genting-owned cruise ship, and soon to come, Las Vegas. The company also owns the franchise to Five Guys in Singapore and Malaysia.SOURCE Resorts World Las Vegas Related Links https://www.rwlasvegas.com
|
edtsum5924
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TEL AVIV, Israel, March 24, 2020 /PRNewswire/ -- Kryon, a leading robotic process automation (RPA) solution provider known for its customer-centric approach and unique technological innovations, including Kryon Process Discovery, today announces the rapid development and implementation of a large scale data RPA process which integrates Maccabi Healthcare Services' testing of COVID-19 with the Israeli Ministry of Health. The implementation began Friday morning and launched Sunday afternoon, enabling the automation of a critical process and the accurate, efficient and prompt treatment of hundreds of Coronavirus patients. VIEW VIDEO INTERVIEW One of the largest non-profit health maintenance organizations (HMOs) in Israel with 2.4 million members, Maccabi is on the frontline of the country's response to the COVID-19 pandemic. Twice daily, the Ministry of Health delivers detailed files with confidential test results of Maccabi patients, but the manual uploading of these documents was creating weeks-long backlogs and a mass of human errors. Spearheaded by Maccabi's CIO, Kryon was able to automate this process within 48 hours, helping to efficiently and quickly improve care. The rapid uploading of critical and sensitive data is now highly accurate, eliminating the opportunities for human error that existed during manual upload. "Robotic process automation isn't just about the future of work and creating scalable businesses. It's a beacon of hope for healthcare organizations around the world as this pandemic strains an already overtaxed system," said Harel Tayeb, CEO of Kryon. "Healthcare professionals are risking their lives to help save ours. It is our responsibility to help overcome this pandemic. Creating processes that ensure every test, chart, and patient status is shared between test centers is an important step in streamlining their efforts." "These are unprecedented times for Maccabi Healthcare Services and Israeli medicine. It is critical to leverage innovative technology to streamline intensive processes so we can focus on creating the best possible patient outcomes," said Ofir Kadosh, CIO, Maccabi Healthcare Services. "Within an hour after calling Kryon Friday morning, we amazingly had a signed agreement, and 48 hours later we had a fully automated integration with the Israeli Ministry of Health. Prior to the automation, this process would have taken 1-2 months of work by several employees. Now we can focus on the important work of testing and treating patients." Kryon is committed to helping fight the spread of the COVID-19 pandemic and will make the process available to any healthcare service or government organization free of charge. For more information, please contact us. ABOUT KRYON Kryon is a leader in enterprise automation, offering the only platform on the market which encompasses bothProcess Discoverytechnology andRobotic Process Automation (RPA). The Kryon Full-Cycle Automation solution maximizes ROI and cuts RPA implementation time by up to 80 percent. Powered by proprietary AI technology, Kryon Process Discovery automatically generates a comprehensive picture of business processes, evaluates them and recommends which ones to automate. Kryon offers desktop-based attended RPA, virtual-machine-based unattended RPA or a hybrid combination of both. The company's award-winning suite is used by enterprises worldwide, including AIG, Allianz, Deutsche Telekom, Ernst & Young, Ferring Pharmaceuticals, HP, Microsoft, Santander Bank, Singtel, Verizon and Wyndham Hotel Group. Contact Details: Chris Thatcher[emailprotected]+1-212-999-5585 SOURCE Kryon Related Links https://www.kryonsystems.com/
Answer:
|
Kryon Provides RPA Solution for Maccabi Healthcare Services' COVID-19 Response in Less Than 48 Hours, Dramatically Expediting the HMO's Ability to Handle COVID-19 Testing English English The process will be made available free of charge to healthcare providers around the world to improve integrations between private, public, and government testing
|
TEL AVIV, Israel, March 24, 2020 /PRNewswire/ -- Kryon, a leading robotic process automation (RPA) solution provider known for its customer-centric approach and unique technological innovations, including Kryon Process Discovery, today announces the rapid development and implementation of a large scale data RPA process which integrates Maccabi Healthcare Services' testing of COVID-19 with the Israeli Ministry of Health. The implementation began Friday morning and launched Sunday afternoon, enabling the automation of a critical process and the accurate, efficient and prompt treatment of hundreds of Coronavirus patients. VIEW VIDEO INTERVIEW One of the largest non-profit health maintenance organizations (HMOs) in Israel with 2.4 million members, Maccabi is on the frontline of the country's response to the COVID-19 pandemic. Twice daily, the Ministry of Health delivers detailed files with confidential test results of Maccabi patients, but the manual uploading of these documents was creating weeks-long backlogs and a mass of human errors. Spearheaded by Maccabi's CIO, Kryon was able to automate this process within 48 hours, helping to efficiently and quickly improve care. The rapid uploading of critical and sensitive data is now highly accurate, eliminating the opportunities for human error that existed during manual upload. "Robotic process automation isn't just about the future of work and creating scalable businesses. It's a beacon of hope for healthcare organizations around the world as this pandemic strains an already overtaxed system," said Harel Tayeb, CEO of Kryon. "Healthcare professionals are risking their lives to help save ours. It is our responsibility to help overcome this pandemic. Creating processes that ensure every test, chart, and patient status is shared between test centers is an important step in streamlining their efforts." "These are unprecedented times for Maccabi Healthcare Services and Israeli medicine. It is critical to leverage innovative technology to streamline intensive processes so we can focus on creating the best possible patient outcomes," said Ofir Kadosh, CIO, Maccabi Healthcare Services. "Within an hour after calling Kryon Friday morning, we amazingly had a signed agreement, and 48 hours later we had a fully automated integration with the Israeli Ministry of Health. Prior to the automation, this process would have taken 1-2 months of work by several employees. Now we can focus on the important work of testing and treating patients." Kryon is committed to helping fight the spread of the COVID-19 pandemic and will make the process available to any healthcare service or government organization free of charge. For more information, please contact us. ABOUT KRYON Kryon is a leader in enterprise automation, offering the only platform on the market which encompasses bothProcess Discoverytechnology andRobotic Process Automation (RPA). The Kryon Full-Cycle Automation solution maximizes ROI and cuts RPA implementation time by up to 80 percent. Powered by proprietary AI technology, Kryon Process Discovery automatically generates a comprehensive picture of business processes, evaluates them and recommends which ones to automate. Kryon offers desktop-based attended RPA, virtual-machine-based unattended RPA or a hybrid combination of both. The company's award-winning suite is used by enterprises worldwide, including AIG, Allianz, Deutsche Telekom, Ernst & Young, Ferring Pharmaceuticals, HP, Microsoft, Santander Bank, Singtel, Verizon and Wyndham Hotel Group. Contact Details: Chris Thatcher[emailprotected]+1-212-999-5585 SOURCE Kryon Related Links https://www.kryonsystems.com/
|
edtsum5926
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBAI, UAE, Oct. 14, 2020 /PRNewswire/ --Changi has been delivering Salesforce CRM cloud-based solutions in the UAE and wider MENA region for 10 years. Reaching this milestone in 2020, amidst COVID-19, is humbling and the company is focused on expanding its platform and partnerships to serve the rapidly increasing demand for digital transformation across the Middle East. Its first partnership is in the eCommerce space with global leader Astound Commerce. Changi made a bet on Salesforce ten years ago based on founder Ghassan Chkaiban's CRM expertise and quest for high quality digital solutions. "Since Changi was created, we have been a passionate advocate of the Salesforce ecosystem and we truly believe that it's the best customer success platform out there; I saw an opportunity for its growth in the Middle East and embarked on this journey 10 years ago, as a Salesforce Partner, by developing a market presence across the region and in multiple industries, through our headquarters in Dubai. With growing momentum, hard work and many learning opportunities along theway, we have built a strong foundation that is well suited to serve the region's appetite for digital transformation," saidGhassan Chkaiban, Founder & Managing Director ofChangi. The sentiment is echoed by seasoned Salesforce executive Robin Fisher, Senior Area Vice President - Growth Markets, who recognized Changi's milestone: "Congratulations Changi on your 10-year celebrations. I am proud to be associated with this amazing team of passionate, consultative, customer centric professionals. You have been instrumental over the past decade in ensuring that our mutual customers grow and benefit from their Salesforce investments. You truly are an example of #Trailblazer. Our valuable partnership over the years has assisted in creating the strong, ever growing Salesforce ecosystem we see in the Middle East. I look forward to our mutual success as we continue to serve our customers together, so that they in turn can better serve their customers, partners and employees. Thank you Changi, enjoy your birthday celebrations." With digital transformation at the core of Changi's ethos, the company is actively building strategic alliances with leading global digital technology companies. Given the growing demand for eCommerce solutions across MENA, Changi proudly introduces its first alliance in 2020 with Astound Commerce, the world's most trusted Digital Commerce Specialist. Terry Hunter, Managing Director at Astound Commerce announced: "We're excited to partner with the team at Changi. Our partnership is not only based on our complementary skill sets in delivering best-of-breed solutions to drive enhanced services. More than that, it's based on our combined commitment to always strive for excellence, which is hard baked into both of our cultures. This means we can now expand our geographic footprint together and offer more customers the digital transformation needed to drive their businesses forwards, deliver success and improve performance." Terry went on to add: "From the very first meeting with Changi, it was clear that both our companies are perfectly aligned in the way we support our clients. It's just as important to both of us to deliver great results as it is to operate with the utmost integrity and ethics at the heart of what we do." Via the cornerstone partnership with Salesforce and the newly formed strategic alliance with Astound Commerce, Changi is looking forward to another 10 years of helping companies across the region take their business processes to the next level and leading their digital transformation efforts, through their merging of combined competencies and experience. Contact Name: Letticia PaswaniEmail: [emailprotected], Phone Number : +971 4 431 9034 https://www.changiconsulting.com/ About ChangiChangi Consulting, LLC, founded in 2010, is a customer-centric consulting firm and a Salesforce partner in the EMEA region. With expertise across major industries and business functions, we build and deliver cloud-based solutions focused on helping companies transform, automate, and optimize business processes. Whether you are new to cloud technology, or you are looking to accelerate your digital strategy, we can help. SOURCE Changi Consulting Related Links https://www.changiconsulting.com/
Answer:
|
Changi Celebrates 10 Years of Salesforce in the MENA Region with new Partnerships USA - English USA - English USA - English
|
DUBAI, UAE, Oct. 14, 2020 /PRNewswire/ --Changi has been delivering Salesforce CRM cloud-based solutions in the UAE and wider MENA region for 10 years. Reaching this milestone in 2020, amidst COVID-19, is humbling and the company is focused on expanding its platform and partnerships to serve the rapidly increasing demand for digital transformation across the Middle East. Its first partnership is in the eCommerce space with global leader Astound Commerce. Changi made a bet on Salesforce ten years ago based on founder Ghassan Chkaiban's CRM expertise and quest for high quality digital solutions. "Since Changi was created, we have been a passionate advocate of the Salesforce ecosystem and we truly believe that it's the best customer success platform out there; I saw an opportunity for its growth in the Middle East and embarked on this journey 10 years ago, as a Salesforce Partner, by developing a market presence across the region and in multiple industries, through our headquarters in Dubai. With growing momentum, hard work and many learning opportunities along theway, we have built a strong foundation that is well suited to serve the region's appetite for digital transformation," saidGhassan Chkaiban, Founder & Managing Director ofChangi. The sentiment is echoed by seasoned Salesforce executive Robin Fisher, Senior Area Vice President - Growth Markets, who recognized Changi's milestone: "Congratulations Changi on your 10-year celebrations. I am proud to be associated with this amazing team of passionate, consultative, customer centric professionals. You have been instrumental over the past decade in ensuring that our mutual customers grow and benefit from their Salesforce investments. You truly are an example of #Trailblazer. Our valuable partnership over the years has assisted in creating the strong, ever growing Salesforce ecosystem we see in the Middle East. I look forward to our mutual success as we continue to serve our customers together, so that they in turn can better serve their customers, partners and employees. Thank you Changi, enjoy your birthday celebrations." With digital transformation at the core of Changi's ethos, the company is actively building strategic alliances with leading global digital technology companies. Given the growing demand for eCommerce solutions across MENA, Changi proudly introduces its first alliance in 2020 with Astound Commerce, the world's most trusted Digital Commerce Specialist. Terry Hunter, Managing Director at Astound Commerce announced: "We're excited to partner with the team at Changi. Our partnership is not only based on our complementary skill sets in delivering best-of-breed solutions to drive enhanced services. More than that, it's based on our combined commitment to always strive for excellence, which is hard baked into both of our cultures. This means we can now expand our geographic footprint together and offer more customers the digital transformation needed to drive their businesses forwards, deliver success and improve performance." Terry went on to add: "From the very first meeting with Changi, it was clear that both our companies are perfectly aligned in the way we support our clients. It's just as important to both of us to deliver great results as it is to operate with the utmost integrity and ethics at the heart of what we do." Via the cornerstone partnership with Salesforce and the newly formed strategic alliance with Astound Commerce, Changi is looking forward to another 10 years of helping companies across the region take their business processes to the next level and leading their digital transformation efforts, through their merging of combined competencies and experience. Contact Name: Letticia PaswaniEmail: [emailprotected], Phone Number : +971 4 431 9034 https://www.changiconsulting.com/ About ChangiChangi Consulting, LLC, founded in 2010, is a customer-centric consulting firm and a Salesforce partner in the EMEA region. With expertise across major industries and business functions, we build and deliver cloud-based solutions focused on helping companies transform, automate, and optimize business processes. Whether you are new to cloud technology, or you are looking to accelerate your digital strategy, we can help. SOURCE Changi Consulting Related Links https://www.changiconsulting.com/
|
edtsum5929
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has revised the outlook to negative from stable for the Long-Term Issuer Credit Rating (Long-Term ICR) and affirmed the Financial Strength Rating (FSR) of B++ (Good) and the Long-Term ICR of bbb+ of The Providence Mutual Fire Insurance Company (Providence Mutual) (Warwick, RI). The outlook of the FSR is stable. The Credit Ratings (ratings) reflect Providence Mutuals balance sheet strength, which AM Best assesses as very strong, as well as its marginal operating performance, limited business profile and appropriate enterprise risk management (ERM). The revised outlook of the Long-Term ICR primarily reflects AM Bests concern over the effectiveness of Providence Mutuals ERM program and its ability to mitigate ongoing operational challenges. The company has been challenged by several issues over the past five years, including severe weather events and increased frequency of large losses, as well as pricing shortfalls in its personal auto business. Management has responded by implementing more restrictive underwriting guidelines, increasing attention to agency management, reducing its risk appetite for unsupported auto business and reducing coastal exposures. Despite these initiatives, volatility continues and negatively impacts its operating performance and the companys ability to generate organic surplus growth through core operations. Providence Mutuals balance sheet strength continues to be supported by its strongest level of risk-adjusted capitalization, as measured by Bests Capital Adequacy Ratio (BCAR), and historically favorable loss reserve development, partially offset by elevated common stock leverage and the aforementioned challenges to grow surplus through underwriting results. While the companys operating performance over the long term has reported a number of years with materially depressed results, its performance in most years has been marginal. The business profile reflects a portfolio that lends itself to consistent volatility, which is reflected in AM Bests assessment of limited. This press release relates to Credit Ratings that have been published on AM Bests website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Bests Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings. For information on the proper media use of Bests Credit Ratings and AM Best press releases, please view Guide for Media - Proper Use of Bests Credit Ratings and AM Best Rating Action Press Releases. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com. Copyright 2021 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
Answer:
|
AM Best Revises Issuer Credit Rating Outlook to Negative for The Providence Mutual Fire Insurance Company
|
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has revised the outlook to negative from stable for the Long-Term Issuer Credit Rating (Long-Term ICR) and affirmed the Financial Strength Rating (FSR) of B++ (Good) and the Long-Term ICR of bbb+ of The Providence Mutual Fire Insurance Company (Providence Mutual) (Warwick, RI). The outlook of the FSR is stable. The Credit Ratings (ratings) reflect Providence Mutuals balance sheet strength, which AM Best assesses as very strong, as well as its marginal operating performance, limited business profile and appropriate enterprise risk management (ERM). The revised outlook of the Long-Term ICR primarily reflects AM Bests concern over the effectiveness of Providence Mutuals ERM program and its ability to mitigate ongoing operational challenges. The company has been challenged by several issues over the past five years, including severe weather events and increased frequency of large losses, as well as pricing shortfalls in its personal auto business. Management has responded by implementing more restrictive underwriting guidelines, increasing attention to agency management, reducing its risk appetite for unsupported auto business and reducing coastal exposures. Despite these initiatives, volatility continues and negatively impacts its operating performance and the companys ability to generate organic surplus growth through core operations. Providence Mutuals balance sheet strength continues to be supported by its strongest level of risk-adjusted capitalization, as measured by Bests Capital Adequacy Ratio (BCAR), and historically favorable loss reserve development, partially offset by elevated common stock leverage and the aforementioned challenges to grow surplus through underwriting results. While the companys operating performance over the long term has reported a number of years with materially depressed results, its performance in most years has been marginal. The business profile reflects a portfolio that lends itself to consistent volatility, which is reflected in AM Bests assessment of limited. This press release relates to Credit Ratings that have been published on AM Bests website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Bests Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings. For information on the proper media use of Bests Credit Ratings and AM Best press releases, please view Guide for Media - Proper Use of Bests Credit Ratings and AM Best Rating Action Press Releases. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com. Copyright 2021 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
|
edtsum5943
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MIAMI, Aug. 24, 2020 /PRNewswire/ --The City of Miami Beach has approved entrepreneur Wayne M. Boich and Boich Companies plans for a mixed-use building in Sunset Harbour. Construction on the five-story project, located at 1910 Alton Road, will begin immediately. (PRNewsfoto/Boich Companies) "We at Boich Companies are not only looking forward to developing this project in one of Miami Beach's most vibrant neighborhoods, but to also making this the new headquarters of our company. 1910 Alton Road will be architecturally significant featuring state of the art construction and design. We're excited to bring new and exceptional spaces to Sunset Harbour,"said Wayne M. Boich, Chairman and CEO, Boich Companies Designed by renowned architect, Kobi Karp, the 15,997 square ft. project will bring world class design to the heart of Sunset Harbour. The five-story building consists of a residential unit on the top floor including an expansive rooftop deck, two floors of office spaces, a ground floor art gallery, secured lobby and 15 private parking spaces. The mixed-use development will also feature interiors by Allison Antrobus of Antrobus Design Collective and is expected to be completed in late 2021. Wayne M. Boich is Chairman and CEO of Boich Companies, a family investment office headquartered in Miami, FL. Boich Companies has a significant real estate portfolio with assets throughout the U.S and invests in a wide range of businesses including energy, specialty finance, telecommunications, technology, and culinary services.About Boich Companies Boich Companies is a family investment office that currently has investments across a wide range of business including real estate, energy, specialty finance, telecommunications, technology, and culinary services. Boich Companies is headquartered in Miami, FL.MEDIA CONTACT:Matt BrooksAlchemy[emailprotected]SOURCE Boich Companies
Answer:
|
Wayne M. Boich Announces Approved 16,000 sq ft Mixed-Use Building in Miami Beach Boich Companies to Make Building New Company Headquarters
|
MIAMI, Aug. 24, 2020 /PRNewswire/ --The City of Miami Beach has approved entrepreneur Wayne M. Boich and Boich Companies plans for a mixed-use building in Sunset Harbour. Construction on the five-story project, located at 1910 Alton Road, will begin immediately. (PRNewsfoto/Boich Companies) "We at Boich Companies are not only looking forward to developing this project in one of Miami Beach's most vibrant neighborhoods, but to also making this the new headquarters of our company. 1910 Alton Road will be architecturally significant featuring state of the art construction and design. We're excited to bring new and exceptional spaces to Sunset Harbour,"said Wayne M. Boich, Chairman and CEO, Boich Companies Designed by renowned architect, Kobi Karp, the 15,997 square ft. project will bring world class design to the heart of Sunset Harbour. The five-story building consists of a residential unit on the top floor including an expansive rooftop deck, two floors of office spaces, a ground floor art gallery, secured lobby and 15 private parking spaces. The mixed-use development will also feature interiors by Allison Antrobus of Antrobus Design Collective and is expected to be completed in late 2021. Wayne M. Boich is Chairman and CEO of Boich Companies, a family investment office headquartered in Miami, FL. Boich Companies has a significant real estate portfolio with assets throughout the U.S and invests in a wide range of businesses including energy, specialty finance, telecommunications, technology, and culinary services.About Boich Companies Boich Companies is a family investment office that currently has investments across a wide range of business including real estate, energy, specialty finance, telecommunications, technology, and culinary services. Boich Companies is headquartered in Miami, FL.MEDIA CONTACT:Matt BrooksAlchemy[emailprotected]SOURCE Boich Companies
|
edtsum5945
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: HOUSTON, July 9, 2020 /PRNewswire/ -- A&R Logistics (A&R), a leading provider of end-to-end supply chain solutions to the chemical industry, recently promoted two members of its finance team. Natalie Masin was named as the Vice President of Finance, Corporate Controller for the company, while Adam Denton assumed the role of Vice President of Finance, Head of Shared Services. Masin and Denton will both report to CFO, Taimur Sharih. "As our company continues to grow, it is my priority to continue to foster an environment where our people have an opportunity to grow as well," said A&R Logistics CEO Mark Holden. "We appreciate Natalie and Adam's meaningful contributions to our company and look forward to working closely with them to achieve our strategic growth plan." Masin joined A&R in February 2020 as a Director of Financial Planning & Analysis. She brings seven years of broad financial experience in energy, technology, manufacturing, industrial distribution and other industries, including financial modeling and analysis, treasury and cash flow management, capital markets, audit, and IPO readiness. She is a Certified Public Accountant and a Chartered Financial Analyst. Masin graduated magna cum laude with a double major in accounting and agricultural business & technology, with a minor in finance, from Washington State University. She earned her master's degree in accounting from The University of Texas at Austin McCombs School of Business where she was named a Sommerfeld Scholar and ranked on the Dean's List. An active member of the CFA Institute & CFA Society Houston, the American Institute of Certified Public Accountants, and the Texas Society of CPAs, Masin also benefits as a mentee in the 2019-2020 Women's Energy Network Mentorship Program. Denton has served in progressive leadership positions at A&R, most recently as a Director of Finance. With 10 years of experience across all aspects of finance and accounting functions, he has significant expertise in leading M&A strategies and a proven history of leveraging financial data to improve decision-making and profitability to maximize revenues. He is a Certified Public Accountant. Denton graduated from University of Louisville with a bachelor's degree in history and is currently enrolled in a Master of Business Administration (MBA) program at Vanderbilt University, with expected completion in 2022. About A&R Logistics A&R Logistics, Inc. is a leading supply chain services company providing dry bulk transportation services, warehousing and packaging, distribution, export and third-party logistics solutions to numerous multinational companies in the chemical industry. A&R provides a comprehensive suite of services including over-the-road transportation, transloading, packaging, warehousing, and end-to-end outsourced transportation management through a nationwide network of facilities, a combination of company-owned equipment and owner-operators, and a non-asset-based transportation management division. SOURCE A&R Logistics Related Links http://arlogistics.com/
Answer:
|
A&R Logistics Promotes Natalie Masin and Adam Denton to VP of Finance Roles
|
HOUSTON, July 9, 2020 /PRNewswire/ -- A&R Logistics (A&R), a leading provider of end-to-end supply chain solutions to the chemical industry, recently promoted two members of its finance team. Natalie Masin was named as the Vice President of Finance, Corporate Controller for the company, while Adam Denton assumed the role of Vice President of Finance, Head of Shared Services. Masin and Denton will both report to CFO, Taimur Sharih. "As our company continues to grow, it is my priority to continue to foster an environment where our people have an opportunity to grow as well," said A&R Logistics CEO Mark Holden. "We appreciate Natalie and Adam's meaningful contributions to our company and look forward to working closely with them to achieve our strategic growth plan." Masin joined A&R in February 2020 as a Director of Financial Planning & Analysis. She brings seven years of broad financial experience in energy, technology, manufacturing, industrial distribution and other industries, including financial modeling and analysis, treasury and cash flow management, capital markets, audit, and IPO readiness. She is a Certified Public Accountant and a Chartered Financial Analyst. Masin graduated magna cum laude with a double major in accounting and agricultural business & technology, with a minor in finance, from Washington State University. She earned her master's degree in accounting from The University of Texas at Austin McCombs School of Business where she was named a Sommerfeld Scholar and ranked on the Dean's List. An active member of the CFA Institute & CFA Society Houston, the American Institute of Certified Public Accountants, and the Texas Society of CPAs, Masin also benefits as a mentee in the 2019-2020 Women's Energy Network Mentorship Program. Denton has served in progressive leadership positions at A&R, most recently as a Director of Finance. With 10 years of experience across all aspects of finance and accounting functions, he has significant expertise in leading M&A strategies and a proven history of leveraging financial data to improve decision-making and profitability to maximize revenues. He is a Certified Public Accountant. Denton graduated from University of Louisville with a bachelor's degree in history and is currently enrolled in a Master of Business Administration (MBA) program at Vanderbilt University, with expected completion in 2022. About A&R Logistics A&R Logistics, Inc. is a leading supply chain services company providing dry bulk transportation services, warehousing and packaging, distribution, export and third-party logistics solutions to numerous multinational companies in the chemical industry. A&R provides a comprehensive suite of services including over-the-road transportation, transloading, packaging, warehousing, and end-to-end outsourced transportation management through a nationwide network of facilities, a combination of company-owned equipment and owner-operators, and a non-asset-based transportation management division. SOURCE A&R Logistics Related Links http://arlogistics.com/
|
edtsum5946
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SACRAMENTO, Calif.--(BUSINESS WIRE)--KB Home (NYSE: KBH) today announced the grand opening of Oaks at Mitchell Village, the homebuilders newest master-planned community in Citrus Heights, California. The new enclave of single-family homes is situated in a desirable neighborhood offering a unique lifestyle that combines comfort and modern design with numerous community amenities. Oaks at Mitchell Village homeowners can stroll through acres of open space, enjoy a picnic at the community park or walk to the shops and restaurants at Sunrise Mall and Marketplace at Birdcage. The new master plan is close to Interstate 80 and Highway 50, providing easy commutes to Sacramento. The community is also near outdoor recreation, including golfing, hiking and biking as well as boating and swimming at Folsom Lake State Recreation Area and Sacramento State Aquatic Center at Lake Natomas. The new homes at Oaks at Mitchell Village showcase desirable design characteristics like gourmet kitchens overlooking expansive great rooms, large bedroom suites with walk-in closets, and ample storage space. The communitys floor plans feature up to five bedrooms and three baths, and range in size from approximately 1,400 to 2,200 square feet. Oaks at Mitchell Village is part of our newest master-planned community in Citrus Heights, a commuter-friendly town that hosts numerous activities and offers premier shopping, dining and entertainment. Homeowners who enjoy an active lifestyle will appreciate the communitys amenities and its proximity to hiking, biking, golfing and other outdoor activities, said Adam Hieb, President of KB Homes Sacramento division. As with other KB Home communities, Oaks at Mitchell Village provides home shoppers the opportunity to purchase a personalized, new KB home at a price that fits their budget. KB Home stands out from other homebuilders as the company gives homebuyers exceptional choice and control. KB Home starts by offering a wide variety of homes at an affordable price. From there, the builder gives buyers the ability to personalize their homes from floor plans to exterior elevations, from design options to where they live in the community. The KB Home team works hand in hand with homeowners every step of the way so they have a real partner in the process. Every KB home is designed to be ENERGY STAR certified thanks to the quality construction techniques and materials utilized that ultimately deliver significant savings on utility bills compared to used homes. Additionally, all new KB homes are designed to deliver an enhanced indoor environment and include high performance ventilation systems, low- or zero-VOC products and other features guided by the Environmental Protection Agencys (EPA) Indoor airPLUS standards. The Oaks at Mitchell Village sales office and model homes are open for private in-person tours by appointment, and walk-in visits are welcome. Homebuyers also have the flexibility to arrange a live video tour with a sales counselor. Pricing starts in the $450,000s. For more information on KB Home, call 888-KB-HOMES or visit kbhome.com. About KB Home KB Home is one of the largest and most recognized homebuilders in the United States and has been building quality homes for over 60 years. Today, KB Home operates in 45 markets across eight states, serving a wide array of buyer groups. What sets us apart is how we give our customers the ability to personalize their homes from homesites and floor plans to cabinets and countertops, at a price that fits their budget. We are the first builder to make every home we build ENERGY STAR certified. In fact, we go beyond the EPA requirements by ensuring every ENERGY STAR certified KB home has been tested and verified by a third-party inspector to meet the EPAs strict certification standards, which help to lower the cost of ownership and to make our new homes healthier and more comfortable than new ones without certification. We also work with our customers every step of the way, building strong personal relationships so they have a real partner in the homebuying process, and the experience is as simple and easy as possible. Learn more about how we build homes built on relationships by visiting kbhome.com.
Answer:
|
KB Home Announces the Grand Opening of Oaks at Mitchell Village, Its Newest Master-planned Community in Citrus Heights, California Homebuilder offers personalized, new homes in a prime Sacramento-area location, priced from the $450,000s
|
SACRAMENTO, Calif.--(BUSINESS WIRE)--KB Home (NYSE: KBH) today announced the grand opening of Oaks at Mitchell Village, the homebuilders newest master-planned community in Citrus Heights, California. The new enclave of single-family homes is situated in a desirable neighborhood offering a unique lifestyle that combines comfort and modern design with numerous community amenities. Oaks at Mitchell Village homeowners can stroll through acres of open space, enjoy a picnic at the community park or walk to the shops and restaurants at Sunrise Mall and Marketplace at Birdcage. The new master plan is close to Interstate 80 and Highway 50, providing easy commutes to Sacramento. The community is also near outdoor recreation, including golfing, hiking and biking as well as boating and swimming at Folsom Lake State Recreation Area and Sacramento State Aquatic Center at Lake Natomas. The new homes at Oaks at Mitchell Village showcase desirable design characteristics like gourmet kitchens overlooking expansive great rooms, large bedroom suites with walk-in closets, and ample storage space. The communitys floor plans feature up to five bedrooms and three baths, and range in size from approximately 1,400 to 2,200 square feet. Oaks at Mitchell Village is part of our newest master-planned community in Citrus Heights, a commuter-friendly town that hosts numerous activities and offers premier shopping, dining and entertainment. Homeowners who enjoy an active lifestyle will appreciate the communitys amenities and its proximity to hiking, biking, golfing and other outdoor activities, said Adam Hieb, President of KB Homes Sacramento division. As with other KB Home communities, Oaks at Mitchell Village provides home shoppers the opportunity to purchase a personalized, new KB home at a price that fits their budget. KB Home stands out from other homebuilders as the company gives homebuyers exceptional choice and control. KB Home starts by offering a wide variety of homes at an affordable price. From there, the builder gives buyers the ability to personalize their homes from floor plans to exterior elevations, from design options to where they live in the community. The KB Home team works hand in hand with homeowners every step of the way so they have a real partner in the process. Every KB home is designed to be ENERGY STAR certified thanks to the quality construction techniques and materials utilized that ultimately deliver significant savings on utility bills compared to used homes. Additionally, all new KB homes are designed to deliver an enhanced indoor environment and include high performance ventilation systems, low- or zero-VOC products and other features guided by the Environmental Protection Agencys (EPA) Indoor airPLUS standards. The Oaks at Mitchell Village sales office and model homes are open for private in-person tours by appointment, and walk-in visits are welcome. Homebuyers also have the flexibility to arrange a live video tour with a sales counselor. Pricing starts in the $450,000s. For more information on KB Home, call 888-KB-HOMES or visit kbhome.com. About KB Home KB Home is one of the largest and most recognized homebuilders in the United States and has been building quality homes for over 60 years. Today, KB Home operates in 45 markets across eight states, serving a wide array of buyer groups. What sets us apart is how we give our customers the ability to personalize their homes from homesites and floor plans to cabinets and countertops, at a price that fits their budget. We are the first builder to make every home we build ENERGY STAR certified. In fact, we go beyond the EPA requirements by ensuring every ENERGY STAR certified KB home has been tested and verified by a third-party inspector to meet the EPAs strict certification standards, which help to lower the cost of ownership and to make our new homes healthier and more comfortable than new ones without certification. We also work with our customers every step of the way, building strong personal relationships so they have a real partner in the homebuying process, and the experience is as simple and easy as possible. Learn more about how we build homes built on relationships by visiting kbhome.com.
|
edtsum5949
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: GREENVILLE, N.C., Jan. 21, 2021 /PRNewswire/ --Grover Gaming, Inc., an industry leader in electronic gaming design and software development since 2013, announced today that it had surpassed$200 millionin monies raised for charities through their charitable gaming and fraternal partners across the United States. Grover Gaming and their Charitable Gaming partners throughout Virginia, North Dakota, Ohio, New Hampshire, and Kentucky recently surpassed $200 Million in monies raised for charity. "We are excited to surpass another important milestone for our charitable gaming partners" ~ Garrett Blackwelder Tweet this These partners represent hundreds of charities, organizations, and fraternal groups throughout Kentucky, North Dakota, Virginia, New Hampshire, and Ohio who have utilized Grover Gaming's Electronic Pull-Tab and Electronic Raffle devices to raise funds for their charitable causes. Organizations including the Loyal Order of the Moose, Veterans of Foreign Wars, the American Legion, and the Fraternal Order of Eagles use these funds to support and care for millions of Americans and Veterans through the establishment of hospitals, schools, retirement homes, children's homes, and research centers. "We are excited to surpass another important milestone for our charitable gaming partners," said Garrett Blackwelder, President of Grover Gaming. "Although the past year has been difficult for many Americans, we are proud to help these charities and fraternal organizations secure the financial resources necessary to help support their local communities and fulfill their core missions during these difficult times." Grover Gaming develops software, game content and gaming systems for lotteries and charitable gaming jurisdictions and is licensed in Ohio, New Hampshire, Kentucky, North Dakota, South Dakota, Montana, Washington, Virginia, and Ontario Canada. The company was recently recognized as one of the fastest growing and most prestigious private companies in the US for a second year in a row, achieving the rank of #194 on Inc Magazine's annual list in 2020. Their games, known throughout the industry for high-resolution graphics, exciting design, and entertaining gameplay, are created at Grover Gaming's design and development facility in Greenville, NC by over 200 talented employees, including developers, artists, audio designers, programmers, and .net developers. For more information about Grover Gaming, visit grovergaming.comSOURCE Grover Gaming, Inc.
Answer:
|
Grover Gaming Surpasses $200 Million Raised for Charities
|
GREENVILLE, N.C., Jan. 21, 2021 /PRNewswire/ --Grover Gaming, Inc., an industry leader in electronic gaming design and software development since 2013, announced today that it had surpassed$200 millionin monies raised for charities through their charitable gaming and fraternal partners across the United States. Grover Gaming and their Charitable Gaming partners throughout Virginia, North Dakota, Ohio, New Hampshire, and Kentucky recently surpassed $200 Million in monies raised for charity. "We are excited to surpass another important milestone for our charitable gaming partners" ~ Garrett Blackwelder Tweet this These partners represent hundreds of charities, organizations, and fraternal groups throughout Kentucky, North Dakota, Virginia, New Hampshire, and Ohio who have utilized Grover Gaming's Electronic Pull-Tab and Electronic Raffle devices to raise funds for their charitable causes. Organizations including the Loyal Order of the Moose, Veterans of Foreign Wars, the American Legion, and the Fraternal Order of Eagles use these funds to support and care for millions of Americans and Veterans through the establishment of hospitals, schools, retirement homes, children's homes, and research centers. "We are excited to surpass another important milestone for our charitable gaming partners," said Garrett Blackwelder, President of Grover Gaming. "Although the past year has been difficult for many Americans, we are proud to help these charities and fraternal organizations secure the financial resources necessary to help support their local communities and fulfill their core missions during these difficult times." Grover Gaming develops software, game content and gaming systems for lotteries and charitable gaming jurisdictions and is licensed in Ohio, New Hampshire, Kentucky, North Dakota, South Dakota, Montana, Washington, Virginia, and Ontario Canada. The company was recently recognized as one of the fastest growing and most prestigious private companies in the US for a second year in a row, achieving the rank of #194 on Inc Magazine's annual list in 2020. Their games, known throughout the industry for high-resolution graphics, exciting design, and entertaining gameplay, are created at Grover Gaming's design and development facility in Greenville, NC by over 200 talented employees, including developers, artists, audio designers, programmers, and .net developers. For more information about Grover Gaming, visit grovergaming.comSOURCE Grover Gaming, Inc.
|
edtsum5950
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, May 7, 2020 /PRNewswire/ -- Building Information Modeling (BIM) market worldwide is projected to grow by US$8.1 Billion, driven by a compounded growth of 16.9%. Software, one of the segments analyzed and sized in this study, displays the potential to grow at over 16.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$6.8 Billion by the year 2025, Software will bring in healthy gains adding significant momentum to global growth. Read the full report: https://www.reportlinker.com/p05798076/?utm_source=PRN - Representing the developed world, the United States will maintain a 18.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$312.8 Million to the region's size and clout in the next 5 to 6 years. Over US$386.4 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Software will reach a market size of US$505.4 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 16.6% over the next couple of years and add approximately US$1.4 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies. - Competitors identified in this market include, among others, Archidata Inc. Asite Ltd. Autodesk, Inc. AVEVA Group plc Beck Technology, Ltd. Bentley Systems, Inc. Cadsoft Corp. Computers and Structures, Inc. Dassault Systemes Intergraph Corporation Nemetschek SE RIB Software SE Robert Mcneel &Associates Trimble Navigation Ltd. Read the full report: https://www.reportlinker.com/p05798076/?utm_source=PRN I. INTRODUCTION, METHODOLOGY & REPORT SCOPEII. EXECUTIVE SUMMARY1. MARKET OVERVIEWProduct OverviewBuilding Analytics: An OverviewBuilding Information Modelling Market in North AmericaIndia has Leading Market Revenue among Australia, New Zealandand IndiaBUILDING INFORMATION MODELLING MARKET IN EUROPERegional wise Consumption Market ShareGlobal Competitor Market SharesBuilding Information Modeling (BIM) Competitor Market ShareScenario Worldwide (in %): 2019 & 20252. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSLeading Players Market Share by Sales VolumeMarket Share by ApplicationsMarket Share by RegionTop PlayersA Survey on Building Information Modeling (BIM) by CountryMarket by IndustryBenefits4. GLOBAL MARKET PERSPECTIVETable 1: Building Information Modeling (BIM) Global MarketEstimates and Forecasts in US$ Million by Region/Country:2018-2025Table 2: Building Information Modeling (BIM) GlobalRetrospective Market Scenario in US$ Million by Region/Country:2009-2017Table 3: Building Information Modeling (BIM) Market Share Shiftacross Key Geographies Worldwide: 2009 VS 2019 VS 2025Table 4: Software (Type) World Market by Region/Country in US$Million: 2018 to 2025Table 5: Software (Type) Historic Market Analysis byRegion/Country in US$ Million: 2009 to 2017Table 6: Software (Type) Market Share Breakdown of WorldwideSales by Region/Country: 2009 VS 2019 VS 2025Table 7: Services (Type) Potential Growth Markets Worldwide inUS$ Million: 2018 to 2025Table 8: Services (Type) Historic Market Perspective byRegion/Country in US$ Million: 2009 to 2017Table 9: Services (Type) Market Sales Breakdown byRegion/Country in Percentage: 2009 VS 2019 VS 2025Table 10: Project Management Support (Type) Geographic MarketSpread Worldwide in US$ Million: 2018 to 2025Table 11: Project Management Support (Type) Region WiseBreakdown of Global Historic Demand in US$ Million: 2009 to2017Table 12: Project Management Support (Type) Market ShareDistribution in Percentage by Region/Country: 2009 VS 2019 VS2025Table 13: Software Support & Maintenance (Type) World MarketEstimates and Forecasts by Region/Country in US$ Million: 2018to 2025Table 14: Software Support & Maintenance (Type) Market HistoricReview by Region/Country in US$ Million: 2009 to 2017Table 15: Software Support & Maintenance (Type) Market ShareBreakdown by Region/Country: 2009 VS 2019 VS 2025Table 16: Pre-Construction (Project Life Cycle) World Market byRegion/Country in US$ Million: 2018 to 2025Table 17: Pre-Construction (Project Life Cycle) Historic MarketAnalysis by Region/Country in US$ Million: 2009 to 2017Table 18: Pre-Construction (Project Life Cycle) Market ShareDistribution in Percentage by Region/Country: 2009 VS 2019 VS2025Table 19: Construction (Project Life Cycle) World MarketEstimates and Forecasts in US$ Million by Region/Country: 2018to 2025Table 20: Construction (Project Life Cycle) Market WorldwideHistoric Review by Region/Country in US$ Million: 2009 to 2017Table 21: Construction (Project Life Cycle) Market PercentageShare Distribution by Region/Country: 2009 VS 2019 VS 2025Table 22: Operation (Project Life Cycle) Market OpportunityAnalysis Worldwide in US$ Million by Region/Country: 2018 to2025Table 23: Operation (Project Life Cycle) Global Historic Demandin US$ Million by Region/Country: 2009 to 2017Table 24: Operation (Project Life Cycle) Market ShareDistribution in Percentage by Region/Country: 2009 VS 2019 VS2025Table 25: Buildings (Application) Worldwide Sales in US$Million by Region/Country: 2018-2025Table 26: Buildings (Application) Historic Demand Patterns inUS$ Million by Region/Country: 2009-2017Table 27: Buildings (Application) Market Share Shift across KeyGeographies: 2009 VS 2019 VS 2025Table 28: Civil Infrastructure (Application) Global MarketEstimates & Forecasts in US$ Million by Region/Country:2018-2025Table 29: Civil Infrastructure (Application) RetrospectiveDemand Analysis in US$ Million by Region/Country: 2009-2017Table 30: Civil Infrastructure (Application) Market ShareBreakdown by Region/Country: 2009 VS 2019 VS 2025Table 31: Oil & Gas (Application) Demand Potential Worldwide inUS$ Million by Region/Country: 2018-2025Table 32: Oil & Gas (Application) Historic Sales Analysis inUS$ Million by Region/Country: 2009-2017Table 33: Oil & Gas (Application) Share Breakdown Review byRegion/Country: 2009 VS 2019 VS 2025Table 34: Industrial (Application) Worldwide Latent DemandForecasts in US$ Million by Region/Country: 2018-2025Table 35: Industrial (Application) Global Historic Analysis inUS$ Million by Region/Country: 2009-2017Table 36: Industrial (Application) Distribution of Global Salesby Region/Country: 2009 VS 2019 VS 2025Table 37: Utilities (Application) Sales Estimates and Forecastsin US$ Million by Region/Country for the Years 2018 through2025Table 38: Utilities (Application) Analysis of Historic Sales inUS$ Million by Region/Country for the Years 2009 to 2017Table 39: Utilities (Application) Global Market ShareDistribution by Region/Country for 2009, 2019, and 2025Table 40: Other Applications (Application) Global OpportunityAssessment in US$ Million by Region/Country: 2018-2025Table 41: Other Applications (Application) Historic SalesAnalysis in US$ Million by Region/Country: 2009-2017Table 42: Other Applications (Application) Percentage ShareBreakdown of Global Sales by Region/Country: 2009 VS 2019 VS2025III. MARKET ANALYSISGEOGRAPHIC MARKET ANALYSISUNITED STATESMarket Facts & FiguresUS Building Information Modeling (BIM) Market Share (in %) byCompany: 2019 & 2025Market AnalyticsTable 43: United States Building Information Modeling (BIM)Market Estimates and Projections in US$ Million by Type: 2018to 2025Table 44: Building Information Modeling (BIM) Market in theUnited States by Type: A Historic Review in US$ Million for2009-2017Table 45: United States Building Information Modeling (BIM)Market Share Breakdown by Type: 2009 VS 2019 VS 2025Table 46: United States Building Information Modeling (BIM)Market Estimates and Projections in US$ Million by Project LifeCycle: 2018 to 2025Table 47: Building Information Modeling (BIM) Market in theUnited States by Project Life Cycle: A Historic Review in US$Million for 2009-2017Table 48: United States Building Information Modeling (BIM)Market Share Breakdown by Project Life Cycle: 2009 VS 2019 VS2025Table 49: United States Building Information Modeling (BIM)Latent Demand Forecasts in US$ Million by Application: 2018 to2025Table 50: Building Information Modeling (BIM) Historic DemandPatterns in the United States by Application in US$ Million for2009-2017Table 51: Building Information Modeling (BIM) Market ShareBreakdown in the United States by Application: 2009 VS 2019 VS2025CANADATable 52: Canadian Building Information Modeling (BIM) MarketEstimates and Forecasts in US$ Million by Type: 2018 to 2025Table 53: Canadian Building Information Modeling (BIM) HistoricMarket Review by Type in US$ Million: 2009-2017Table 54: Building Information Modeling (BIM) Market in Canada:Percentage Share Breakdown of Sales by Type for 2009, 2019, and2025Table 55: Canadian Building Information Modeling (BIM) MarketEstimates and Forecasts in US$ Million by Project Life Cycle:2018 to 2025Table 56: Canadian Building Information Modeling (BIM) HistoricMarket Review by Project Life Cycle in US$ Million: 2009-2017Table 57: Building Information Modeling (BIM) Market in Canada:Percentage Share Breakdown of Sales by Project Life Cycle for2009, 2019, and 2025Table 58: Canadian Building Information Modeling (BIM) MarketQuantitative Demand Analysis in US$ Million by Application:2018 to 2025Table 59: Building Information Modeling (BIM) Market in Canada:Summarization of Historic Demand Patterns in US$ Million byApplication for 2009-2017Table 60: Canadian Building Information Modeling (BIM) MarketShare Analysis by Application: 2009 VS 2019 VS 2025JAPANTable 61: Japanese Market for Building Information Modeling(BIM): Annual Sales Estimates and Projections in US$ Million byType for the Period 2018-2025Table 62: Building Information Modeling (BIM) Market in Japan:Historic Sales Analysis in US$ Million by Type for the Period2009-2017Table 63: Japanese Building Information Modeling (BIM) MarketShare Analysis by Type: 2009 VS 2019 VS 2025Table 64: Japanese Market for Building Information Modeling(BIM): Annual Sales Estimates and Projections in US$ Million byProject Life Cycle for the Period 2018-2025Table 65: Building Information Modeling (BIM) Market in Japan:Historic Sales Analysis in US$ Million by Project Life Cyclefor the Period 2009-2017Table 66: Japanese Building Information Modeling (BIM) MarketShare Analysis by Project Life Cycle: 2009 VS 2019 VS 2025Table 67: Japanese Demand Estimates and Forecasts for BuildingInformation Modeling (BIM) in US$ Million by Application: 2018to 2025Table 68: Japanese Building Information Modeling (BIM) Marketin US$ Million by Application: 2009-2017Table 69: Building Information Modeling (BIM) Market ShareShift in Japan by Application: 2009 VS 2019 VS 2025CHINATable 70: Chinese Building Information Modeling (BIM) MarketGrowth Prospects in US$ Million by Type for the Period2018-2025Table 71: Building Information Modeling (BIM) Historic MarketAnalysis in China in US$ Million by Type: 2009-2017Table 72: Chinese Building Information Modeling (BIM) Market byType: Percentage Breakdown of Sales for 2009, 2019, and 2025Table 73: Chinese Building Information Modeling (BIM) MarketGrowth Prospects in US$ Million by Project Life Cycle for thePeriod 2018-2025Table 74: Building Information Modeling (BIM) Historic MarketAnalysis in China in US$ Million by Project Life Cycle:2009-2017Table 75: Chinese Building Information Modeling (BIM) Market byProject Life Cycle: Percentage Breakdown of Sales for 2009,2019, and 2025Table 76: Chinese Demand for Building Information Modeling(BIM) in US$ Million by Application: 2018 to 2025Table 77: Building Information Modeling (BIM) Market Review inChina in US$ Million by Application: 2009-2017Table 78: Chinese Building Information Modeling (BIM) MarketShare Breakdown by Application: 2009 VS 2019 VS 2025EUROPEMarket Facts & FiguresEuropean Building Information Modeling (BIM) Market: CompetitorMarket Share Scenario (in %) for 2019 & 2025Market AnalyticsTable 79: European Building Information Modeling (BIM) MarketDemand Scenario in US$ Million by Region/Country: 2018-2025Table 80: Building Information Modeling (BIM) Market in Europe:A Historic Market Perspective in US$ Million by Region/Countryfor the Period 2009-2017Table 81: European Building Information Modeling (BIM) MarketShare Shift by Region/Country: 2009 VS 2019 VS 2025Table 82: European Building Information Modeling (BIM) MarketEstimates and Forecasts in US$ Million by Type: 2018-2025Table 83: Building Information Modeling (BIM) Market in Europein US$ Million by Type: A Historic Review for the Period2009-2017Table 84: European Building Information Modeling (BIM) MarketShare Breakdown by Type: 2009 VS 2019 VS 2025Table 85: European Building Information Modeling (BIM) MarketEstimates and Forecasts in US$ Million by Project Life Cycle:2018-2025Table 86: Building Information Modeling (BIM) Market in Europein US$ Million by Project Life Cycle: A Historic Review for thePeriod 2009-2017Table 87: European Building Information Modeling (BIM) MarketShare Breakdown by Project Life Cycle: 2009 VS 2019 VS 2025Table 88: European Building Information Modeling (BIM)Addressable Market Opportunity in US$ Million by Application:2018-2025Table 89: Building Information Modeling (BIM) Market in Europe:Summarization of Historic Demand in US$ Million by Applicationfor the Period 2009-2017Table 90: European Building Information Modeling (BIM) MarketShare Analysis by Application: 2009 VS 2019 VS 2025FRANCETable 91: Building Information Modeling (BIM) Market in Franceby Type: Estimates and Projections in US$ Million for thePeriod 2018-2025Table 92: French Building Information Modeling (BIM) HistoricMarket Scenario in US$ Million by Type: 2009-2017Table 93: French Building Information Modeling (BIM) MarketShare Analysis by Type: 2009 VS 2019 VS 2025Table 94: Building Information Modeling (BIM) Market in Franceby Project Life Cycle: Estimates and Projections in US$ Millionfor the Period 2018-2025Table 95: French Building Information Modeling (BIM) HistoricMarket Scenario in US$ Million by Project Life Cycle: 2009-2017Table 96: French Building Information Modeling (BIM) MarketShare Analysis by Project Life Cycle: 2009 VS 2019 VS 2025Table 97: Building Information Modeling (BIM) QuantitativeDemand Analysis in France in US$ Million by Application:2018-2025Table 98: French Building Information Modeling (BIM) HistoricMarket Review in US$ Million by Application: 2009-2017Table 99: French Building Information Modeling (BIM) MarketShare Analysis: A 17-Year Perspective by Application for 2009,2019, and 2025GERMANYTable 100: Building Information Modeling (BIM) Market inGermany: Recent Past, Current and Future Analysis in US$Million by Type for the Period 2018-2025Table 101: German Building Information Modeling (BIM) HistoricMarket Analysis in US$ Million by Type: 2009-2017Table 102: German Building Information Modeling (BIM) MarketShare Breakdown by Type: 2009 VS 2019 VS 2025Table 103: Building Information Modeling (BIM) Market inGermany: Recent Past, Current and Future Analysis in US$Million by Project Life Cycle for the Period 2018-2025Table 104: German Building Information Modeling (BIM) HistoricMarket Analysis in US$ Million by Project Life Cycle: 2009-2017Table 105: German Building Information Modeling (BIM) MarketShare Breakdown by Project Life Cycle: 2009 VS 2019 VS 2025Table 106: Building Information Modeling (BIM) Market inGermany: Annual Sales Estimates and Forecasts in US$ Million byApplication for the Period 2018-2025Table 107: German Building Information Modeling (BIM) Market inRetrospect in US$ Million by Application: 2009-2017Table 108: Building Information Modeling (BIM) Market ShareDistribution in Germany by Application: 2009 VS 2019 VS 2025ITALYTable 109: Italian Building Information Modeling (BIM) MarketGrowth Prospects in US$ Million by Type for the Period2018-2025Table 110: Building Information Modeling (BIM) Historic MarketAnalysis in Italy in US$ Million by Type: 2009-2017Table 111: Italian Building Information Modeling (BIM) Marketby Type: Percentage Breakdown of Sales for 2009, 2019, and 2025Table 112: Italian Building Information Modeling (BIM) MarketGrowth Prospects in US$ Million by Project Life Cycle for thePeriod 2018-2025Table 113: Building Information Modeling (BIM) Historic MarketAnalysis in Italy in US$ Million by Project Life Cycle:2009-2017Table 114: Italian Building Information Modeling (BIM) Marketby Project Life Cycle: Percentage Breakdown of Sales for 2009,2019, and 2025Table 115: Italian Demand for Building Information Modeling(BIM) in US$ Million by Application: 2018 to 2025Table 116: Building Information Modeling (BIM) Market Review inItaly in US$ Million by Application: 2009-2017Table 117: Italian Building Information Modeling (BIM) MarketShare Breakdown by Application: 2009 VS 2019 VS 2025UNITED KINGDOMTable 118: United Kingdom Market for Building InformationModeling (BIM): Annual Sales Estimates and Projections in US$Million by Type for the Period 2018-2025Table 119: Building Information Modeling (BIM) Market in theUnited Kingdom: Historic Sales Analysis in US$ Million by Typefor the Period 2009-2017Table 120: United Kingdom Building Information Modeling (BIM)Market Share Analysis by Type: 2009 VS 2019 VS 2025Table 121: United Kingdom Market for Building InformationModeling (BIM): Annual Sales Estimates and Projections in US$Million by Project Life Cycle for the Period 2018-2025Table 122: Building Information Modeling (BIM) Market in theUnited Kingdom: Historic Sales Analysis in US$ Million byProject Life Cycle for the Period 2009-2017Table 123: United Kingdom Building Information Modeling (BIM)Market Share Analysis by Project Life Cycle: 2009 VS 2019 VS2025Table 124: United Kingdom Demand Estimates and Forecasts forBuilding Information Modeling (BIM) in US$ Million byApplication: 2018 to 2025Table 125: United Kingdom Building Information Modeling (BIM)Market in US$ Million by Application: 2009-2017Table 126: Building Information Modeling (BIM) Market ShareShift in the United Kingdom by Application: 2009 VS 2019 VS2025REST OF EUROPETable 127: Rest of Europe Building Information Modeling (BIM)Market Estimates and Forecasts in US$ Million by Type:2018-2025Table 128: Building Information Modeling (BIM) Market in Restof Europe in US$ Million by Type: A Historic Review for thePeriod 2009-2017Table 129: Rest of Europe Building Information Modeling (BIM)Market Share Breakdown by Type: 2009 VS 2019 VS 2025Table 130: Rest of Europe Building Information Modeling (BIM)Market Estimates and Forecasts in US$ Million by Project LifeCycle: 2018-2025Table 131: Building Information Modeling (BIM) Market in Restof Europe in US$ Million by Project Life Cycle: A HistoricReview for the Period 2009-2017Table 132: Rest of Europe Building Information Modeling (BIM)Market Share Breakdown by Project Life Cycle: 2009 VS 2019 VS2025Table 133: Rest of Europe Building Information Modeling (BIM)Addressable Market Opportunity in US$ Million by Application:2018-2025Table 134: Building Information Modeling (BIM) Market in Restof Europe: Summarization of Historic Demand in US$ Million byApplication for the Period 2009-2017Table 135: Rest of Europe Building Information Modeling (BIM)Market Share Analysis by Application: 2009 VS 2019 VS 2025ASIA-PACIFICTable 136: Building Information Modeling (BIM) Market inAsia-Pacific by Type: Estimates and Projections in US$ Millionfor the Period 2018-2025Table 137: Asia-Pacific Building Information Modeling (BIM)Historic Market Scenario in US$ Million by Type: 2009-2017Table 138: Asia-Pacific Building Information Modeling (BIM)Market Share Analysis by Type: 2009 VS 2019 VS 2025Table 139: Building Information Modeling (BIM) Market inAsia-Pacific by Project Life Cycle: Estimates and Projectionsin US$ Million for the Period 2018-2025Table 140: Asia-Pacific Building Information Modeling (BIM)Historic Market Scenario in US$ Million by Project Life Cycle:2009-2017Table 141: Asia-Pacific Building Information Modeling (BIM)Market Share Analysis by Project Life Cycle: 2009 VS 2019 VS2025Table 142: Building Information Modeling (BIM) QuantitativeDemand Analysis in Asia-Pacific in US$ Million by Application:2018-2025Table 143: Asia-Pacific Building Information Modeling (BIM)Historic Market Review in US$ Million by Application: 2009-2017Table 144: Asia-Pacific Building Information Modeling (BIM)Market Share Analysis: A 17-Year Perspective by Application for2009, 2019, and 2025REST OF WORLDTable 145: Rest of World Building Information Modeling (BIM)Market Estimates and Forecasts in US$ Million by Type: 2018 to2025Table 146: Rest of World Building Information Modeling (BIM)Historic Market Review by Type in US$ Million: 2009-2017Table 147: Building Information Modeling (BIM) Market in Restof World: Percentage Share Breakdown of Sales by Type for 2009,2019, and 2025Table 148: Rest of World Building Information Modeling (BIM)Market Estimates and Forecasts in US$ Million by Project LifeCycle: 2018 to 2025Table 149: Rest of World Building Information Modeling (BIM)Historic Market Review by Project Life Cycle in US$ Million:2009-2017Table 150: Building Information Modeling (BIM) Market in Restof World: Percentage Share Breakdown of Sales by Project LifeCycle for 2009, 2019, and 2025Table 151: Rest of World Building Information Modeling (BIM)Market Quantitative Demand Analysis in US$ Million byApplication: 2018 to 2025Table 152: Building Information Modeling (BIM) Market in Restof World: Summarization of Historic Demand Patterns in US$Million by Application for 2009-2017Table 153: Rest of World Building Information Modeling (BIM)Market Share Analysis by Application: 2009 VS 2019 VS 2025IV. COMPETITIONARCHIDATA INC.ASITE LTD.AUTODESKAVEVA GROUP PLCBECK TECHNOLOGY, LTD.BENTLEY SYSTEMS, INCORPORATEDCADSOFTCOMPUTERS AND STRUCTURES, INC.DASSAULT SYSTMESINTERGRAPH CORPORATIONNEMETSCHEK SERIB SOFTWARE SEROBERT MCNEEL &ASSOCIATESTRIMBLE NAVIGATIONV. CURATED RESEARCHRead the full report: https://www.reportlinker.com/p05798076/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com
Answer:
|
Global Building Information Modeling (BIM) Industry
|
NEW YORK, May 7, 2020 /PRNewswire/ -- Building Information Modeling (BIM) market worldwide is projected to grow by US$8.1 Billion, driven by a compounded growth of 16.9%. Software, one of the segments analyzed and sized in this study, displays the potential to grow at over 16.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$6.8 Billion by the year 2025, Software will bring in healthy gains adding significant momentum to global growth. Read the full report: https://www.reportlinker.com/p05798076/?utm_source=PRN - Representing the developed world, the United States will maintain a 18.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$312.8 Million to the region's size and clout in the next 5 to 6 years. Over US$386.4 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Software will reach a market size of US$505.4 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 16.6% over the next couple of years and add approximately US$1.4 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies. - Competitors identified in this market include, among others, Archidata Inc. Asite Ltd. Autodesk, Inc. AVEVA Group plc Beck Technology, Ltd. Bentley Systems, Inc. Cadsoft Corp. Computers and Structures, Inc. Dassault Systemes Intergraph Corporation Nemetschek SE RIB Software SE Robert Mcneel &Associates Trimble Navigation Ltd. Read the full report: https://www.reportlinker.com/p05798076/?utm_source=PRN I. INTRODUCTION, METHODOLOGY & REPORT SCOPEII. EXECUTIVE SUMMARY1. MARKET OVERVIEWProduct OverviewBuilding Analytics: An OverviewBuilding Information Modelling Market in North AmericaIndia has Leading Market Revenue among Australia, New Zealandand IndiaBUILDING INFORMATION MODELLING MARKET IN EUROPERegional wise Consumption Market ShareGlobal Competitor Market SharesBuilding Information Modeling (BIM) Competitor Market ShareScenario Worldwide (in %): 2019 & 20252. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSLeading Players Market Share by Sales VolumeMarket Share by ApplicationsMarket Share by RegionTop PlayersA Survey on Building Information Modeling (BIM) by CountryMarket by IndustryBenefits4. GLOBAL MARKET PERSPECTIVETable 1: Building Information Modeling (BIM) Global MarketEstimates and Forecasts in US$ Million by Region/Country:2018-2025Table 2: Building Information Modeling (BIM) GlobalRetrospective Market Scenario in US$ Million by Region/Country:2009-2017Table 3: Building Information Modeling (BIM) Market Share Shiftacross Key Geographies Worldwide: 2009 VS 2019 VS 2025Table 4: Software (Type) World Market by Region/Country in US$Million: 2018 to 2025Table 5: Software (Type) Historic Market Analysis byRegion/Country in US$ Million: 2009 to 2017Table 6: Software (Type) Market Share Breakdown of WorldwideSales by Region/Country: 2009 VS 2019 VS 2025Table 7: Services (Type) Potential Growth Markets Worldwide inUS$ Million: 2018 to 2025Table 8: Services (Type) Historic Market Perspective byRegion/Country in US$ Million: 2009 to 2017Table 9: Services (Type) Market Sales Breakdown byRegion/Country in Percentage: 2009 VS 2019 VS 2025Table 10: Project Management Support (Type) Geographic MarketSpread Worldwide in US$ Million: 2018 to 2025Table 11: Project Management Support (Type) Region WiseBreakdown of Global Historic Demand in US$ Million: 2009 to2017Table 12: Project Management Support (Type) Market ShareDistribution in Percentage by Region/Country: 2009 VS 2019 VS2025Table 13: Software Support & Maintenance (Type) World MarketEstimates and Forecasts by Region/Country in US$ Million: 2018to 2025Table 14: Software Support & Maintenance (Type) Market HistoricReview by Region/Country in US$ Million: 2009 to 2017Table 15: Software Support & Maintenance (Type) Market ShareBreakdown by Region/Country: 2009 VS 2019 VS 2025Table 16: Pre-Construction (Project Life Cycle) World Market byRegion/Country in US$ Million: 2018 to 2025Table 17: Pre-Construction (Project Life Cycle) Historic MarketAnalysis by Region/Country in US$ Million: 2009 to 2017Table 18: Pre-Construction (Project Life Cycle) Market ShareDistribution in Percentage by Region/Country: 2009 VS 2019 VS2025Table 19: Construction (Project Life Cycle) World MarketEstimates and Forecasts in US$ Million by Region/Country: 2018to 2025Table 20: Construction (Project Life Cycle) Market WorldwideHistoric Review by Region/Country in US$ Million: 2009 to 2017Table 21: Construction (Project Life Cycle) Market PercentageShare Distribution by Region/Country: 2009 VS 2019 VS 2025Table 22: Operation (Project Life Cycle) Market OpportunityAnalysis Worldwide in US$ Million by Region/Country: 2018 to2025Table 23: Operation (Project Life Cycle) Global Historic Demandin US$ Million by Region/Country: 2009 to 2017Table 24: Operation (Project Life Cycle) Market ShareDistribution in Percentage by Region/Country: 2009 VS 2019 VS2025Table 25: Buildings (Application) Worldwide Sales in US$Million by Region/Country: 2018-2025Table 26: Buildings (Application) Historic Demand Patterns inUS$ Million by Region/Country: 2009-2017Table 27: Buildings (Application) Market Share Shift across KeyGeographies: 2009 VS 2019 VS 2025Table 28: Civil Infrastructure (Application) Global MarketEstimates & Forecasts in US$ Million by Region/Country:2018-2025Table 29: Civil Infrastructure (Application) RetrospectiveDemand Analysis in US$ Million by Region/Country: 2009-2017Table 30: Civil Infrastructure (Application) Market ShareBreakdown by Region/Country: 2009 VS 2019 VS 2025Table 31: Oil & Gas (Application) Demand Potential Worldwide inUS$ Million by Region/Country: 2018-2025Table 32: Oil & Gas (Application) Historic Sales Analysis inUS$ Million by Region/Country: 2009-2017Table 33: Oil & Gas (Application) Share Breakdown Review byRegion/Country: 2009 VS 2019 VS 2025Table 34: Industrial (Application) Worldwide Latent DemandForecasts in US$ Million by Region/Country: 2018-2025Table 35: Industrial (Application) Global Historic Analysis inUS$ Million by Region/Country: 2009-2017Table 36: Industrial (Application) Distribution of Global Salesby Region/Country: 2009 VS 2019 VS 2025Table 37: Utilities (Application) Sales Estimates and Forecastsin US$ Million by Region/Country for the Years 2018 through2025Table 38: Utilities (Application) Analysis of Historic Sales inUS$ Million by Region/Country for the Years 2009 to 2017Table 39: Utilities (Application) Global Market ShareDistribution by Region/Country for 2009, 2019, and 2025Table 40: Other Applications (Application) Global OpportunityAssessment in US$ Million by Region/Country: 2018-2025Table 41: Other Applications (Application) Historic SalesAnalysis in US$ Million by Region/Country: 2009-2017Table 42: Other Applications (Application) Percentage ShareBreakdown of Global Sales by Region/Country: 2009 VS 2019 VS2025III. MARKET ANALYSISGEOGRAPHIC MARKET ANALYSISUNITED STATESMarket Facts & FiguresUS Building Information Modeling (BIM) Market Share (in %) byCompany: 2019 & 2025Market AnalyticsTable 43: United States Building Information Modeling (BIM)Market Estimates and Projections in US$ Million by Type: 2018to 2025Table 44: Building Information Modeling (BIM) Market in theUnited States by Type: A Historic Review in US$ Million for2009-2017Table 45: United States Building Information Modeling (BIM)Market Share Breakdown by Type: 2009 VS 2019 VS 2025Table 46: United States Building Information Modeling (BIM)Market Estimates and Projections in US$ Million by Project LifeCycle: 2018 to 2025Table 47: Building Information Modeling (BIM) Market in theUnited States by Project Life Cycle: A Historic Review in US$Million for 2009-2017Table 48: United States Building Information Modeling (BIM)Market Share Breakdown by Project Life Cycle: 2009 VS 2019 VS2025Table 49: United States Building Information Modeling (BIM)Latent Demand Forecasts in US$ Million by Application: 2018 to2025Table 50: Building Information Modeling (BIM) Historic DemandPatterns in the United States by Application in US$ Million for2009-2017Table 51: Building Information Modeling (BIM) Market ShareBreakdown in the United States by Application: 2009 VS 2019 VS2025CANADATable 52: Canadian Building Information Modeling (BIM) MarketEstimates and Forecasts in US$ Million by Type: 2018 to 2025Table 53: Canadian Building Information Modeling (BIM) HistoricMarket Review by Type in US$ Million: 2009-2017Table 54: Building Information Modeling (BIM) Market in Canada:Percentage Share Breakdown of Sales by Type for 2009, 2019, and2025Table 55: Canadian Building Information Modeling (BIM) MarketEstimates and Forecasts in US$ Million by Project Life Cycle:2018 to 2025Table 56: Canadian Building Information Modeling (BIM) HistoricMarket Review by Project Life Cycle in US$ Million: 2009-2017Table 57: Building Information Modeling (BIM) Market in Canada:Percentage Share Breakdown of Sales by Project Life Cycle for2009, 2019, and 2025Table 58: Canadian Building Information Modeling (BIM) MarketQuantitative Demand Analysis in US$ Million by Application:2018 to 2025Table 59: Building Information Modeling (BIM) Market in Canada:Summarization of Historic Demand Patterns in US$ Million byApplication for 2009-2017Table 60: Canadian Building Information Modeling (BIM) MarketShare Analysis by Application: 2009 VS 2019 VS 2025JAPANTable 61: Japanese Market for Building Information Modeling(BIM): Annual Sales Estimates and Projections in US$ Million byType for the Period 2018-2025Table 62: Building Information Modeling (BIM) Market in Japan:Historic Sales Analysis in US$ Million by Type for the Period2009-2017Table 63: Japanese Building Information Modeling (BIM) MarketShare Analysis by Type: 2009 VS 2019 VS 2025Table 64: Japanese Market for Building Information Modeling(BIM): Annual Sales Estimates and Projections in US$ Million byProject Life Cycle for the Period 2018-2025Table 65: Building Information Modeling (BIM) Market in Japan:Historic Sales Analysis in US$ Million by Project Life Cyclefor the Period 2009-2017Table 66: Japanese Building Information Modeling (BIM) MarketShare Analysis by Project Life Cycle: 2009 VS 2019 VS 2025Table 67: Japanese Demand Estimates and Forecasts for BuildingInformation Modeling (BIM) in US$ Million by Application: 2018to 2025Table 68: Japanese Building Information Modeling (BIM) Marketin US$ Million by Application: 2009-2017Table 69: Building Information Modeling (BIM) Market ShareShift in Japan by Application: 2009 VS 2019 VS 2025CHINATable 70: Chinese Building Information Modeling (BIM) MarketGrowth Prospects in US$ Million by Type for the Period2018-2025Table 71: Building Information Modeling (BIM) Historic MarketAnalysis in China in US$ Million by Type: 2009-2017Table 72: Chinese Building Information Modeling (BIM) Market byType: Percentage Breakdown of Sales for 2009, 2019, and 2025Table 73: Chinese Building Information Modeling (BIM) MarketGrowth Prospects in US$ Million by Project Life Cycle for thePeriod 2018-2025Table 74: Building Information Modeling (BIM) Historic MarketAnalysis in China in US$ Million by Project Life Cycle:2009-2017Table 75: Chinese Building Information Modeling (BIM) Market byProject Life Cycle: Percentage Breakdown of Sales for 2009,2019, and 2025Table 76: Chinese Demand for Building Information Modeling(BIM) in US$ Million by Application: 2018 to 2025Table 77: Building Information Modeling (BIM) Market Review inChina in US$ Million by Application: 2009-2017Table 78: Chinese Building Information Modeling (BIM) MarketShare Breakdown by Application: 2009 VS 2019 VS 2025EUROPEMarket Facts & FiguresEuropean Building Information Modeling (BIM) Market: CompetitorMarket Share Scenario (in %) for 2019 & 2025Market AnalyticsTable 79: European Building Information Modeling (BIM) MarketDemand Scenario in US$ Million by Region/Country: 2018-2025Table 80: Building Information Modeling (BIM) Market in Europe:A Historic Market Perspective in US$ Million by Region/Countryfor the Period 2009-2017Table 81: European Building Information Modeling (BIM) MarketShare Shift by Region/Country: 2009 VS 2019 VS 2025Table 82: European Building Information Modeling (BIM) MarketEstimates and Forecasts in US$ Million by Type: 2018-2025Table 83: Building Information Modeling (BIM) Market in Europein US$ Million by Type: A Historic Review for the Period2009-2017Table 84: European Building Information Modeling (BIM) MarketShare Breakdown by Type: 2009 VS 2019 VS 2025Table 85: European Building Information Modeling (BIM) MarketEstimates and Forecasts in US$ Million by Project Life Cycle:2018-2025Table 86: Building Information Modeling (BIM) Market in Europein US$ Million by Project Life Cycle: A Historic Review for thePeriod 2009-2017Table 87: European Building Information Modeling (BIM) MarketShare Breakdown by Project Life Cycle: 2009 VS 2019 VS 2025Table 88: European Building Information Modeling (BIM)Addressable Market Opportunity in US$ Million by Application:2018-2025Table 89: Building Information Modeling (BIM) Market in Europe:Summarization of Historic Demand in US$ Million by Applicationfor the Period 2009-2017Table 90: European Building Information Modeling (BIM) MarketShare Analysis by Application: 2009 VS 2019 VS 2025FRANCETable 91: Building Information Modeling (BIM) Market in Franceby Type: Estimates and Projections in US$ Million for thePeriod 2018-2025Table 92: French Building Information Modeling (BIM) HistoricMarket Scenario in US$ Million by Type: 2009-2017Table 93: French Building Information Modeling (BIM) MarketShare Analysis by Type: 2009 VS 2019 VS 2025Table 94: Building Information Modeling (BIM) Market in Franceby Project Life Cycle: Estimates and Projections in US$ Millionfor the Period 2018-2025Table 95: French Building Information Modeling (BIM) HistoricMarket Scenario in US$ Million by Project Life Cycle: 2009-2017Table 96: French Building Information Modeling (BIM) MarketShare Analysis by Project Life Cycle: 2009 VS 2019 VS 2025Table 97: Building Information Modeling (BIM) QuantitativeDemand Analysis in France in US$ Million by Application:2018-2025Table 98: French Building Information Modeling (BIM) HistoricMarket Review in US$ Million by Application: 2009-2017Table 99: French Building Information Modeling (BIM) MarketShare Analysis: A 17-Year Perspective by Application for 2009,2019, and 2025GERMANYTable 100: Building Information Modeling (BIM) Market inGermany: Recent Past, Current and Future Analysis in US$Million by Type for the Period 2018-2025Table 101: German Building Information Modeling (BIM) HistoricMarket Analysis in US$ Million by Type: 2009-2017Table 102: German Building Information Modeling (BIM) MarketShare Breakdown by Type: 2009 VS 2019 VS 2025Table 103: Building Information Modeling (BIM) Market inGermany: Recent Past, Current and Future Analysis in US$Million by Project Life Cycle for the Period 2018-2025Table 104: German Building Information Modeling (BIM) HistoricMarket Analysis in US$ Million by Project Life Cycle: 2009-2017Table 105: German Building Information Modeling (BIM) MarketShare Breakdown by Project Life Cycle: 2009 VS 2019 VS 2025Table 106: Building Information Modeling (BIM) Market inGermany: Annual Sales Estimates and Forecasts in US$ Million byApplication for the Period 2018-2025Table 107: German Building Information Modeling (BIM) Market inRetrospect in US$ Million by Application: 2009-2017Table 108: Building Information Modeling (BIM) Market ShareDistribution in Germany by Application: 2009 VS 2019 VS 2025ITALYTable 109: Italian Building Information Modeling (BIM) MarketGrowth Prospects in US$ Million by Type for the Period2018-2025Table 110: Building Information Modeling (BIM) Historic MarketAnalysis in Italy in US$ Million by Type: 2009-2017Table 111: Italian Building Information Modeling (BIM) Marketby Type: Percentage Breakdown of Sales for 2009, 2019, and 2025Table 112: Italian Building Information Modeling (BIM) MarketGrowth Prospects in US$ Million by Project Life Cycle for thePeriod 2018-2025Table 113: Building Information Modeling (BIM) Historic MarketAnalysis in Italy in US$ Million by Project Life Cycle:2009-2017Table 114: Italian Building Information Modeling (BIM) Marketby Project Life Cycle: Percentage Breakdown of Sales for 2009,2019, and 2025Table 115: Italian Demand for Building Information Modeling(BIM) in US$ Million by Application: 2018 to 2025Table 116: Building Information Modeling (BIM) Market Review inItaly in US$ Million by Application: 2009-2017Table 117: Italian Building Information Modeling (BIM) MarketShare Breakdown by Application: 2009 VS 2019 VS 2025UNITED KINGDOMTable 118: United Kingdom Market for Building InformationModeling (BIM): Annual Sales Estimates and Projections in US$Million by Type for the Period 2018-2025Table 119: Building Information Modeling (BIM) Market in theUnited Kingdom: Historic Sales Analysis in US$ Million by Typefor the Period 2009-2017Table 120: United Kingdom Building Information Modeling (BIM)Market Share Analysis by Type: 2009 VS 2019 VS 2025Table 121: United Kingdom Market for Building InformationModeling (BIM): Annual Sales Estimates and Projections in US$Million by Project Life Cycle for the Period 2018-2025Table 122: Building Information Modeling (BIM) Market in theUnited Kingdom: Historic Sales Analysis in US$ Million byProject Life Cycle for the Period 2009-2017Table 123: United Kingdom Building Information Modeling (BIM)Market Share Analysis by Project Life Cycle: 2009 VS 2019 VS2025Table 124: United Kingdom Demand Estimates and Forecasts forBuilding Information Modeling (BIM) in US$ Million byApplication: 2018 to 2025Table 125: United Kingdom Building Information Modeling (BIM)Market in US$ Million by Application: 2009-2017Table 126: Building Information Modeling (BIM) Market ShareShift in the United Kingdom by Application: 2009 VS 2019 VS2025REST OF EUROPETable 127: Rest of Europe Building Information Modeling (BIM)Market Estimates and Forecasts in US$ Million by Type:2018-2025Table 128: Building Information Modeling (BIM) Market in Restof Europe in US$ Million by Type: A Historic Review for thePeriod 2009-2017Table 129: Rest of Europe Building Information Modeling (BIM)Market Share Breakdown by Type: 2009 VS 2019 VS 2025Table 130: Rest of Europe Building Information Modeling (BIM)Market Estimates and Forecasts in US$ Million by Project LifeCycle: 2018-2025Table 131: Building Information Modeling (BIM) Market in Restof Europe in US$ Million by Project Life Cycle: A HistoricReview for the Period 2009-2017Table 132: Rest of Europe Building Information Modeling (BIM)Market Share Breakdown by Project Life Cycle: 2009 VS 2019 VS2025Table 133: Rest of Europe Building Information Modeling (BIM)Addressable Market Opportunity in US$ Million by Application:2018-2025Table 134: Building Information Modeling (BIM) Market in Restof Europe: Summarization of Historic Demand in US$ Million byApplication for the Period 2009-2017Table 135: Rest of Europe Building Information Modeling (BIM)Market Share Analysis by Application: 2009 VS 2019 VS 2025ASIA-PACIFICTable 136: Building Information Modeling (BIM) Market inAsia-Pacific by Type: Estimates and Projections in US$ Millionfor the Period 2018-2025Table 137: Asia-Pacific Building Information Modeling (BIM)Historic Market Scenario in US$ Million by Type: 2009-2017Table 138: Asia-Pacific Building Information Modeling (BIM)Market Share Analysis by Type: 2009 VS 2019 VS 2025Table 139: Building Information Modeling (BIM) Market inAsia-Pacific by Project Life Cycle: Estimates and Projectionsin US$ Million for the Period 2018-2025Table 140: Asia-Pacific Building Information Modeling (BIM)Historic Market Scenario in US$ Million by Project Life Cycle:2009-2017Table 141: Asia-Pacific Building Information Modeling (BIM)Market Share Analysis by Project Life Cycle: 2009 VS 2019 VS2025Table 142: Building Information Modeling (BIM) QuantitativeDemand Analysis in Asia-Pacific in US$ Million by Application:2018-2025Table 143: Asia-Pacific Building Information Modeling (BIM)Historic Market Review in US$ Million by Application: 2009-2017Table 144: Asia-Pacific Building Information Modeling (BIM)Market Share Analysis: A 17-Year Perspective by Application for2009, 2019, and 2025REST OF WORLDTable 145: Rest of World Building Information Modeling (BIM)Market Estimates and Forecasts in US$ Million by Type: 2018 to2025Table 146: Rest of World Building Information Modeling (BIM)Historic Market Review by Type in US$ Million: 2009-2017Table 147: Building Information Modeling (BIM) Market in Restof World: Percentage Share Breakdown of Sales by Type for 2009,2019, and 2025Table 148: Rest of World Building Information Modeling (BIM)Market Estimates and Forecasts in US$ Million by Project LifeCycle: 2018 to 2025Table 149: Rest of World Building Information Modeling (BIM)Historic Market Review by Project Life Cycle in US$ Million:2009-2017Table 150: Building Information Modeling (BIM) Market in Restof World: Percentage Share Breakdown of Sales by Project LifeCycle for 2009, 2019, and 2025Table 151: Rest of World Building Information Modeling (BIM)Market Quantitative Demand Analysis in US$ Million byApplication: 2018 to 2025Table 152: Building Information Modeling (BIM) Market in Restof World: Summarization of Historic Demand Patterns in US$Million by Application for 2009-2017Table 153: Rest of World Building Information Modeling (BIM)Market Share Analysis by Application: 2009 VS 2019 VS 2025IV. COMPETITIONARCHIDATA INC.ASITE LTD.AUTODESKAVEVA GROUP PLCBECK TECHNOLOGY, LTD.BENTLEY SYSTEMS, INCORPORATEDCADSOFTCOMPUTERS AND STRUCTURES, INC.DASSAULT SYSTMESINTERGRAPH CORPORATIONNEMETSCHEK SERIB SOFTWARE SEROBERT MCNEEL &ASSOCIATESTRIMBLE NAVIGATIONV. CURATED RESEARCHRead the full report: https://www.reportlinker.com/p05798076/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com
|
edtsum5953
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: COMMERCE, Mich., Nov. 12, 2020 /PRNewswire/ --Nuspire, a leadingmanaged security services provider (MSSP), today announced the release of its Q3 2020 Quarterly Threat Landscape Report, outlining new cybercriminal activity and tactics, techniques and procedures (TTPs) with additional insight from its threat intelligence partner, Recorded Future. "With the combination of Nuspire's 24x7x365 security experts and Recorded Future's deep threat intelligence, these powerful insights are exactly what organizations need to know in order to enhance their security program," said Craig Robinson, Program Director, Security Services at IDC. "The surge in threats covered in Nuspire's latest report highlights how cybersecurity readiness is increasingly critical for organizations to address." The Q3 2020 Threat Landscape Report demonstrates threat actors becoming even more ruthless. Throughout Q3, hackers shifted focus from home networks to overburdened public entities, including the education sector and the Election Assistance Commission (EAC). Malware campaigns, like Emotet, utilized these events as phishing lure themes to assist in delivery. "We continue to see attackers use newsjacking and typosquatting techniques to attack organizations with ransomware, especially this quarter with the Presidential election and schools moving to a virtual learning model," said John Ayers, Nuspire Chief Strategy Product Officer. "It's important for organizations to understand the latest threat landscape is changing so they can better prepare for current themes and better understand their risk." Nuspire observed a significant increase in malware activity over the course of Q3 2020; the 128% increase from Q2 represents more than 43,000 malware variants detected a day. As Emotet made a significant appearance, Nuspire and Recorded Future discovered new features in Emotet modules, implying the group will likely continue operations throughout the remainder of the next quarter to successfully gauge the viability of these new features. "Intelligence is key to identifying these top threats like Emotet," said Greg Lesnewich, Senior Intelligence Analyst, Recorded Future. "Keeping a vigilant eye on how threats evolve, grow and adapt over time helps us understand how threat actors have been retooling their tactics. It's more important than ever to consistently have visibility into the threat landscape." Additional notable findings from Nuspire's Q3 2020 Threat Landscape Report include: The ZeroAccess botnet made another big appearance in Q3. It resurged in Q2, coming in second for most used botnet, but then went quiet towards the end of Q2, coming back up in Q3. Office document phishing skyrocketed during the second half of Q3, which could be due to the upcoming election, or because attackers have just finished retooling. Ransomware attack on the automotive industry is on the rise. At the end of Q3 2020, references have already surpassed the 2019 total at 18,307, an increase of 79.15% with Q4 still remaining. H-Worm Botnet, also known as Houdini, Dunihi, njRAT, NJw0rm, Wshrat, and Kognito, surged to the top of Nuspire's witnessed Botnet traffic for Q3 from the actors behind the botnet by deploying instances of Remote Access Trojans (RATs) using COVID-19 phishing lures and executable names. Learn how to best protect your organization from these cyberattacks and download Nuspire's Q3 2020 Threat Report. To sign up for Nuspire and Recorded Future's Q3 Threat Report Findings webinar on November 18, register here. About Nuspire Nuspire is a leading managed security services provider (MSSP) that is revolutionizing the cybersecurity experience by taking an optimistic and people first approach. Our deep bench of cybersecurity experts, world-class threat intelligence and 24x7 security operations centers (SOCs) detect, respond and remediate advanced cyber threats. We offer comprehensive services that combine award-winning threat detection with superior response capabilities to provide end-to-end protection across the gateway, network and endpoint ecosystem. Our client base spans thousands of enterprises of all sizes, across multiple industries, and achieves the greatest risk reduction per cyber-dollar spent. At Nuspire, we are laser-focused on delivering an extraordinary cybersecurity experience that exceeds client expectations. For more information, visit www.nuspire.com and follow @Nuspire. About Recorded Future Recorded Future delivers security intelligence to amplify the effectiveness of security and IT teams in reducing exposure by uncovering unknown threats and informing better, faster decisions. Working to provide a singular view of digital, brand, and third-party risk, the Recorded Future Platform provides proactive and predictive intelligence, analyzing data from open, proprietary, and aggregated customer-provided sources. Recorded Future arms threat analysts, vulnerability management teams, security operations centers, and incident responders with context-rich, actionable intelligence in real time that's ready for integration across the security ecosystem. Learn more at www.recordedfuture.com and follow us on Twitter at @RecordedFuture. SOURCE Nuspire Networks
Answer:
|
Security Experts Discover Threat Actors Becoming More Ruthless with the Resurgence of Emotet Latest Nuspire Threat Report examines the most current cybercriminal tactics with insight from threat intelligence partner, Recorded Future
|
COMMERCE, Mich., Nov. 12, 2020 /PRNewswire/ --Nuspire, a leadingmanaged security services provider (MSSP), today announced the release of its Q3 2020 Quarterly Threat Landscape Report, outlining new cybercriminal activity and tactics, techniques and procedures (TTPs) with additional insight from its threat intelligence partner, Recorded Future. "With the combination of Nuspire's 24x7x365 security experts and Recorded Future's deep threat intelligence, these powerful insights are exactly what organizations need to know in order to enhance their security program," said Craig Robinson, Program Director, Security Services at IDC. "The surge in threats covered in Nuspire's latest report highlights how cybersecurity readiness is increasingly critical for organizations to address." The Q3 2020 Threat Landscape Report demonstrates threat actors becoming even more ruthless. Throughout Q3, hackers shifted focus from home networks to overburdened public entities, including the education sector and the Election Assistance Commission (EAC). Malware campaigns, like Emotet, utilized these events as phishing lure themes to assist in delivery. "We continue to see attackers use newsjacking and typosquatting techniques to attack organizations with ransomware, especially this quarter with the Presidential election and schools moving to a virtual learning model," said John Ayers, Nuspire Chief Strategy Product Officer. "It's important for organizations to understand the latest threat landscape is changing so they can better prepare for current themes and better understand their risk." Nuspire observed a significant increase in malware activity over the course of Q3 2020; the 128% increase from Q2 represents more than 43,000 malware variants detected a day. As Emotet made a significant appearance, Nuspire and Recorded Future discovered new features in Emotet modules, implying the group will likely continue operations throughout the remainder of the next quarter to successfully gauge the viability of these new features. "Intelligence is key to identifying these top threats like Emotet," said Greg Lesnewich, Senior Intelligence Analyst, Recorded Future. "Keeping a vigilant eye on how threats evolve, grow and adapt over time helps us understand how threat actors have been retooling their tactics. It's more important than ever to consistently have visibility into the threat landscape." Additional notable findings from Nuspire's Q3 2020 Threat Landscape Report include: The ZeroAccess botnet made another big appearance in Q3. It resurged in Q2, coming in second for most used botnet, but then went quiet towards the end of Q2, coming back up in Q3. Office document phishing skyrocketed during the second half of Q3, which could be due to the upcoming election, or because attackers have just finished retooling. Ransomware attack on the automotive industry is on the rise. At the end of Q3 2020, references have already surpassed the 2019 total at 18,307, an increase of 79.15% with Q4 still remaining. H-Worm Botnet, also known as Houdini, Dunihi, njRAT, NJw0rm, Wshrat, and Kognito, surged to the top of Nuspire's witnessed Botnet traffic for Q3 from the actors behind the botnet by deploying instances of Remote Access Trojans (RATs) using COVID-19 phishing lures and executable names. Learn how to best protect your organization from these cyberattacks and download Nuspire's Q3 2020 Threat Report. To sign up for Nuspire and Recorded Future's Q3 Threat Report Findings webinar on November 18, register here. About Nuspire Nuspire is a leading managed security services provider (MSSP) that is revolutionizing the cybersecurity experience by taking an optimistic and people first approach. Our deep bench of cybersecurity experts, world-class threat intelligence and 24x7 security operations centers (SOCs) detect, respond and remediate advanced cyber threats. We offer comprehensive services that combine award-winning threat detection with superior response capabilities to provide end-to-end protection across the gateway, network and endpoint ecosystem. Our client base spans thousands of enterprises of all sizes, across multiple industries, and achieves the greatest risk reduction per cyber-dollar spent. At Nuspire, we are laser-focused on delivering an extraordinary cybersecurity experience that exceeds client expectations. For more information, visit www.nuspire.com and follow @Nuspire. About Recorded Future Recorded Future delivers security intelligence to amplify the effectiveness of security and IT teams in reducing exposure by uncovering unknown threats and informing better, faster decisions. Working to provide a singular view of digital, brand, and third-party risk, the Recorded Future Platform provides proactive and predictive intelligence, analyzing data from open, proprietary, and aggregated customer-provided sources. Recorded Future arms threat analysts, vulnerability management teams, security operations centers, and incident responders with context-rich, actionable intelligence in real time that's ready for integration across the security ecosystem. Learn more at www.recordedfuture.com and follow us on Twitter at @RecordedFuture. SOURCE Nuspire Networks
|
edtsum5954
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TOULOUSE, France--(BUSINESS WIRE)--Regulatory News: Latcore (Paris:LAT), a tier 1 partner to major international aircraft carriers, has made public on its website its consolidated financial statements at December 31, 2020 and the notes attached to the consolidated financial statements. This document is available on the company's website: https://www.latecoere.aero/en/finance/investors/ About Latcore As a "Tier 1" international partner of the world's major aircraft manufacturers (Airbus, Boeing, Bombardier, Dassault, Embraer and Mitsubishi Aircraft), Latcore is active in all segments of the aeronautics industry (commercial, regional, business and military aircraft), in two areas of activity: As of December 31, 2020, the Group employed 4,169 people in 13 different countries. Latcore, a French limited company capitalised at 189,637,036 divided into 94,818,518 shares with a par value of 2, is listed on Euronext Paris - Compartment B, ISIN Codes: FR0000032278 - Reuters: LAEP.PA - Bloomberg: LAT.FP
Answer:
|
Latcore: Consolidated Financial Statements at December 31, 2020 and the Notes Attached to the Consolidated Financial Statements
|
TOULOUSE, France--(BUSINESS WIRE)--Regulatory News: Latcore (Paris:LAT), a tier 1 partner to major international aircraft carriers, has made public on its website its consolidated financial statements at December 31, 2020 and the notes attached to the consolidated financial statements. This document is available on the company's website: https://www.latecoere.aero/en/finance/investors/ About Latcore As a "Tier 1" international partner of the world's major aircraft manufacturers (Airbus, Boeing, Bombardier, Dassault, Embraer and Mitsubishi Aircraft), Latcore is active in all segments of the aeronautics industry (commercial, regional, business and military aircraft), in two areas of activity: As of December 31, 2020, the Group employed 4,169 people in 13 different countries. Latcore, a French limited company capitalised at 189,637,036 divided into 94,818,518 shares with a par value of 2, is listed on Euronext Paris - Compartment B, ISIN Codes: FR0000032278 - Reuters: LAEP.PA - Bloomberg: LAT.FP
|
edtsum5960
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: News Summary: Dell Technologies helps renowned film school keep curriculum on track and implement remote learning solution for 1,500 students Dell Precision workstations allow students to work with creative applications while cutting render times by more than half* Vancouver Film School deploys a virtual learning environment within two weeks ROUND ROCK, Texas, Aug. 24, 2020 /PRNewswire/ - Dell Technologies (NYSE: DELL) is helping students from Vancouver Film School(VFS) keep their creative pursuits on track whether they're in the physical or virtual classroom. With powerful Dell Precision workstations combined with Dell EMC infrastructure solutions on the backend students can access the latest technology for their graphics-intensive curriculum, even when quickly transitioning to a remote learning environment. Vancouver Film School is one of the most distinguished entertainment arts schools in the world, offering year-long programs for around 1,500 students across eight campuses. VFS students create hundreds of productions every year, with the curriculum spanning Film Production, 3D Animation & Visual Effects, Digital Design, Game Design, and VR/AR Design & Development. Their alumni have gone on to be some of the most sought-after artists, creators and storytellers in the industry. Class is in session via remote learning VFS was in the process of deploying hundreds of Dell Precision 5820 workstationsand Dell displaysfor their on-campus teaching labs when they quickly pivoted to a remote learning environment. This virtual setup needed to be accessible to all teachers and students, including those students that had returned to their homes outside of Vancouver. The IT department faced two primary obstacles as they started evaluating remote learning needs. First, access to the latest technology. Direct production opportunities and access to industry-leading instruction is what attracts students to VFS, so it was critical to provide the same technology to create innovative content in 6k, 4k and AR/VR. Second,minimal disruption to students.One of the unique elements of the school's curriculum is that classes run 9am 10pm every day, with courses starting every two months and lasting up to a year. This meant there was no time to waste for the IT department. Learning from leading global production studios supporting remote workforces, VFS deployed 900 Dell Precision workstations with NVIDIA Quadro RTX 5000 GPUsin their labs in a week and a half. By week two, VFS had combined the workstations with Teradici PCoIPremote protocol solutions, giving most students remote access to their workstations and virtual access to the curriculum. Loaner PCs and monitors were shipped to students who lacked the technology to complete their learning and coursework from home. "VFS students know they are getting access to not only the best teachers, but also the most powerful and reliable technology built to bring their ideas to life," said Bernard Gucake, head of Information Technology, Vancouver Film School. "Without a doubt, this has been one of the most challenging and rewarding experiences in my career. Although we were already on a digital transformation journey, the unexpected happened, and we're proud of what we managed to achieve within a couple of weeks with Dell Technologies." Consistent Learning Regardless of Location Regardless of where the learning happens, VFS students have access to consistent, reliable and powerful technology. With enterprise-class components and extensive software certifications on Dell Precision workstations, VFS students can now use creative applications like Maxon Redshift, Autodesk Arnold, Unreal Engine, Unity and Avid Media Composer from home. VFS also benefitted from Dell Precision Optimizer features, which dynamically optimizes the system's performance using Artificial Intelligence. VFS was able to examine system performance metrics to identify and remove bottlenecks. Combined with NVIDIA Quadro RTX 5000 GPUsthat provide accelerated ray tracing and AI, the deployed Precision 5820 workstations cut render times by 60 percent* and have allowed students to easily apply special effects techniques prevalent in games and movies today. "Vancouver Film School is a great example of virtual learning done right, and it will help prepare the next-generation of professionals for creating in remote environments," said Tom Tobul, vice president, Commercial Client Solutions Specialty, Dell Technologies. "The combination of clear strategy setting, strong communication and integrated technology solutions provided the recipe for success during these unexpected circumstances." Dell Precisionis the workstation of choice for professional creators and production studios, vfx specialists and game developers. Dell's creative solutions have been used to help some of the world's leading studios integrate onsite and remove environments, even when handling large volumes of high-resolution and sensitive content. For more information about Dell Technologies solutions for creative workflows, please visit: www.delltechnologies.com/precision *Based on VFS testing, February 2020, using Red Shift & Arnold renders within Maya 2020 benchmark to measure render times of Bug City on Arnold on its existing (competitor) workstations equipped with Intel Xeon 1620 v4 and Nvidia P4000 GPU, compared to Dell Precision 5820 workstations equipped with Intel Xeon W3345 and NVIDIA Quadro RTX 5000 GPU. Actual performance may vary based on usage, configuration, and manufacturing variability. About Vancouver Film School In 1987, Vancouver Film School introduced the world's first true immersion film program. Today, VFS is Canada's premier post-secondary entertainment arts institution, offering an immersive curriculum in film, animation, video game production, VR/AR development, motion and interactive design, programming, art/production foundation, and other related programs. VFS is known for providing high-quality education in accelerated timeframes. VFS alumni are consistently credited on the most successful products in the entertainment economies. About Dell Technologies Dell Technologies (NYSE: DELL) helps organizations and individuals build their digital future and transform how they work, live and play. The company provides customers with the industry's broadest and most innovative technology and services portfolio for the data era. SOURCE Vancouver Film School Related Links www.vfs.com
Answer:
|
Acclaimed Vancouver Film School Selects Dell Technologies to Power Creative Arts Education
|
News Summary: Dell Technologies helps renowned film school keep curriculum on track and implement remote learning solution for 1,500 students Dell Precision workstations allow students to work with creative applications while cutting render times by more than half* Vancouver Film School deploys a virtual learning environment within two weeks ROUND ROCK, Texas, Aug. 24, 2020 /PRNewswire/ - Dell Technologies (NYSE: DELL) is helping students from Vancouver Film School(VFS) keep their creative pursuits on track whether they're in the physical or virtual classroom. With powerful Dell Precision workstations combined with Dell EMC infrastructure solutions on the backend students can access the latest technology for their graphics-intensive curriculum, even when quickly transitioning to a remote learning environment. Vancouver Film School is one of the most distinguished entertainment arts schools in the world, offering year-long programs for around 1,500 students across eight campuses. VFS students create hundreds of productions every year, with the curriculum spanning Film Production, 3D Animation & Visual Effects, Digital Design, Game Design, and VR/AR Design & Development. Their alumni have gone on to be some of the most sought-after artists, creators and storytellers in the industry. Class is in session via remote learning VFS was in the process of deploying hundreds of Dell Precision 5820 workstationsand Dell displaysfor their on-campus teaching labs when they quickly pivoted to a remote learning environment. This virtual setup needed to be accessible to all teachers and students, including those students that had returned to their homes outside of Vancouver. The IT department faced two primary obstacles as they started evaluating remote learning needs. First, access to the latest technology. Direct production opportunities and access to industry-leading instruction is what attracts students to VFS, so it was critical to provide the same technology to create innovative content in 6k, 4k and AR/VR. Second,minimal disruption to students.One of the unique elements of the school's curriculum is that classes run 9am 10pm every day, with courses starting every two months and lasting up to a year. This meant there was no time to waste for the IT department. Learning from leading global production studios supporting remote workforces, VFS deployed 900 Dell Precision workstations with NVIDIA Quadro RTX 5000 GPUsin their labs in a week and a half. By week two, VFS had combined the workstations with Teradici PCoIPremote protocol solutions, giving most students remote access to their workstations and virtual access to the curriculum. Loaner PCs and monitors were shipped to students who lacked the technology to complete their learning and coursework from home. "VFS students know they are getting access to not only the best teachers, but also the most powerful and reliable technology built to bring their ideas to life," said Bernard Gucake, head of Information Technology, Vancouver Film School. "Without a doubt, this has been one of the most challenging and rewarding experiences in my career. Although we were already on a digital transformation journey, the unexpected happened, and we're proud of what we managed to achieve within a couple of weeks with Dell Technologies." Consistent Learning Regardless of Location Regardless of where the learning happens, VFS students have access to consistent, reliable and powerful technology. With enterprise-class components and extensive software certifications on Dell Precision workstations, VFS students can now use creative applications like Maxon Redshift, Autodesk Arnold, Unreal Engine, Unity and Avid Media Composer from home. VFS also benefitted from Dell Precision Optimizer features, which dynamically optimizes the system's performance using Artificial Intelligence. VFS was able to examine system performance metrics to identify and remove bottlenecks. Combined with NVIDIA Quadro RTX 5000 GPUsthat provide accelerated ray tracing and AI, the deployed Precision 5820 workstations cut render times by 60 percent* and have allowed students to easily apply special effects techniques prevalent in games and movies today. "Vancouver Film School is a great example of virtual learning done right, and it will help prepare the next-generation of professionals for creating in remote environments," said Tom Tobul, vice president, Commercial Client Solutions Specialty, Dell Technologies. "The combination of clear strategy setting, strong communication and integrated technology solutions provided the recipe for success during these unexpected circumstances." Dell Precisionis the workstation of choice for professional creators and production studios, vfx specialists and game developers. Dell's creative solutions have been used to help some of the world's leading studios integrate onsite and remove environments, even when handling large volumes of high-resolution and sensitive content. For more information about Dell Technologies solutions for creative workflows, please visit: www.delltechnologies.com/precision *Based on VFS testing, February 2020, using Red Shift & Arnold renders within Maya 2020 benchmark to measure render times of Bug City on Arnold on its existing (competitor) workstations equipped with Intel Xeon 1620 v4 and Nvidia P4000 GPU, compared to Dell Precision 5820 workstations equipped with Intel Xeon W3345 and NVIDIA Quadro RTX 5000 GPU. Actual performance may vary based on usage, configuration, and manufacturing variability. About Vancouver Film School In 1987, Vancouver Film School introduced the world's first true immersion film program. Today, VFS is Canada's premier post-secondary entertainment arts institution, offering an immersive curriculum in film, animation, video game production, VR/AR development, motion and interactive design, programming, art/production foundation, and other related programs. VFS is known for providing high-quality education in accelerated timeframes. VFS alumni are consistently credited on the most successful products in the entertainment economies. About Dell Technologies Dell Technologies (NYSE: DELL) helps organizations and individuals build their digital future and transform how they work, live and play. The company provides customers with the industry's broadest and most innovative technology and services portfolio for the data era. SOURCE Vancouver Film School Related Links www.vfs.com
|
edtsum5967
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BOULDER, Colo.--(BUSINESS WIRE)--For the fifth consecutive year, small satellite manufacturer Blue Canyon Technologies (BCT) has provided critical hardware for the winner of the AIAA Small Satellite of the Year Award. The award was presented at the 2020 AIAA Small Satellite Conference, which was held virtually this year. The American Institute of Aeronautics and Astronautics (AIAA) Technical Committee awarded the 2020 title to the Hyper-Angular Rainbow Polarimeter (HARP) mission, led by principal investigator Dr. J. Vanderlei Martins from the University of Maryland, Baltimore County (UMBC). The spacecraft was manufactured by the Space Dynamics Laboratory to carry the UMBC Earth and Space Institute-built HARP payload, and was deployed from the International Space Station (ISS) in February after being delivered to the station on a Cygnus cargo spacecraft. The CubeSat carries an imaging polarimeter designed to measure properties of cloud and aerosol particles in Earths atmosphere. BCT supplied the XACT-15 model of its state-of-the-art XACT Attitude Control System for the HARP mission, providing Space Dynamics Laboratory with industry leading pointing accuracy for its CubeSat. The Small Satellite of the Year Awards are presented annually to a mission that has demonstrated a significant improvement in the capability of small satellites. Eligible missions must have individual satellite wet mass of less than 150 kg, and must have launched, established communication, and have acquired results from on-orbit after January 1 of the previous year. Previous award-winning missions Blue Canyon Technologies has supported also include: BCT's contribution to Space Dynamics Laboratory's award is the latest in a series of milestone accomplishments in 2020 including being selected for the Inc. 5000 list of most successful companies in America, a number of high-profile contracts including phases 2 and 3 of the Blackjack program for DARPA, as well as the opening of its state-of-the-art Crescent manufacturing facility. About BCT Blue Canyon Technologies, Inc., (BCT) a Colorado-based private company founded in 2008 to bring innovative, reliable and affordable solutions to space missions, is an experienced integrator of aerospace systems and developer of advanced aerospace products and technologies. BCT is a vertically integrated spacecraft manufacturer supporting nearly 50 unique missions with over 90 spacecraft. The company currently has more than 90 satellites in production and recently opened a new 80,000-square-foot facility for high rate production. BCT has supported missions for The U.S. Air Force, NASA, The Defense Advanced Research Projects Agency (DARPA) and many others and provided the Attitude Control Systems for the first interplanetary CubeSats which successfully traveled to Mars. The company has been recognized with awards including Inc Magazines 5000 Fastest Growing Private Companies, 2017 Colorado Companies to Watch, 2019 Best in Biz and the 2019 Colorado Biz Made in Colorado Emerging Manufacturer Winner. For the latest news on Blue Canyon Technologies and for other company information, please visit www.bluecanyontech.com.
Answer:
|
Blue Canyon Technologies Provides Key Hardware for Fifth Consecutive AIAA/USU Small Satellite of the Year Award Winner
|
BOULDER, Colo.--(BUSINESS WIRE)--For the fifth consecutive year, small satellite manufacturer Blue Canyon Technologies (BCT) has provided critical hardware for the winner of the AIAA Small Satellite of the Year Award. The award was presented at the 2020 AIAA Small Satellite Conference, which was held virtually this year. The American Institute of Aeronautics and Astronautics (AIAA) Technical Committee awarded the 2020 title to the Hyper-Angular Rainbow Polarimeter (HARP) mission, led by principal investigator Dr. J. Vanderlei Martins from the University of Maryland, Baltimore County (UMBC). The spacecraft was manufactured by the Space Dynamics Laboratory to carry the UMBC Earth and Space Institute-built HARP payload, and was deployed from the International Space Station (ISS) in February after being delivered to the station on a Cygnus cargo spacecraft. The CubeSat carries an imaging polarimeter designed to measure properties of cloud and aerosol particles in Earths atmosphere. BCT supplied the XACT-15 model of its state-of-the-art XACT Attitude Control System for the HARP mission, providing Space Dynamics Laboratory with industry leading pointing accuracy for its CubeSat. The Small Satellite of the Year Awards are presented annually to a mission that has demonstrated a significant improvement in the capability of small satellites. Eligible missions must have individual satellite wet mass of less than 150 kg, and must have launched, established communication, and have acquired results from on-orbit after January 1 of the previous year. Previous award-winning missions Blue Canyon Technologies has supported also include: BCT's contribution to Space Dynamics Laboratory's award is the latest in a series of milestone accomplishments in 2020 including being selected for the Inc. 5000 list of most successful companies in America, a number of high-profile contracts including phases 2 and 3 of the Blackjack program for DARPA, as well as the opening of its state-of-the-art Crescent manufacturing facility. About BCT Blue Canyon Technologies, Inc., (BCT) a Colorado-based private company founded in 2008 to bring innovative, reliable and affordable solutions to space missions, is an experienced integrator of aerospace systems and developer of advanced aerospace products and technologies. BCT is a vertically integrated spacecraft manufacturer supporting nearly 50 unique missions with over 90 spacecraft. The company currently has more than 90 satellites in production and recently opened a new 80,000-square-foot facility for high rate production. BCT has supported missions for The U.S. Air Force, NASA, The Defense Advanced Research Projects Agency (DARPA) and many others and provided the Attitude Control Systems for the first interplanetary CubeSats which successfully traveled to Mars. The company has been recognized with awards including Inc Magazines 5000 Fastest Growing Private Companies, 2017 Colorado Companies to Watch, 2019 Best in Biz and the 2019 Colorado Biz Made in Colorado Emerging Manufacturer Winner. For the latest news on Blue Canyon Technologies and for other company information, please visit www.bluecanyontech.com.
|
edtsum5970
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TEL AVIV, Israel and RALEIGH, N.C., March 25, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that RedHill Biopharma Inc., AztraZeneca AB and AstraZenca Pharmaceuticals LP ("AZ") and Nektar Therapeutics ("Nektar") have entered into a settlement and license agreement with MSN Pharmaceuticals, Inc. and MSN Laboratories PVT. LTD. ("MSN") resolving their patent litigation in the U.S. in response to MSN's Abbreviated New Drug Application ("ANDA") seeking approval by the US. Food and Drug Administration ("FDA") to market a generic version of Movantik (naloxegol). RedHill acquired from AstraZeneca in April 2020 the global rights to Movantik, excluding Europe and Canada. Under the terms of the settlement agreement, MSN may not sell a generic version of Movantik in the U.S. until October 1, 2030 (subject to U.S. FDA approval) or earlier under certain circumstances. The parties to the settlement agreement have also agreed to file a stipulation and order of dismissal with the U.S. District Court for the District of Delaware which will conclude this litigation with respect to MSN. As required by law, the parties will submit the settlement agreement to the U.S. Federal Trade Commission and the U.S. Department of Justice for review. The settlement with MSN does not end RedHill's ongoing litigation against the other two ANDA filers. About RedHill Biopharma RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs, Movantik for opioid-induced constipation in adults[1], Talicia for the treatment of Helicobacter pylori (H. pylori) infection in adults[2], and Aemcolo for the treatment of travelers' diarrhea in adults[3]. RedHill's key clinical late-stage development programs include: (i) RHB-204,with an ongoing Phase 3 study for pulmonary nontuberculous mycobacteria (NTM) disease; (ii) opaganib (Yeliva), a first-in-class SK2 selective inhibitor targeting multiple indications with a Phase 2/3 program for COVID-19 and Phase 2 studies for prostate cancer and cholangiocarcinoma ongoing; (iii) RHB-107 (upamostat), a serine protease inhibitor in a U.S. Phase 2/3 study for symptomatic COVID-19, and targeting multiple other cancer and inflammatory gastrointestinal diseases; (iv) RHB-104, with positive results from a first Phase 3 study for Crohn's disease; (v) RHB-102 (Bekinda), with positive results from a Phase 3 study for acute gastroenteritis and gastritis and positive results from a Phase 2 study for IBS-D; and (vi) RHB-106, an encapsulated bowel preparation. More information about the Company is available at www.redhillbio.com / https://twitter.com/RedHillBio. This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control and cannot be predicted or quantified, and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties associated with (i) the initiation, timing, progress and results of the Company's research, manufacturing, preclinical studies, clinical trials, and other therapeutic candidate development efforts, and the timing of the commercial launch of its commercial products and ones it may acquire or develop in the future; (ii) the Company's ability to advance its therapeutic candidates into clinical trials or to successfully complete its preclinical studies or clinical trials (iii) the extent and number and type of additional studies that the Company may be required to conduct and the Company's receipt of regulatory approvals for its therapeutic candidates, and the timing of other regulatory filings, approvals and feedback; (iv) the risk that the Company will not succeed to complete the patient recruitment; the risk that the Company will not receive the relevant data required for benefiting from the Fast Track designation; the risk that the U.S. Phase 3 clinical study evaluating RHB-204 will not be successful or, if successful, will not suffice for regulatory marketing approval without the need for additional clinical and/or other studies; (v) the manufacturing, clinical development, commercialization, and market acceptance of the Company's therapeutic candidates and Talicia; (vi) the Company's ability to successfully commercialize and promote Movantik, Talicia and Aemcolo; (vii) the Company's ability to establish and maintain corporate collaborations; (viii) the Company's ability to acquire products approved for marketing in the U.S. that achieve commercial success and build and sustain its own marketing and commercialization capabilities; (ix) the interpretation of the properties and characteristics of the Company's therapeutic candidates and the results obtained with its therapeutic candidates in research, preclinical studies or clinical trials; (x) the implementation of the Company's business model, strategic plans for its business and therapeutic candidates; (xi) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its therapeutic candidates and commercial products and its ability to operate its business without infringing the intellectual property rights of others; (xii) parties from whom the Company licenses its intellectual property defaulting in their obligations to the Company; (xiii) estimates of the Company's expenses, future revenues, capital requirements and needs for additional financing; (xiv) the effect of patients suffering adverse events using investigative drugs under the Company's Expanded Access Program; and (xv) competition from other companies and technologies within the Company's industry. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 20-F filed with the SEC on March 4, 2020. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement, whether as a result of new information, future events or otherwise unless required by law. Company contact: Adi Frish Chief Corporate & Business Development Officer RedHill Biopharma +972-54-6543-112 [emailprotected] Media contact (U.S.): Bryan Gibbs Vice President Finn Partners +1 212 529 2236 [emailprotected] [1] Full prescribing information for Movantik (naloxegol) is available at: www.Movantik.com. [2] Full prescribing information for Talicia (omeprazole magnesium, amoxicillin and rifabutin) is available at: www.Talicia.com. [3] Full prescribing information for Aemcolo (rifamycin) is available at: www.Aemcolo.com. SOURCE RedHill Biopharma Ltd.
Answer:
|
RedHill Biopharma Announces Settlement of Movantik Patent Litigation with MSN Pharmaceuticals USA - English USA - English
|
TEL AVIV, Israel and RALEIGH, N.C., March 25, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that RedHill Biopharma Inc., AztraZeneca AB and AstraZenca Pharmaceuticals LP ("AZ") and Nektar Therapeutics ("Nektar") have entered into a settlement and license agreement with MSN Pharmaceuticals, Inc. and MSN Laboratories PVT. LTD. ("MSN") resolving their patent litigation in the U.S. in response to MSN's Abbreviated New Drug Application ("ANDA") seeking approval by the US. Food and Drug Administration ("FDA") to market a generic version of Movantik (naloxegol). RedHill acquired from AstraZeneca in April 2020 the global rights to Movantik, excluding Europe and Canada. Under the terms of the settlement agreement, MSN may not sell a generic version of Movantik in the U.S. until October 1, 2030 (subject to U.S. FDA approval) or earlier under certain circumstances. The parties to the settlement agreement have also agreed to file a stipulation and order of dismissal with the U.S. District Court for the District of Delaware which will conclude this litigation with respect to MSN. As required by law, the parties will submit the settlement agreement to the U.S. Federal Trade Commission and the U.S. Department of Justice for review. The settlement with MSN does not end RedHill's ongoing litigation against the other two ANDA filers. About RedHill Biopharma RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs, Movantik for opioid-induced constipation in adults[1], Talicia for the treatment of Helicobacter pylori (H. pylori) infection in adults[2], and Aemcolo for the treatment of travelers' diarrhea in adults[3]. RedHill's key clinical late-stage development programs include: (i) RHB-204,with an ongoing Phase 3 study for pulmonary nontuberculous mycobacteria (NTM) disease; (ii) opaganib (Yeliva), a first-in-class SK2 selective inhibitor targeting multiple indications with a Phase 2/3 program for COVID-19 and Phase 2 studies for prostate cancer and cholangiocarcinoma ongoing; (iii) RHB-107 (upamostat), a serine protease inhibitor in a U.S. Phase 2/3 study for symptomatic COVID-19, and targeting multiple other cancer and inflammatory gastrointestinal diseases; (iv) RHB-104, with positive results from a first Phase 3 study for Crohn's disease; (v) RHB-102 (Bekinda), with positive results from a Phase 3 study for acute gastroenteritis and gastritis and positive results from a Phase 2 study for IBS-D; and (vi) RHB-106, an encapsulated bowel preparation. More information about the Company is available at www.redhillbio.com / https://twitter.com/RedHillBio. This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control and cannot be predicted or quantified, and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties associated with (i) the initiation, timing, progress and results of the Company's research, manufacturing, preclinical studies, clinical trials, and other therapeutic candidate development efforts, and the timing of the commercial launch of its commercial products and ones it may acquire or develop in the future; (ii) the Company's ability to advance its therapeutic candidates into clinical trials or to successfully complete its preclinical studies or clinical trials (iii) the extent and number and type of additional studies that the Company may be required to conduct and the Company's receipt of regulatory approvals for its therapeutic candidates, and the timing of other regulatory filings, approvals and feedback; (iv) the risk that the Company will not succeed to complete the patient recruitment; the risk that the Company will not receive the relevant data required for benefiting from the Fast Track designation; the risk that the U.S. Phase 3 clinical study evaluating RHB-204 will not be successful or, if successful, will not suffice for regulatory marketing approval without the need for additional clinical and/or other studies; (v) the manufacturing, clinical development, commercialization, and market acceptance of the Company's therapeutic candidates and Talicia; (vi) the Company's ability to successfully commercialize and promote Movantik, Talicia and Aemcolo; (vii) the Company's ability to establish and maintain corporate collaborations; (viii) the Company's ability to acquire products approved for marketing in the U.S. that achieve commercial success and build and sustain its own marketing and commercialization capabilities; (ix) the interpretation of the properties and characteristics of the Company's therapeutic candidates and the results obtained with its therapeutic candidates in research, preclinical studies or clinical trials; (x) the implementation of the Company's business model, strategic plans for its business and therapeutic candidates; (xi) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its therapeutic candidates and commercial products and its ability to operate its business without infringing the intellectual property rights of others; (xii) parties from whom the Company licenses its intellectual property defaulting in their obligations to the Company; (xiii) estimates of the Company's expenses, future revenues, capital requirements and needs for additional financing; (xiv) the effect of patients suffering adverse events using investigative drugs under the Company's Expanded Access Program; and (xv) competition from other companies and technologies within the Company's industry. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 20-F filed with the SEC on March 4, 2020. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement, whether as a result of new information, future events or otherwise unless required by law. Company contact: Adi Frish Chief Corporate & Business Development Officer RedHill Biopharma +972-54-6543-112 [emailprotected] Media contact (U.S.): Bryan Gibbs Vice President Finn Partners +1 212 529 2236 [emailprotected] [1] Full prescribing information for Movantik (naloxegol) is available at: www.Movantik.com. [2] Full prescribing information for Talicia (omeprazole magnesium, amoxicillin and rifabutin) is available at: www.Talicia.com. [3] Full prescribing information for Aemcolo (rifamycin) is available at: www.Aemcolo.com. SOURCE RedHill Biopharma Ltd.
|
edtsum5978
|
You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: AUSTIN, Texas, June 25, 2020 /PRNewswire/ --Financial Gravity Companies, Inc. (OTCQB: FGCO) and its subsidiary, Forta Financial Group, Inc., announced that the Matt Rzepka Team has left Cambridge Investments to join Forta Financial Group as registered representatives and advisors. Forta Financial Group is a dually registered broker dealer and registered investment advisor with the resources necessary to help advisors compete and win. Forta helps advisors achieve their goals and grow their business utilizing four key differentiators Entrepreneurship, Practice Management, Marketing/Leads, and Financial Innovation. Scott Winters, CEO of Financial Gravity explained, "Matt is exactly the profile of the consummate professional so highly admired in our industry that we want to be a part of the leadership in our company. He has a tremendous reputation and proven skills of building a strong organization." Matt Rzepka replied, "I plan to begin immediately adding over 1,000 existing accounts and about $45 million in AUM (Assets Under Management) to Forta Financial Group and Financial Gravity. I look forward to working with the full suite of services offered by all of the different Financial Gravity subsidiaries to provide to my clients." Rzepka provides services to clients across the country and will continue to operate out of Kalamazoo, Michigan. He is a CPA and CFP professional and has earned an extensive list of licenses and certifications throughout his career. Rzepka attended Saginaw Valley State University where he met his beautiful wife Amber, and they reside in Kalamazoo with their two children Elizabeth and Paul. He is joined in his transition to Forta by his business associate Philip Kehoe. About Financial Gravity Companies, Inc.Financial Gravity Companies is a parent company of financial services companies including brokerage, wealth management, estate planning, family office services, risk management, business and personal tax planning, business consulting, and financial advisor services. Financial Gravity's mission is to synergistically bring together companies that create symbiotic advantages to each other in order to bring a complete financial experience to our clients. www.financialgravity.com Forward-Looking StatementsThis press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from the current expectations. No forward-looking statement can be guaranteed. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Financial Gravity's business, and Financial Gravity undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. SOURCE Financial Gravity Companies, Inc. Related Links http://financialgravity.com
Answer:
|
Matt Rzepka Joins Forta Financial Group and Financial Gravity Companies
|
AUSTIN, Texas, June 25, 2020 /PRNewswire/ --Financial Gravity Companies, Inc. (OTCQB: FGCO) and its subsidiary, Forta Financial Group, Inc., announced that the Matt Rzepka Team has left Cambridge Investments to join Forta Financial Group as registered representatives and advisors. Forta Financial Group is a dually registered broker dealer and registered investment advisor with the resources necessary to help advisors compete and win. Forta helps advisors achieve their goals and grow their business utilizing four key differentiators Entrepreneurship, Practice Management, Marketing/Leads, and Financial Innovation. Scott Winters, CEO of Financial Gravity explained, "Matt is exactly the profile of the consummate professional so highly admired in our industry that we want to be a part of the leadership in our company. He has a tremendous reputation and proven skills of building a strong organization." Matt Rzepka replied, "I plan to begin immediately adding over 1,000 existing accounts and about $45 million in AUM (Assets Under Management) to Forta Financial Group and Financial Gravity. I look forward to working with the full suite of services offered by all of the different Financial Gravity subsidiaries to provide to my clients." Rzepka provides services to clients across the country and will continue to operate out of Kalamazoo, Michigan. He is a CPA and CFP professional and has earned an extensive list of licenses and certifications throughout his career. Rzepka attended Saginaw Valley State University where he met his beautiful wife Amber, and they reside in Kalamazoo with their two children Elizabeth and Paul. He is joined in his transition to Forta by his business associate Philip Kehoe. About Financial Gravity Companies, Inc.Financial Gravity Companies is a parent company of financial services companies including brokerage, wealth management, estate planning, family office services, risk management, business and personal tax planning, business consulting, and financial advisor services. Financial Gravity's mission is to synergistically bring together companies that create symbiotic advantages to each other in order to bring a complete financial experience to our clients. www.financialgravity.com Forward-Looking StatementsThis press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from the current expectations. No forward-looking statement can be guaranteed. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Financial Gravity's business, and Financial Gravity undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. SOURCE Financial Gravity Companies, Inc. Related Links http://financialgravity.com
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.